bromocriptine has been researched along with Pituitary Neoplasms in 1315 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 764 (58.10) | 18.7374 |
| 1990's | 298 (22.66) | 18.2507 |
| 2000's | 136 (10.34) | 29.6817 |
| 2010's | 92 (7.00) | 24.3611 |
| 2020's | 25 (1.90) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, X; Ma, C; Tang, C; Yang, J; Yuan, F; Zhu, J | 1 |
| Dai, C; Guan, S; Kang, J; Li, Y; Liu, H; Sun, B; Wang, W; Zhang, J | 1 |
| Chen, S; Dong, J; Gu, J; Jiang, X; Li, D; Wen, X; Zou, Y | 1 |
| Chen, Y; Wang, A; Wang, S; Wang, X; Wu, J; Zhang, Y; Zhu, K | 1 |
| Cai, X; Cong, Z; Ma, C; Tang, C; Yang, J; Yuan, F; Zhu, J | 1 |
| Auriemma, RS; Colao, A; Negri, M; Patalano, R; Pirchio, R; Pivonello, C; Pivonello, R | 1 |
| Canturk, S; Dogansen, S; Hacisahinogullari, H; Yarman, S | 1 |
| Abbas, M; Mahmood, Q; Mahmood, Z; Malik, A; Mehmood, MH; Naz, F; Rasool, G; Riaz, M | 1 |
| Inder, WJ; Jang, C | 1 |
| Hamidianjahromi, A; Tritos, NA | 1 |
| Mamelak, A | 1 |
| Arastu, MI; Curiale, AM; Lipton, BA; Longo, S; Nanda, S; Tessier, S | 1 |
| Huang, Q; Li, M; Tan, J; Zeng, Y; Zhou, W; Zou, Y | 1 |
| Cescato, VAS; Cunha-Neto, MBC; Glezer, A; Musolino, NRC; Pinheiro, FMM; Silva, GO; Stumpf, MAM | 1 |
| Miller, KK; Tritos, NA | 1 |
| Attanasio, R; Basile, M; Bozzao, A; Cappabianca, P; Caputo, M; Cozzi, R; Cruciani, F; De Menis, E; Doglietto, F; Esposito, F; Ferrante, E; Ferraù, F; Grimaldi, F; Iatì, G; Lania, AG; Laureti, S; Lello, S; Locatelli, D; Maffei, P; Mazzatenta, D; Minniti, G; Mitrova, Z; Paoletta, A; Papini, E; Peri, A; Persichetti, A; Poggi, M; Rudà, R; Ruini, C; Samperi, I; Saulle, R; Scoppola, A; Settanni, F; Silvani, A; Simona Auriemma, R; Tortora, F; Vecchi, S; Veronese, N | 1 |
| Li, D; Luo, P; Tan, H; Wang, Y; Yu, Y | 1 |
| Ajduk, J; Košec, A; Kruljac, I | 1 |
| Farrant, MT; Gunn, AJ; Milsom, SR; O'Sullivan, SM; Ogilvie, CM | 1 |
| Bronstein, MD; Glezer, A | 1 |
| He, X; Kong, C; Yang, Y; Ye, Y | 1 |
| Alemayehu, Y; Ayele, B; Mengesha, A; Wotiye, A | 1 |
| Deng, Q; Li, Z; Liang, J; Liu, Z; Shao, Z; Song, C; Wang, X; Xiao, Z; Yang, X; Zhang, K | 1 |
| Li, Z; Liu, Z; Shao, Z; Song, C; Wang, X; Xiao, Z; Yang, X; Zhang, K | 1 |
| Oearsakul, T; Taweesomboonyat, C | 1 |
| Chen, Y; Fang, Q; Gao, H; Gui, S; Guo, J; Li, C; Liu, C; Wang, J; Wang, Z; Xie, W; Zhang, Y; Zhao, P; Zhu, H | 1 |
| Biermasz, NR; Chanson, P; Jorgensen, JOL; Kuhn, E; Weinreich, AA | 1 |
| Chen, Z; Du, Q; Fan, X; Hu, B; Jiang, X; Lei, N; Mao, Z; Wang, H; Wang, X; Wang, Z; Zhu, Y | 1 |
| Araujo, B; Belo, S; Carvalho, D | 1 |
| Filipowicz, D; Kuśmierek, A; Mohol, J; Ruchała, M; Stajgis, M; Szczepanek-Parulska, E | 1 |
| Bao, X; Hu, M; Wang, J; Wang, R; Wu, H; Xing, X; Yang, C | 1 |
| Bilbao, I; Egaña, N; García, C; Olaizola, I | 1 |
| Davies, JS; Hayhurst, C; Leach, P; Logier, N; Ved, R | 1 |
| Bao, X; Deng, K; Feng, M; Gao, J; Liu, X; Liu, Y; Wang, R; Yao, Y | 1 |
| Lian, W; Liu, N; Wang, RZ; Xing, B; Yao, Y | 1 |
| Michael Besser, G; Pfeiffer, RF; Thorner, MO | 1 |
| Ennaifer, H; Grira, W; Jemel, M; Kammoun, I; Kandar, H; Salem, LB | 1 |
| Hu, Y; Jiang, S; Lv, L; Ma, W; Wang, X; Yang, Y; Yin, S; Zhang, S; Zhou, P | 1 |
| OʼLaughlin, D | 1 |
| Almeida, R; Araújo, C; Marques, O; Santos, MJ | 1 |
| Huang, HY; Hui, GZ; Tang, H; Wu, ZB; Zhai, W | 1 |
| Du, Q; Feng, Y; Jian, M; Mao, Z; Wang, H; Wang, X; Xiao, Z; Zhu, D; Zhu, Y | 1 |
| Arita, H; Goto, Y; Hayashi, R; Kitamura, T; Morii, E; Mukai, K; Oshino, S; Otsuki, M; Saiki, A; Saitoh, Y; Shimomura, I; Tamada, D | 1 |
| Wang, YB; Wu, YP; Wu, ZB | 1 |
| Maiter, D | 1 |
| Du, Q; Hu, B; Jiang, X; Mao, Z; Wang, H; Wang, X; Wang, Z; Xiao, Z; Zhu, D; Zhu, Y | 1 |
| Krytskyy, T; Kulchinska, V; Naumova, L; Pasyechko, N | 1 |
| Cong, Z; Luo, X; Ma, C; Sun, R; Tang, C; Wen, G; Yang, J; Zhong, C; Zhu, J | 1 |
| Akinduro, OO; Bernet, V; Chaichana, KL; De Biase, G; Donaldson, A; Izzo, A; Lu, VM; Meyer, FB; Olomu, O; Quinones-Hinojosa, A; Van Gompel, JJ; Vilanilam, G | 1 |
| Ashida, K; Kawano, S; Nakamura, Y; Nakayama, H; Nomura, M; Ohki, T; Oshige, T; Sasaki, Y; Tajiri, Y; Tokubuchi, I; Tsuruta, M; Yamada, K | 1 |
| Bai, J; Gui, S; Zhang, Y | 1 |
| Dosi, RV; Joshi, HK; Patell, RD; Shah, PJ | 1 |
| Alic, E; Dervisefendic, M; Hajder, E; Hajder, M; Samardzic, R | 1 |
| Cheng, SW; Jiang, S; Xue, XC; Yin, SL; Zhong, CH; Zhou, PZ | 1 |
| Góth, M | 1 |
| Arita, H; Goto, Y; Kinoshita, M; Kitamura, T; Oshino, S; Otsuki, M; Saitoh, Y; Shimomura, I; Yoshimine, T | 1 |
| Bai, J; Cao, L; Gao, H; Hong, L; Lan, X; Li, C; Lu, R; Wang, F; Wu, Y; Zhang, Y | 1 |
| Cai, L; Li, Q; Li, W; Lin, S; Liu, J; Lu, J; Su, Z; Wu, J; Wu, Z; Xiong, Z; Zheng, W; Zhuge, Q | 1 |
| Carvalheiro, M; Gomes, L; Paiva, S; Ruas, L; Saraiva, J | 1 |
| Shi, TY; Yang, YJ; Zhang, FC; Zhang, LN | 1 |
| Barkan, A; Benbassat, C; Bronstein, MD; Shapiro, J; Shimon, I; Tsvetov, G | 1 |
| Figueroa-Núñez, C; González, E; Gutierrez, M; Hernán Martínez, J; Mangual-García, M; Mansilla-Letelier, P; Miranda, Mde L; Palermo-Garofalo, C; Sánchez, A; Santiago, M; Torres, O; Trinidad, R | 1 |
| Bonadei, I; Curnis, A; D'Aloia, A; Metra, M; Piovanelli, B; Rovetta, R; Vizzardi, E | 1 |
| Ge, J; Guo, L; Qiu, Y; Zhang, N | 1 |
| Krysiak, R; Samborek, M; Stojko, R | 1 |
| Bretón Lesmes, I; Cózar León, MV; García de Quirós Muñoz, JM; Serrano Aguayo, P | 1 |
| Arihara, Z; Inoshita, N; Niitsuma, S; Sakurai, K; Takahashi, K; Ueno, T; Yamada, S; Yamamura, N; Yamashita, R | 1 |
| Bai, J; Lan, X; Li, C; Li, Z; Liu, Q; Wu, Y; Yu, G; Zhang, Y; Zong, X | 1 |
| Cámara Gómez, R; Del Olmo García, M; Merino Torres, JF; Querol Ripoll, R; Simal Julián, JA | 1 |
| Abliz, Z; He, J; Liu, Y; Wang, R; Yue, X; Zang, Q; Zhang, R | 1 |
| Lian, W; Liu, N; Wang, R; Xing, B; Yao, Y | 1 |
| Chong, KK; Li, CL; Lok, JY; Yip, NK; Young, AL | 1 |
| Couldwell, WT; Eloy, JA; Liu, JK; Wong, A | 1 |
| Alvarez Berastegui, GR; Anand, VK; Raza, SM; Schwartz, TH | 1 |
| Cheon, YH; Hahm, JR; Kim, HO; Lee, SI; Lee, WS; Oh, YJ; Suh, YS; Yoo, WH | 1 |
| Couldwell, WT; Eloy, JA; Hajart, AF; Jethwa, PR; Liu, JK; Patel, TD | 1 |
| Akhtar, S; Bakhach, M; Gonzalez-Martinez, J; Haider, A; Patel, L; Raissouni, N; Rogers, D; Schweiger, M; Tsilianidis, L | 1 |
| Cai, L; Guo, YH; Jin, K; Leng, ZG; Lin, SJ; Lu, JL; Su, ZP; Wei, LF; Wu, ZB; Wu, ZR; Zhuge, QC | 1 |
| Cai, Q; Chen, Q; Deng, G; Ji, B; Kong, DK; Li, M; Liu, B; Peng, Z; Tian, D; Wang, H; Wang, J; Wang, L; Wu, L; Xu, Z; Zhang, A; Zhang, S | 1 |
| Guo, R; Lv, J; Pan, M; Pan, Y; Zhang, Y | 1 |
| Dogansen, SC; Selcukbiricik, OS; Tanrikulu, S; Yarman, S | 1 |
| Alfieri, A; Ballarino, MC; Boero, L; Chervin, A; Danilowicz, K; Diez, S; Fainstein Day, P; García-Basavilbaso, N; Glerean, M; Guitelman, M; Katz, D; Loto, MG; Mallea-Gil, MS; Manavela, M; Martinez, M; Miragaya, K; Moncet, D; Rogozinski, AS; Servidio, M; Stalldecker, G; Vitale, M | 1 |
| Bronstein, MD; Espinosa, E; Glezer, A; Greenman, Y; Mendoza, V; Mercado, M; Popovic, V; Shimon, I; Sosa, E; Tirosh, A | 1 |
| Cooper, O; Gertych, A; Greenman, Y; Jonas-Kimchi, T; Melmed, S; Ram, Z; Robenshtok, E; Sagiv, N; Shimon, I; Stern, N; Yaish, I; Yuan, X | 1 |
| Ding, X; Hu, G; Huang, J; Jiang, L; Sun, W; Zhang, C; Zhang, F | 1 |
| Chapman, IM; De Sousa, SM; Falhammar, H; Torpy, DJ | 1 |
| Atkinson, JL; Donegan, D; Erickson, B; Erickson, D; Jentoft, M; Meyer, F; Natt, N; Nippoldt, TB | 1 |
| Andereggen, L; Andres, RH; Beck, J; Christ, E; El-Koussy, M; Frey, J; Seiler, RW | 1 |
| Ihn, H; Jinnin, M; Johno, T; Kajihara, I; Maeda, S; Ogata, A | 1 |
| Braga, J; Galvão, A; Gonçalves, D; Inocêncio, G; Moreira, M; Silva, C | 1 |
| Dhanjal, MK; Knight, M; Lambert, K; McCance, DR; Rees, K; Seed, PT; Williamson, C | 1 |
| Beckers, A; Bonneville, JF; Brue, T; Castinetti, F; Cuny, T; Dufour, H; Eroukhmanoff, J; Potorac, I; Tejedor, I; Touraine, P; Weryha, G | 1 |
| Chen, Z; Geng, X; Li, J; Li, M; Li, Z; Ma, L; Sun, Q; Wang, Q | 1 |
| Duan, L; Gu, F; Huang, M; Yan, H; Zhang, Y | 1 |
| Bell, CD; Cusimano, M; Horvath, E; Kovacs, K; Lloyd, RV; Rotondo, F; Scheithauer, BW | 1 |
| Lin, SQ; Ma, WB; Yu, Q; Zhang, YH; Zhen, JR | 1 |
| Bolaman, Z; Coskun, A; Guney, E; Kadikoylu, G; Kucuk, M; Yavasoglu, I | 1 |
| Bell, DC; Kovacs, K; Rotondo, F; Scheithauer, BW | 1 |
| De Paul, AL; Gutiérrez, S; Mukdsi, JH; Palmeri, CM; Petiti, JP; Sosa, Ldel V; Torres, AI | 1 |
| Bahuleyan, B; Easwer, HV; Krishna, K; Menon, G; Nair, S; Rao, BR | 1 |
| Mezosi, E; Nemes, O | 1 |
| Radojicic, A; Sternic, N; Sundic, A; Vujovic, S; Zidverc-Trajkovic, J | 1 |
| Chen, Y; Lin, C; Su, ZP; Wang, CD; Wu, JS; Wu, ZB; Zeng, YJ; Zheng, WM; Zhuge, QC | 1 |
| Cantelmi, D; Cusimano, M; Horvath, E; Kovacs, K; Lloyd, RV; Salehi, F; Scheithauer, BW | 1 |
| Ben Hadj, AB; Ben Nasr, S; Ghanem, A; Mouna, A | 1 |
| Anoop, TM; Jabbar, PK; Pappachan, JM | 1 |
| Amano, K; Hori, T; Izumi, S; Kawamata, T; Makino, R; Miki, N; Okada, Y; Ono, M; Seki, T; Takano, K | 1 |
| Klibanski, A | 1 |
| Bohmerova, K; Gavornik, P | 1 |
| Burger, P; Menucci, M; Quiñones-Hinojosa, A; Salvatori, R | 1 |
| Hong, JW; Kim, SH; Lee, EJ; Lee, SK; Yang, MS | 1 |
| Lee, J; Ng, KW; Swapna, V | 1 |
| Molitch, ME | 6 |
| Cahyanur, R; Purnamasari, D; Setyawan, W; Setyowati, S; Soewondo, P; Sudrajat, DG | 1 |
| Sorisky, A; Tailor, C; Teo, I | 1 |
| Chen, Y; Lu, L; Sanai, N; Su, Z; Wang, C; Wu, J; Wu, ZB; Xue, X; Zheng, W; Zhuge, Q | 1 |
| Elenkova, A; Kalinov, K; Shabani, R; Zacharieva, S | 1 |
| Kedzia, A; Krysiak, R; Okopień, B | 1 |
| Bilge, A; Kurtulmus, N; Yarman, S | 1 |
| Chen, Y; Jiang, X; Jin, K; Li, Q; Liu, J; Su, Z; Wang, C; Wu, J; Wu, Z; Zheng, W; Zhuge, Q | 1 |
| Kang, SH; Kim, MJ; Park, DW; Shin, IY; Sohn, JW; Yoon, YK | 1 |
| Deukmedjian, AR; Hann, S; Morrison, AD; Shah, V; Vale, FL | 1 |
| Alkabbani, A; Doshi, K; Hamrahian, A; Hatipoglu, B; Kennedy, L; Makin, V; Mon, SY; Olansky, L; Thorton, JN; Weil, R | 1 |
| Chen, YX; Li, Q; Li, WQ; Liu, J; Su, ZP; Wu, JS; Wu, ZB; Xiong, ZK | 1 |
| Abaci, A; Altincik, A; Bober, E; Buyukgebiz, A; Can, S; Catli, G; Demir, K | 1 |
| Lou, XH; Wu, ZB; Zhang, YZ | 1 |
| Bian, X; Chen, W; Gai, M; Zhang, Y | 1 |
| Liu, C; Tyrrell, JB | 1 |
| Bronstein, MD; Musolino, NR; Passos, VQ; Souza, JJ | 1 |
| Arginteanu, MS; King, WA; Post, KD; Shrivastava, RK | 1 |
| Balsa, JA; Barceló, B; García-Uría, J; Lucas, T; Sancho-Rof, JM; Varela, C | 1 |
| Freed, DJ; Gillam, MP; Middler, S; Molitch, ME | 1 |
| Boivin, GP; Cruz-Soto, ME; Gregerson, KA; Horseman, ND; Scheiber, MD | 1 |
| Ishiguro, T; Iwai, Y; Komiyama, M; Matsuzaka, Y; Morikawa, T; Yamanaka, K; Yasui, T | 1 |
| Gawne-Cain, ML; Lees, PD; Masding, MG; Sandeman, DD | 1 |
| Ben Slama, C; Bouguerra, R; Chamakhi, S; Essaïs, O; Hadjri, S; Hamzaoui, J; Marrakchi, Z; Zidi, B | 1 |
| Carneiro, C; Cordon-Cardo, C; Hu, M; Jiao, MS; Koff, A; Pandolfi, PP; Park, M; Shaffer, D | 1 |
| Cavallero, D; Fazzuoli, L; Giusti, M; Valenti, S | 1 |
| Goadsby, PJ; Levy, MJ; Matharu, MS | 1 |
| Aizawa, T; Hashizume, K; Katai, M; Oiwa, A; Sakuma, T; Sakurai, A; Sato, Y; Yamashita, K | 1 |
| Hashimoto, S; Midorikawa, S; Sanada, H; Watanabe, T; Yatabe, J | 1 |
| Bodack, MI | 1 |
| Ando, H; Fukugaki, H; Matsuzawa, K; Mizutani, S; Murata, Y; Nagasaka, T; Saito, K; Takahashi, I | 1 |
| Horvath, E; Kovacs, K; Kuroki, T; Lloyd, RV; Scheithauer, BW; Vidal, S | 2 |
| Gondim, J; Pinheiro, I; Ramos Júnior, F; Schops, M; Tella Júnior, OI | 1 |
| Facchetti, M; Memo, M; Missale, C; Uberti, D | 1 |
| Ball, SG; Hall, K; James, RA; Kendall-Taylor, P; Pearce, SH; Quinton, R; Sibal, L; Ugwu, P | 1 |
| Ho, WL; Shen, CC; Yang, MY | 1 |
| Carrasco Sánchez, FJ; Cuesta López, F; Martín Suárez, I; Pujol de la LLave, E; Suárez Marrero, MC | 1 |
| Braucks, GR; Gadelha, MR; Naliato, EC; Tabet, AL; Violante, AH | 1 |
| Akada, K; Haraoka, J; Nishioka, H | 1 |
| Gruszka, A; Kunert-Radek, J; Pawlikowski, M | 2 |
| Chang, JY; Kattah, JC; Orth, EH; Talkad, AV; Xu, MY | 1 |
| Murai, T; Murakami, N; Nagai, T; Obata, K; Sakazume, S; Sakuta, R; Takahashi, E; Yoshino, A | 1 |
| Osamura, YR; Sanno, N; Tahara, S; Teramoto, A | 1 |
| Couldwell, WT; Liu, JK | 1 |
| Stanhope, R; Torpiano, J; Vanderpump, M | 1 |
| Trifonov, I | 1 |
| Reuman, PD | 1 |
| Casulari, LA; Mello, PA; Naves, LA; Papadia, C; Pereira Neto, A | 1 |
| Kwaśniewska, A; Semczuk, M; Skoczyński, M | 1 |
| Huang, PL; Lee, TC; Yang, LC | 1 |
| Abs, R; Verhelst, J | 1 |
| Goadsby, PJ; Levy, MJ; Matharu, MS; Meeran, K; Powell, M | 1 |
| Howell, DL; Hudgins, RJ; Mazewski, CM; Meacham, LR; Wasilewski, K | 1 |
| Biswas, M; Davies, JS; Evans, LM; Jadon, D; McEwan, P; Rees, DA; Scanlon, MF; Smith, J | 1 |
| Greenman, Y; Osher, E; Ouaknine, G; Reider-Groswasser, II; Segev, Y; Shenkerman, G; Stern, N; Tordjman, K; Veshchev, I | 1 |
| Delgrange, E; Jan, M; Perrin, G; Sassolas, G; Trouillas, J | 1 |
| Adler, I; Barsi, P; Czirják, S; Gergics, P; Jakab, C; Rácz, K; Varga, I | 1 |
| Benveniste, RJ; Delman, BN; King, WA; Lee, JS; Post, KD; Walsh, J | 1 |
| Culler, MD; Dong, JZ; Gruszka, A; Kunert-Radek, J; Pawlikowski, M; Pisarek, H; Radek, A; Taylor, J | 1 |
| Aihara, N; Mase, M; Yamada, K | 1 |
| Crosignani, PG | 1 |
| Góth, MI; Iván, G; Nagy, GM; Oláh, M; Szigeti-Csúcs, N | 1 |
| Hisano, M; Kitagawa, M; Murashima, A; Sakata, M; Watanabe, N; Yamaguchi, K | 1 |
| Bhansali, A; Chattopadhyay, A; Masoodi, SR | 1 |
| Bronstein, MD | 2 |
| Boulos, PT; Hamilton, DK; Laws, ER; Vance, ML | 1 |
| Gong, J; Wu, Z; Yu, C | 1 |
| Su, ZP; Wu, JS; Wu, ZB; Yu, CJ; Zheng, WM; Zhuge, QC | 1 |
| Bangash, MH; Clarke, DB; Holness, RO | 1 |
| Faridi, MM; Shah, D; Verma, S | 1 |
| Sugino, N | 1 |
| Pakawut, N; Panamonta, O | 1 |
| Bednarek-Tupikowska, G; Bohdanowicz-Pawlak, A; Bolanowski, M; Daroszewski, J; Kaluzny, M; Podgorski, JK; Szymczak, J; Zatonska, K; Zielinski, G | 1 |
| Mascarell, S; Sarne, DH | 1 |
| Tokhunts, KA | 1 |
| Abouzari, M; Aghazadeh, J; Hazrati, SM; Mohtarami, F; Rashidi, A | 1 |
| Cun, EH; Sun, W; Yan, CX; Yang, J; Yu, CJ; Zhang, HW | 1 |
| Colao, A; Di Somma, C; Lombardi, G; Pivonello, R; Savastano, S; Tauchmanovà, L | 1 |
| Arantes, HP; Feibelmann, TC; Fernandes, ML; Fonseca, AR; Gonçalves, FT; Jorge, PT | 1 |
| Greenman, Y | 1 |
| Hirata, Y; Kawamura, M; Miki, H; Miyazaki, S; Nakano, T; Tamura, Y | 1 |
| Clarke, DB; Imran, SA; Ur, E | 1 |
| Su, ZP; Wu, JS; Wu, ZB; Zheng, WM; Zhong, M; Zhuge, QC | 1 |
| Horikawa, F; Kawabata, Y; Miki, N; Miyake, H; Ono, M; Ueno, Y | 1 |
| Konopelska, S; Quinkler, M; Strasburger, CJ; Ventz, M | 1 |
| Casanueva, FF; Giustina, A; Mancini, T | 1 |
| Caldas, D; Cesar de Oliveira Naliato, E; Colao, A; Dutra Violante, AH; Fontes, R; Gomes de Souza, R; Guerra, E; Lamounier Filho, A; Rezende Loureiro, C; Schrank, Y; Sebastian, A; Vaisman, M | 1 |
| Chen, S; Kansra, S; Miller, M; Woodliff, J | 1 |
| Bailey, LC; Clayton, RN | 1 |
| Frölich, M; Moolenaar, AJ; Roelfsema, F | 1 |
| Fujita, T; Hirata, Y; Ikeda, M; Nakashima, H; Tomita, M; Uchihashi, M | 1 |
| Jewelewicz, R; Vande Wiele, RL | 1 |
| Gérard, J | 1 |
| Goldfine, ID; Vigneri, R | 1 |
| Anapliotou, M; Batrinos, ML; Panitsa-Faflia, C; Pitoulis, S | 1 |
| Jenkins, JS; Kennedy, SJ; O'Sullivan, JP; Prysor-Jones, RA | 1 |
| Crombie, A; Hall, K; Hall, R; Johnston, DG; Kendall-Taylor, P; McGregor, A; Prescott, RW | 1 |
| Molitch, ME; Reichlin, S | 1 |
| Bergland, R; O'Reilly, G; Ransil, BJ; Spark, RF; Wills, CA | 1 |
| Froesch, ER; Keller, PJ; Landolt, AM; Mueller, J | 1 |
| Bowley, NB; Ch'ng, JL; Joplin, GF; Jung, RT; Mashiter, K | 1 |
| Faglia, G; Giovanelli, MA; Moriondo, P; Travaglini, P | 1 |
| Ayalon, D; Eckstein, N; Eshel, A; Homonnai, ZT; Paz, GF; Reider, I | 1 |
| Krieger, DT | 1 |
| D'Urso, R; Falaschi, P; Frajese, G; Pompei, P; Rocco, A | 1 |
| Chang, RJ | 1 |
| Ishibashi, M; Yamaji, T | 2 |
| del Pozo, E; Hayek, J; Landolt, AM | 1 |
| Cook, DB; Hall, K; Johnston, DG; Kendall-Taylor, P; Patrick, D; Watson, M | 1 |
| Buchfelder, M; Fahlbusch, R; Rjosk, HK; von Werder, K | 1 |
| Demura, H; Shizume, K; Suda, T; Tomori, N; Tozawa, F | 1 |
| Adams, EF; Bhuttacharji, SC; Birch, G; Halliwell, CL; Loizou, M; Mashiter, K | 1 |
| Cronin, MJ; Faure, N; Martial, JA; Weiner, RI | 1 |
| Matsumura, S; Mori, S; Uozumi, T | 1 |
| Bricaire, H; Luton, JP; Rohmer, V; Strauch, G | 1 |
| Fujimoto, M; Hirakawa, K; Mizukawa, N; Ueda, S; Yoshino, E | 1 |
| Gen, M; Ito, A; Kajiwara, H; Mori, S; Naito, M; Shinohara, S; Uozumi, T | 1 |
| Beardwell, CG; Chapman, AJ; Dutton, J; MacFarlane, IA; Shalet, SM; Sutton, ML | 1 |
| Evans, WS; Thorner, MO; Vance, ML | 1 |
| Barrow, DL; Tindall, GT | 1 |
| Kobilková, J; Kucera, E; Marek, J; Srámková, J; Zivný, J | 1 |
| Besser, GM; Thorner, MO; Wass, JA | 1 |
| Birkenhäger, JC; de Jong, FH; de Quijada, M; Klijn, JG; Lamberts, SW; Timmermans, HA; Uitterlinden, P | 1 |
| Geyer, G | 1 |
| Hara, I; Kageyama, N; Kuwayama, A; Mizuno, S; Oiso, Y; Suzuki, S; Tomita, A; Yogo, H | 1 |
| Weiss, MH | 2 |
| de Lange, SA; Lamberts, SW; Stefanko, SZ | 1 |
| Adams, EF; Ashby, MJ; Brown, SM; Mashiter, K; White, MC | 1 |
| Aronin, N; Bybee, DE; Frohman, LA; Kopin, IJ; Krieger, DT; Wiesen, M | 1 |
| Bigorgne, JC; Galland, F; Mercier, P; Rohmer, V | 1 |
| Hesch, RD; Wagner, TO | 1 |
| Franks, S; Hockley, AD; Horrocks, PM; London, DR; Rolfe, EB; Van Noorden, S | 1 |
| Besser, GM; Wass, JA | 1 |
| Klijn, JG; Lamberts, SW; Liuzzi, A; Stefanko, SZ; van Vroonhoven, CC | 1 |
| Kirpatovskaia, LE; Krymskiĭ, VA; Liass, FM; Minakova, EI; Snigireva, RIa | 1 |
| Bertagna, X; Cabanis, EA; Luton, JP; Metzger, J; Rieu, M; Strauch, G | 1 |
| Gáspár, L; Kemény, A; Kocsis, J; László, FA; Pásztor, E | 1 |
| Endoh, M; Horino, M; Kakita, K; Matsuki, M; Nagase, Y; Nishida, S; Oyama, H; Tenku, A | 1 |
| Walton, J | 1 |
| Bons, EG; Hackeng, WH; Lamberts, SW; Oosterom, R; Uitterlinden, P; Verleun, T; Zuiderwijk, JM | 1 |
| Jacobs, HS; van der Spuy, ZM | 1 |
| Braunstein, GD; Carlson, HE; Kovacs, K; Linfoot, JA; Young, RT | 1 |
| Chandler, WF; Gikas, PW; Lloyd, RV | 1 |
| Barbieri, RL; Ryan, KJ | 1 |
| Blackwell, RE; Bradley, EL; Chang, RJ; DeVane, GW; Duvall, ER; Kline, LB; Vitek, JJ | 1 |
| Nelson, PB; Robinson, AG | 1 |
| Canales, ES; Cano, C; Pilonieta, CJ; Zárate, A | 1 |
| Franks, S; Jacobs, HS | 1 |
| Ruiz-Velasco, V; Tolis, G | 1 |
| Pepperell, RJ | 5 |
| Tolis, G; Welt, M; Wrzesinki, T | 1 |
| Alaghband-Zadeh, J; Chung, KF; Guz, A | 1 |
| Thomas, JP | 1 |
| de Wit, W | 1 |
| Fink, RR | 1 |
| von Werder, K | 3 |
| Konopka, P; Merceron, RE; Raymond, JP; Seneze, J | 1 |
| Breidahl, HD; Pike, JW; Topliss, DJ | 1 |
| Avidan, S; Ayalon, D; Caufriez, A; Eckstein, N; Eshel, A; L'Hermite, M; Spitz, I; Zylber-Haran, E | 1 |
| Fisher, JN | 1 |
| D'Ambrogio, G; D'Antona, N; De Leo, M; De Leo, V; Franchi, F; Genazzani, AR; Inaudi, P; La Rosa, R | 1 |
| Bryceland, N; Daya, S; Shewchuk, AB | 1 |
| Beitins, IZ; Klibanski, A; McArthur, JW; Merriam, GR; Ridgway, EC; Zervas, NT | 1 |
| Chang, RJ; Goodman, LA | 1 |
| Besser, GM; Cookson, JC; Drury, PL; Price, PA; Turner, TH; Wass, JA | 1 |
| Berezin, M; Lunenfeld, B; Olchovsky, D; Pines, A; Tadmor, R | 1 |
| Assies, H; Krenning, EP; Lamberts, SW; Oosterom, R; Verleun, T | 1 |
| Aono, T; Koike, K; Koizumi, K; Kurachi, K | 1 |
| Dimaline, R; Graham, K; Lightman, SL; McGarrick, G; Unwin, RJ | 1 |
| Daibo, M; Niwa, J; Okuyama, T; Sato, O | 1 |
| Hayakawa, T; Ikeda, T; Matsumoto, K; Mizuta, T; Mogami, H; Mori, H; Mori, S; Nagatani, M; Otsuki, H; Ushio, Y | 1 |
| Buonaguidi, R; Ferdeghini, M | 1 |
| Borowski, GD; Rose, LI | 1 |
| Ovsiannikova, TV; Pshenichnikova, TV | 1 |
| Crosignani, P; Ferrari, C; Mattei, AM | 1 |
| Federman, DD; Siegel, AJ | 1 |
| Di Paolo, T; Falardeau, P | 1 |
| Delori, P; Grisoli, F; Gunz, G; Hassoun, J; Jaquet, P; Weintraub, BD | 1 |
| Klÿn, JG; Lamberts, SW; Oosterom, R | 1 |
| Finkel, DM; Savino, PJ; Schatz, NJ; Snyder, PJ; Warfield, A | 1 |
| Matsushima, R; Sumi, C; Yokoro, K | 3 |
| Coelingh Bennink, HJ; de Wit, W; Gerards, LJ | 1 |
| Godó, G; Kemény, A; Pásztor, E; Piffkó, P; Sas, M | 1 |
| Demura, H; Demura, R; Jibiki, K; Kitamura, K; Kubo, O; Odagiri, E; Shizume, K | 1 |
| Cocchi, D; Ganzetti, I; Müller, EE; Novelli, A | 1 |
| Friedman, E; Katznelson, D; Sack, J; Sahar, A; Tadmor, R | 1 |
| Heffernan, LP; Holness, RO; Shlossberg, AH | 1 |
| Kabayama, Y; Kato, Y; Matsunaga, K; Ota, H; Shimazu, A | 1 |
| Comaru-Schally, AM; Coy, DH; Góth, M; Irsy, G; Schally, AV; Szabolcs, I; Szilágyi, G | 1 |
| Ma, HK; Sung, ML; Tang, LC | 1 |
| Dickinson, A; Martinez, C; Pepperell, RJ | 2 |
| Long, FL; Newcombe, RL; Wilson, JD | 1 |
| Brandeis, V; Jones, JR; Kemmann, E | 1 |
| Falsetti, L; Loda, G; Pontiroli, AE; Roggia, A; Scagliola, T; Schimberni, M; Turla, R | 1 |
| Arafah, BM; Brodkey, JS; Pearson, OH; Rainieri, J; Wilhite, BL | 1 |
| Benato, M; Ferruzzi, E; Gangemi, M; Guacci, AM; Marchesoni, D; Meneghetti, G | 1 |
| Corenblum, B; Taylor, PJ | 2 |
| Radowicki, S; Teter, J | 2 |
| Frick, J; Galvan, G | 1 |
| Cook, DB; Crombie, AL; Hall, K; Hall, R; Johnston, DG; Kendall-Taylor, P; McGregor, A; Prescott, RW; Watson, MJ | 1 |
| Davajan, V; Kletzky, OA; Marrs, RP | 1 |
| Ayers, JW | 1 |
| Deák, G; Genszky, K; Oó, M; Pintér, E; Rábai, K; Szalóczy, P; Szilágyi, G; Szücs, K | 1 |
| Jaffe, RB; Martin, MC; Schriock, ED | 1 |
| Uozumi, T | 1 |
| Fukushima, T; Kitahara, S; Takakura, K; Teramoto, A | 1 |
| Wu, JZ | 2 |
| Giampietro, O; Petrini, M | 1 |
| Akagawa, S; Inoue, Y; Kobayashi, K; Niwa, J; Sato, O | 1 |
| Ackermann, RH; Happ, J; Hey, O; Hoffmann, G; Pollow, K | 1 |
| Barrow, DL; Hoffman, JC; Horvath, E; Kovacs, K; Thorner, MO; Tindall, GT | 1 |
| Colombo, N; Perani, D; Scotti, G; Tonon, C | 1 |
| Bassetti, M; Giannattasio, G; Pezzo, G; Spada, A | 1 |
| Clifton-Bligh, P; Colagiuri, S; Grunstein, H; Posen, S; Robertson, S; Rushworth, R; Wilkinson, M | 1 |
| Leavens, ME; Sacca, R; Samaan, NA; Schultz, PN; Smith, K | 1 |
| Dudzinski, M; Hammond, CB; Handwerger, SH; Maxson, WS | 1 |
| Benco, R; Caldara, R; Crosignani, PG; Ferrari, C; Mattei, AM; Picciotti, MC; Ragni, G; Rampini, P | 1 |
| Edwards, CR; Feek, CM; Irvine, WJ; McLelland, J; Padfield, PL; Seth, J; Toft, AD | 1 |
| Berselli, ME; Chiodini, PG; Dallabonzana, D; Liuzzi, A; Lodrini, S; Loli, P; Luccarelli, G; Oppizzi, G; Tagliaferri, M; Verde, G | 1 |
| Ichihara, K; Kageyama, N; Katoh, T; Kuwayama, A; Sasaki, F; Takahashi, T | 1 |
| Kern, PA; Robbins, RJ; Thompson, TL | 1 |
| Landolt, AM; Osterwalder, V | 1 |
| Borghi, G; Chiodini, P; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Silvestrini, F; Spelta, B; Tonon, C | 1 |
| Bergh, T; Enoksson, P; Nillius, SJ; Wide, L | 1 |
| Andersen, AN; Arends, J; Pedersen, H; Schiøler, V; Westergaard, JG | 1 |
| Gen, M; Ito, A; Kajiwara, H; Mori, S; Ohta, M; Uozumi, T | 1 |
| Nabarro, JD | 2 |
| Horvath, E; Kovacs, K; Thorner, MO; Tindall, GT | 1 |
| Buvat, J; Buvat-Herbaut, M | 1 |
| Halfen, A; Jewelewicz, R | 1 |
| de Quijada, M; Lamberts, SW; MacLeod, RM; Timmermans, HA | 1 |
| Bruno, M; Campagnoli, C; Gilli, V; Mansueto, MG; Olivieri, A | 1 |
| Anile, C; Barbarino, A; De Marinis, L; Maira, G | 1 |
| Carlström, K; Furuhjelm, M; Rydner, T | 1 |
| Tolis, G | 1 |
| Conway, BP; Howards, SS; MacLeod, RM; Martin, WH; Morris, JL; Perryman, RL; Rogol, AD; Thorner, MO; Wolfman, MG | 1 |
| Ambrosi, B; Arosio, M; Beck-Peccoz, P; Faglia, G; Moriondo, P; Puglisi, FC; Secchi, F; Travaglini, P | 1 |
| Farber, M; Mitchell, GW; Turksoy, RN | 1 |
| Kageyama, N; Kimura, T; Kuwayama, A; Narita, O; Suzuki, M; Tomoda, Y | 1 |
| Brismar, K | 1 |
| Byers, RM; Jesse, RH; Larson, DL; Leavens, ME; Samaan, NA | 1 |
| Gerretsen, G; Hekster, RE; van der Vijver, JC; van Roon, E; Wattendorff, RA | 1 |
| Caldara, R; Crosignani, PG; Ferrari, C; Malinverni, A; Picciotti, MC; Scarduelli, C | 1 |
| Bestetti, G; Casanueva, F; Cocchi, D; Flauto, C; Locatelli, V; Müller, E; Rossi, GL; Zambotti, F | 1 |
| Bethea, CL; Jaffe, RB; Ramsdell, JS; Weiner, RI; Wilson, CB | 1 |
| De Gennes, JL; Heshmati, HM; Turpin, G | 1 |
| Schaison, G | 2 |
| Besser, GM; Dacie, JE; Moult, PJ; Rees, LH | 1 |
| Ainslie, G; Beardwell, CG; MacFarlane, IA; Rankin, E; Shalet, SM | 1 |
| Besser, GM; Charlesworth, M; Doniach, I; Halliday, AM; Kingsley, DP; McDonald, WI; Rees, LH; Wass, JA; Williams, J | 1 |
| Badawy, SZ; Marshall, LD; Notman, DD; Omar, MM; Springer, JM; Streeten, DH; Sunderlin, FS | 1 |
| Thorner, MO | 4 |
| Ambrosi, B; Bochicchio, D; Faglia, G; Moriondo, P; Nava, C; Nissim, M; Travaglini, P | 1 |
| Besser, GM; McDonald, WI; Wass, JA | 1 |
| Choe, JK; Dawood, MY; Jarrett, JC | 1 |
| Carlson, HE; Hershman, JM; Melmed, S; Odenheimer, D | 1 |
| Fujimoto, A; Maeda, T; Okuda, K; Sugimoto, O; Ueki, M; Ushiroyama, T | 1 |
| Andersen, AN; Jensen, HK; Starup, J; Tabor, A; Westergaard, JG | 1 |
| Landolt, AM | 4 |
| Jones, JR; Kemmann, E | 2 |
| Abboud, CF; Coulam, CB; Fode, NC; Laws, ER; Randall, RV | 1 |
| Patton, ML; Woolf, PD | 1 |
| Gittinger, JW; King, LW; Molitch, ME; Stern, J; Wolpert, SM | 1 |
| Bierman, EL; Hershon, KS; Kelly, WA; Schwartz, R; Shaw, CM | 1 |
| Bowman, ZL; Grimson, BS | 1 |
| Chiodini, PG; Dallabonzana, D; Liuzzi, A; Luccarelli, G; Oppizzi, G; Spelta, B; Tonon, C | 1 |
| Imura, H; Komatsu, Y; Kono, T; Oseko, F; Taniguchi, A | 1 |
| Landolt, AM; Landolt, TA; Minder, H; Osterwalder, V | 1 |
| Aso, T; Horie, K; Matsuoka, M; Motohashi, T; Su, JH; Takahashi, A; Tojo, S | 1 |
| Goto, T; Kageyama, N; Kuwayama, A; Narita, O; Suganuma, N; Suzuki, M; Tomoda, Y | 1 |
| Jenkins, JS; Prysor-Jones, RA; Silverlight, JJ | 2 |
| Higashiyama, S; Mizukawa, N; Murakami, T; Ohno, Y; Okada, H; Tamaya, T; Wada, K | 1 |
| Canonico, PL; MacLeod, RM; Valdenegro, CA | 1 |
| Reyniak, JV | 1 |
| Coca, JM; Díaz de Tuesta, JI; Izquierdo, JM; San Emeterio, F | 1 |
| Feldon, S; Gott, P; Weiss, MH; Wycoff, RR; Yadley, R | 1 |
| Althaus, B; Gratzl, O; Staub, JJ; Wiggli, U | 1 |
| Bonneville, JF; Cattin, F; Dietemann, JL; Mollet, E; Portha, C | 1 |
| Divers, WA; Yen, SS | 1 |
| Abboud, CF; Fode, NC; Kempers, RD; Laws, ER; Randall, RV | 1 |
| Gehring, WG; Schneider, J; Völker, W; von zur Mühlen, A | 1 |
| Martin, JB; Zervas, NT | 1 |
| Jeske, W | 1 |
| Hammond, CB; Vaughn, TC | 1 |
| Alipov, VI; Beskrovnaia, NI | 1 |
| Ginsberg, J; McGregor, AM | 1 |
| Beaven, DW; Donald, RA; Espiner, EA; Katz, EJ | 1 |
| del Pozo, E; Flückiger, E; von Werder, K | 1 |
| Andersen, T; Karle, A; Wollesen, F | 2 |
| Rjosk, HK; von Werder, K | 1 |
| Baker, R; Bergland, R; Bienfang, DC; Spark, RF | 1 |
| Baskin, DS; Wilson, CB | 2 |
| Beardwell, CG; Chapman, AJ; Davies, D; Kelly, WF; Laing, I; Randall, S; Shalet, SM | 1 |
| Booth, J; Burch, P; Cannon, W; Sy, L; Yuen, BH | 1 |
| Carayon, A; De Gennes, JL; Heshmati, HM; Turpin, G | 1 |
| De Gennes, JL; Gaham, N; Heshmati, HM; Turpin, G; Van Effenterre, R; Zygelman, N | 1 |
| Grisoli, F; Guibout, M; Jaquet, P; Mouly, A; Tapias, PL | 1 |
| Christiaens, JL; Fermon, C; Fossati, P; Grenier, JL; Linquette, M; Stevenard, C | 1 |
| Bricaire, H | 1 |
| Hall, R; McGregor, A; Scanlon, MF | 1 |
| Gardeur, D; Houlbert, D; Metzger, J; Pehuet, M | 1 |
| Crosignani, PG; Ferrari, C; Giovanelli, MA; Mattei, A | 1 |
| Quabbe, HJ | 1 |
| Jefferies, BF; Rengachary, SS; Tomita, T; Watanabe, I | 1 |
| Bonneville, JF; Cattin, F; Couturier, M; Dietemann, JL; Mollet, E; Poulignot, D | 1 |
| Bixler, EO; Cadieux, RJ; Gordon, R; Kales, A; Santen, RJ | 1 |
| Lamberts, SW; Oosterom, R; Verleun, T | 1 |
| Chiodini, PG; Dallabonzana, D; Pieralli, S; Scialfa, G; Scotti, G; Spelta, B | 1 |
| del Pozo, E | 1 |
| González, ER | 3 |
| Ambrosi, B; Arosio, M; Faglia, G; Nissim, M | 1 |
| Assies, J | 1 |
| Afshar, F; Thomas, A | 1 |
| Fahlbusch, R; Rjosk, HK; von Werder, K | 4 |
| Cronin, MJ; Dabney, LG; Keefer, DA; MacLeod, RM; Valdenegro, CA | 1 |
| Fukushima, T; Osamura, Y; Takakura, K; Teramoto, A | 1 |
| Cronin, MJ; Keefer, DA; MacLeod, RM; Perkins, SN | 1 |
| Canales, ES; Cano, C; Castelo, J; Loyo, M; Vázquez, C; Zárate, A | 1 |
| Aono, T; Kurachi, K | 1 |
| Kahn, SE; Miller, JL | 1 |
| Hokama, Y; Hori, T; Muraoka, K; Saito, Y; Takami, M | 1 |
| Dochi, T; Kusuda, M; Nagata, I; Nozaki, M | 1 |
| Abate, F; Barresi, M; Baviera, G; La Malfa, L; Oliva, A | 1 |
| Bergh, T; Enoksson, P; Lundberg, PO; Moström, U; Nillius, SJ; Ohman, L; Wide, L | 1 |
| Berning, R; Gehring, WG; Schmidt, RC; Schneider, J; Völker, W; von zur Mühlen, A | 1 |
| Abraham, G | 1 |
| Martinez Montes, EA | 1 |
| Bergh, T; Enoksson, P; Larsson, SG; Nillius, SJ; Wide, L | 1 |
| Cunningham, JR; Duchesneau, PM; Gidwani, GP; Gupta, MS; Schumacher, OP | 1 |
| Angeletti, G; Filipponi, P; Nicoletti, I; Nunzi, E; Santeusanio, F | 1 |
| Bramanti, P; Deodato, M; Di Perri, R; Grasso, A; Meduri, M; Volpe, A | 1 |
| Lemaitre, BJ | 1 |
| Ben-David, M; Polishuk, WZ; Sahar, A; Schenker, JG; Siew, FP; Weinstein, D; Yarkoni, S | 1 |
| Benco, R; Crosignani, PG; Dellabonzana, D; Ferrari, C; Liuzzi, A; Mattei, A; Rampini, P; Scarduelli, C; Spelta, B | 1 |
| Archer, DF; Harger, JH; Herbert, DL; Lattanzi, DR; Moore, EE | 1 |
| Strong, JA | 2 |
| Jenkins, JS; Prysor-Jones, RA | 2 |
| Anniko, M; Wersäll, J | 1 |
| Frick, J; Galvan, G; Irnberger, T | 1 |
| Andersen, AN; Hertz, JB; Schiøler, V; Tabor, A | 1 |
| Yamaji, T | 1 |
| Grahne, B; Hirvonen, E; Karonen, SL; Pelkonen, R; Salmi, J; Tikkanen, M; Valtonen, S | 1 |
| Conway, BP; Login, IS; Macleod, RM; Morris, JL; Perryman, RL; Rogol, AD; Thorner, MO | 1 |
| Bergh, T; Nillius, SJ | 1 |
| Maeyama, M; Matsuura, K; Mizumoto, J; Nakayama, M | 1 |
| Hales, M; Martin, NA; Wilson, CB | 1 |
| Pasqual, A; Tsai, JS | 1 |
| Canales, ES; García, IC; Ruíz, JE; Zárate, A | 1 |
| Khouqueer, F; Sieck, JO; Woodhouse, NJ | 1 |
| Borghi, G; Chiodini, P; Cozzi, R; Dallabonzana, D; Horowski, R; Liuzzi, A; Luccarelli, G; Oppizzi, G; Rainer, E; Silvestrini, F; Spelta, B; Verde, G | 1 |
| Bergh, T; Larsson, SG; Nillius, SJ; Wide, L | 1 |
| Malarkey, WB; Tallo, D | 1 |
| Melmed, S | 1 |
| Corenblum, B; Hanley, DA | 1 |
| Eichinger, R; Eversmann, T; Fahlbusch, R; Rjosk, HK; von Werder, K | 1 |
| Claeys, L; Liesenborghs, L; Pulinx, EM | 1 |
| Finkenstedt, G; Gasser, RW; Skrabal, F | 1 |
| Hall, K; Hall, R; Johnston, DG; Kendall-Taylor, P; McGregor, A; Ross, WM | 1 |
| Satgunasingam, N | 1 |
| McGregor, AM | 1 |
| Randall, RV | 1 |
| Alvino, N; Cardone, A; Marafioti, F; Passannanti, G | 1 |
| Cannon, W; Ho Yuen, B; Lewis, J; Sy, L; Woolley, S | 1 |
| Adamson, GD; Ezrin, C; Lessard, P; Shewchuk, AB | 1 |
| Booij, D; van Leusden, HA | 1 |
| Farnarier, P; Grisoli, F; Guibout, M; Hassoun, J; Jaquet, P; Vincentelli, F | 1 |
| McAlhany, HJ; Riesenberg, DE | 1 |
| Kobayashi, S; Nakazawa, S; Shimura, T | 1 |
| MacLeod, RM; Nagy, I; Valdenegro, CA | 1 |
| Belforte, L; Bruno, M; Campagnoli, C; Fessia, L; Massara, F; Pinna, N | 1 |
| Frantz, AG; Kleinberg, DL | 2 |
| Friesen, HG | 1 |
| Besser, GM; Evans, WS; MacLeod, RM; Morris, JL; Nunley, WC; Rogol, AD; Thorner, MO | 1 |
| Jewelewicz, R | 1 |
| Giraud, F; Grisoli, F; Guibout, M; Jaquet, P; Lucas, C | 1 |
| Chapman, C; Gibson, RM; Hancock, KW; Lamb, JT; Scott, JS | 2 |
| Marshall, JR | 1 |
| O'Herlihy, C | 1 |
| Laatikainen, T; Lehtovirta, P; Ranta, T; Seppälä, M; Stenman, UH | 1 |
| Corston, RN; Godwin-Austen, RB | 1 |
| de Quijada, M; Lamberts, SW; Timmermans, HA | 1 |
| Burdman, JA; De Nicola, AF; Kalbermann, LE; Machiavelli, GA; Weissenberg, LS | 1 |
| Van Loon, GR | 3 |
| Beierle, JW; Kletzky, OA; Marrs, RP; Rundall, TT; Weiss, MH | 1 |
| Fukuyama, H; Hirai, O; Kawamura, J; Matsubayashi, K; Matsuda, M; Munemitsu, H | 1 |
| Calhaz-Jorge, C; Maurício, JC; Nunes, MC; Santos, MA; Sobrinho, LG | 1 |
| Assies, J; Dommerholt, HB; Van der Werf, AJ | 1 |
| Carras, D; Vassilouthis, J; Velentzas, C | 1 |
| Dardenne, M; Kelly, PA; Kuttenn, F; Leite-de-Moraes, MC; Touraine, P | 1 |
| Kondo, S; Morimura, T; Takeuchi, J; Yin, D | 2 |
| Bergstralh, EJ; Groover, RV; Horvath, E; Kane, LA; Kovacs, K; Laws, ER; Leinung, MC; Scheithauer, BW; Zimmerman, D | 1 |
| Takechi, A | 1 |
| Bevilacqua, MG; Calderaro, C; Caronti, B; Esposito, V; Gulino, A; Jaffrain-Rea, ML; Palladini, G; Petrangeli, E; Tamburrano, G | 1 |
| Cavagnini, F; Danesi, L; De Martin, M; Invitti, C | 1 |
| Abs, R; Beckers, A; Verhelst, J | 1 |
| Garcia, MM; Kapcala, LP | 1 |
| Arita, N; Ekramullah, SM; Hayakawa, T; Ohnishi, T; Saitoh, Y; Taki, T | 1 |
| Asa, SL; Collu, R; Deal, CL; Drews, RT; Dubuis, JM; Goodyer, CG; Lagacé, G; Van Vliet, G | 1 |
| Arita, K; Eguchi, K; Ito, A; Kawamoto, K; Kurisu, K; Uozumi, T | 2 |
| Endo, T; Haraguchi, K; Ohtaka, M; Onaya, T; Takazawa, K | 1 |
| D'Angelo, V; Di Fazio, P; Dicembrino, F; Liuzzi, A; Scarabino, T; Scillitani, A; Vettori, PP | 1 |
| Nikolou, H; Thalassinos, N; Tsagarakis, S; Tsiganou, E; Tzavara, I | 1 |
| Jacobi, JM; Lloyd, HM; Willgoss, DA | 1 |
| Arita, J; Kimura, F; Kojima, Y; Kuwana, N | 1 |
| Aiba, T; Kovacs, K; Sano, T; Sawano, S; Shishiba, Y; Takada, K; Yamada, S | 1 |
| Vance, ML | 1 |
| Beauregard, H; Serri, O; Somma, M | 1 |
| Kourides, IA | 1 |
| Samuels, MH | 1 |
| Becker, W; Buchfelder, M; Fahlbusch, R; Horvath, E; Kovacs, K; Stefaneanu, L | 1 |
| Jacobs, HS; Powell, M; Soule, SG | 1 |
| Howlett, TA; Khan, EG | 1 |
| Bauduceau, B; Ducorps, M; Eulry, F; Helie, C; Mayaudon, H; Riveline, JP | 1 |
| Rüedi, B | 1 |
| Cohen, AJ | 1 |
| Jacobs, HS; Soule, SG | 1 |
| Colao, A; Di Sarno, A; Di Somma, C; Ferone, D; Landi, ML; Merola, B; Nappi, C; Sarnacchiaro, F; Schettini, G; Selleri, A | 1 |
| Holdaway, IM; Wallace, EA | 1 |
| Duthel, R; Estour, B; Malluret, J; Rachidi-Koussa, H; Vergely, N | 1 |
| Burman, P; Kämpe, O; Karlsson, FA; Westlin, JE; Wide, L | 1 |
| Chevallier, P; Claustrat, B; Dubray, C; Girod, C; Hooghe-Peters, E; Rousset, B; Trouillas, J | 1 |
| Akai, T; Hasan, S; Mizokawa, T; Nakada, Y; Nakagawa, H; Rettig, KJ; Wachtel, H; Yamaguchi, M | 1 |
| Ahn, SK; Chang, SN; Lee, SH | 1 |
| Chanson, P; Derome, PJ; Dib, A; Visot, A | 1 |
| Calaf-Alsina, J; Espinós, JJ; Rodríguez-Espinosa, J; Webb, SM | 1 |
| Barziliai, S; Glaser, B; Nesher, Y | 1 |
| Brue, T; Cahen, S; Chabert-Orsini, V; Girard, N; Grisoli, F; Jaquet, P; Poncet, M; Raybaud, C | 1 |
| Benarous, R; Caccavelli, L; Dewailly, D; Enjalbert, A; Feron, F; Jaquet, P; Kordon, C; Morange, I; Rouer, E | 1 |
| Krishna, AY; Phillips, LS | 1 |
| Chandy, MJ; Cherian, AM; Kanagasbapathy, AS; Seshadri, MS; Sud, A; Thomas, J | 1 |
| Mithal, A; Trivedi, N | 1 |
| Alcañiz, J; Barcelò, B; Blanco, C; Davila, N; Estrada, J; Lucas, T; Serrano, P | 1 |
| Archer, DJ; Bell, BA; Cook, RJ; Uttley, D; Wilkins, PR | 1 |
| Bermúdez, JA; Fonseca, ME; Morán, C; Ochoa, R; Tena, G; Zárate, A | 1 |
| Astorga, R; Cortés, A; García-Luna, PP; Leal-Cerro, A; Pereira, JL; Revuelta, M; Trujillo, F; Vaquero, F; Villamil, F | 1 |
| Aral, F; Barlas, O; Bayindir, C; Can, M; Hepgül, K; Kiriş, T; Sencer, E; Unal, F | 1 |
| Allen, SH; Braun, AL; McMurray, RW; Rodriguez, F; Walker, SE | 1 |
| Kleinberg, D; Kupersmith, MJ; Rosenberg, C | 1 |
| Ajossa, S; Cagnacci, A; Depau, GF; Guerriero, S; Mais, V; Melis, GB; Murgia, C; Paoletti, AM; Serra, GG | 1 |
| Endoh, M; Iouh, S; Nagai, M; Wakai, S | 1 |
| Bisset, S; Braun, M; Leclère, J; Morel-Jean, J; Pascal-Vigneron, V; Weryha, G | 1 |
| Wang, YC; Yang, DY | 1 |
| Buchfelder, M; Fahlbusch, R; Thierauf, P; Todo, T | 1 |
| Blackard, WG | 1 |
| Bakke, S; Bjøro, T; Brownell, J; Djøseland, O; Halse, J; Hansen, E; Jervell, J; Kvistborg, A | 1 |
| Assies, J; Bosch, DA; Hofland, LJ; Verhoeff, NP | 1 |
| Autz, A; Jean-Simon, ML; Peter, SA | 1 |
| Lange, M; Mojto, J; Müller, OA; Renner, U; Stalla, GK; von Werder, K | 1 |
| Adriaanse, R; Bemelman, FJ; Brabant, G; Endert, E; Wiersinga, WM | 1 |
| Carrozza, C; De Rosa, G; Giacomini, D; Testa, A | 1 |
| David, R; Reggiardo, D; Sklar, C; Tyson, D | 1 |
| Kamio, M | 1 |
| De Nicola, AF; Diaz-Torga, G; Ferrini, M; Grillo, C; Libertun, C; Piroli, G | 1 |
| Yuang, BN; Zhong, Y | 1 |
| Crawford, PJ; Dewar, JH; Hall, K; Kendall-Taylor, P; Mbanya, JC; Mendelow, AD | 1 |
| Burkert, W; Rainov, NG | 2 |
| Brue, T; Chabert-Orsini, V; Cortesi, L; Girard, N; Jaquet, P; Maman, P; Raybaud, C | 2 |
| Brisman, MH; Fetell, MR; Post, KD | 1 |
| Bucht, E; Hulting, AL; Isberg, B; Sjöberg, HE; Tørring, O | 1 |
| Daniels, M; Dewar, JH; Harris, PE; James, RA; Kendall-Taylor, P; Turner, SJ | 1 |
| Bemelman, FJ; van Royen, EA; Verhoeff, NP; Wiersinga, WM | 1 |
| Balsari, A; Boroni, F; Dal Toso, R; Giovanelli, M; Losa, M; Missale, C; Spano, P; Zanellato, A | 1 |
| Benker, G; Haase, R; Jaspers, C; Pfingsten, H; Reinwein, D | 1 |
| de Kerdanet, M; Lebrethon, MC; Lecornu, M | 1 |
| Downs, TR; Eberhardt, NL; Ebersold, MJ; Frohman, LA; Horvath, E; Kovacs, K; Scheithauer, BW; Whitaker, MD; Young, WF; Zimmerman, D | 1 |
| Aiba, T; Kovacs, K; Sano, T; Sawano, S; Shishiba, Y; Stefaneanu, L; Yamada, S | 1 |
| Avataneo, T; Camanni, F; Ciccarelli, E; Grottoli, S; Lancranjan, I; Miola, C | 1 |
| Benker, G; Haase, R; Jaspers, C; Lancranja, I; Orri-Fend, M; Pfingsten, H; Reinwein, D; Schulte, HM | 1 |
| Katayanagi, N; Miyachi, Y | 1 |
| Açikgöz, B; Erbengi, T; Ozcan, OE; Ozgen, T; Ruacan, S; Sumnu, M | 1 |
| Aversa, A; Baldelli, R; Fabbrini, A; Falaschi, P; Mori, F; Munizzi, MR; Nardone, MR; Rocco, A | 1 |
| Imamura, P; Lancranjan, I; Lengyel, AM; Mussio, W; Vieira, JG | 1 |
| van der Lely, AJ | 1 |
| Billaud, L; Cousin, I; Guilhaume, B; Luton, JP | 1 |
| Balsari, A; Boroni, F; Giovanelli, M; Losa, M; Missale, C; Spano, PF | 1 |
| Başkal, N; Cesur, V; Erdoğan, G; Kamel, N; Uysal, AR | 1 |
| Badenhoop, K; Rau, H; Usadel, KH | 1 |
| Cerbone, G; Colao, A; Di Sarno, A; Ferone, D; Landi, ML; Lombardi, G; Marzullo, P; Merola, B; Sarnacchiaro, F | 1 |
| Downey, DE; Feigenbaum, SL; Jaffe, RB; Wilson, CB | 1 |
| Delgrange, E; Donckier, J; Maiter, D | 1 |
| Kerner, W; Kreft, B; Peters, A | 1 |
| Kawano, M; Kishimoto, T; Masuda, C; Nishisaka, N; Sakakura, T; Tsujino, T; Yasumoto, R | 1 |
| Check, JH; Shanis, BS | 1 |
| Camanni, F; Ciccarelli, E | 1 |
| Lee, WH | 1 |
| de Herder, WW; Hofland, LJ; Lamberts, SW; van der Lely, AJ | 1 |
| Choudhury, SD; Goswami, A | 1 |
| Di Gesù, I; Diaferia, A; Loizzi, P; Nicastri, PL; Tartagni, M | 1 |
| Adachi, M; Ikuyama, S; Nakagaki, H; Nawata, H; Osamura, Y; Sakai, Y; Sanno, N; Takayanagi, R; Yanase, T | 1 |
| Balsari, A; Giovanelli, M; Losa, M; Missale, C; Sigala, S; Spano, PF | 1 |
| Gulino, A; Jaffrain-Rea, ML; Lunardi, P; Minniti, G; Tamburrano, G | 1 |
| Brue, T; Jaquet, P; Morange, I | 1 |
| Chanson, P | 1 |
| al-Semaan, Y | 1 |
| Heinonen, PK; Rossi, AM; Vilska, S | 1 |
| Caccavelli, L; Enjalbert, A; Jaquet, P; Kordon, C; Morange-Ramos, I | 1 |
| Hashi, K; Niwa, J; Tanabe, S | 1 |
| Barlier, A; Brue, T; Enjalbert, A; Jaquet, P; Morange, I; Pellegrini, I | 1 |
| Brisman, MH; Katz, G; Post, KD | 1 |
| Howng, SL; Wang, CJ | 2 |
| Barth, JH; Belchetz, PE; Bridges, LR; McNichol, AM; Page, MD | 1 |
| Chen, HH; Fagan, RH; Harrington, JF; Malchoff, CD; Rothfield, NF; Taxel, P; Waitzman, DM | 1 |
| Ferretti, E; Gulino, A; Jaffrain-Rea, ML; Minniti, G; Tamburrano, G | 1 |
| Angelberger, P; Asenbaum, S; Brücke, T; Czech, T; Deecke, L; Kornhuber, J; Luger, A; Pirker, W; Podreka, I; Riedl, M; Rössler, K | 1 |
| Andonova, K; Andreeva, M; Kalinov, K; Matrozov, P; Stoeva, I; Zacharieva, S | 1 |
| Loh, KC; Shlossberg, AH | 1 |
| Abboud, C; Calle-Rodrigue, R; Davis, DH; Jin, L; Kovacs, K; Kulig, E; Lloyd, RV; Qian, X; Scheithauer, BW | 1 |
| Ihle, SL | 1 |
| Hey, O; Klose, S; Kopf, D; Lehnert, H; Perneczky, A; Reschke, K; Rohrer, T | 1 |
| Gerl, H; Knappe, G; Lehmann, R; Puhlmann, B; Rohde, W; Ventz, M | 1 |
| Berezin, M; Maor, Y | 1 |
| Molitch, ME; Thorner, MO; Wilson, C | 1 |
| Hashi, K; Hashizume, K; Kunimoto, M; Ochi, S; Takizawa, K; Tanaka, T; Yonemasu, Y; Yoshida, K | 1 |
| Bácsy, E; Czirják, S; Fazekas, I; Pásztor, E; Slowik, F | 1 |
| Finardi, A; Fiorentini, C; Giovanelli, M; Losa, M; Missale, C; Sigala, S; Spano, P | 1 |
| Barlier, A; Enjalbert, A; Gunz, G; Jaquet, P; Pellegrini-Bouiller, I | 1 |
| Delgrange, E; Donckier, J; Maiter, D; Tourniaire, J; Trouillas, J | 1 |
| Jaquet, P | 2 |
| Cheng, W; Zhang, Z | 1 |
| De Herder, WW; Hofland, LJ; Kros, MJ; Lamberts, SW; Uitterlinden, P; Van Koetsveld, PM; Van Uffelen, C; Visser-Wisselaar, HA; Waaijers, M; Zuyderwijk, J | 1 |
| Aron, DC; Justice, AC; King, JT | 1 |
| Asensio Egea, L; Hita Rosino, E; Hita Villaplana, G; López Cubillana, P; Rigabert Montiel, M; Server Falgás, G; Server Pastor, G | 1 |
| Pullan, PT; Walsh, JP | 1 |
| Kokunai, T; Tamaki, N; Yonezawa, K | 1 |
| Furui, A; Nagasaka, T; Nakashima, N; Wakabayashi, T; Yoshida, J | 1 |
| Casanueva, F; Damjanovic, S; Dieguez, C; Djurovic, M; Ilic, L; Micic, D; Obradovic, S; Popovic, V; Simic, M | 1 |
| Arzberger, T; Lange, M; Leimgruber, S; Müller, A; Pagotto, U; Renner, U; Stalla, GK; Uhl, E; Weindl, A | 1 |
| Crabbé, J; Delgrange, E; Donckier, J | 1 |
| Haller, D; Landolt, AM; Lomax, N; Scheib, S; Schubiger, O; Siegfried, J; Wellis, G | 1 |
| Forsbach, G; Güitrón, A; Olivares, F; Vázquez, J | 1 |
| Alfonso Collado, JI; Domínguez Ugidos, LJ; Martínez Subías, J; Sancho Serrano, E; Urpegui García, A; Vallés Varela, H | 1 |
| Ahn, BT; Baik, SH; Lee, BL; Lee, SY | 1 |
| Greenman, Y; Stern, N; Tordjman, K | 1 |
| Morrison, E | 1 |
| Brauner, R; Pinto, G; Trivin, C; Zerah, M | 1 |
| Cappa, M; Colao, A; Di Sarno, A; Facciolli, G; Landi, ML; Loche, S; Lombardi, G; Sarnacchiaro, F | 1 |
| Finkenstedt, G; Gasser, R; Höfle, G; Mohsenipour, I | 1 |
| Harada, K; Ishihara, T; Ito, H; Kashiwagi, S; Nishizaki, T; Setoguchi, M; Takahashi, M | 1 |
| Handa, J; Nakasu, S; Nakasu, Y; Shiino, A | 1 |
| McLaren, EH; Pollock, A | 1 |
| Nakamura, M; Saeki, N; Sunami, K; Yamaura, A | 1 |
| Calle, A; Chevallier, P; Cohen, R; Hooghe-Peters, EL; Rajas, F; Remy, C; Rousset, B; Trouillas, J | 1 |
| Buchfelder, M; Eiter, H; Komminoth, P; Popadić, A; Witzmann, A | 1 |
| Deneux, C; Kuttenn, F; Mauvais-Jarvis, P; Plu-Bureau, G; Touraine, P | 1 |
| Brucker-Davis, F; Doppman, JL; Oldfield, EH; Skarulis, MC; Weintraub, BD | 1 |
| Badawy, SZ; Chang, JK; Joy, SE; Marziale, JC; Rosenbaum, AE | 1 |
| Kawamura, S; Komaki, T; Murai, T; Yamakita, N | 1 |
| Warchoł, JB; Waśko, R; Wołuń, M | 1 |
| Feldkamp, J; Höppner, W; Neumann, NJ; Schock-Skasa, G; Schuppe, HC | 1 |
| Abs, R; Beckers, A; Coremans, P; Lamberigts, G; Mahler, C; Maiter, D; Mockel, J; Petrossians, P; Raftopoulos, C; Stevenaert, A; van den Bruel, A; Vandeweghe, M; Velkeniers, B; Verhelst, J; Verlooy, J | 1 |
| Ihara, C; Mizuta, H; Murabe, H; Nakamura, Y; Nakao, K; Shimatsu, A | 1 |
| Alatli, C; Aydin, Y; Can, SM; Gŭlkilik, A; Tŭrkmenoglu, O; Ziyal, I | 1 |
| Beń-Skowronek, I; Szewczyk, L; Witkowski, D | 1 |
| Black, PM; Garber, JR; Glickman, JN; Lidov, HG; McCowen, KC; Zervas, NT | 1 |
| Ambrosio, G; Battista, C; Cascini, GL; Mansi, L; Panza, N; Rambaldi, PF; Schillirò, F | 1 |
| de Herder, WW; Hofland, LJ; Lamberts, SW; Uitterlinden, P; van Koetsveld, PM; Waaijers, M; Zuijderwijk, J | 1 |
| Atkin, SL; Foy, PM; Hadden, DR; Leong, KS; MacFarlane, IA; Swift, AC | 1 |
| Dilouya, A; Nataf, F; Piketty, ML; Roux, FX | 1 |
| Acikgoz, B; Oruckaptan, HH; Ozcan, OE; Ozgen, T | 1 |
| Boquete, HR; Fideleff, HL; Giaccio, A; Sequera, A; Sobrado, P; Suárez, M | 1 |
| Colao, A; Di Sarno, A; Di Somma, C; Klain, M; Loche, S; Lombardi, G; Pietrosante, M; Pivonello, R; Salvatore, M | 1 |
| Hulting, AL; Melkersson, K | 1 |
| Oruçkaptan, HH; Ozcan, OE; Ozgen, T; Senmevsim, O | 1 |
| Donath, MY; Gross, DJ | 1 |
| Davies, JS; Rees, DA; Scanlon, MF | 1 |
| Bai, X; Hu, W; Jiang, X; Lei, T; Liu, K; Xue, D | 1 |
| Fukunaga, K; Kanasaki, H; Miyamoto, E; Miyazaki, K; Takahashi, K | 1 |
| De Nicolao, G; Faglia, G; Liberati, D; Pizzocaro, A; Sartorio, A; Veldhuis, JD | 1 |
| Djoumessi, S; Dong A Zok, F; Dongmo, L; Juimo, AG; Moukouri, E; Muna, WF; Nouedoui, C | 1 |
| Akamine, S; Hiramatsu, H; Miyamoto, T; Nishizawa, S; Sugiura, Y; Takehara, S; Yokota, N | 1 |
| Colman, PG; Hewage, UC; Kaye, A | 1 |
| Delgrange, E; Donckier, J; Guigard, MP; Jan, M; Jouanneau, E; Maiter, D; Perrin, G; Tourniaire, J; Trouillas, J | 1 |
| Ando, H; Kobayashi, K; Nagai, Y; Nohara, E; Takamura, T; Yamashita, H | 1 |
| Weiss, DK | 1 |
| Davis, M; Prelevic, GM; Randeva, HS | 1 |
| Hall, K; James, RA; Jones, SE; Kendall-Taylor, P | 1 |
| Kamihigashi, S; Kawano, Y; Miyakawa, I; Nakamura, S | 1 |
| Chazova, IE; Dmitriev, VV; Masenko, VP; Mychka, VB | 1 |
| Flitsch, J; Lüdecke, DK; Saeger, W; Stahnke, N; Wiebel, J | 1 |
| Freneau, E; Morange, I; Rohmer, V; Simonetta, C | 1 |
| Beji, C; Kuttenn, F; Mauvais-Jarvis, P; Plu-Bureau, G; Touraine, P | 1 |
| Tammann, T | 1 |
| Agostini, S; Billeci, D; Conte, N; De Menis, E; Marton, E; Tramontin, P; Visentin, A | 1 |
| Gulati, MS; Kalra, S; Mittal, S; Sood, A | 1 |
| Açbay, O; Demir, G; Gazioglu, N; Gundogdu, S; Kadioglu, P | 1 |
| Barrali, E; Bonneville, F; Bonneville, J; Cattin, F; Lucas, X; Narboux, Y | 1 |
| Barkan, AL; Chandler, WF; Orrego, JJ | 1 |
| Fukui, M; Iwaki, T; Morioka, T; Nishio, S; Suzuki, S; Takeshita, I | 1 |
| De Seta, F; Giolo, E; Guaschino, S; Nucera, G; Pozzobon, C; Ricci, G | 1 |
| Brabant, G; Schöfl, C; Schöfl-Siegert, B; von zur Mühlen, A | 1 |
| Barzaghi, ME; Beck-Peccoz, P; Bortolani, E; Corti, D; Forloni, F; Giovilli, M; Pecis, C; Preziosi, A | 1 |
| Buchfelder, M; Fahlbusch, R; Horvath, E; Kovacs, K; Lancranjan, L; Stefaneanu, L | 1 |
| Asano, S; Kirino, T; Suzuki, I; Ueki, K | 1 |
| Arikan, E; Hatemi, H; Sabuncu, T; Tasan, E | 1 |
| Hirano, H; Maeda, T; Mori, H; Okada, Y; Saitoh, Y; Tsuji, M | 1 |
| Cappabianca, P; Colao, A; Di Salle, F; Di Sarno, A; Di Somma, C; Faggiano, A; Landi, ML; Lombardi, G; Pivonello, R; Rossi, FW | 1 |
| Sachse, D | 1 |
| Cai, P; Dai, J; Pan, L; Wang, B; Wang, E; Zhang, N; Zhang, W | 1 |
| Arzberger, T; Müller, A; Pagotto, U; Saeger, W; Schaaf, L; Schumann, EM; Stalla, GK; Tatsch, K; Theodoropoulou, M; Trenkwalder, C; Winkelmann, J | 1 |
| Itoh, J; Kawai, K; Matsuno, A; Ogawa, K; Osamura, RY; Serizawa, A; Watanabe, K; Yamamoto, Y | 1 |
| De Martini, D; Fiore, G; Gabrielli, M; Gasbarrini, A; Giacovazzo, M; Padalino, C; Pola, P; Santarelli, L | 1 |
| Akada, K; Azuma, S; Haraoka, J; Nishioka, H | 1 |
| Colao, A; di Sarno, A; di Somma, C; Lombardi, G; Pivonello, R | 1 |
| Teramoto, A | 1 |
| Bousser, MG; El Amrani, M; Emperauger, B; Launay, JM; Levy, C; Massiou, H | 1 |
| Casanueva, F; Dieguez, C; Doknic, M; Medic-Stojanoska, M; Pekic, S; Popovic, V; Zarkovic, M | 1 |
| Burger, HG; Healy, DL | 1 |
| Fraser, IS; Shearman, RP | 1 |
| Adams, E; Beard, M; Holley, A; Mashiter, K | 1 |
| Rubenstein, R | 1 |
| Mauricio, JC; Nunes, MC; Santos, MA; Sobrinho, LG | 1 |
| Corenblum, B | 2 |
| Buckingham, MS; Elstein, M; Milligan, MP; Moore, DM; Singh, MM | 1 |
| Yuen, BH | 1 |
| Fellmann, H; Landolt, AM; Wüthrich, R | 1 |
| Cowden, EA; Doyle, D; Macpherson, P; Ratcliffe, JG; Teasdale, GM; Thomson, JA | 1 |
| Besser, GM; Charlesworth, M; Dacie, JE; Jones, AE; Moult, PJ; Thorner, MO; Wass, JA | 1 |
| Chiodini, PG; Cozzi, R; Favales, F; Liuzzi, A; Verde, G | 1 |
| Kumahara, Y; Matsumura, S; Miyai, K; Mori, S; Ohnishi, T; Ohta, M; Takimoto, N; Uozumi, T; Watanabe, M | 1 |
| Modena, G; Portioli, I | 1 |
| Auvray, E; Murie, N; Rio, M; Scarabin, JM | 1 |
| Arauco, R; Esquivel, R; Fanghanel-S, G; Larraza, O; Martinez Campos, A; Valverde-R, C | 1 |
| Birkenhäger, JC; Klijn, JG; Kwa, GH; Lamberts, SW | 1 |
| Banks, LM; Doyle, FH; Joplin, GF; Kelly, WF; Mashiter, K | 1 |
| Birkenhäger, JC; de Lange, SA; Klijn, JG; Lamberts, SW; Singh, R; Stefanko, SZ | 1 |
| Adams, EF; Brajkovich, IE; Mashiter, K | 1 |
| Anile, C; Barbarino, A; de Marinis, L; Maira, G; Menini, E | 1 |
| Castro, M; Pineda, G; Stevenson, C; Valdes, M | 1 |
| Werner, S | 1 |
| Avidan, S; Ayalon, D; Cordova, T; Harell, A; Jedwab, G; Persitz, E; Ravid, R | 1 |
| Ando, S; Vermeulen, A | 1 |
| Flaks, A; Hamilton, JM; Maguire, S; Saluja, PG | 1 |
| Fossati, P; Linquette, M | 1 |
| Ogborn, AD | 1 |
| Ezrin, C; Horvath, E; Kovacs, K | 1 |
| Coustenoble, J; Georges, D; Schaison, G | 1 |
| Carter, JN; Faiman, C; Friesen, HG; Tolis, G; Tyson, JE; Van Vliet, S | 1 |
| Mühlenstedt, D; Osmers, F; Schneider, HP | 1 |
| Halves, E | 1 |
| Istfan, N; Salti, IS | 1 |
| Bloch, B; Brun, JM; Bugnon, C; Putelat, R | 1 |
| France, JT; Frengley, PA; Graham, FM; Holdaway, IM; Ibbertson, HK; Mountjoy, KG | 1 |
| Bergh, T; Nillius, SJ; Wide, L | 5 |
| Frantz, AG | 1 |
| Birkenhäger, JC; De Jong, FH; Docter, R; Kwa, HG; Lamberts, SW | 1 |
| Besser, GM; Thorner, MO | 2 |
| Arezzini, C; Carminati, R; Cocchi, D; Gil-Ad, I; Locatelli, V; Müller, EE | 1 |
| Parkes, D | 1 |
| Birkenhäger, JC; De Lange, SA; Klijn, JG; Lamberts, SW | 1 |
| Claustrat, B; Gagnaire, JC; Hugues, B; Mornex, R; Orgiazzi, J | 1 |
| Abu-fadil, S; Lachelin, GC; Yen, SS | 1 |
| Cei, S; Cosimato, F; Lombardi, G; Minozzi, M; Panza, N | 1 |
| De Camilli, P; Macconi, D; Spada, A | 1 |
| Burrow, GN; Ezrin, C; George, SR; Zinman, B | 1 |
| Aronoff, SL; Daughaday, WH; Laws, ER | 1 |
| Bergh, T; Lundberg, PO; Nillius, SJ; Wide, L | 1 |
| Hall, K; Hall, R; McGregor, AM; Scanlon, MF | 2 |
| Eversmann, T; Fahlbusch, R; Rjosk, HK; von Werder, K | 2 |
| Friesen, HG; Kellett, J | 1 |
| Braun, P; Griffith, RW; Turkalj, I | 1 |
| Lamberts, SW; MacLeod, RM | 1 |
| Köchli, HP; König, MP; Studer, H | 1 |
| Brandi, AM; Bression, D; Cesselin, F; Mauborgne, A; Nousbaum, A; Peillon, F; Zygelman, N | 1 |
| Modena, G; Pagliani, A | 1 |
| Grall, JY; Le Pogamp, C; Massart, C; Ramée, A; Toulouse, R | 1 |
| Banks, LM; Doyle, FH; Gordon, H; Joplin, GF; Kelly, WF; Mashiter, K | 1 |
| Caldara, R; Crosignani, PG; Faglia, G; Ferrari, C; Mattei, A; Moriondo, P; Travaglini, P | 1 |
| Alger, M; Canales, ES; Forsbach, G; Zárate, A | 1 |
| Besser, GM; Charlesworth, M; Dacie, JE; Edwards, CR; Jones, AE; Moult, PJ; Rees, LH; Thorner, MO | 1 |
| Cabeza de Flores, A; Flores Lozano, F; Pérez Peña, E | 1 |
| Tscherne, G | 2 |
| Bertrand, G; Pinter, E; Tolis, G | 1 |
| Burry, KA; Harris, AB; Heinrichs, L; Mills, RP | 1 |
| Aparicio, NJ; Debeljuk, L; Guitelman, A; Mancini, AM | 1 |
| Baviera, G; Grasso, A; Maccarrone, G; Montanari, GD; Oliva, A; Volpe, A | 1 |
| Birkenhäger, JC; Kwa, HG; Lamberts, SW; Seldenrath, HJ | 1 |
| Mroueh, AM; Siler-Khodr, TM | 1 |
| Cassar, J; Joplin, GF; Mashiter, K | 1 |
| Corbey, RS; Cruysberg, JR; Rolland, R | 1 |
| Birkenhäger, JC; de Lange, SA; Lamberts, SW | 1 |
| Greve, EL; Van Dalen, JT | 1 |
| Kamio, M; Sanada, S | 1 |
| Buvat, J; Decoulx, M; Gasnault, JP; Gauthier, A; Laine, E; Linquette, M; Pagniez, I | 1 |
| Asfour, M; Boutemy, JJ; Buvat, J; Fossati, P | 1 |
| Holgate, RC; Kovacs, K; Pritzker, KP; Schwartz, ML; Trokoudes, KM; Walfish, PG | 1 |
| Cesselin, E; de Gennes, JL; Heshmati, HM; Lagoguey, M; Turpin, G | 1 |
| Ang, V; Jenkins, JS; Nagulesparen, M | 1 |
| Burry, KA; Harris, B; Heinrichs, L; Mills, R; Schiller, HS | 1 |
| Declercq, A; Schellen, TM | 1 |
| Seppälä, M | 1 |
| Brandi, A; Cesselin, F; Mauborgne, A; Peillon, F; Zygelman, N | 1 |
| Bergh, T; Lundberg, PO; Nillius, SJ; Stahle, J; Wide, L | 1 |
| Jacobs, HS; Wright, CS | 1 |
| Besser, GM | 1 |
| Ngan, A; Wong, WP | 1 |
| Fahlbusch, R; Landgraf, R; Pickardt, CR; Rjosk, HK; Scriba, PC; Werder, Kv | 1 |
| Grizelj, V | 1 |
| Cook, DB; Hall, K; Hall, R; McGregor, AM; Scanlon, MF | 1 |
| Reichlin, S | 1 |
| Perez-Lopez, FR | 1 |
| Franks, S; Hull, MG; Jacobs, HS; Murray, MA; Nabarro, JD; Steele, SJ | 1 |
| Hörl, R; Landgraf, R; Landraf-Leurs, MM; Scriba, PC; von Werder, K; Weissmann, A | 1 |
| Franks, S; Hull, MG; Jacobs, HS; Nabarro, JD; Steele, SJ | 1 |
| Nillius, SJ; Skarin, O | 1 |
| Clemens, R; Naftolin, F; Pallotta, J; Spark, RF | 1 |
| Fahlbusch, R; Rjosk, HK; Werder, K | 1 |
| Compton, P; Judd, SJ; Lazarus, L | 1 |
| Fahlbusch, R; Landgraf, R; Pickardt, CR; Rjosk, HK; Scriba, PC; von Werder, K | 1 |
| Dipalma, JR | 1 |
| Martin, FI; Perry-Keene, DA; Warne, GL | 1 |
| Hibroven, E; Leppăluoto, J; Ranta, T; Seppălă, M; Virkkunen, P | 1 |
| Franks, S; Jacobs, HS; Jequier, AM; Murray, MA; Nabarro, JD; Steele, SJ | 1 |
| Franks, S; Jacobs, H | 1 |
| Child, DF; Gordon, H; Joplin, GF; Mashiter, K | 1 |
| Besser, GM; Dacie, J; Jones, A; Jones, AE; Thorner, MO | 1 |
| Coulam, CB; Hammond, CB | 1 |
| Brue, T; Figarella-Branger, D; Gunz, G; Jaquet, P; Morange, I | 1 |
| Audinot, V; Caccavelli, L; Cussac, D; Enjalbert, A; Jaquet, P; Pellegrini, I | 1 |
| Brue, T; Jaquet, P; Morange, I; Pellegrini, I; Priou, A | 1 |
| Caruso, E; Colao, A; Di Sarno, A; Di Somma, C; Lombardi, G; Merola, B; Sarnacchiaro, F | 1 |
| Huete, I; López, JM; Sapunar, J; Tagle, R | 1 |
| Caruso, E; Colao, A; de Divitiis, E; Lombardi, G; Merola, B; Pacilio, G; Panza, N; Schettini, G; Spaziante, R | 1 |
| Makowska, A; Soszyński, P; Słowińska-Srzednicka, J; Zgliczyński, S; Zgliczyński, W | 1 |
| Janik, J; Jeske, W; Makowska, A; Słowinska-Srzednicka, J; Walecki, J; Zgliczyński, S; Zgliczyński, W | 2 |
| Brownell, J; Brue, T; Dewailly, D; Enjalbert, A; Gunz, G; Jaquet, P; Morange, I; Pellegrini, I | 1 |
| Blackwell, RE | 2 |
| Bevan, JS; Burke, CW; Scanlon, MF; Webster, J | 1 |
| Asa, SL; Horvath, E; Kovacs, K; Singer, W; Smyth, HS | 1 |
| Barkan, AL; Jaffe, CA | 1 |
| Couldwell, WT; Weiss, MH | 1 |
| Cannavó, S; Curtó, L; De Natale, R; Li Calzi, L; Trimarchi, F | 1 |
| Harris, AG; Lamberts, SW; van der Lely, AJ | 1 |
| Demura, H; Demura, R; Isawa, M; Naruse, K; Naruse, M; Onoda, N; Yamakado, M | 1 |
| Chiarini, V; Cremonini, N; Graziano, E; Sforza, A; Zampa, GA | 1 |
| Hayashi, H; Kuroki, M; Nakajima, T; Tamura, T; Tanaka, R | 1 |
| Agnoli, AL; Bauer, T; Fassbender, WJ; Federlin, K; Hildebrandt, G; Mueller, HW; Roosen, K; Stracke, H | 1 |
| Csecsei, G; Hildebrandt, G; Mueller, HW; Stracke, H; Zierski, J | 1 |
| Hofland, LJ; Hooghe-Peters, EL; Kazemzadeh, M; Lamberts, SW; van Koetsveld, PM; vd Lely, AJ; Velkeniers, B; Waaijers, M | 1 |
| Eljamel, MS; Foy, PM; MacFarlane, IA; Swift, AC | 1 |
| Bonilla, A; Sancho, M | 1 |
| Ishizawa, M; Ishizuka, T; Mercado-Asis, LB; Miura, K; Murayama, M; Shimokawa, K; Yasuda, K | 1 |
| Bhoola, KD; Figueroa, CD; Jones, TH; Smith, CM | 1 |
| Berezin, M; Findler, G; Gutman, I; Horowitz, A; Tadmor, R | 1 |
| Amato, G; Carella, C; Costagliola, C; Mastropasqua, L | 1 |
| MacFarlane, IA; MacKenzie, JM; Petterson, T; Shaw, MD | 1 |
| Ach, K; Chadli-Chaieb, M; Chaieb, L; Kacem, M; Sfar, MH; Zebidi, A | 1 |
| Bhoola, KD; Cullen, DR; Figueroa, CD; Jones, TH; Smith, CM | 1 |
| García Calzado, MC; Ruiz Buendía, A | 1 |
| Lin, SQ | 1 |
| Kobras, G | 1 |
| Besser, GM; Liuzzi, A; Sobrinho, LG | 1 |
| Ahmed, M; al-Dossary, E; Woodhouse, NJ | 1 |
| Freychet, P; Sadoul, JL; Thyss, A | 1 |
| Delahunt, JW; Feek, CM; Grebe, SK | 1 |
| Kawamoto, K; Kurisu, K; Mukada, K; Sakoda, K; Uozumi, T; Yano, T | 1 |
| Walter, GF | 1 |
| Chayen, SD; Glaser, B; Gross, D; Makhoul, O | 1 |
| Abs, R; Beckers, A; de Longueville, M; Flandroy, P; Lancranjan, I; Petrossians, P; Stadnik, T; Stevenaert, A | 1 |
| Kairam, R; Khandji, A; Levine, LS; Nagel, M; Nino, M; Oberfield, SE; Pang, S; Riddick, L | 1 |
| Caruso, E; Colao, A; Lancranjan, I; Lombardi, G; Merola, B; Sarnacchiaro, F; Schettini, G | 1 |
| Crosignani, P; D'Alberton, A; de Vincentiis, S; Ferrari, C; Mattei, AM; Paracchi, A | 1 |
| Chanson, P; Duranteau, L; Horlait, S; Kuhn, JM; Lavoinne, A; Lubetzki, J | 1 |
| Brownell, J; Lamberts, SW; van der Lely, AJ | 1 |
| Fujishima, M; Ikenoue, H; Kuroda, T; Okamura, K; Sato, K; Tokuyama, T; Yoshinari, M | 1 |
| Müller, OA; von Werder, K | 1 |
| Geyer, G; Knosp, E; Luger, A; Svoboda, T | 1 |
| Brownell, J; Crottaz, B; Gomez, F; Rey, F; Reymond, MJ; Siegel, RA; Uske, A | 1 |
| Abs, R; Beckers, A; Hennen, G; Mahler, C; Pirens, G; Stevenaert, A; Vandalem, JL | 1 |
| Kawano, T; Kuroda, S; Yonekawa, Y | 1 |
| Brue, T; Dewailly, D; Jaquet, P; Lancranjan, I; Louvet, JP; Roger, P | 1 |
| Itoh, Y; Maeda, T; Mori, H; Moriwaki, K; Sawada, K | 1 |
| Alagna, S; Brunani, A; Cavagnini, F; Ginanni, A; Lancranjan, I; Maraschini, C; Masala, A; Moro, M; Rovasio, PP; Toja, P | 1 |
| Asensio Lahoz, LA; Correas Gomez, M; Fernandez Gomez, JM; Gutierrez Banos, JL; Hernandez Rodriguez, R; Martin Garcia, B; Masip, TC; Portillo Martin, JA | 1 |
| Garrido Pérez, M; López de la Torre Casares, M; Moreno Esteban, B; Rodríguez Poyo-Guerrero, P | 1 |
| De Min, C; Fabris, N; Faglia, G; Mocchegiani, E; Re, T; Travaglini, P | 1 |
| Brabant, G; Hesch, RD; Lancranjan, I; Schulz, A; Schuppert, F; Schürmeyer, T; von zur Mühlen, A | 1 |
| Briganti, F; Caruso, E; Colao, A; Lancranjan, I; Lombardi, G; Merola, B; Sarnacchiaro, F; Schettini, G | 1 |
| Domínguez Jiménez, A; Fletes Rabago, VM; Padilla Ruiz, R; Torres Farias, S | 1 |
| Bassetti, M; Beck-Peccoz, P; Bianchi, P; Faglia, G; Persani, L; Quatrini, M; Travella, B | 1 |
| Banks, WA; Barrera, CM; Ruiz, AE | 1 |
| Fiad, TM; McKenna, TJ | 1 |
| Brue, T; Dewailly, D; Hartemann, P; James-Deidier, A; Jaquet, P; Louvet, JP; Roger, P; Schaison, G; Schlienger, JL | 1 |
| Boquete, HR; Fideleff, HL; Holland, ME; Orlandi, AM; Wainstein, L | 1 |
| Hamon, P; Labat-Moleur, F; Leriche-Polverelli, A; Robert, M; Tourniaire, J | 1 |
| Bergström, M; Muhr, C | 1 |
| Kato, Y | 2 |
| af Trampe, E; Moberg, E; Werner, S; Wersäll, J | 1 |
| Abs, R; Beckers, A; Parizel, PM | 1 |
| Ge, QS; Gu, CX; Lin, SQ; Wang, HL; Xu, L | 1 |
| Daemen, BJ; Doorenbos, H; Elsinga, PH; Paans, AM; Vaalburg, W; Zwertbroek, R | 1 |
| Kamijo, K; Minase, T; Saito, T; Sato, M; Yachi, A | 1 |
| Hayashi, H; Mercado-Asis, LB; Miura, K; Murayama, M; Yamakita, N; Yasuda, K | 1 |
| Deng, J | 1 |
| Lancranjan, I | 1 |
| Djordjević, P; Kendereski, A; Manojlović, D; Mićić, D; Mićić, J; Nesović, M; Popović, V | 1 |
| Rasmussen, C | 1 |
| Hulting, AL; Lundberg, PO; Muhr, C; Werner, S | 2 |
| Lamberts, SW; Quik, RF | 1 |
| Cooper, P; Donahue, B; Lee, C; Newall, J; Persky, M; Rush, S | 1 |
| Buchfelder, M; Fahlbusch, R; Horvath, E; Kovacs, K; Lancranjan, I; Lloyd, RV; Stefaneanu, L | 1 |
| Croughs, RJ; van 't Verlaat, JW | 1 |
| Besser, M; Cunnah, D | 1 |
| DeMichele, D; Di Chiro, G; Francavilla, TL; Miletich, RS; Oldfield, EH; Patronas, NJ; Weintraub, BD | 1 |
| Chen, GL; Jin, ZM; Shi, YF | 1 |
| Cohen, MJ; Holroyd, S | 1 |
| Fanghanel, G; Fanghanel, L; Larraza, O; Velasco, F; Velasco, M; Villalobos, M | 1 |
| Fuse, H; Katayama, T; Kazama, T; Terada, T | 1 |
| Diop, AG; Gueye, M; Kabre, A; Mauferon, JB; Ndiaye, IP; Ndiaye, MM | 1 |
| Ho, LT; Jap, TS; Kwok, CF | 1 |
| Fujimoto, NA; Ito, A; Ito, N; Nakamura, A; Ogawa, K; Shirai, T; Wada, S | 1 |
| Yokoyama, M | 1 |
| Caruso, E; Colao, A; Lancranjan, I; Lombardi, G; Merola, B; Miletto, P; Schettini, G | 1 |
| Bergh, T; Larsson, SG; Rasmussen, C | 2 |
| Neal, JH; Weiss, MH | 1 |
| Abs, R; Beckers, A; De Schepper, A; Hennen, G; Stevenaert, A; Van de Vyver, FL | 1 |
| Cigognini, A; De Bernardi, B; Della Casa Alberighi, O; Honorati, C; Hu, C; Scorza, R; Togni, ME; Travaglini, P | 1 |
| De Bernardi, B; Honorati, MC; Hu, C; Radelli, L; Scorza, R; Togni, ME; Travaglini, P; Vanoli, M; Zanussi, C | 1 |
| Balabolkin, MI; Gerasimov, GA | 2 |
| Boulanger, JC | 1 |
| Bosma, NJ; Croughs, RJ; Hendriks, MJ; van 't Verlaat, JW | 1 |
| Kocijancic, A; Lancranjan, I; Prezelj, J; Vrhovec, I | 1 |
| Acosta, D; Cortés, A; García-Luna, PP; Leal-Cerro, A; Navarro, E; Pereira, JL; Revuelta, M; Santos, C; Trujillo, F; Villamil, F | 1 |
| Camboni, MG; Gianola, D; Montini, M; Pagani, G; Pagani, MD; Piolini, R | 1 |
| Boghen, D; Lesser, RL; Odel, JG; Robbins, RJ; Zheutlin, JD | 1 |
| Gaver-Shavit, A; Gilboa, Y; Katzir, D; Ramot, Y; Rosenberg, T | 1 |
| Chevallier, P; Claustrat, B; Girod, C; Joly-Pharaboz, MO; Trouillas, J | 1 |
| Wass, JA | 1 |
| Dominoni, P; Ferrari, L; Gianola, D; Gualteroni, L; Montini, M; Pagani, G; Pagani, MD; Sileo, F; Stroppa, S; Tengattini, F | 1 |
| Hildebrandt, G | 1 |
| Davis, JR; Heath, DA; Sheppard, MC | 1 |
| Hofland, LJ; Kwekkeboom, DJ; Lamberts, SW; Singh, R; van den Berge, JH; van Koetsveld, PM | 1 |
| Andreeva, M; Shterev, A; Tomova, A | 1 |
| Ridgway, EC; Thorner, MO; Vance, ML | 1 |
| Kieffer, JD; Ridgway, EC; Ross, DS; Shupnik, MA | 1 |
| Hayashi, M; Kabuto, M; Kubota, T; Yamamoto, S | 1 |
| Inoue, H; Ishiyama, N; Kazuno, T; Nakamura, T; Otani, M; Shinozaki, T; Suzuki, M; Takenaka, N; Toya, S | 1 |
| Fukushima, T; Ishibashi, M; Takaku, F; Teramoto, A; Yamaji, T | 1 |
| Fukushima, M; Hasegawa, H; Ishino, Y; Kowada, M; Mineura, K; Sakamoto, T; Wakisaka, A | 1 |
| Bikkal, HA; Black, PM; Klibanski, A; Kliman, B; Shupnik, MA; Zervas, NT | 1 |
| Otsuka, R | 1 |
| Inoue, A; Kitamura, H; Nakai, O; Saito, S | 1 |
| Glaser, B; Gomori, JM; Gross, DJ; Halperin, Y | 1 |
| Herzog, A; Minne, H; Ziegler, R | 1 |
| Hanew, K; Ishii, K; Saitoh, T; Sasaki, A; Saso, S; Sato, S; Shimizu, Y; Sugawara, A; Tazawa, S; Yoshinaga, K | 1 |
| Hofland, LJ; Lamberts, SW; van Koetsveld, PM; Verleun, TM | 1 |
| Bevan, JS; Burke, CW | 2 |
| Astorga Jiménez, R; Bernal Valls, G; García García, J; García García-Revillo, J; García Luna, PP; Jiménez Reina, L; Leal Cerro, A | 1 |
| de Jong, FH; Kwekkeboom, DJ; Lamberts, SW | 1 |
| Camanni, F; Ciccarelli, E; Giordano, G; Giusti, M; Miola, C; Potenzoni, F; Sghedoni, D | 1 |
| Miyakawa, I | 1 |
| Avataneo, T; Besser, GM; Camanni, F; Ciccarelli, E; Grossman, A; Miola, C | 1 |
| Busnardo, B; Girelli, ME; Piccolo, M; Rubello, D | 1 |
| Candrina, R; Tosoni, M | 1 |
| Adams, CB; Ballabio, M; Bevan, JS; Burke, CW; Esiri, MM; Faglia, G; Nissim, M | 1 |
| Roelfsema, F; van Schaardenburg, D; van Seters, AP; Vielvoye, GJ | 1 |
| Besser, GM; Charlesworth, M; Grossman, A; Howlett, TA; Plowman, PN; Rees, LH; Savage, MO; Touzel, R; Wass, JA | 1 |
| Azad, N; Cernius, M; Emanuele, NV; Kirsteins, L; Lawrence, AM; Nayyar, R; Tentler, J | 1 |
| Burdina, LM; Korneeva, IE; Ovsiannikova, TV; Pshenichnikova, TIa | 1 |
| Kanchaveli, ZSh; Kurashvili, RB; Sabakhtarashvili, MA; Veĭnberg, EG | 1 |
| Bevan, JS; Hourihan, M; Peters, JR; Roberts, A; Sussman, J | 1 |
| Beniko, M; Ikota, A; Ikota, T; Mashio, Y; Mizumoto, H; Sato, S; Suzuki, S; Tashiro, T; Yamaguchi, O | 1 |
| Acosta, D; Astorga, R; García-Luna, PP; Leal-Cerro, A; Mazuelos, C; Montero, C; Pereira, JL; Trujillo, F | 1 |
| Falsetti, L; Gastaldi, A; Pasinetti, E; Schivardi, MR | 1 |
| Biggs, PJ; Mayfield, RK; Mordes, DB; Mountcastle, RB; Rawe, SE; Roof, BS; Sagel, J | 1 |
| Christophis, P; Hildebrandt, G; Klug, N; Lancranjan, I; Laun, A; Schatz, H; Zierski, J | 1 |
| Koike, K; Miyake, A; Ohmichi, M; Tanizawa, O | 1 |
| Tiwary, CM | 1 |
| Costa, R; Grisoli, F; Jaquet, P; Pellegrini, I | 1 |
| Kimura, T; Kondo, I; Masahashi, T; Matsuzawa, K; Mizutani, S; Narita, O; Osawa, M; Suganuma, N; Tomoda, Y | 1 |
| Bertrand, P; Delivet, S; Enjalbert, A; Gunz, G; Jaquet, P; Jedynak, CP; Kordon, C; Peillon, F; Pellegrini, I; Rasolonjanahary, R | 1 |
| al-Suleiman, SA; Najashi, S; Rahman, J; Rahman, MS | 1 |
| Bouchard, J; Comtois, R; Robert, F | 1 |
| Benabou, S; Bronstein, MD; Marino, R; Musolino, NR | 1 |
| Besser, GM; Coates, PJ; Doniach, I; Grossman, A; Hale, AC; Howlett, TA; Rees, LH | 1 |
| Ng, CS; Tsakok, FH; Yong, YM | 1 |
| Chiodini, PG; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Verde, GG | 1 |
| Buchfelder, M; Fahlbusch, R | 1 |
| Ciric, I | 1 |
| Lamberts, SW | 3 |
| Gautvik, KM; Haug, E; Iversen, JG; Sletholt, K | 1 |
| Minagawa, F; Nakabayashi, H; Takeda, R | 1 |
| Laws, ER; Randall, RV; Sheline, GE; Wass, JA | 1 |
| Chiodini, PG; Cozzi, R; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Petroncini, MM; Verde, G | 1 |
| Jacobs, HS; Tan, SL | 2 |
| Ibayashi, H; Ikuyama, S; Kato, K; Natori, S; Nawata, H | 1 |
| Hashi, K; Minase, T; Mori, M; Niwa, J | 3 |
| Del Pozo, E; Hofland, L; Lamberts, SW; Verleun, T | 1 |
| Bernstein, J; Buckman, MT; Mattox, JH | 1 |
| Barkan, AL; Beitins, IZ; Hopwood, NJ; Kelch, RP | 1 |
| Bertrand, JH; Evrad, C; Grollier, G; Mahoudeau, JA; Potier, JC; Reznik, Y; Ritz, P | 1 |
| Croughs, RJ; Thijssen, JH; van 't Verlaat, JW; van Ginkel, LA; Vos, P | 1 |
| del Pozo, E; Lamberts, SW | 1 |
| Halperin Rabinovich, I | 1 |
| Arrington, JA; Bryan, RN; Kumar, AJ; Yousem, DM; Zinreich, SJ | 1 |
| Adashi, EY; Katz, E; Schran, HF | 1 |
| Daru, J; Godó, G; Koloszár, S; Sas, M; Szilágyi, I | 1 |
| Budzilovitch, G; Cooper, P; Kleinberg, D; Kupersmith, MJ; Warren, FA | 1 |
| Hilliker, JK; Saul, RF | 1 |
| Baluk, KhM; Golubev, VA; Pamfamirov, IuK; Zaets, VV | 1 |
| de Gennes, JL; Scherrer, H; Turpin, G; Vermet, M | 1 |
| Golubev, VA; Pamfamirov, IuK; Semeniuta, AN; Zaets, VV | 1 |
| Bergström, K; Enoksson, P; Lundberg, PO; Muhr, C; Thuomas, KA | 1 |
| Hamester, U; Lüdecke, DK; Saeger, W | 1 |
| Donald, RA; Espiner, EA; Fox, H; Livesey, JH; Wittert, G | 1 |
| Fujita, T; Hirata, Y; Nakashima, H; Tomita, M; Uchihashi, M | 1 |
| Bots, GT; Luyendijk, W; van Dulken, H; van Seters, AP; Vielvoye, GJ | 1 |
| Ando, M; Ibayashi, H; Kato, K; Nawata, H; Sekiya, K; Yanase, T | 1 |
| Cantau, P; Castanas, E; Giraud, P; Gunz, G; Jaquet, P | 1 |
| Fode, NC; Laws, ER; Redmond, MJ | 1 |
| Cabezas-Cerrato, J; De la Fuente, A; García López, JM; Gaudiero, GJ; Mato Mato, JA; Odriozola, A; Tomé, MA | 1 |
| Tolstoi, LG | 1 |
| Kinouchi, T; Shimizu, N; Takeda, F; Yoshida, H | 1 |
| Abraham, RR; Altaher, AR; Campbell, EA; Gillham, B; Jenkins, J; Jones, MT; Prysor-Jones, A; Thody, AJ; Wynn, V | 1 |
| Jordan, RM; Kohler, PO | 1 |
| Braun, IF; Davis, PC; Hoffman, JC; Spencer, T; Tindall, GT | 1 |
| Hoffman, J; Jenkins, JS; Prysor-Jones, RA; Silverlight, JJ | 1 |
| Cardenal, C; Casamitjana, R; Halperin, I; Lienas, V; Martinez Osaba, MJ; Rodriguez, MD; Vilardell, E | 1 |
| Dluhy, RG | 1 |
| Gautvik, KM; Haug, E; Iversen, JG; Johansen, PW; Sand, O | 1 |
| Aono, T; Koizumi, K | 1 |
| Bevers, MM; Croughs, RJ; Rijnberk, A; Rutteman, GR; Stolp, R | 1 |
| Cook, DB; Crombie, AL; Hall, K; Johnston, DG; Kendall-Taylor, P; Ross, WM; Watson, MJ | 1 |
| D'Antona, N; Danero, S; De Leo, V; Genazzani, AR; Petraglia, F; Sardelli, S | 1 |
| de Jong, FH; Hofland, L; Lamberts, SW; Loeber, JG; Oosterom, R; Stefanko, SZ; van Ginkel, LA; van Vroonhoven, CC; Verleun, T | 1 |
| Black, PM; Crowley, WF; Deutsch, PJ; Habener, JF; Hsu, DW; Jameson, JL; Klibanski, A; Ridgway, EC | 1 |
| Heidvall, K; Hulting, AL | 1 |
| Huang, KE; McDonald, JV; Muechler, EK; Tang, L | 1 |
| Conti, A; Faglia, G; Mailland, F; Muratori, M; Togni, E; Travaglini, P; Zanotti, A | 1 |
| Finkenstedt, G; Gasser, RW; Grunert, V; Mayr, U; Mueller-Holzner, E; Skrabal, F; Spoendlin, H; Tabarelli, M; Twerdy, K | 1 |
| Jeffcoate, WJ; Tyack, AJ | 1 |
| Chrétien, M; Ibayashi, H; Iguchi, H; Kato, K; Nakagaki, H; Natori, S; Nawata, H | 1 |
| Day, RN; Hinkle, PM | 1 |
| Alexander, WD; Connell, JM; Davies, DL; McLellan, AR | 1 |
| Arteaga, E; Fernández, C; Huete, I; López, JM; López, X | 1 |
| Ayala, AR; Grimaldo, J; López Espinoza, E; Verulo Reyes, TB; Villanueva, C | 1 |
| Courtois, H; Gancel, A; Kuhn, JM; Schrub, JC; Tadie, M; Weinstein, A; Wolf, LM | 1 |
| Arita, K; Ohta, M; Uozumi, T | 1 |
| Hymer, WC; Phelps, CJ | 1 |
| Clements, JA; Fuller, PJ; MacDonald, RJ; Matheson, BA; Verity, K | 1 |
| Asa, SL; Duffy, AE; Kovacs, K | 1 |
| Chihara, K; Fujita, T; Matsumoto, S; Shibata, Y; Shirataki, K; Tamaki, N | 1 |
| Benker, G; Mehdorn, M; Rauhut, F; Reinhardt, V | 1 |
| Hildebrandt, G; Schatz, H; Stracke, H | 1 |
| Maeda, T; Mori, H; Onishi, T; Saitoh, Y | 1 |
| Artese, R; Boero, L; Cáceres Narizzano, O; Caputi, E; Kulczycki, A; Molocznik, I | 1 |
| Jakubowski, J; Kemeny, AA; Smith, C; Stawowy, A; Timperley, WR | 1 |
| Engelhardt, D; Fink, U; Hörmann, R; Mann, K; Oeckler, R; Schineis, E | 1 |
| Althoff, PH; Fassbinder, W; Haak, T; Jungmann, E; Schöffling, K | 1 |
| Astorga Jiménez, R; García-Luna, PP; Leal-Cerro, A | 1 |
| Lawton, NF | 1 |
| Asscheman, H; Assies, J; de Slegte, R; Gooren, LJ; van Kessel, H | 1 |
| Marut, EL; Schneider, AB; Scoccia, B; Scommegna, A | 1 |
| Croughs, RJ; Hendriks, MJ; van 't Verlaat, JW; Zelissen, PM | 1 |
| Barrow, DL; Mizuno, J; Tindall, GT | 1 |
| Aller Granda, J; Boix Pallarés, P; Díaz Cadorniga, FJ; Díaz de Greñu Martínez, C; Menéndez Torre, EL; Rabal Artal, A | 1 |
| Cirillo, S; Fariello, C; Fusco, R; Lancranjan, I; Lombardi, G; Merola, B; Miletto, P; Schettini, G | 1 |
| Lamberts, SW; Van Cutsem, EJ | 1 |
| Astorga, R; García-Luna, PP; Leal-Cerro, A; Revuelta, M | 1 |
| Ross, DA; Wilson, CB | 1 |
| Horvath, E; Jalalah, S; Kovacs, K | 1 |
| Ferrari, MD; Haan, J; van Seters, AP | 1 |
| Croughs, RJ; Hendriks, MJ; Lancranjan, I; van 't Verlaat, JW | 1 |
| Cancio, E; Cocchi, D; Dall'Ara, A; Devesa, J; Di Salle, E; Lima, L; Müller, EE | 1 |
| Cheyne, KL; Comerci, GD; Lightner, ES | 1 |
| Chan, T; Lam, KS; Liu, MY; Ma, JT; Wang, C; Yeung, RT | 1 |
| Klimaszewski, J; Lastowiecki, PM; Romer, TE | 1 |
| Bar-Meir, A; Dickstein, G; Landman, L; Sharf, M; Spindel, A; Tal, Y | 1 |
| Bollati, A; Candrina, R; Galli, G; Giustina, G; Gualandi, GF; Orlandini, A; Pizzocolo, G | 1 |
| McKenna, MJ; Mellinger, RC; Saeed-uz-Zafar, M | 1 |
| Minisci, N; Negri, P; Pittini, L | 1 |
| Chimbira, TH; Kasule, J | 1 |
| Trygstad, O | 1 |
| Besser, M; Cook, RJ | 1 |
| Borgundvaag, B; George, SR; Haas, DA; Sturtridge, WC | 1 |
| Kato, K; Seki, K; Shima, K | 1 |
| Weil, C | 2 |
| Andoh, N; Ikeda, H; Sasano, N | 1 |
| Skaf, RA | 1 |
| Muraszko, K; Post, KD | 1 |
| Crosignani, PG; Ferrari, C | 1 |
| Blackwell, RE; Dollar, JR | 1 |
| Darbois, Y; de Gennes, JL; Metzger, J; Scherrer, H; Turpin, G | 1 |
| Aono, T; Fukui, H; Ikegami, H; Koike, K; Koizumi, K; Tanizawa, O | 1 |
| Arao, M; Kishimoto, S; Koga, M; Mori, S; Morimoto, Y; Nakao, H; Noma, K; Sato, B; Uozumi, T | 1 |
| Mahomed, K | 1 |
| Andreis, M; Camanni, F; Ciccarelli, E; Ghigo, E; Lancranjan, I; Massara, F; Mazza, E | 1 |
| Dunne, JW; Pullan, PT; Stewart-Wynne, EG | 1 |
| Bronstein, MD; Cardim, CS; Marino, R | 1 |
| Aono, T; Arita, N; Hayakawa, T; Koizumi, K; Matsumoto, K; Mogami, H; Mori, H; Saitoh, Y | 1 |
| Melzer, H | 1 |
| Fonseca, ME; Loyo, M; Medina, M; Miranda, R; Moran, C; Zarate, A | 1 |
| Friesen, HG; Thliveris, JA; Vrontakis, ME | 1 |
| Landolt, AM; Landolt, TA; Osterwalder, V | 2 |
| D'Emden, MC; Harrison, LC | 1 |
| Bergh, T; Rasmussen, C; Wide, L | 1 |
| Atkinson, AB; Carson, DJ; Dalzell, GW; Sheridan, B | 1 |
| Adams, CB; Bevan, JS; Burke, CW; Esiri, MM; Molyneux, AJ; Moore, RA; Morton, KE | 1 |
| Besser, GM; Grossman, A; Wass, JA | 1 |
| Flanigan, S; Jordan, RM; Kohler, PO; Murphy, FY; Vesely, DL | 1 |
| Kleihues, P; Landolt, AM; Shibata, T | 1 |
| Buchfelder, M; Fahlbusch, R; Schrell, U | 1 |
| Abboud, CF; Hubbard, JL; Laws, ER; Scheithauer, BW | 1 |
| Bannister, P; Sheridan, P | 1 |
| Fagin, J; Leung, M; Melmed, S | 1 |
| Blackwell, RE; Chang, RJ | 1 |
| Blackwell, RE; Younger, JB | 1 |
| Brostrom, CO; Brostrom, MA; Wolfe, SE | 1 |
| Beck, W; Stubbe, P | 1 |
| Greenspan, SL; Klibanski, A; Neer, RM; Ridgway, EC | 1 |
| Besser, GM; Grossman, A; Ross, R; Wass, JA | 1 |
| Ferrari, L; Gianola, D; Lancranjan, I; Montini, M; Pagani, G; Pagani, MD; Salmoiraghi, M | 1 |
| Anniko, M; Ritzén, EM | 1 |
| Adams, CB; Bevan, JS; Burke, CW; Esiri, MM | 1 |
| Ahmed, SR; Shalet, SM | 1 |
| Caselitz, J; Lüdecke, DK; Saeger, W; Schottke, H | 1 |
| Arita, N; Hayakawa, T; Koizumi, K; Mogami, H; Mori, S; Nagatani, M; Saitoh, Y; Tanizawa, O; Uozumi, T | 1 |
| Bosma, NJ; Croughs, RJ; Hendriks, MJ; Nortier, JW; Thijssen, JH; van 't Verlaat, JW | 1 |
| Armando, I; Barontini, M; Kleiman, A; Levin, G; Mancini, AM; Molocznik, I; Razumny, J | 1 |
| Fagel, WJ; Hekster, RE; Smith, SJ; van der Vijver, JC | 1 |
| Jacobs, HS; Morris, D; Tan, SL | 1 |
| Bernstein, J; Buckman, MT; Kellner, R; Mattox, JH; Pathak, D | 1 |
| Osamura, RY; Teramoto, A; Watanabe, K | 1 |
| Osamura, RY; Watanabe, K | 1 |
| Hahn, F; Huseman, CA; Rizk, G | 1 |
| Hofland, L; Lamberts, SW; Oosterom, R; Verleun, T | 1 |
| Leavens, ME; Leavens, TA; Lee, YY; Samaan, NA; Schultz, PN | 1 |
| Benker, G; Freundlieb, O; Gieshoff, B; Lancranjan, I; Reinwein, D; Schulte, HM; Windeck, R | 1 |
| Belchetz, PE; Carty, A; Clearkin, LG; Davis, JC; Jeffreys, RV; Rae, PG | 1 |
| Baldwin, D; Bevan, JS; Burke, CW | 1 |
| Gao, SM; Jin, ZM; Shi, YF | 1 |
| Newman, SA | 1 |
| Fujii, T; Kakegawa, T; Misumi, S; Tamura, M | 1 |
| Grossman, A | 1 |
| Kageyama, N; Katoh, T; Kuwayama, A; Takahashi, T | 1 |
| Fukushima, T; Hirakawa, T; Kibe, M; Matsuda, T; Tashiro, Y; Tomonaga, M; Yamashita, M | 1 |
| Caselitz, J; Lüdecke, DK; Saeger, W; Thiel, M | 1 |
| Carroll, WM; Chakera, TM; Khangure, MS; Pullan, PT; Vaughan, RJ | 1 |
| Bendsen, BB; Wollesen, F | 1 |
| Blackwell, RE; Caldwell, B; Chang, RJ; Elton, RL; Jaffe, R; Joplin, G; Molitch, ME; Robbins, RJ; Thorner, MO; Tyson, J | 1 |
| Newman, G; Shukla, S; Turner, WJ | 1 |
| Magyar, DM | 1 |
| Buvat, J; Dewailly, D; Fossati, P; Fourlinnie, JC; Lemaitre, G; Mazzuca, M; Thomas, P; Wemeau, JL | 1 |
| Fossati, P; Linquette, M; Mazzuca, M | 1 |
| Bartke, A; Morgan, WW; Smith, MS; Steger, RW; Sweeney, CA | 1 |
| Besser, GM; Grossman, A | 1 |
| Conti, A; Faglia, G; Moriondo, P; Nissim, M; Travaglini, P | 1 |
| Collu, R; Eljarmak, D; Lis, M; Marchisio, AM | 1 |
| Klijn, JG; Lamberts, SW; Stefanko, SZ; van Vroonhoven, CC | 1 |
| Ambrosi, B; Elli, R; Faglia, G; Giovine, C; Nava, C | 1 |
| Burch, WM | 1 |
| Althoff, PH; Schöffling, K | 1 |
| Compton, PJ; Ho, KY; Lazarus, L; Smythe, GA | 1 |
| Bazsa-Kassai, Z; Kunkel, S; Rudolf, K; Smid, I | 1 |
| Melzer, H; Uhlmann, G | 1 |
| Grisoli, F; Gunz, G; Jaquet, P | 1 |
| Kato, K; Seki, K | 1 |
| Ge, QS; Gu, CX; Lin, SQ; Shi, YF; Wang, HL; Xie, YZ; Xu, L; Xu, YD; Yu, KM; Zang, X | 1 |
| Berl, T; Bichet, D; Kern, PA; Robbins, RJ; Verbalis, JG | 1 |
| Arita, N; Hayakawa, T; Matsumoto, K; Mogami, H; Mori, H; Mori, S; Saitoh, Y | 1 |
| Moon, YS; Shin, DH; Yuen, BH | 1 |
| Braunstein, GD; Karpf, DB | 1 |
| Al-Mefty, O; el-Akkad, S; Jinkins, JR; Niles, NL; Sieck, JO; Woodhouse, N | 1 |
| König, MP; Kopp, P | 1 |
| Halse, J; Hansen, E; Jervell, J; Kjartanson, O; Kollevold, T | 1 |
| Horvath, E; Kovacs, KT; Laws, ER; Randall, RV; Scheithauer, BW; Whitaker, MD | 1 |
| Dluhy, RG; Kolodny, J | 1 |
| Berczi, I; Friesen, HG; Nagy, E; Sehon, AH | 1 |
| McCorkell, S; McDonald, D; Niles, N; Woodhouse, NJ | 1 |
| Bruchovsky, N; Gout, PW; Prior, JC; Rennie, PS | 1 |
| Clark, JD; Edwards, OM; Wheatley, T | 1 |
| Krupp, P; Ruch, R; Turkalj, I | 1 |
| Djawari, D; Weidner, FO | 1 |
| Aquilar-Parada, E; González-Angulo, A; Klériga, E; Loyo, M; Morán, C; Zárate, A | 1 |
| Cantin, M; Carrière, PD; Collu, R; Eljarmak, D; Lis, M | 1 |
| Asai, M; Kimura, T; Masahashi, T; Mizutani, S; Narita, O; Osawa, M; Suganuma, N; Tomoda, Y | 1 |
| Aono, T; Arita, N; Matsumoto, K; Mogami, H; Mori, H; Mori, S; Saitoh, Y; Uozumi, T | 1 |
| Bergh, T; Nillius, SJ; Rasmussen, C; Wide, L | 1 |
| Su, YH | 1 |
| Alhajje, A; Crabbé, J; Lambert, M | 1 |
| Chiodini, P; Cozzi, R; Dallabonzana, D; Liuzzi, A; Luccarelli, G; Oppizzi, G; Verde, GG | 1 |
| Bartelink, AK; Kok, JG; Merx, H; Meyer, E; Pieters, G; Schulte, BP; Smals, A | 1 |
| Froesch, ER; Landolt, AM | 1 |
| Clayton, RN; Dunn, PJ; Heath, DA; Hockley, AD; Rolfe, EB; Webb, J | 1 |
| Adams, CB; Besser, GM; Charlesworth, M; Doniach, I; Grossman, A; Ross, R; Wass, JA | 1 |
| Israel, JM; Jaquet, P; Vincent, JD | 1 |
| Assa, S; Kauli, R; Laron, Z; Math, S; Ovadia, Y; Schoenfeld, A | 1 |
| Andonian, C; Devictor, B; Grisoli, F; Gunz, G; Hassoun, J; Jaquet, P; Toga, M | 1 |
| Chiodini, PG; Dallabonzana, D; Liuzzi, A; Luccarelli, G; Oppizzi, G; Verde, G | 1 |
| Al-Mefty, O; Woodhouse, N | 1 |
| Drapier-Faure, E | 1 |
| Gauer, J; Heberling, HJ; Lohmann, D; Richardt, W; Stubert, B | 1 |
| Meng, W; Nehmzow, M; Ventz, M | 1 |
| Zhang, YW | 1 |
| Handa, Y; Hayashi, M; Ishii, H; Kabuto, M; Kawano, H; Kobayashi, H; Shirasaki, N | 1 |
| Dash, RJ; Majeed, PA; Saini, JS | 1 |
| Blumhardt, C; Harris, P; Kellner, C | 1 |
| Burdman, JA; Evans, WS; Hellmann, P; Kovacs, K; McComb, DJ; Scott, D; Thorner, MO | 1 |
| Davies, G; Grant, DB; Ritzén, EM; Wettrell, G | 1 |
| Kletzky, OA; Lahteenmaki, P; Marrs, RP; Schechter, J; Zacharias, S | 1 |
| Kato, K; Kikuchi, Y; Kizawa, I; Momose, E; Mukai, K; Oomori, K; Seki, K; Shima, K | 1 |
| Gáspár, L; Julesz, J; Kocsis, J; László, F; Pásztor, E | 1 |
| Boulanger, CM; Chang, RJ; Mashchak, CA | 1 |
| Buvat, J; Buvat-Herbaut, M; Fossati, P; Fourlinnie, JC; Lemaire, A; Racadot, A | 1 |
| Strauch, G | 1 |
| Bourdelle-Hego, MF; Buvat, J; Clarisse, J; Dewailly, D; Fermon, C; Fossati, P; Lemaire, A; Lemaitre, G; Pouyol-Motte, H; Thomas-Desrousseaux, P | 1 |
| Goldstein, E; Konopka, P; Leleu, MF; Loria, Y; Merceron, RE; Raymond, JP | 1 |
| Saunders, NJ | 1 |
| Gautvik, KM; Haug, E; Johansen, PW | 1 |
| Fujimoto, N; Ito, A; Kawashima, K; Naito, M; Watanabe, H | 1 |
| Chakera, TM; Khangure, MS; Pullen, P | 1 |
| Bosley, TM; Moster, ML; Savino, PJ; Schatz, NJ; Sergott, RC; Snyder, PJ | 1 |
| Godó, G; Koloszár, S; Sas, M | 1 |
| Domínguez, JR; Estopiñán, V; Picó, A; Varela, C | 1 |
| Demura, H; Demura, R; Kitamura, K; Kubo, O; Shizume, K | 1 |
| Clausen, OP; Fossum, S; Gautvik, KM; Haug, E; Johansen, PW | 1 |
| De Leon, FD | 1 |
| Schneider, HP | 1 |
| Held, HJ; Justus, B; Köhler, K; Richter, B; Schaps, P; Seiler, E | 1 |
| De Gennes, JL; Heshmati, HM; Metzger, J; Schaison-Cusin, M; Scherrer, H; Thibierge, M; Turpin, G | 1 |
| Acosta Delgado, D; Astorga Jiménez, R; García-Luna, PP; Leal Cerro, A; Santos Español, C; Villamil, F | 1 |
| Matsubayashi, T; Nishimura, T; Nishinuma, K; Takeda, M; Tanino, S; Yamashita, S | 1 |
| Assies, J; Schellekens, AP; Touber, JL | 1 |
130 review(s) available for bromocriptine and Pituitary Neoplasms
| Article | Year |
|---|---|
Evolution of a refractory prolactin-secreting pituitary adenoma into a pituitary carcinoma: report of a challenging case and literature review.
Topics: Adult; Bromocriptine; Carcinoma; Craniotomy; Disease Progression; Female; Hormone Antagonists; Humans; Neoplasm Recurrence, Local; Neurosurgical Procedures; Pituitary Neoplasms; Prolactinoma; Radiosurgery; Reoperation; Spinal Cord Neoplasms | 2021 |
The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis.
Topics: Bromocriptine; Cabergoline; Deprescriptions; Dopamine Agonists; Humans; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactinoma | 2021 |
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Aminoquinolines; beta-Arrestins; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Filamins; Growth Hormone-Secreting Pituitary Adenoma; Humans; Lisuride; MicroRNAs; Pergolide; Pituitary Neoplasms; Prolactinoma; Receptors, Dopamine D2 | 2021 |
Bromocriptine therapy: Review of mechanism of action, safety and tolerability.
Topics: Acromegaly; Bromocriptine; Diabetes Mellitus, Type 2; Dopamine Agonists; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin | 2022 |
Treatment of Prolactinoma.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Female; Humans; Pituitary Neoplasms; Pregnancy; Prolactinoma; Treatment Outcome | 2022 |
Impulse control disorders in hyperprolactinemic patients on dopamine agonist therapy.
Topics: Bromocriptine; Cabergoline; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms | 2022 |
The efficacy and safety of quinagolide in hyperprolactinemia treatment: A systematic review and meta-analysis.
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Drug-Related Side Effects and Adverse Reactions; Humans; Hyperprolactinemia; Pituitary Neoplasms | 2023 |
How to manage intolerance to dopamine agonist in patients with prolactinoma.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactinoma | 2023 |
Diagnosis and Management of Pituitary Adenomas: A Review.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Bromocriptine; Cabergoline; Child; Female; Human Growth Hormone; Humans; Hypopituitarism; Pituitary Neoplasms; Pregnancy; Prolactinoma | 2023 |
A giant invasive macroprolactinoma with recurrent nasal bleeding as the first clinical presentation: case report and review of literature.
Topics: Adult; Bromocriptine; Epistaxis; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Young Adult | 2023 |
Prolactinomas in pregnancy: considerations before conception and during pregnancy.
Topics: Bromocriptine; Dopamine Agonists; Female; Humans; Pituitary Neoplasms; Pregnancy; Prolactinoma | 2020 |
Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literature.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Female; Humans; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prolactinoma; Tumor Burden; Young Adult | 2021 |
Successful management of octreotide-insensitive thyrotropin-secreting pituitary adenoma with bromocriptine and surgery: A case report and literature review.
Topics: Adenoma; Antineoplastic Agents, Hormonal; Bromocriptine; Combined Modality Therapy; Hormone Antagonists; Humans; Male; Middle Aged; Octreotide; Pituitary Gland; Pituitary Neoplasms; Thyrotropin | 2017 |
ANNIVERSARY REVIEW: 50 years since the discovery of bromocriptine.
Topics: Acromegaly; Animals; Anniversaries and Special Events; Antiparkinson Agents; Bromocriptine; Diabetes Mellitus, Type 2; Dopamine Agonists; Drug Discovery; Drug Therapy, Combination; Ergotism; History, 20th Century; Hormone Antagonists; Humans; Hyperprolactinemia; Hypoglycemic Agents; Parkinson Disease; Pituitary Neoplasms | 2018 |
Management of Dopamine Agonist-Resistant Prolactinoma.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Humans; Pituitary Neoplasms; Prolactinoma | 2019 |
[Drug therapy for acromegaly].
Topics: Acromegaly; Aminoquinolines; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Interdisciplinary Communication; Membrane Proteins; Octreotide; Patient Care Team; Peptides, Cyclic; Pituitary Neoplasms; Somatostatin | 2013 |
[Endocrinologic diseases management during breastfeeding].
Topics: Breast Feeding; Bromocriptine; Contraindications; Diabetes Mellitus, Type 2; Diet, Diabetic; Dopamine Agonists; Endocrine System Diseases; Estrogens; Female; Humans; Hyperprolactinemia; Hypoglycemic Agents; Hypopituitarism; Infant; Infant, Newborn; Insulin; Lactation; Milk, Human; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy in Diabetics; Prolactin; Prolactinoma; Puerperal Disorders; Thyroid Diseases | 2015 |
Update on prolactinomas. Part 2: Treatment and management strategies.
Topics: Bromocriptine; Cabergoline; Disease Management; Dopamine Agonists; Drug Administration Schedule; Drug Resistance, Neoplasm; Ergolines; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neuroendoscopy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Radiosurgery; Sphenoid Sinus | 2015 |
Epistaxis and pituitary apoplexy due to ruptured internal carotid artery aneurysm embedded within pituitary adenoma.
Topics: Aneurysm, Ruptured; Angiography, Digital Subtraction; Balloon Occlusion; Bromocriptine; Carotid Artery Diseases; Carotid Artery, Internal; Epistaxis; Hormone Antagonists; Hormone Replacement Therapy; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Pituitary Apoplexy; Pituitary Neoplasms; Prolactinoma; Radiosurgery; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
[Treatment of pituitary adenomas].
Topics: Acromegaly; ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenocorticotropic Hormone; Aminoquinolines; Bromocriptine; Cushing Syndrome; Dopamine Agonists; Female; Growth Hormone-Secreting Pituitary Adenoma; Human Growth Hormone; Humans; Hypophysectomy; Incidental Findings; Male; Pituitary Hormones; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Radiosurgery; Receptors, Somatotropin; Somatostatin; Thyrotropin | 2009 |
Clinical practice. Prolactinomas.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Visual Fields | 2010 |
Blurred vision during airline flight reveals prolactinoma.
Topics: Altitude; Aviation; Bromocriptine; Diagnostic Techniques, Endocrine; Dopamine Agonists; Female; Fundus Oculi; Hemianopsia; Humans; Magnetic Resonance Imaging; Middle Aged; Pituitary Neoplasms; Prolactinoma; Treatment Outcome; Visual Acuity; Visual Field Tests; Visual Fields | 2003 |
Dopamine resistance of prolactinomas.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Humans; Pituitary Neoplasms; Prolactinoma | 2003 |
Contemporary management of prolactinomas.
Topics: Bromocriptine; Cabergoline; Contraindications; Diagnosis, Differential; Ergolines; Female; Humans; Hypophysectomy; Magnetic Resonance Imaging; Male; Pituitary Diseases; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Radiosurgery; Remission Induction | 2004 |
[Prolactinoma and pregnancy].
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma | 2004 |
A rare case of pregnancy and delivery of a healthy neonate by a woman with microprolactinoma and review of the literature.
Topics: Adult; Bromocriptine; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Progesterone; Prolactinoma | 2004 |
Hyperprolactinemia: pathophysiology and management.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Estrogens; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Radiotherapy; Surgical Procedures, Operative | 2003 |
[Treatment of benign brain tumor in elderly patients].
Topics: Adenoma; Aged; Bromocriptine; Cochlear Nerve; Combined Modality Therapy; Cranial Nerve Neoplasms; Dopamine Agonists; Humans; Monitoring, Intraoperative; Neuronavigation; Neurosurgical Procedures; Pituitary Neoplasms; Prognosis; Radiotherapy | 2005 |
Current treatment issues in female hyperprolactinaemia.
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Pregnancy; Prolactinoma | 2006 |
Treatment of pituitary tumors: dopamine agonists.
Topics: Adenoma; Bromocriptine; Cabergoline; Dopamine; Dopamine Agonists; Ergolines; Humans; Pituitary Neoplasms; Receptors, Dopamine | 2005 |
Prolactinomas and pregnancy.
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma | 2005 |
Pharmacologic resistance in prolactinoma patients.
Topics: Bromocriptine; Cabergoline; Cell Proliferation; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Resistance; Ergolines; Estrogens; Female; Humans; Male; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Receptors, Dopamine D2 | 2005 |
[Amenorrhea-galactorrhea syndrome].
Topics: Amenorrhea; Bromocriptine; Dopamine Agonists; Female; Galactorrhea; Hirsutism; Humans; Hyperprolactinemia; Hypophysectomy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Syndrome | 2006 |
[Discrepancy between IGF-1 and GH during 75 g oral glucose tolerance test measures to acromegaly screening in a patient with macroprolactinoma--case report and literature review].
Topics: Acromegaly; Bromocriptine; Glucose Tolerance Test; Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma | 2007 |
Managing prolactin-secreting adenomas during pregnancy.
Topics: Adult; Bromocriptine; Female; Humans; Monitoring, Physiologic; Physicians, Family; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prenatal Care; Prognosis; Prolactinoma; Risk Assessment | 2007 |
Difficulties in the medical treatment of prolactinoma in a patient with schizophrenia--a case report with a review of the literature.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Clozapine; Dopamine Agonists; Dopamine Antagonists; Drug Antagonism; Female; Haloperidol; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Prolactinoma; Schizophrenia | 2008 |
Hyperprolactinemia and prolactinomas.
Topics: Bromocriptine; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactinoma | 2008 |
[5 cases of hyperprolactinemia. Review of the physiology of prolactin and its role in pathology].
Topics: Adolescent; Amenorrhea; Bromocriptine; Circadian Rhythm; Cushing Syndrome; Empty Sella Syndrome; Estrogens; Female; Galactorrhea; Genitalia; Gonadotropins, Pituitary; Homeostasis; Humans; Hyperthyroidism; Hypothyroidism; Lactation Disorders; Male; Middle Aged; Neurosecretory Systems; Neurotransmitter Agents; Pituitary Neoplasms; Pregnancy; Prolactin; Receptors, Cell Surface | 1980 |
Pharmacologic therapy of patients with pituitary tumors secreting prolactin, growth hormone and adrenocorticotropin.
Topics: Adrenergic alpha-Antagonists; Adrenocorticotropic Hormone; Amenorrhea; Antineoplastic Agents; Bromocriptine; Cyproheptadine; Ergolines; Estrogens; Female; Galactorrhea; Growth Hormone; Humans; Hypothalamus; Levodopa; Pituitary Gland; Pituitary Neoplasms; Pregnancy; Prolactin | 1980 |
Physiopathology of Cushing's disease.
Topics: Adenoma; Biomechanical Phenomena; Bromocriptine; Circadian Rhythm; Cushing Syndrome; Cyproheptadine; Disease Models, Animal; Forecasting; Glucocorticoids; Humans; In Vitro Techniques; Neurotransmitter Agents; Peptides; Pituitary Gland; Pituitary Hormones, Anterior; Pituitary Neoplasms; Pro-Opiomelanocortin; Protein Precursors | 1983 |
Hyperprolactinemia and menstrual dysfunction.
Topics: Anovulation; Arcuate Nucleus of Hypothalamus; Bromocriptine; Endocrine System Diseases; Female; Humans; Hypothalamic Diseases; Male; Menstruation Disturbances; Neurotransmitter Agents; Pituitary Neoplasms; Prolactin | 1983 |
Drugs five years later. Bromocriptine.
Topics: Acromegaly; Adenoma; Bromocriptine; Dyskinesia, Drug-Induced; Edema; Female; Growth Hormone; Hepatic Encephalopathy; Humans; Huntington Disease; Infertility, Female; Lactation; Luteal Phase; Male; Mental Disorders; Parkinson Disease; Pituitary Neoplasms; Pregnancy; Premenstrual Syndrome; Prolactin | 1984 |
Pituitary adenomas. An update on their management with an emphasis on the role of bromocriptine.
Topics: Adenoma; Animals; Bromocriptine; Combined Modality Therapy; Female; Humans; Male; Microsurgery; Pituitary Neoplasms; Prolactin; Rats; Sphenoid Sinus; Tomography, X-Ray Computed | 1983 |
The medical management of hormone-secreting tumors of the pituitary.
Topics: Acromegaly; Adrenocorticotropic Hormone; Bromocriptine; Cushing Syndrome; Growth Hormone; Humans; Pituitary Neoplasms; Prolactin | 1983 |
Pituitary adenomas: diagnostic and therapeutic considerations.
Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Growth Hormone; Humans; Hydrocortisone; Microsurgery; Pituitary Hormones; Pituitary Neoplasms; Prolactin; Sella Turcica; Thyrotropin; Tomography, X-Ray Computed; Vasopressins | 1984 |
Management of endocrine disorders in pregnancy. Part II. Pituitary, ovarian and adrenal disease.
Topics: Addison Disease; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adult; Bromocriptine; Cushing Syndrome; Female; Humans; Middle Aged; Ovarian Diseases; Ovarian Neoplasms; Pheochromocytoma; Pituitary Diseases; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prolactin; Thecoma | 1984 |
Bromocriptine: endocrine pharmacology and therapeutic applications.
Topics: Bromocriptine; Dopamine; Endocrine Glands; Female; Humans; Hypothalamo-Hypophyseal System; Infertility, Female; Lactation; Menstruation Disturbances; Pituitary Neoplasms; Pregnancy; Prolactin | 1983 |
Prolactinomas in women: current therapies.
Topics: Adenoma; Age Factors; Amenorrhea; Bromocriptine; Dopamine; Female; Galactorrhea; Humans; Pituitary Neoplasms; Pregnancy; Prolactin | 1983 |
Pregnancy in hyperprolactinemic women.
Topics: Adenoma; Bromocriptine; Clomiphene; Female; Humans; Metergoline; Pituitary Neoplasms; Postnatal Care; Pregnancy; Pregnancy Complications, Neoplastic; Prenatal Care; Prolactin | 1984 |
Use of bromocriptine in the treatment of gynaecologic disorders.
Topics: Bromocriptine; Female; Galactorrhea; Genital Diseases, Female; Humans; Infertility, Female; Menstruation Disturbances; Ovulation Induction; Pituitary Neoplasms; Pregnancy; Prolactin | 1984 |
[Role of prolactin in galactorrhea and pregnancy: physiologic and pathologic aspects].
Topics: Bromocriptine; Diagnosis, Differential; Female; Galactorrhea; Humans; Lactation Disorders; Ovulation Induction; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin | 1984 |
Treatment of acromegaly.
Topics: Acromegaly; Adenoma; Bromocriptine; Growth Hormone; Humans; Methods; Neoplasm Recurrence, Local; Pituitary Irradiation; Pituitary Neoplasms | 1983 |
Pituitary prolactinomas.
Topics: Adenoma, Chromophobe; Adult; Aged; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin | 1982 |
[Prolactin, bromocriptine and gonadal function in women: recent advances. II. Treatment of female hyperprolactinemia and other indications for the use of bromocriptine].
Topics: Anovulation; Bromocriptine; Female; Humans; Infertility, Female; Pituitary Neoplasms; Pregnancy; Premenstrual Syndrome; Prolactin | 1982 |
Abnormal pituitary prolactin secretion impact on gestation.
Topics: Adrenal Cortex Hormones; Adrenal Glands; Amniotic Fluid; Bromocriptine; Female; Fetus; Humans; Lactation; Lung; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Vision Disorders | 1982 |
Prolatin secreting pituitary adenomas.
Topics: Adenoma; Amenorrhea; Bromocriptine; Contraceptives, Oral; Female; Galactorrhea; Humans; Infertility; Male; Pituitary Neoplasms; Pregnancy; Prolactin; Radiography; Sella Turcica; Sex Factors; Thyrotropin-Releasing Hormone | 1981 |
Current concepts in cancer: management of hormone-secreting pituitary adenomas.
Topics: Adenoma; Adult; Bromocriptine; Child; Cushing Syndrome; Female; Gonadotropins, Pituitary; Growth Hormone; Humans; Male; Pituitary Hormones, Anterior; Pituitary Neoplasms; Pregnancy | 1980 |
Prolactin-producing pituitary tumors: medical therapy.
Topics: Bromocriptine; Female; Humans; Levodopa; Pituitary Neoplasms; Prolactin | 1980 |
[Bromocryptin in obstetrics and gynecology].
Topics: Acromegaly; Adenoma; Amenorrhea; Bromocriptine; Female; Galactorrhea; Genital Diseases, Female; Humans; Lactation; Lactation Disorders; Ovary; Pituitary Neoplasms; Pregnancy; Premenstrual Syndrome; Prolactin; Puerperal Disorders; Syndrome; Teratogens | 1980 |
Pituitary surgery for endocrine disorders.
Topics: Acromegaly; Adenoma; Bromocriptine; Cushing Syndrome; Endocrine System Diseases; Female; Humans; Male; Methods; Nelson Syndrome; Pituitary Gland; Pituitary Neoplasms; Postoperative Period; Prednisolone; Prolactin; Radiography | 1980 |
Dilemmas in the management of functioning pituitary tumours.
Topics: Adenoma; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Prolactin | 1981 |
Prolactin. Physiology, pharmacology and clinical findings.
Topics: Animals; Bromocriptine; Female; Fertility; Humans; Lactation; Male; Pituitary Gland; Pituitary Neoplasms; Pregnancy; Prolactin; Rats; Sella Turcica | 1982 |
[Pregnancy and puerperium after treated hyperprolactinemia].
Topics: Abortion, Therapeutic; Amenorrhea; Bromocriptine; Edema; Female; Humans; Infant, Newborn; Lactation; Pituitary Neoplasms; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy in Diabetics; Prolactin; Vision Disorders | 1982 |
Management of acromegaly: a review.
Topics: Acromegaly; Adenoma; Bromocriptine; Growth Hormone; Humans; Octreotide; Pituitary Neoplasms; Radiotherapy, High-Energy | 1994 |
Bromocriptine-induced cerebrospinal fluid fistula in patients with macroprolactinomas: report of three cases and a review of the literature.
Topics: Adult; Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Female; Fistula; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Tomography, X-Ray Computed | 1994 |
[Massive intraventricular hemorrhage from prolactinoma during bromocriptine therapy: case report].
Topics: Administration, Oral; Bromocriptine; Cerebral Hemorrhage; Cerebral Ventricles; Humans; Male; Middle Aged; Pituitary Apoplexy; Pituitary Neoplasms; Prolactinoma | 1994 |
[Thyrotropin secreting adenoma].
Topics: Adenoma; Bromocriptine; Combined Modality Therapy; Humans; Octreotide; Pituitary Gland; Pituitary Neoplasms; Thyrotropin | 1993 |
[The treatment of prolactinomas during pregnancy and the lactation period].
Topics: Bromocriptine; Dopamine Agonists; Female; Humans; Hypophysectomy; Lactation Disorders; Pituitary Irradiation; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma | 1996 |
[The therapy of a macroprolactinoma with the intramuscular application of a long-acting bromocriptine preparation].
Topics: Adult; Bromocriptine; Delayed-Action Preparations; Dopamine Agonists; Female; Humans; Injections, Intramuscular; Pituitary Neoplasms; Prolactin; Prolactinoma; Remission Induction; Time Factors | 1996 |
Diagnosis and drug therapy of prolactinoma.
Topics: Bromocriptine; Dopamine Agonists; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactin; Prolactinoma | 1996 |
[Prolactinoma; diagnosis and treatment].
Topics: Algorithms; Bromocriptine; Combined Modality Therapy; Dopamine Agonists; Hormone Antagonists; Humans; Pituitary Neoplasms; Prolactinoma | 1996 |
Pituitary corticotroph macrotumors. Diagnosis and treatment.
Topics: Adenoma; Animals; Bromocriptine; Dog Diseases; Dogs; Dopamine Agonists; Mitotane; Monoamine Oxidase Inhibitors; Octreotide; Pituitary Gland, Anterior; Pituitary Neoplasms; Radiotherapy; Somatostatin | 1997 |
Nerve growth factor suppresses the tumoral phenotype of human prolactinomas.
Topics: Animals; Bromocriptine; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Nerve Growth Factors; Phenotype; Pituitary Neoplasms; Prolactinoma; Tumor Cells, Cultured | 1997 |
[Homeoproteins and pituitary adenoma].
Topics: Adenoma; Animals; Bromocriptine; Dopamine Agonists; Drug Resistance, Neoplasm; Growth Hormone; Homeodomain Proteins; Humans; Mice; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Transcription Factors | 1997 |
[Quinagolide and macroprolactinomas a progress?].
Topics: Aminoquinolines; Bromocriptine; Dopamine Agonists; Drug Resistance, Neoplasm; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma | 1997 |
[Invasive giant prolactinoma].
Topics: Adult; Bromocriptine; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasms, Second Primary; Pituitary Neoplasms; Prolactinoma; Skull Base Neoplasms | 1998 |
Diagnosis and treatment of prolactinomas.
Topics: Bromocriptine; Female; Fetus; Hormone Antagonists; Humans; Hyperprolactinemia; Male; Neurosecretion; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma | 1999 |
Malignant prolactinoma: case report and review of the literature.
Topics: Antineoplastic Agents; Bromocriptine; Chemotherapy, Adjuvant; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Hormone-Dependent; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiotherapy, Adjuvant; Tomography, X-Ray Computed | 1999 |
Medical treatment of prolactinomas.
Topics: Animals; Bromocriptine; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Neurosecretory Systems; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma | 1999 |
CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas.
Topics: Adult; Bromocriptine; Cabergoline; Cerebrospinal Fluid Rhinorrhea; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Tomography, X-Ray Computed | 2000 |
Prolactin secreting pituitary adenomas: analysis of 429 surgically treated patients, effect of adjuvant treatment modalities and review of the literature.
Topics: Bromocriptine; Chemotherapy, Adjuvant; Combined Modality Therapy; Humans; Hypophysectomy; Injections, Intralesional; Neoplasm Invasiveness; Pituitary Irradiation; Pituitary Neoplasms; Prolactinoma; Radiotherapy, Adjuvant; Treatment Outcome | 1999 |
Pituitary adenomas: results of 684 surgically treated patients and review of the literature.
Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up Studies; Hormones, Ectopic; Humans; Hypophysectomy; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pituitary Gland; Pituitary Irradiation; Pituitary Neoplasms; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome | 2000 |
Prolactinoma and pregnancy.
Topics: Bromocriptine; Dopamine Agonists; Female; Hormone Antagonists; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma | 2000 |
Acromegaly.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Child; Follow-Up Studies; Humans; Hypophysectomy; Male; Pituitary Neoplasms; Postoperative Care; Radiotherapy Dosage; Time Factors | 2001 |
Dopamine receptor agonists for treating prolactinomas.
Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Ergot Alkaloids; Female; Humans; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma | 2002 |
Review: human prolactin--recent advances in physiology and therapy.
Topics: Adenoma; Adult; Amenorrhea; Animals; Bromocriptine; Child; Erectile Dysfunction; Female; Galactorrhea; Humans; Hypothalamus; Infant; Infant, Newborn; Kidney; Male; Pituitary Gland, Anterior; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactin Release-Inhibiting Factors; Receptors, Cell Surface; Thyrotropin-Releasing Hormone | 1977 |
[Hyperprolactinism and antiprolactin drugs].
Topics: Adenoma; Amenorrhea; Bromocriptine; Dihydroxyphenylalanine; Estrogens; Female; Galactorrhea; Humans; Hypogonadism; Male; Pituitary Neoplasms; Postpartum Period; Pregnancy; Prolactin | 1977 |
[Hyperprolactinemia. Pathophysiology, clinical significance, therapy].
Topics: Adenoma; Amenorrhea; Bromocriptine; Endocrine System Diseases; Female; Humans; Lactation Disorders; Male; Pituitary Diseases; Pituitary Neoplasms; Pregnancy; Prolactin; Syndrome | 1977 |
Prolactin.
Topics: Amenorrhea; Animals; Behavior, Animal; Breast Neoplasms; Bromocriptine; Estrogens; Female; Galactorrhea; Growth Hormone; Humans; Levodopa; Male; Pituitary Neoplasms; Pregnancy; Prolactin; Rats; Stress, Physiological; Tranquilizing Agents | 1978 |
Drug therapy: Bromocriptine.
Topics: Acromegaly; Adenoma; Amantadine; Bromocriptine; Female; Galactorrhea; Growth Hormone; Humans; Infertility; Lactation; Levodopa; Male; Parkinson Disease; Pituitary Neoplasms; Pregnancy; Prolactin | 1979 |
The treatment of acromegaly.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Growth Hormone; Humans; Pituitary Irradiation; Pituitary Neoplasms; Prolactin | 1979 |
Prolactin.
Topics: Age Factors; Animals; Bromocriptine; Circadian Rhythm; Feedback; Female; Fetus; Growth; Humans; Hypogonadism; Male; Menopause; Menstruation; Menstruation Disturbances; Pituitary Hormone Release Inhibiting Hormones; Pituitary Neoplasms; Pregnancy; Prolactin; Puberty; Rats; Serotonin; Sex Factors; Thyrotropin-Releasing Hormone | 1977 |
D2 dopaminergic receptors: normal and abnormal transduction mechanisms.
Topics: Arachidonic Acid; Bromocriptine; Calcium; Drug Resistance; GTP-Binding Proteins; Humans; Pituitary Neoplasms; Prolactinoma; Receptors, Dopamine D2; Signal Transduction | 1992 |
Hyperprolactinemia. Evaluation and management.
Topics: Aminoquinolines; Animals; Bromocriptine; Dopamine Agents; Female; Humans; Hyperprolactinemia; Infertility; Ovary; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma | 1992 |
Dopamine agonists and pituitary tumor shrinkage.
Topics: Adenoma; Bromocriptine; Cell Division; Dopamine Agents; Female; Humans; Male; Meta-Analysis as Topic; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma | 1992 |
Treatment of acromegaly with dopamine agonists.
Topics: Acromegaly; Adenoma; Bromocriptine; Dopamine Agents; Growth Hormone; Humans; Pituitary Gland, Anterior; Pituitary Neoplasms | 1992 |
[Clinical aspects, morphology and biology of prolactinomas after therapy with dopamine agonists. A review of the literature].
Topics: Animals; Bromocriptine; Combined Modality Therapy; Humans; Hypophysectomy; Microscopy, Electron; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactinoma | 1992 |
Proceedings of the workshop, "Practical approaches to the diagnosis and treatment of acromegaly".
Topics: Acromegaly; Adenoma; Bromocriptine; Cholelithiasis; Dopamine; Humans; Octreotide; Pituitary Neoplasms | 1992 |
[Hyperprolactinemia].
Topics: Bromocriptine; Dopamine Agents; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Prolactinoma | 1991 |
Positron emission tomography applied in the study of pituitary adenomas.
Topics: Adenoma; Amino Acids; Animals; Bromocriptine; Dopamine Antagonists; Humans; Macaca mulatta; Methionine; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiography; Receptors, Dopamine; Receptors, Dopamine D2; Tamoxifen; Tomography, Emission-Computed | 1991 |
[Drug therapy of pituitary tumors].
Topics: Bromocriptine; Cushing Syndrome; Cyproheptadine; Female; Humans; Male; Metyrapone; Octreotide; Pituitary Neoplasms; Prolactinoma | 1991 |
The medical treatment of prolactin and growth hormone-secreting pituitary tumours.
Topics: Bromocriptine; Dopamine Agents; Growth Hormone; Humans; Octreotide; Pituitary Neoplasms; Prolactin; Prolactinoma | 1990 |
Management of prolactinoma.
Topics: Bromocriptine; Humans; Hyperprolactinemia; Male; Osteoporosis; Pituitary Neoplasms; Prolactinoma | 1990 |
Management of prolactinomas.
Topics: Bromocriptine; Combined Modality Therapy; Female; Humans; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma | 1991 |
[Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
Topics: Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Prolactinoma | 1989 |
Pituitary adenocarcinoma in an acromegalic patient: response to bromocriptine and pituitary testing: a review of the literature on 36 cases of pituitary carcinoma.
Topics: Acromegaly; Adenocarcinoma; Animals; Bromocriptine; Cricetinae; Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Pituitary Neoplasms | 1989 |
Medical treatment of pituitary adenomas: effects on tumor growth.
Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Dihydroergotoxine; Dopamine; Drug Administration Schedule; Ergolines; Growth Hormone; Levodopa; Lisuride; Metergoline; Methysergide; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1985 |
Pituitary tumors.
Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Corticotropin-Releasing Hormone; Dexamethasone; Follicle Stimulating Hormone; Glucose; Gonadotropin-Releasing Hormone; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin-Like Growth Factor I; Luteinizing Hormone; Pituitary Neoplasms; Prolactin; Somatostatin; Thyrotropin; Thyrotropin-Releasing Hormone; Tomography, X-Ray Computed | 1985 |
[Differential diagnosis of hyperprolactinemia].
Topics: Adenoma; Bromocriptine; Diagnosis, Differential; Humans; Hyperprolactinemia; Levodopa; Nomifensine; Pituitary Neoplasms; Prolactin; Prolactin Release-Inhibiting Factors; Thyrotropin-Releasing Hormone | 1986 |
The treatment of acromegaly.
Topics: Acromegaly; Adenoma; Bromocriptine; Dietary Carbohydrates; Growth Hormone; Humans; Hypogonadism; Pituitary Neoplasms; Radiation Dosage; Radiation Injuries; Somatostatin; Surgical Procedures, Operative; Tomography, X-Ray Computed | 1986 |
Hyperprolactinemia in nonpregnant women due to pituitary tumors.
Topics: Adenoma; Amenorrhea; Animals; Bone Diseases; Bromocriptine; Circadian Rhythm; Dopamine; Estrogens; Female; Galactorrhea; Humans; Hyperprolactinemia; Infertility, Female; Lactation; Ovary; Pituitary Gland, Anterior; Pituitary Neoplasms; Pregnancy; Prolactin; Receptors, Cell Surface; Receptors, Dopamine; Receptors, Prolactin; Thyrotropin-Releasing Hormone | 1986 |
[Drug and radiotherapy of pituitary tumors].
Topics: Acromegaly; Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Cushing Syndrome; Cyproheptadine; Growth Hormone; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Reserpine; Valproic Acid | 1986 |
Recent advances in diagnosis and treatment of pituitary tumors.
Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Combined Modality Therapy; Female; Growth Hormone; Humans; Infertility, Female; Male; Pituitary Neoplasms; Pregnancy; Prolactin; Tomography, X-Ray Computed | 1987 |
Diagnosis and management of hyperprolactinemia.
Topics: Bromocriptine; Combined Modality Therapy; Female; Humans; Hyperprolactinemia; Hypophysectomy; Male; Pituitary Neoplasms; Prolactin | 1988 |
Pregnancy in the hyperprolactinaemic patient.
Topics: Adenoma; Animals; Bromocriptine; Female; Humans; Hyperprolactinemia; Infant, Newborn; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Rats; Thyrotropin-Releasing Hormone | 1986 |
[Current problems of hyperprolactinemia. II. Selection and systematization of the treatment].
Topics: Bromocriptine; Dopamine Antagonists; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Thyroidectomy | 1987 |
Prolactinomas: medical or surgical treatment?
Topics: Adenoma; Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Pregnancy; Prolactin | 1987 |
The safety of bromocriptine in long-term use: a review of the literature.
Topics: Acromegaly; Adenoma; Bromocriptine; Female; Fetus; Humans; Male; Parkinson Disease; Pituitary Hormones; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Time Factors | 1986 |
The safety of bromocriptine in hyperprolactinaemic female infertility: a literature review.
Topics: Abnormalities, Drug-Induced; Adenoma; Bromocriptine; Endocrine Glands; Female; Humans; Hyperprolactinemia; Infant; Infertility, Female; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prolactin; Risk; Time Factors | 1986 |
[Morphology of pituitary neoplasms].
Topics: Adenoma; Bromocriptine; Diagnosis, Differential; Growth Hormone; Humans; Hyperplasia; Pituitary Gland; Pituitary Neoplasms; Prolactin | 1986 |
Prolactinoma and bromocriptine therapy.
Topics: Adenoma; Amenorrhea; Bromocriptine; Combined Modality Therapy; Female; Galactorrhea; Humans; Infertility, Female; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1986 |
Management of pituitary tumors.
Topics: Acromegaly; Adenoma; Bromocriptine; Cushing Syndrome; Humans; Nelson Syndrome; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin | 1986 |
Medical treatment of hyperprolactinaemic disorders.
Topics: Acromegaly; Bromocriptine; Delayed-Action Preparations; Dopamine; Ergolines; Female; Humans; Hyperprolactinemia; Lisuride; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Psychoses, Substance-Induced; Tamoxifen | 1986 |
Diagnosis and management of prolactinomas.
Topics: Adenoma; Bromocriptine; Female; Follow-Up Studies; Galactorrhea; Humans; Male; Microscopy, Electron; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Tomography, X-Ray Computed | 1986 |
Effect rates of different modalities for treatment of prolactin adenomas.
Topics: Adenoma; Adult; Bromocriptine; Combined Modality Therapy; Evaluation Studies as Topic; Female; Humans; Male; Neoplasm Recurrence, Local; Pituitary Function Tests; Pituitary Neoplasms; Prolactin | 1985 |
Diagnosis and treatment of hyperprolactinemic syndromes.
Topics: Adenoma; Amenorrhea; Bromocriptine; Diagnosis; Dopamine Antagonists; Female; Galactorrhea; Humans; Hypophysectomy; Ovulation; Pituitary Neoplasms; Pregnancy; Prolactin; Sella Turcica; Syndrome; Tomography, X-Ray Computed | 1985 |
Pregnancy and the hyperprolactinemic woman.
Topics: Adenoma; Anovulation; Bromocriptine; Combined Modality Therapy; Estrogens; Female; Humans; Hypophysectomy; Infertility, Female; Lactation; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Progesterone; Prolactin | 1985 |
Amenorrhea, galactorrhea, and hyperprolactinemia.
Topics: Adenoma; Adolescent; Adult; Amenorrhea; Bromocriptine; Empty Sella Syndrome; Female; Galactorrhea; Humans; Hyperprolactinemia; Hypothyroidism; Lactation Disorders; Male; Pituitary Neoplasms; Prolactin | 1985 |
Prolactinomas.
Topics: Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Prolactin | 1985 |
Cushing's disease. A review.
Topics: Adenoma; Adolescent; Adrenalectomy; Adult; Animals; Bromocriptine; Child; Combined Modality Therapy; Cushing Syndrome; Cyproheptadine; Female; Humans; Hypophysectomy; Male; Microsurgery; Middle Aged; Pituitary Neoplasms; Prognosis; Radiotherapy; Recurrence; Reserpine; Sella Turcica; Valproic Acid | 1985 |
46 trial(s) available for bromocriptine and Pituitary Neoplasms
| Article | Year |
|---|---|
Prolactinomas in infertile women: clinical and endocrine characteristics before and after 24 months of treatment with bromocriptine.
Topics: Adult; Bromocriptine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hormone Antagonists; Humans; Infertility, Female; Pituitary Neoplasms; Prolactin; Prolactinoma; Prospective Studies; Time Factors; Treatment Outcome | 2013 |
Circulating nitric oxide changes throughout the menstrual cycle in healthy women and women affected by pathological hyperprolactinemia on dopamine agonist therapy.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Estradiol; Female; Humans; Hyperprolactinemia; Luteal Phase; Menstrual Cycle; Nitric Oxide; Ovulation; Pituitary Neoplasms; Progesterone; Prolactinoma; Reference Values | 2002 |
Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function.
Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Follicle Stimulating Hormone; Humans; Hypopituitarism; Luteinizing Hormone; Male; Middle Aged; Pergolide; Pituitary Function Tests; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone; Thyrotropin | 2002 |
Bromocriptine treatment of invasive giant prolactinomas involving the cavernous sinus: results of a long-term follow up.
Topics: Adolescent; Adult; Bromocriptine; Cavernous Sinus; Dopamine Agonists; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Treatment Outcome | 2006 |
[Comparative evaluation of effectiveness of treatment of hyperprolactinemia].
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Ergolines; Female; Humans; Hyperprolactinemia; Ovulation; Pituitary Neoplasms; Treatment Outcome | 2007 |
Quality of life in women with microprolactinoma treated with dopamine agonists.
Topics: Adult; Antineoplastic Agents; Brazil; Bromocriptine; Cabergoline; Case-Control Studies; Cross-Sectional Studies; Dopamine Agonists; Ergolines; Female; Health Status Indicators; Humans; Hyperprolactinemia; Middle Aged; Multivariate Analysis; Pituitary Neoplasms; Prolactin; Prolactinoma; Quality of Life; Reproducibility of Results; Surveys and Questionnaires; Treatment Outcome | 2008 |
Comparison of dopamine agonists in the treatment of hyperprolactinemic syndromes: a multicenter study.
Topics: Adolescent; Adult; Aged; Amenorrhea; Bromocriptine; Clinical Trials as Topic; Dopamine; Ergolines; Female; Galactorrhea; Humans; Middle Aged; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Random Allocation | 1983 |
Follow-up of patients with prolactinomas after discontinuation of long-term therapy with bromocriptine.
Topics: Adult; Amenorrhea; Bromocriptine; Clinical Trials as Topic; Female; Follow-Up Studies; Galactorrhea; Humans; Pituitary Neoplasms; Pregnancy; Prolactin; Time Factors | 1983 |
Vasoactive intestinal polypeptide stimulation of prolactin release and renin activity in normal man and patients with hyperprolactinaemia: effects of pretreatment with bromocriptine and dexamethazone.
Topics: Adenoma; Adult; Bromocriptine; Dexamethasone; Female; Heart Rate; Hematocrit; Humans; Male; Pituitary Neoplasms; Prolactin; Renin; Vasoactive Intestinal Peptide | 1984 |
Bromocriptine in management of large pituitary tumours.
Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Female; Growth Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prospective Studies; Vision Disorders; Visual Fields | 1982 |
[Clinical trial of the size reducing effect of bromocriptine on pituitary tumors].
Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Pituitary Neoplasms | 1981 |
Effect of injectable bromocriptine in patients with Cushing's disease.
Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Amenorrhea; Bromocriptine; Corticotropin-Releasing Hormone; Cushing Syndrome; Dopamine Agonists; Female; Humans; Hydrocortisone; Injections, Intramuscular; Male; Middle Aged; Petrosal Sinus Sampling; Pituitary Neoplasms; Prolactin | 1995 |
Effectiveness of a long-acting injectable form of bromocriptine in patients with prolactin and growth hormone secreting macroadenomas.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Delayed-Action Preparations; Drug Administration Schedule; Growth Hormone; Humans; Injections, Intramuscular; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 1995 |
Positive response to compound CV 205-502 in hyperprolactinemic patients resistant to or intolerant of bromocriptine.
Topics: Administration, Oral; Adult; Aminoquinolines; Bromocriptine; Delayed-Action Preparations; Dopamine Agonists; Drug Resistance; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors; Tomography, X-Ray Computed | 1994 |
Long-acting repeatable bromocriptine in the treatment of patients with microprolactinoma intolerant or resistant to oral dopaminergics.
Topics: Administration, Oral; Adult; Bromocriptine; Delayed-Action Preparations; Dopamine Agents; Drug Resistance; Female; Humans; Injections, Intravenous; Longitudinal Studies; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 1994 |
Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
Topics: Administration, Oral; Adolescent; Adult; Aminoquinolines; Bromocriptine; Dopamine Agonists; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Treatment Outcome | 1994 |
Long-term treatment of macroprolactinomas with CV 205-502.
Topics: Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Drug Tolerance; Erectile Dysfunction; Estradiol; Female; Humans; Libido; Longitudinal Studies; Male; Menstruation; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Radioimmunoassay; Sex Hormone-Binding Globulin; Testosterone; Visual Fields | 1993 |
Control of prolactin-secreting macroadenomas with parenteral, long-acting bromocriptine in 30 patients treated for up to 3 years.
Topics: Adolescent; Adult; Aged; Bromocriptine; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors | 1993 |
Comparison among different dopamine-agonists of new formulation in the clinical management of macroprolactinomas.
Topics: Administration, Oral; Adolescent; Adult; Aminoquinolines; Bromocriptine; Dopamine Agonists; Female; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Radioimmunoassay; Reagent Kits, Diagnostic; Tomography, X-Ray Computed | 1995 |
Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine.
Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactinoma | 1996 |
Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.
Topics: Adult; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Treatment Outcome | 2001 |
Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy.
Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Hypopituitarism; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Radioimmunoassay; Retrospective Studies | 2001 |
Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine.
Topics: Adolescent; Adult; Basal Metabolism; Body Weight; Bromocriptine; Dopamine; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Leptin; Male; Middle Aged; Obesity; Pituitary Neoplasms; Prolactin; Prolactinoma | 2002 |
New drugs in the treatment of pituitary disorders.
Topics: Adenoma; Adult; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Erectile Dysfunction; Humans; Libido; Male; Pituitary Diseases; Pituitary Gland, Posterior; Pituitary Hormone Release Inhibiting Hormones; Pituitary Hormone-Releasing Hormones; Pituitary Neoplasms; Stimulation, Chemical; Vision Disorders | 1977 |
Bromocriptine treatment of hyperprolactinaemic hypogonadism.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Female; Follicle Stimulating Hormone; Galactorrhea; Growth Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; Menopause; Middle Aged; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Radiography | 1978 |
Hyperprolactinaemic amenorrhoea--results of treatment with bromocriptine.
Topics: Adult; Amenorrhea; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Radiography | 1978 |
Bromocriptine treatment of 42 hyperprolactinaemic women with secondary amenorrhoea.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Estradiol; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Luteinizing Hormone; Ovulation Induction; Pituitary Neoplasms; Pregnancy; Prolactin | 1978 |
Incidence and significance of hyperprolactinaemia in women with amenorrhea.
Topics: Adult; Amenorrhea; Anorexia Nervosa; Bromocriptine; Clinical Trials as Topic; Contraceptives, Oral; Female; Galactorrhea; Gonadotropins; Humans; Hypophysectomy; Obesity; Ovarian Diseases; Pituitary Neoplasms; Pregnancy; Prolactin | 1975 |
New long-acting bromocriptine (Parlodel MR and Parlodel LAR) in the treatment of pituitary tumours with hyperprolactinemia.
Topics: Adult; Bromocriptine; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Visual Fields | 1992 |
Mixed pituitary tumours--effects of bromocriptine treatment: Parlodel MR and Parlodel LAR.
Topics: Adult; Bromocriptine; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Mixed Tumor, Malignant; Pituitary Hormones; Pituitary Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 1992 |
The efficacy and tolerability of CV 205-502 (a nonergot dopaminergic drug) in macroprolactinoma patients and in prolactinoma patients intolerant to bromocriptine.
Topics: Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Tolerance; Female; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors | 1991 |
[Treatment of prolactinoma with a new dopamine agonist].
Topics: Adult; Aged; Aminoquinolines; Bromocriptine; Dopamine Agents; Female; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors | 1991 |
A long-acting repeatable form of bromocriptine as long-term treatment of prolactin-secreting macroadenomas: a multicenter study.
Topics: Adenoma; Adult; Bromocriptine; Delayed-Action Preparations; Drug Administration Schedule; Female; Follow-Up Studies; Galactorrhea; Humans; Infertility, Female; Injections, Intramuscular; Menstrual Cycle; Microspheres; Pituitary Neoplasms; Prolactin | 1992 |
Chronic treatment with parlodel LAR of patients with prolactin-secreting tumours. Different responsiveness of micro- and macroprolactinomas.
Topics: Adolescent; Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Female; Humans; Injections; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 1991 |
Efficacy and tolerability of a long-acting intramuscularly injectable depot preparation of bromocriptine: the results of a double blind study.
Topics: Adolescent; Adult; Bromocriptine; Double-Blind Method; Female; Humans; Hyperprolactinemia; Injections, Intramuscular; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors | 1991 |
[Alternative to bromocriptine (BEC) management in patients with prolactinoma and intolerance to oral BEC].
Topics: Administration, Intravaginal; Adult; Bromocriptine; Drug Evaluation; Female; Humans; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Prospective Studies | 1991 |
[Short-term effect of delayed-action injectable bromocriptine in macroprolactinoma. French multicenter study].
Topics: Adult; Bromocriptine; Delayed-Action Preparations; Drug Administration Schedule; Drug Tolerance; Female; France; Humans; Injections, Intramuscular; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma | 1991 |
Hyperprolactinaemia--a clinical study with special reference to long-term follow-up, treatment with dopamine agonists, and pregnancy.
Topics: Adolescent; Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Menstruation; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Radiography; Sella Turcica | 1990 |
A comparison of the efficacy and safety of pergolide and bromocriptine in the treatment of hyperprolactinemia.
Topics: Adult; Amenorrhea; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy; Female; Galactorrhea; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Radiography | 1991 |
Rapid and long-lasting suppression of prolactin secretion and shrinkage of prolactinomas after injection of long-acting repeatable form of bromocriptine (Parlodel LAR).
Topics: Adolescent; Adult; Bromocriptine; Delayed-Action Preparations; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Tomography, X-Ray Computed; Visual Fields | 1990 |
Light microscopical morphometry of prolactin secreting adenomas under treatment with dopamine agonists.
Topics: Adult; Aged; Bromocriptine; Combined Modality Therapy; Female; Humans; Immunohistochemistry; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 1987 |
Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapy
Topics: Adult; Aged; Aldosterone; Blood Pressure; Bromocriptine; Catecholamines; Dopamine; Female; Humans; Kidney; Male; Middle Aged; Norepinephrine; Pergolide; Pituitary Neoplasms; Prolactin; Renin; Stimulation, Chemical | 1988 |
Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including pre-operative bromocriptine therapy.
Topics: Adenoma; Adult; Aged; Bromocriptine; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Pituitary Gland, Anterior; Pituitary Neoplasms; Postoperative Complications; Prolactin | 1987 |
Effect of bromocriptine on plasma catecholamines in normal subjects and prolactin-secreting tumor patients.
Topics: Adolescent; Adult; Bromocriptine; Catecholamines; Dopamine; Epinephrine; Female; Humans; Norepinephrine; Pituitary Neoplasms; Prolactin; Receptors, Dopamine | 1986 |
Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study.
Topics: Adenoma; Adult; Bromocriptine; Clinical Trials as Topic; Estradiol; Female; Humans; Male; Middle Aged; Pituitary Function Tests; Pituitary Neoplasms; Prolactin; Testosterone; Tomography, X-Ray Computed; Visual Fields | 1985 |
Treatment of human hyperprolactinaemia with a new dopamine agonist: CU 32085 (mesulergin).
Topics: Administration, Oral; Adolescent; Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Gonads; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Receptors, Dopamine; Tomography, X-Ray Computed | 1985 |
1139 other study(ies) available for bromocriptine and Pituitary Neoplasms
| Article | Year |
|---|---|
Curcumin Sensitizes Prolactinoma Cells to Bromocriptine by Activating the ERK/EGR1 and Inhibiting the AKT/GSK-3β Signaling Pathway In Vitro and In Vivo.
Topics: Animals; Apoptosis; Bromocriptine; Cell Cycle; Cell Line, Tumor; Curcumin; Dopamine Agonists; Glycogen Synthase Kinase 3 beta; Mice; Pituitary Neoplasms; Prolactinoma; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2021 |
The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas.
Topics: Animals; Apoptosis; Bromocriptine; Cell Line, Tumor; Disease Models, Animal; Dopamine Agonists; Drug Resistance; Estradiol; Female; Gene Expression Regulation; Mitogen-Activated Protein Kinase 11; Mitogen-Activated Protein Kinase 12; Mitogen-Activated Protein Kinase 13; Mitogen-Activated Protein Kinase 14; p38 Mitogen-Activated Protein Kinases; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Signal Transduction | 2021 |
ACT001 reverses resistance of prolactinomas via AMPK-mediated EGR1 and mTOR pathways.
Topics: AMP-Activated Protein Kinases; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Cabergoline; Drug Resistance, Neoplasm; Drug Synergism; Early Growth Response Protein 1; Furans; Humans; Pituitary Neoplasms; Prolactinoma; TOR Serine-Threonine Kinases | 2021 |
Dopamine agonist for the rapid improvement of visual field defects in giant and macro-prolactinomas.
Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Female; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Vision Disorders; Visual Fields | 2022 |
Surgery as a first-line option for prolactinomas.
Topics: Bromocriptine; Dopamine Agonists; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactinoma | 2022 |
Long-term low-dose cabergoline usage: Another association with cardiac valvulopathy.
Topics: Bromocriptine; Cabergoline; Ergolines; Heart Valve Diseases; Humans; Middle Aged; Pituitary Neoplasms | 2023 |
Italian Guidelines for the Management of Prolactinomas.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Pituitary Neoplasms; Prolactin; Prolactinoma | 2023 |
Remission of Recurrent Cochlear Hydrops Associated With Bromocriptine Treatment for Macroprolactinoma.
Topics: Adult; Audiometry, Pure-Tone; Bromocriptine; Cochlear Diseases; Diuretics; Furosemide; Glucocorticoids; Hearing Loss, Sensorineural; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Pituitary Neoplasms; Prolactinoma; Recurrence | 2019 |
An observational study of pregnancy and post-partum outcomes in women with prolactinoma treated with dopamine agonists.
Topics: Abortion, Spontaneous; Adenoma; Adolescent; Adult; Bromocriptine; Cabergoline; Cohort Studies; Dopamine Agonists; Female; Humans; Infertility; Lactation; Pituitary Neoplasms; Postpartum Period; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma; Retrospective Studies; Young Adult | 2020 |
Notable effect of bromocriptine monotherapy on macroprolactinoma with self-limited cerebrospinal fluid rhinorrhea.
Topics: Adult; Anti-Bacterial Agents; Bromocriptine; Cefdinir; Cerebrospinal Fluid Rhinorrhea; Dopamine Agonists; Humans; Male; Pituitary Neoplasms; Poland; Prolactinoma; Treatment Outcome; Young Adult | 2019 |
Giant Pituitary Adenoma Presenting with Foster-Kennedy Syndrome in a 21-Year Old Ethiopian Patient: A Rarely Reported Phenomenon: A Case Report.
Topics: Adult; Brain; Bromocriptine; Diagnosis, Differential; Dopamine Agonists; Ethiopia; Humans; Magnetic Resonance Imaging; Male; Optic Nerve Diseases; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Young Adult | 2020 |
Pimozide augments bromocriptine lethality in prolactinoma cells and in a xenograft model via the STAT5/cyclin D1 and STAT5/Bcl‑xL signaling pathways.
Topics: Animals; bcl-X Protein; Bromocriptine; Cell Line, Tumor; Cyclin D1; Humans; Mice; Mice, Nude; Pimozide; Pituitary Neoplasms; Prolactinoma; Rats; Signal Transduction; STAT5 Transcription Factor; Xenograft Model Antitumor Assays | 2021 |
Estrogen receptor α/prolactin receptor bilateral crosstalk promotes bromocriptine resistance in prolactinomas.
Topics: Adolescent; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Cell Line, Tumor; Cyclin D1; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Hypophysectomy; Male; MAP Kinase Signaling System; Middle Aged; Neoplasm Recurrence, Local; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Receptors, Prolactin; Young Adult | 2020 |
Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
Topics: Acromegaly; Adult; Antineoplastic Agents, Hormonal; Bromocriptine; Chemotherapy, Adjuvant; Female; Growth Hormone-Secreting Pituitary Adenoma; Hormone Antagonists; Humans; Insulin-Like Growth Factor I; Logistic Models; Male; Microsurgery; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neuroendoscopy; Neurosurgical Procedures; Pituitary Neoplasms; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Reoperation; Retrospective Studies; Sex Factors; Sphenoid Sinus; Treatment Failure; Treatment Outcome; Tumor Burden | 2021 |
Genomic and transcriptomic analysis of pituitary adenomas reveals the impacts of copy number variations on gene expression and clinical prognosis among prolactin-secreting subtype.
Topics: Adenoma; Adult; Aged; Bromocriptine; Cell Proliferation; DNA Copy Number Variations; Dopamine Agonists; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genomics; Growth Hormone-Secreting Pituitary Adenoma; Humans; Male; Middle Aged; Neoplasm Invasiveness; Oncogene Proteins v-erbB; Organelle Biogenesis; Pituitary Neoplasms; Prognosis; Prolactin; Prolactinoma; Proto-Oncogene Proteins c-myc; Ribosomes; RNA-Seq; Signal Transduction; TOR Serine-Threonine Kinases; Transaminases; Whole Genome Sequencing; Young Adult | 2020 |
Combined treatment with artesunate and bromocriptine has synergistic anticancer effects in pituitary adenoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; Autophagy; Bromocriptine; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Humans; MicroRNAs; Pituitary Hormones; Pituitary Neoplasms; PTEN Phosphohydrolase | 2017 |
Pregnancy and Tumor Outcomes in Women with Prolactinoma.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Outcome Assessment, Health Care; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma; Retrospective Studies; Young Adult | 2017 |
Remarkable remission of an invasive giant prolactinoma under high-dose bromocriptine monotherapy.
Topics: Adult; Antineoplastic Agents; Bromocriptine; Humans; Male; Pituitary Neoplasms; Prolactinoma; Treatment Outcome | 2017 |
Failure of a second temozolomide cycle in a patient with a prolactin-secreting pituitary carcinoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bromocriptine; Cabergoline; Combined Modality Therapy; Dacarbazine; Drug Substitution; Ergolines; Fatal Outcome; Headache; Humans; Hyperprolactinemia; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Prolactinoma; Proton Therapy; Temozolomide | 2017 |
Pituitary xanthogranulomas: clinical features, radiological appearances and post-operative outcomes.
Topics: Adolescent; Adult; Bromocriptine; Child; Dopamine Agonists; Female; Humans; Male; Middle Aged; Pituitary Diseases; Pituitary Gland; Pituitary Neoplasms; Prospective Studies; Retrospective Studies; Young Adult | 2018 |
Combination Treatment with Bromocriptine and Metformin in Patients with Bromocriptine-Resistant Prolactinomas: Pilot Study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Female; Humans; Male; Metformin; Pituitary Neoplasms; Prolactin; Prolactinoma | 2018 |
Analysis of bromocriptine treatment in pregnant pituitary prolactinoma patients.
Topics: Adult; Bromocriptine; China; Chorionic Gonadotropin; Drug Monitoring; Female; Fetal Development; Hormone Antagonists; Humans; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Progesterone; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome | 2017 |
Developed diplopia due to a pituitary macroadenoma during pregnancy.
Topics: Adenoma; Adult; Bromocriptine; Diplopia; Female; Headache; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Vision Disorders | 2018 |
Giant Prolactinomas: Outcomes of Multimodal Treatments for 42 Cases with Long-Term Follow-Up.
Topics: Adult; Bromocriptine; Combined Modality Therapy; Dopamine Agonists; Female; Follow-Up Studies; Humans; Male; Outcome Assessment, Health Care; Pituitary Neoplasms; Prolactinoma; Retrospective Studies | 2019 |
Infertility secondary to a pituitary adenoma.
Topics: Adult; Amenorrhea; Bromocriptine; Female; Hormone Antagonists; Humans; Infertility, Female; Magnetic Resonance Imaging; Pituitary Neoplasms | 2018 |
Macroprolactinomas: longitudinal assessment of biochemical and imaging therapeutic responses.
Topics: Adult; Biomarkers, Tumor; Bromocriptine; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Tumor Burden; Young Adult | 2018 |
Cabergoline for the treatment of bromocriptine-resistant invasive giant prolactinomas.
Topics: Adolescent; Adult; Bromocriptine; Cabergoline; Drug Resistance, Neoplasm; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Treatment Failure; Tumor Burden; Young Adult | 2018 |
Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1.
Topics: Adolescent; Adult; Animals; Apoptosis; Biomarkers, Tumor; Bromocriptine; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Humans; Male; Mice, Nude; MicroRNAs; Middle Aged; Pituitary Neoplasms; Prognosis; Prolactinoma; Tumor Cells, Cultured; Tumor Protein, Translationally-Controlled 1; Xenograft Model Antitumor Assays; Young Adult | 2019 |
Clinical Characteristics of Acromegalic Patients With Paradoxical GH Response to Oral Glucose Load.
Topics: Acromegaly; Adult; Biomarkers; Bromocriptine; Case-Control Studies; Female; Follow-Up Studies; Gastrointestinal Agents; Glucose; Hormone Antagonists; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Prognosis; Retrospective Studies | 2019 |
Bromocriptine-responsive supersellar germinoma with the expression of dopamine receptors: A case report.
Topics: Brain Neoplasms; Bromocriptine; Dopamine Agonists; Female; Germinoma; Humans; Pituitary Neoplasms; Prolactin; Receptors, Dopamine; Young Adult | 2019 |
miR-93-5p targets Smad7 to regulate the transforming growth factor-β1/Smad3 pathway and mediate fibrosis in drug-resistant prolactinoma.
Topics: Adult; Bromocriptine; Drug Resistance, Neoplasm; Female; Fibrosis; Humans; Male; MicroRNAs; Middle Aged; Pituitary Neoplasms; Prolactinoma; Signal Transduction; Smad3 Protein; Smad7 Protein; Transforming Growth Factor beta1; Up-Regulation | 2019 |
SUCCESSFUL TREATMENT OF A PROLACTINOMA (CASE REPORT).
Topics: Bromocriptine; Dopamine Antagonists; Female; Galactorrhea; Humans; Infertility, Female; Menstruation Disturbances; Pituitary Neoplasms; Pregnancy; Pregnancy Outcome; Prolactin; Prolactinoma; Treatment Outcome; Young Adult | 2019 |
Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively.
Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Bromocriptine; Cabergoline; Cell Line, Tumor; Early Growth Response Protein 1; Extracellular Signal-Regulated MAP Kinases; Female; Mice; Mice, Nude; Microtubule-Associated Proteins; Pituitary Neoplasms; Prolactinoma; Proto-Oncogene Proteins c-akt; Rats; RNA Interference; RNA, Small Interfering; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
Radiographic and Hormonal Regression in Prolactinomas: An Analysis of Treatment Failure.
Topics: Adult; Bromocriptine; Cabergoline; Disease Progression; Dopamine Agonists; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Sex Factors; Treatment Failure; Tumor Burden | 2019 |
Bromocriptine as a Potential Glucose-lowering Agent for the Treatment of Prolactinoma with Type 2 Diabetes.
Topics: Amenorrhea; Bromocriptine; Diabetes Mellitus, Type 2; Female; Galactorrhea; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Young Adult | 2019 |
Suppression of MMQ cells by fulvestrant: possible mechanism of action and potential application for bromocriptine-resistant prolactinomas.
Topics: Adult; Animals; beta Catenin; Bromocriptine; Cell Line; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Hormone Antagonists; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Rats; Young Adult | 2013 |
Diabetic ketoacidosis: an unusual presentation of acromegaly.
Topics: Acromegaly; Adenoma; Bromocriptine; Diabetic Ketoacidosis; Growth Hormone; Humans; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Treatment Outcome | 2013 |
[Effects of bromocriptine on the treatment of prolactinomas in male patients and its influences on their sexual function].
Topics: Adolescent; Adult; Aged; Bromocriptine; Erectile Dysfunction; Hormone Antagonists; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Sexual Dysfunction, Physiological; Testosterone; Young Adult | 2013 |
Gsp mutation in acromegaly and its influence on TRH-induced paradoxical GH response.
Topics: Acromegaly; Adult; Aged; Bromocriptine; Female; Human Growth Hormone; Humans; Male; Middle Aged; Mutation; Octreotide; Pituitary Neoplasms; Polymerase Chain Reaction; Thyrotropin-Releasing Hormone | 2014 |
Low levels of PRB3 mRNA are associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.
Topics: Adolescent; Adult; Base Sequence; Bromocriptine; Chi-Square Distribution; Dopamine Agonists; Eye Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Mucins; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactinoma; Proteins; RNA, Messenger; Salivary Proline-Rich Proteins; Young Adult | 2014 |
Dopamine receptor D2S gene transfer improves the sensitivity of GH3 rat pituitary adenoma cells to bromocriptine.
Topics: Adenoma; Adenoviridae; Animals; Apoptosis; Blotting, Western; Bromocriptine; Cell Line, Tumor; Cell Survival; Female; Gene Transfer Techniques; Green Fluorescent Proteins; Mice; Mice, Nude; Pituitary Neoplasms; Rats; Receptors, Dopamine D2; Transduction, Genetic; Transfection; Xenograft Model Antitumor Assays | 2014 |
Giant macroprolactinoma and pregnancy.
Topics: Adult; Bromocriptine; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Infant, Newborn; Infertility, Female; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Treatment Outcome | 2013 |
An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine.
Topics: Bromocriptine; Female; Granulomatous Mastitis; Hormone Antagonists; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Pituitary Neoplasms; Prednisone; Prolactinoma; Recurrence; Young Adult | 2014 |
Women with prolactinomas presented at the postmenopausal period.
Topics: Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Middle Aged; Pituitary Neoplasms; Postmenopause; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome | 2014 |
Young female with acromegaloid features and pituitary macroadenoma: what is your diagnosis?
Topics: Acanthosis Nigricans; Acromegaly; Adult; Bromocriptine; Cabergoline; Diagnosis, Differential; Ergolines; Female; Gastrointestinal Diseases; Hirsutism; Human Growth Hormone; Humans; Hyperprolactinemia; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prognathism; Prolactinoma | 2014 |
A case of iatrogenic severe mitral regurgitation.
Topics: Antineoplastic Agents; Bromocriptine; Cabergoline; Drug Therapy, Combination; Ergolines; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hormone Antagonists; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Pituitary Neoplasms; Prolactinoma; Treatment Outcome | 2013 |
Endoscopic transsphenoidal treatment of a prolactinoma patient with brain and optic chiasmal herniations.
Topics: Bromocriptine; Dopamine Agonists; Endoscopy; Female; Hernia; Herniorrhaphy; Humans; Neurosurgical Procedures; Optic Chiasm; Pituitary Neoplasms; Prolactinoma; Sella Turcica; Sphenoid Bone; Treatment Outcome; Young Adult | 2014 |
Anti-inflammatory effects of bromocriptine in a patient with autoimmune polyglandular syndrome type 2.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Bromocriptine; Female; Humans; Pituitary Neoplasms; Polyendocrinopathies, Autoimmune; Prolactinoma | 2014 |
Bromocriptine, a dopamine agonist, increases growth hormone secretion in a patient with acromegaly.
Topics: Acromegaly; Aged; Brain; Bromocriptine; Dopamine Agonists; Human Growth Hormone; Humans; Immunohistochemistry; Insulin-Like Growth Factor I; Magnetic Resonance Imaging; Male; Octreotide; Pituitary Neoplasms; Prolactin | 2014 |
The role of TGF-β/Smad signaling in dopamine agonist-resistant prolactinomas.
Topics: Adult; Animals; Antineoplastic Agents; Bromocriptine; Cell Line, Tumor; Dopamine Agonists; Drug Resistance, Neoplasm; Estradiol; Female; Fulvestrant; Humans; Male; Middle Aged; Phosphorylation; Pituitary Neoplasms; Prolactinoma; Protein Processing, Post-Translational; Rats; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Young Adult | 2015 |
[Pituitary apoplexy in a pregnant woman with cystic microprolactinoma].
Topics: Adult; Bromocriptine; Cabergoline; Combined Modality Therapy; Contraindications; Dopamine Agonists; Drug Substitution; Ergolines; Female; Headache; Hormone Replacement Therapy; Humans; Hydrocortisone; Hypophysectomy; Infant, Newborn; Male; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prolactinoma; Thyroxine; Vision Disorders | 2015 |
A sensitive and rapid HPLC-MS/MS method for the quantitative determination of trace amount of bromocriptine in small clinical prolactinoma tissue.
Topics: Bromocriptine; Chromatography, High Pressure Liquid; Dopamine Agonists; Drug Monitoring; Humans; Pituitary Neoplasms; Prolactinoma; Sensitivity and Specificity; Tandem Mass Spectrometry | 2015 |
[Analysis of treating prolactinoma patients with bromocriptine during pregnancy].
Topics: Adenoma; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Progesterone; Prolactin; Prolactinoma; Retrospective Studies | 2015 |
Idiopathic hypertrophic pachymeningitis mimicking prolactinoma with recurrent vision loss.
Topics: Adult; Bromocriptine; Diagnosis, Differential; Female; Hormone Antagonists; Humans; Meningitis; Pituitary Neoplasms; Prolactinoma; Vision Disorders | 2015 |
Endonasal endoscopic transsphenoidal chiasmapexy using a clival cranial base cranioplasty for visual loss from massive empty sella following macroprolactinoma treatment with bromocriptine: case report.
Topics: Bromocriptine; Craniotomy; Empty Sella Syndrome; Endoscopy; Female; Hormone Antagonists; Humans; Middle Aged; Nasal Cavity; Neurosurgical Procedures; Optic Chiasm; Pituitary Neoplasms; Prolactinoma; Skull Base; Sphenoid Bone; Treatment Outcome; Vision Disorders | 2016 |
Sjögren's Syndrome Accompanied by Prolactinoma: a case report and literature review.
Topics: Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Bromocriptine; Dopamine Agonists; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactin; Prolactinoma; Sjogren's Syndrome; Treatment Outcome; Young Adult | 2017 |
Cost-Effectiveness Analysis of Microscopic and Endoscopic Transsphenoidal Surgery Versus Medical Therapy in the Management of Microprolactinoma in the United States.
Topics: Adult; Aged; Bromocriptine; Cabergoline; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Ergolines; Female; Health Care Costs; Hormone Antagonists; Humans; Hyperprolactinemia; Life Expectancy; Male; Medicare; Microsurgery; Middle Aged; Monte Carlo Method; Neuroendoscopy; Pituitary Neoplasms; Prolactinoma; Quality-Adjusted Life Years; Sphenoid Sinus; Time Factors; Treatment Outcome; United States | 2016 |
Fifteen-Year-Old Female With Delayed Progression of Puberty and Visual Disturbances.
Topics: Adolescent; Bromocriptine; Diagnosis, Differential; Dopamine Agonists; Fatigue; Female; Humans; Magnetic Resonance Imaging; Pituitary Gland; Pituitary Neoplasms; Prolactinoma; Puberty, Delayed; Tomography, X-Ray Computed; Vision Disorders | 2016 |
Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas.
Topics: Adolescent; Adult; Aged; Animals; Bromocriptine; Case-Control Studies; Cell Proliferation; Cell Survival; Cells, Cultured; Dopamine Agonists; Drug Resistance, Neoplasm; Female; Gene Knockdown Techniques; Human Umbilical Vein Endothelial Cells; Humans; Male; Middle Aged; Neoplasm Proteins; Neovascularization, Pathologic; Pituitary Neoplasms; Prolactinoma; Proteoglycans; Rats; Young Adult | 2016 |
Pituitary Prolactinoma Imaged by 99mTc-Sestamibi SPECT/CT in a Multiple Endocrine Neoplasia Type 1 Patient.
Topics: Adult; Bromocriptine; Female; Hormone Antagonists; Humans; Hypercalcemia; Hyperinsulinism; Hyperparathyroidism, Primary; Hyperprolactinemia; Magnetic Resonance Imaging; Multiple Endocrine Neoplasia Type 1; Parathyroid Glands; Parathyroidectomy; Pituitary Neoplasms; Prolactinoma; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Sestamibi | 2016 |
Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?
Topics: Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Deprescriptions; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Selection; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Time Factors; Tumor Burden; Young Adult | 2016 |
Prolactinomas: evolution after menopause.
Topics: Adenoma; Adult; Bromocriptine; Cabergoline; Disease Progression; Dopamine Agonists; Ergolines; Female; Humans; Menopause; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome; Withholding Treatment | 2016 |
Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas.
Topics: Adolescent; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Child; Ergolines; Female; Galactorrhea; Headache; Hormone Antagonists; Humans; Male; Middle Aged; Neurosurgical Procedures; Pituitary Neoplasms; Prolactinoma; Sexual Dysfunction, Physiological; Treatment Outcome; Tumor Burden; Vision Disorders; Young Adult | 2016 |
Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists.
Topics: Adenoma; Adult; Aged; Bromocriptine; Cabergoline; Disease Progression; Dopamine Agonists; Ergolines; Female; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Receptors, Dopamine; Receptors, Estrogen; Treatment Outcome | 2016 |
Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Bromocriptine; Cell Line, Tumor; Dopamine Agonists; Female; Gene Expression; Gene Knockdown Techniques; Humans; Male; Middle Aged; Neoplasm Grading; Pituitary Neoplasms; Prolactin; Prolactinoma; Proteolysis; S-Phase Kinase-Associated Proteins; Tumor Burden; Tumor Suppressor Protein p53; Ubiquitination | 2017 |
Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists.
Topics: Adult; Aged; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hypogonadism; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Sexual Dysfunction, Physiological | 2017 |
SURGICAL OUTCOMES OF PROLACTINOMAS IN RECENT ERA: RESULTS OF A HETEROGENOUS GROUP.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurosurgical Procedures; Pituitary Neoplasms; Prolactinoma; Remission Induction; Retrospective Studies; Treatment Failure; Treatment Outcome; Tumor Burden; Young Adult | 2017 |
10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; Humans; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome; Young Adult | 2017 |
Bromoderma in a pituitary adenoma patient treated with bromocriptine.
Topics: Adenoma; Administration, Topical; Aged; Anti-Infective Agents, Local; Bromocriptine; Clobetasol; Drug Eruptions; Glucocorticoids; Humans; Male; Pituitary Neoplasms; Silver Sulfadiazine; Skin Ulcer | 2017 |
Prolactinoma and pregnancy - a series of cases including pituitary apoplexy.
Topics: Adult; Breast Feeding; Bromocriptine; Cesarean Section; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Infant, Newborn; Magnetic Resonance Imaging; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Retrospective Studies; Withholding Treatment | 2017 |
Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
Topics: Adenoma; Adult; Amenorrhea; Antineoplastic Agents; Bromocriptine; Cabergoline; Case-Control Studies; Cesarean Section; Dopamine Agonists; Ergolines; Female; Galactorrhea; Humans; Incidence; Pituitary Neoplasms; Pre-Eclampsia; Preconception Care; Pregnancy; Pregnancy Complications, Neoplastic; Premature Birth; Prolactinoma; Prospective Studies; Stillbirth; United Kingdom; Vision Disorders; Young Adult | 2017 |
MRI follow-up is unnecessary in patients with macroprolactinomas and long-term normal prolactin levels on dopamine agonist treatment.
Topics: Adult; Aminoquinolines; Belgium; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; France; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies | 2017 |
Bromocriptine Induces Autophagy-Dependent Cell Death in Pituitary Adenomas.
Topics: Adenoma; Adult; Aged; Animals; Autophagy; Bromocriptine; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Hormone Antagonists; Humans; Male; Middle Aged; Pituitary Neoplasms; Rats | 2017 |
An Economic Analysis of Bromocriptine Versus Trans-Sphenoidal Surgery for the Treatment of Prolactinoma.
Topics: Adult; Bromocriptine; Cost-Benefit Analysis; Dopamine Agonists; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Young Adult | 2017 |
Immunohistochemical expression of SNAP-25 protein in adenomas of the human pituitary.
Topics: Adenoma; Bromocriptine; Human Growth Hormone; Humans; Immunohistochemistry; Octreotide; Pituitary Neoplasms; Prolactin; Synaptosomal-Associated Protein 25 | 2008 |
[Cost-effectiveness analysis of two therapeutic methods for prolactinoma].
Topics: Adult; Bromocriptine; Cost-Benefit Analysis; Female; Humans; Hypophysectomy; Markov Chains; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Prospective Studies; Retrospective Studies; Treatment Outcome; Young Adult | 2008 |
Polycystic ovary syndrome and prolactinoma association.
Topics: Adult; Bromocriptine; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Polycystic Ovary Syndrome; Prolactinoma; Treatment Outcome | 2009 |
Rab3B immunoexpression in human pituitary adenomas.
Topics: Adenoma; Bromocriptine; Humans; Octreotide; Pituitary Gland; Pituitary Neoplasms; rab3 GTP-Binding Proteins | 2009 |
Bromocriptine induces parapoptosis as the main type of cell death responsible for experimental pituitary tumor shrinkage.
Topics: Animals; Apoptosis; Bromocriptine; Cell Death; Male; MAP Kinase Kinase 2; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Pituitary Neoplasms; Prolactinoma; Protein Kinase C-delta; Rats; Rats, Wistar | 2009 |
Non-surgical management of cystic prolactinomas.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Follow-Up Studies; Gadolinium; Hormones; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Young Adult | 2009 |
Bilateral SUNCT-like headache in a patient with prolactinoma responsive to lamotrigine.
Topics: Bromocriptine; Calcium Channel Blockers; Female; Functional Laterality; Hormone Antagonists; Humans; Lamotrigine; Magnetic Resonance Imaging; Pituitary Gland; Pituitary Neoplasms; Prolactinoma; SUNCT Syndrome; Treatment Outcome; Triazines; Young Adult | 2009 |
Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation with the response to bromocriptine and with tumor biological behavior.
Topics: Adult; Bromocriptine; Drug Resistance, Neoplasm; Endoscopy; Female; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Prospective Studies; Protein Isoforms; Receptors, Dopamine D2; Receptors, Estrogen; Retrospective Studies; RNA, Messenger; Statistics as Topic; Statistics, Nonparametric; Young Adult | 2010 |
Immunohistochemical expression of pituitary tumor transforming gene (PTTG) in pituitary adenomas: a correlative study of tumor subtypes.
Topics: Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Bromocriptine; Hormone Antagonists; Humans; Immunoenzyme Techniques; Neoplasm Proteins; Octreotide; Pituitary Neoplasms; Securin | 2010 |
[Clinical and therapeutic particularities of depression associated with pituitary adenoma].
Topics: Adenoma; Adult; Bromocriptine; Depressive Disorder, Major; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Pituitary Neoplasms | 2009 |
Lactation associated with a pituitary tumour in a man.
Topics: Adult; Bromocriptine; Erectile Dysfunction; Female; Galactorrhea; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma | 2010 |
Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
Topics: Adult; Birth Weight; Bromocriptine; Cabergoline; Cohort Studies; Dopamine Agonists; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Progesterone; Prolactin; Prolactinoma | 2010 |
Management of pituitary macroprolactinoma in a 27-year-old male patient from Taiwan.
Topics: Adult; Bromocriptine; Dopamine Agonists; Humans; Male; Pituitary Neoplasms; Prolactinoma | 2010 |
Effect of dopaminergic drug treatment on surgical findings in prolactinomas.
Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Child; Dopamine Agents; Ergolines; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Young Adult | 2011 |
Clinical management and outcome of 36 invasive prolactinomas treated with dopamine agonist.
Topics: Adult; Bromocriptine; Dopamine Agonists; Female; Headache; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Perceptual Disorders; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Sexual Dysfunction, Physiological; Visual Fields; Young Adult | 2011 |
Management of a patient with schizophrenia and underlying pituitary macroadenoma.
Topics: Adenoma; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bromocriptine; Dopamine Antagonists; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Olanzapine; Piperazines; Pituitary Neoplasms; Quinolones; Risperidone; Schizophrenia; Serotonin Antagonists; Trifluoperazine | 2010 |
Pituitary tumors: cabergoline versus bromocriptine: a meta-analysis?
Topics: Antineoplastic Agents; Bromocriptine; Cabergoline; Ergolines; Humans; Meta-Analysis as Topic; Pituitary Neoplasms; Treatment Outcome | 2011 |
Diagnosis and management of acromegaly: giant invasive adenoma.
Topics: Acromegaly; Bromocriptine; Follicle Stimulating Hormone; Growth Hormone; Hormone Antagonists; Humans; Hypoglycemic Agents; Insulin-Like Growth Factor I; Luteinizing Hormone; Magnetic Resonance Imaging; Male; Metformin; Middle Aged; Pituitary Neoplasms | 2011 |
Giant prolactinoma: where's the prolactin?
Topics: Aged; Bromocriptine; Craniocerebral Trauma; Dopamine Agonists; Headache; Hormone Antagonists; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma | 2011 |
microRNA expression profile and differentially-expressed genes in prolactinomas following bromocriptine treatment.
Topics: Adult; Antineoplastic Agents; Bromocriptine; Cluster Analysis; Dopamine Agonists; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Male; MicroRNAs; Middle Aged; Pituitary Neoplasms; Prolactinoma; Young Adult | 2012 |
Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment.
Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Case-Control Studies; Dopamine Agonists; Echocardiography; Ergolines; Female; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Male; Middle Aged; Pituitary Neoplasms; Prevalence; Prolactinoma; Prospective Studies | 2012 |
[The effect of oxcarbamazepine on the clinical effectiveness of dopamine agonists in the treatment of prolactinoma].
Topics: Adult; Brain Injuries; Bromocriptine; Carbamazepine; Dopamine Agonists; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Pituitary Neoplasms; Prolactinoma | 2011 |
Optimal effective doses of cabergoline and bromocriptine and valvular leasions in men with prolactinomas.
Topics: Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Pituitary Neoplasms; Prevalence; Prolactinoma; Retrospective Studies; Risk Factors; Ultrasonography; Young Adult | 2012 |
Differential effects of nerve growth factor on expression of dopamine 2 receptor subtypes in GH3 rat pituitary tumor cells.
Topics: Animals; Apoptosis; Bromocriptine; Cell Line, Tumor; Cell Survival; Flow Cytometry; Nerve Growth Factor; Pituitary Neoplasms; Rats; Real-Time Polymerase Chain Reaction; Receptors, Dopamine D2; RNA, Messenger | 2012 |
Bromocriptine for control of hyperthermia in a patient with mixed autonomic hyperactivity after neurosurgery: a case report.
Topics: Adult; Brain; Bromocriptine; Craniopharyngioma; Female; Fever; Hormone Antagonists; Humans; Hyperkinesis; Magnetic Resonance Imaging; Neurosurgical Procedures; Pituitary Neoplasms; Radionuclide Imaging; Tomography, X-Ray Computed | 2012 |
Medically treated prolactin-secreting pituitary adenomas: when should we operate?
Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Ergolines; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Postmenopause; Premenopause; Prolactinoma; Prospective Studies; Retrospective Studies; Sphenoid Bone; Time Factors; Treatment Failure | 2013 |
Risk of thromboembolic events in patients with prolactinomas compared with patients with nonfunctional pituitary adenomas.
Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Thromboembolism; Young Adult | 2013 |
[Inhibitory effect of adenovirus-mediated D2S gene plus bromocriptine therapy on primary cultures of human non-functioning pituitary adenoma cells].
Topics: Adenoviridae; Apoptosis; Bromocriptine; Cell Proliferation; Humans; Pituitary Neoplasms; Receptors, Dopamine D2; Transfection; Tumor Cells, Cultured | 2012 |
Hyperprolactinemia in children: clinical features and long-term results.
Topics: Adolescent; Bromocriptine; Cabergoline; Child; Combined Modality Therapy; Ergolines; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Treatment Outcome | 2012 |
Bromocriptine-induced brainstem angulation in a patient with invasive prolactinoma.
Topics: Adult; Brain Stem; Bromocriptine; Empty Sella Syndrome; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma | 2013 |
[Management of prolactinomas during pregnancy].
Topics: Adenoma; Adult; Bromocriptine; Combined Modality Therapy; Dopamine Agonists; Female; Humans; Infertility, Female; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactin; Prolactinoma; Retrospective Studies | 2002 |
Successful treatment of a large macroprolactinoma with cabergoline during pregnancy.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma | 2001 |
Long-term follow-up of prolactinomas: normoprolactinemia after bromocriptine withdrawal.
Topics: Adolescent; Adult; Aged; Bromocriptine; Child; Cohort Studies; Female; Follow-Up Studies; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome | 2002 |
Giant prolactinomas: clinical management and long-term follow up.
Topics: Adult; Bromocriptine; Dopamine Agonists; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Outcome Assessment, Health Care; Pituitary Gland; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Sphenoid Sinus; Time Factors | 2002 |
Varying additive effects of bromocriptine with two somatostatin analogs in cultures of GH-secreting adenomas.
Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Cyclic AMP; Dopamine Agonists; Female; Hormone Antagonists; Hormones; Human Growth Hormone; Humans; Male; Middle Aged; Octreotide; Peptides, Cyclic; Pituitary Neoplasms; Sex Characteristics; Somatostatin; Tumor Cells, Cultured | 2002 |
The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma.
Topics: Adult; Anastrozole; Aromatase Inhibitors; Bromocriptine; Cabergoline; Dopamine Agonists; Enzyme Inhibitors; Ergolines; Hormone Replacement Therapy; Humans; Magnetic Resonance Imaging; Male; Nitriles; Pituitary Neoplasms; Prolactin; Prolactinoma; Sexual Dysfunction, Physiological; Testosterone; Treatment Outcome; Triazoles | 2002 |
Pituitary tumorigenesis in prolactin gene-disrupted mice.
Topics: Adenoma; Animals; Bromocriptine; Dopamine; Endoplasmic Reticulum; Estrogens; Feedback; Female; Fluorescent Antibody Technique; Growth Hormone; Hyperplasia; Immunohistochemistry; Mice; Mice, Knockout; Microscopy, Confocal; Pituitary Gland; Pituitary Neoplasms; Prolactin | 2002 |
[Results of treatment for male prolactinomas].
Topics: Adult; Bromocriptine; Dopamine Agonists; Humans; Lisuride; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Apoplexy; Pituitary Neoplasms; Prolactin; Prolactinoma | 2002 |
Visual field compression by a non-secreting pituitary tumour during pregnancy.
Topics: Adenoma; Adult; Bromocriptine; Constriction, Pathologic; Dopamine Agonists; Female; Humans; Hyperplasia; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Vision Disorders | 2003 |
Efficacy and safety of bromocriptine in the treatment of macroprolactinomas.
Topics: Adult; Bromocriptine; Female; Follow-Up Studies; Hormone Antagonists; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Time Factors | 2002 |
p27 deficiency desensitizes Rb-/- cells to signals that trigger apoptosis during pituitary tumor development.
Topics: Animals; Apoptosis; Bromocriptine; Cell Cycle; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p27; Dopamine; Dopamine Agonists; Fibroblasts; Mice; Mice, Mutant Strains; Pituitary Gland; Pituitary Neoplasms; Retinoblastoma Protein; Signal Transduction; Tumor Suppressor Protein p14ARF; Tumor Suppressor Proteins | 2003 |
Prolactinomas, dopamine agonists and headache: two case reports.
Topics: Adult; Amenorrhea; Anti-Inflammatory Agents, Non-Steroidal; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Headache; Humans; Indomethacin; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiography | 2003 |
Pituitary adenomas in adolescent patients with multiple endocrine neoplasia type 1.
Topics: Adolescent; Bromocriptine; Female; Hormone Antagonists; Humans; Male; Multiple Endocrine Neoplasia Type 1; Pedigree; Pituitary Neoplasms; Prolactinoma | 2002 |
Inhibition of growth hormone excess reduces insulin resistance and ovarian dysfunction in a lean case of polycystic ovary syndrome with a growth-hormone-producing pituitary adenoma.
Topics: Acanthosis Nigricans; Acromegaly; Adenoma; Adult; Bromocriptine; Dopamine Agents; Female; Glucose Tolerance Test; Human Growth Hormone; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Lisuride; Magnetic Resonance Imaging; Menstrual Cycle; Ovary; Pancreatic Function Tests; Pituitary Function Tests; Pituitary Neoplasms; Polycystic Ovary Syndrome; Theca Cells | 2003 |
Successful pregnancy after bromocriptine therapy in an anovulatory woman complicated with ovarian hyperstimulation caused by follicle-stimulating hormone-producing plurihormonal pituitary microadenoma.
Topics: Adenoma; Adult; Anovulation; Bromocriptine; Estradiol; Female; Follicle Stimulating Hormone; Follicle Stimulating Hormone, beta Subunit; Humans; Infertility, Female; Magnetic Resonance Imaging; Ovarian Hyperstimulation Syndrome; Pituitary Neoplasms; Pregnancy; Prolactin; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tomography, X-Ray Computed | 2003 |
Expression of hypoxia-inducible factor-1alpha (HIF-1alpha) in pituitary tumours.
Topics: Adenoma; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Bromocriptine; Carcinoma; Cell Division; Cell Nucleolus; Cell Nucleus; Child; Cytoplasm; Dopamine Agonists; Endothelium, Vascular; Female; Hormone Antagonists; Hormones; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Male; Microcirculation; Middle Aged; Neovascularization, Pathologic; Octreotide; Pituitary Neoplasms; Somatostatin; Transcription Factors | 2003 |
Minimally invasive pituitary surgery in a hemorrhagic necrosis of adenoma during pregnancy.
Topics: Adult; Bromocriptine; Female; Hematoma; Hemorrhage; Hormone Antagonists; Humans; Minimally Invasive Surgical Procedures; Necrosis; Neurosurgical Procedures; Optic Nerve Neoplasms; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Trimester, Third; Prolactinoma | 2003 |
Nerve growth factor restores p53 function in pituitary tumor cell lines via trkA-mediated activation of phosphatidylinositol 3-kinase.
Topics: Animals; Base Sequence; Bromocriptine; Cell Division; Cell Line, Tumor; DNA Primers; Humans; Mice; Nerve Growth Factor; Phosphatidylinositol 3-Kinases; Pituitary Neoplasms; Prolactinoma; Protein Conformation; Receptor, trkA; Reverse Transcriptase Polymerase Chain Reaction; Tumor Suppressor Protein p53 | 2004 |
Treatments of multi-invasive giant prolactinoma.
Topics: Aged; Bromocriptine; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Microscopy, Electron, Transmission; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiotherapy | 2004 |
[Acromegaly presenting with severe hyperhidrosis].
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Dopamine Agonists; Growth Hormone; Humans; Hyperhidrosis; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Treatment Outcome | 2003 |
[Clinical and therapeutic aspects of prolactinoma in men].
Topics: Adolescent; Adult; Age of Onset; Biomarkers; Bromocriptine; Cabergoline; Chi-Square Distribution; Dopamine Agonists; Ergolines; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Pituitary Neoplasms; Prolactin; Prolactinoma; Statistics, Nonparametric; Treatment Outcome | 2003 |
Fibrous bodies are associated with lower GH production and decreased expression of E-cadherin in GH-producing pituitary adenomas.
Topics: Adenoma; Adult; Aged; Biomarkers; Bromocriptine; Cadherins; Female; Growth Hormone; Hormone Antagonists; Humans; Immunohistochemistry; Insulin-Like Growth Factor I; Keratins; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Retrospective Studies | 2003 |
The effect of octreotide and bromocriptine on expression of a pro-apoptotic Bax protein in rat prolactinoma.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Bromocriptine; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Immunohistochemistry; Male; Octreotide; Pituitary Neoplasms; Prolactin; Prolactinoma; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred F344 | 2004 |
Prolactinoma presenting as painful postganglionic Horner syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Bromocriptine; Cabergoline; Carotid Arteries; Dopamine Agonists; Ergolines; Horner Syndrome; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Migraine Disorders; Neoplasm Recurrence, Local; p-Hydroxyamphetamine; Pituitary Neoplasms; Prolactin; Prolactinoma; Remission Induction | 2004 |
Bromocriptine treatment of prolactinoma restores growth hormone secretion and causes catch-up growth in a prepubertal child.
Topics: Adolescent; Bromocriptine; Dopamine Agonists; Growth Disorders; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Prolactinoma | 2004 |
Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Topics: Adenoma; Adult; Antineoplastic Agents, Hormonal; Bromocriptine; Female; Growth Hormone; Hormone Antagonists; Humans; Immunohistochemistry; Male; Microscopy, Electron; Middle Aged; Octreotide; Pituitary Neoplasms; Prolactin; Retrospective Studies; Staining and Labeling; Thyrotropin | 2004 |
The management of sellar masses: not all pituitary tumours require surgery for diagnosis and/or therapy.
Topics: Bromocriptine; Child; Dopamine Agonists; Female; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Sella Turcica; Thyroxine; Treatment Outcome | 2004 |
First reported pediatric case of systemic lupus erythematosus associated with prolactinoma.
Topics: Adolescent; Arthritis; Bromocriptine; Female; Hormone Antagonists; Humans; Inflammation Mediators; Lupus Erythematosus, Systemic; Pituitary Neoplasms; Prolactin; Prolactinoma; Treatment Outcome | 2004 |
Nelson's syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment.
Topics: Adenoma; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Bromocriptine; Cabergoline; Cyproheptadine; Dopamine Agonists; Ergolines; Female; Hormone Replacement Therapy; Humans; Magnetic Resonance Imaging; Nelson Syndrome; Pituitary Neoplasms | 2004 |
Treatment of empty sella syndrome with ventriculoperitoneal shunt.
Topics: Adult; Bromocriptine; Empty Sella Syndrome; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactinoma; Ventriculoperitoneal Shunt | 2005 |
The clinical characteristics of headache in patients with pituitary tumours.
Topics: Adenoma; Adult; Aminoquinolines; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Disability Evaluation; Dopamine Agonists; Ergolines; Female; Headache; Humans; Male; Migraine Disorders; Octreotide; Peptides, Cyclic; Pituitary Neoplasms; Severity of Illness Index; Somatostatin; Time Factors | 2005 |
The use of high-dose daily cabergoline in an adolescent patient with macroprolactinoma.
Topics: Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Treatment Outcome | 2005 |
Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas.
Topics: Adolescent; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2005 |
Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth.
Topics: Adenoma; Adult; Aged; Bromocriptine; Cohort Studies; Dopamine Agonists; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Pituitary Neoplasms; Postoperative Period; Survival Analysis; Thyrotropin-Releasing Hormone; Treatment Outcome | 2005 |
Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
Topics: Adult; Aged; Bromocriptine; Dopamine Agonists; Drug Resistance; Female; Humans; Hypophysectomy; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Mitotic Index; Neoplasm Invasiveness; Neoplasm Staging; Pituitary Gland; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Sex Factors | 2005 |
Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine.
Topics: Adult; Bromocriptine; Combined Modality Therapy; Diagnosis, Differential; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Prolactinoma | 2005 |
Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Bromocriptine; Child; Combined Modality Therapy; Female; Hormone Antagonists; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Neurosurgical Procedures; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Postoperative Complications; Predictive Value of Tests; Radiotherapy; Reoperation; Retrospective Studies; Sphenoid Bone; Treatment Outcome | 2005 |
The effect of selective sst1, sst2, sst5 somatostatin receptors agonists, a somatostatin/dopamine (SST/DA) chimera and bromocriptine on the "clinically non-functioning" pituitary adenomas in vitro.
Topics: Adenoma; Adult; Aged; Biomarkers, Tumor; Bromocriptine; Cell Survival; Dopamine Agonists; Drug Synergism; Female; Humans; Immunohistochemistry; Male; Middle Aged; Pituitary Neoplasms; Receptors, Dopamine; Receptors, Somatostatin; Recombinant Fusion Proteins; Tumor Cells, Cultured | 2006 |
An acromegalic woman first diagnosed in pregnancy.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Dopamine Agonists; Female; Humans; Optic Chiasm; Optic Nerve Neoplasms; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Vision Disorders | 2006 |
Long-term efficacy of bromocriptine in macroprolactinomas and giant prolactinomas in men.
Topics: Adolescent; Adult; Bromocriptine; Dopamine Agonists; Humans; Male; Middle Aged; Pituitary Function Tests; Pituitary Neoplasms; Prolactin; Prolactinoma; Prospective Studies; Visual Fields | 2005 |
Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.
Topics: Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Remission Induction; Retrospective Studies; Treatment Outcome | 2005 |
Combined treatment of invasive giant prolactinomas.
Topics: Adolescent; Adult; Bromocriptine; Combined Modality Therapy; Craniotomy; Dopamine Agonists; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Treatment Outcome | 2005 |
Brain & chiasmal herniations into sella after medical treatment of prolactinoma.
Topics: Aged; Bromocriptine; Encephalocele; Frontal Lobe; Hemianopsia; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Optic Chiasm; Pituitary Neoplasms; Postoperative Complications; Prolactin; Prolactinoma; Sella Turcica | 2006 |
Breastfeeding a baby with mother on Bromocripine.
Topics: Adult; Breast Feeding; Bromocriptine; Counseling; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Infant Nutritional Physiological Phenomena; Infant, Newborn; Pituitary Neoplasms; Prolactinoma | 2006 |
Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy.
Topics: Adolescent; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 2006 |
Galactorrhea in a 14-year-old girl.
Topics: Adolescent; Bromocriptine; Diagnosis, Differential; Female; Galactorrhea; Hormone Antagonists; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactin; Prolactinoma | 2006 |
A follow-up of 130 patients with acromegaly in a single centre.
Topics: Acromegaly; Adenoma; Adult; Aged; Aged, 80 and over; Bromocriptine; Female; Follow-Up Studies; Hormone Antagonists; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Pituitary Neoplasms | 2006 |
Clinical presentation and response to therapy in patients with massive prolactin hypersecretion.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone | 2007 |
Immunotherapy of prolactinoma with a T helper 1 activator adjuvant and autoantigens: a case report.
Topics: Adjuvants, Immunologic; Adult; Autoantigens; Bromocriptine; Female; Hormone Antagonists; Humans; Immunotherapy; Lymphocyte Activation; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Prolactinoma; Th1 Cells | 2006 |
[Bromocriptine treatment of invasive giant prolactinomas prior to comprehensive treatments: results of a long-term follow up].
Topics: Adolescent; Adult; Aged; Bromocriptine; Combined Modality Therapy; Female; Follow-Up Studies; Hormone Antagonists; Humans; Hypophysectomy; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Radiosurgery; Retrospective Studies; Time Factors; Treatment Outcome | 2006 |
Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome.
Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Body Height; Body Mass Index; Bromocriptine; Cabergoline; Combined Modality Therapy; Ergolines; Female; Growth Hormone; Growth Hormone-Secreting Pituitary Adenoma; Headache; Hormone Antagonists; Humans; Insulin Resistance; Insulin-Like Growth Factor I; Male; Menstruation Disturbances; Octreotide; Peptides, Cyclic; Pituitary Neoplasms; Retrospective Studies; Somatostatin; Treatment Outcome | 2007 |
Dopaminergic treatment of nonfunctioning pituitary adenomas.
Topics: Adenoma; Bromocriptine; Cabergoline; Dopamine Agents; Dopamine Agonists; Ergolines; Humans; Pituitary Neoplasms; Prolactin | 2007 |
Bromocriptine-responsive Cushing's disease; clinical and biochemical remission accompanied by amelioration of impaired ocular movement.
Topics: Adenoma; Aged; Bromocriptine; Female; Hormone Antagonists; Humans; Ocular Motility Disorders; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Remission Induction; Treatment Outcome | 2007 |
Five years follow-up of invasive prolactinomas with special reference to the control of cavernous sinus invasion.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Bromocriptine; Cavernous Sinus; Chemotherapy, Adjuvant; Dopamine Agonists; Empty Sella Syndrome; Female; Follow-Up Studies; Hernia; Humans; Magnetic Resonance Imaging; Male; Microsurgery; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Optic Chiasm; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiotherapy, Adjuvant; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult | 2008 |
Remarkable effects of cabergoline in a patient with huge prolactinoma resistant to high-dose bromocriptine: case report.
Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Humans; Male; Pituitary Neoplasms; Prolactinoma; Treatment Outcome | 2008 |
Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bromocriptine; Cell Proliferation; Clone Cells; Curcumin; Cyclin D3; Cyclins; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Phosphorylation; Pituitary Hormones; Pituitary Neoplasms; Prolactinoma; Rats; Retinoblastoma Protein; Time Factors; Tumor Cells, Cultured | 2008 |
Dopamine agonist- and antagonist-induced modulation of pituitary gonadotrophin releasing hormone receptors are independent of changes in serum prolactin.
Topics: Animals; Bromocriptine; Domperidone; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Male; Metoclopramide; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, LHRH | 1984 |
The influence of bromocriptine and transsphenoidal surgery on urinary androgen metabolite excretion in acromegaly.
Topics: Acromegaly; Adenoma, Acidophil; Androgens; Androsterone; Bromocriptine; Dehydroepiandrosterone; Etiocholanolone; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pituitary Neoplasms | 1984 |
Effects of bromocriptine and cyproheptadine on basal and corticotropin-releasing factor (CRF)-induced ACTH release in a patient with Nelson's syndrome.
Topics: Adrenocorticotropic Hormone; Adult; Basal Metabolism; beta-Endorphin; Bromocriptine; Corticotropin-Releasing Hormone; Cyproheptadine; Endorphins; Female; Gonadotropin-Releasing Hormone; Humans; Lypressin; Nelson Syndrome; Pituitary Neoplasms; Thyrotropin-Releasing Hormone | 1984 |
Clinical course and outcome of pregnancy in twenty-five patients with pituitary microadenomas.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Infant, Newborn; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin | 1980 |
Prolactin and placental hormone levels during pregnancy in prolactinomas.
Topics: Adenoma; Adult; Amniotic Fluid; Bromocriptine; Chorionic Gonadotropin; Female; Gonadal Steroid Hormones; Gonadotropins; Humans; Infant, Newborn; Male; Pituitary Irradiation; Pituitary Neoplasms; Placental Hormones; Placental Lactogen; Pregnancy; Pregnancy Complications; Prolactin; Umbilical Cord | 1981 |
Effect of bromocriptine, somatostatin, and oestradiol-17 beta on hormone secretion and ultrastructure of human pituitary tumours in vitro.
Topics: Adenoma; Adolescent; Adult; Aged; Animals; Bromocriptine; Estradiol; Female; Growth Hormone; Humans; Male; Mice; Mice, Nude; Middle Aged; Neoplasms, Experimental; Pituitary Gland; Pituitary Neoplasms; Prolactin; Somatostatin | 1981 |
Hyperprolactinaemia in men-response to bromocriptine therapy.
Topics: Adult; Bromocriptine; Erectile Dysfunction; Growth Hormone; Humans; Hydrocortisone; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Testosterone; Thyroxine; Tomography, X-Ray Computed | 1982 |
Prolactinomas: bromocriptine rules O.K.?
Topics: Adenoma; Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Pregnancy; Prolactin | 1982 |
Hyperprolactinemic disorders.
Topics: Adolescent; Adult; Amenorrhea; Animals; Bromocriptine; Endocrine System Diseases; Erectile Dysfunction; Female; Galactorrhea; Humans; Hypothalamo-Hypophyseal System; Hypothalamus; Infertility, Female; Male; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactin Release-Inhibiting Factors; Rats; Receptors, Cell Surface; Receptors, Prolactin; Thyrotropin-Releasing Hormone; Tomography, X-Ray Computed | 1982 |
Hyperprolactinaemia in males with and without pituitary macroadenomas.
Topics: Adenoma; Adult; Aged; Bromocriptine; Erectile Dysfunction; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Sella Turcica; Testosterone; Tomography, X-Ray Computed | 1982 |
Bromocriptine: Does it jeopardise the result of later surgery for prolactinomas?
Topics: Adenoma; Bromocriptine; Humans; Pituitary Neoplasms; Prolactin | 1982 |
Does bromocriptine jeopardise the response to later yttrium-90 irradiation for macroprolactinemias?
Topics: Brachytherapy; Bromocriptine; Pituitary Neoplasms; Prolactin; Yttrium Radioisotopes | 1982 |
Influence of previous bromocriptine therapy on surgery for microprolactinoma.
Topics: Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactin | 1983 |
Effects of long-term treatment with bromocriptine on pituitary prolactinoma in a male.
Topics: Adult; Bromocriptine; Humans; Infertility, Male; Male; Pituitary Neoplasms; Prolactin | 1982 |
Reproductive parameters in prolactinaemic men.
Topics: Adenoma; Antipsychotic Agents; Bromocriptine; Erectile Dysfunction; Humans; Male; Metoclopramide; Pituitary Neoplasms; Prolactin; Sperm Count | 1983 |
Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Cells, Cultured; Dopamine; Endorphins; Female; Growth Hormone; Haloperidol; Humans; Levodopa; Male; Middle Aged; Norepinephrine; Pituitary Gland; Pituitary Neoplasms; Prolactin; Somatostatin; Thyrotropin-Releasing Hormone | 1984 |
Injectable bromocriptine to treat acute, oestrogen-induced swelling of invasive prolactinoma.
Topics: Adenoma; Bromocriptine; Estrogens; Female; Humans; Middle Aged; Pituitary Neoplasms; Prolactin | 1984 |
Effect of dopamine agonist withdrawal after long-term therapy in prolactinomas. Studies with high-definition computerised tomography.
Topics: Adult; Aged; Bromocriptine; Dopamine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Function Tests; Pituitary Neoplasms; Pregnancy; Prolactin; Sella Turcica; Tomography, X-Ray Computed | 1984 |
Influence of preoperative bromocriptine therapy on success of surgery for microprolactinoma.
Topics: Bromocriptine; Female; Humans; Pituitary Neoplasms; Preoperative Care; Prolactin | 1984 |
Effects of corticotropin-releasing factor and other materials on adrenocorticotropin secretion from pituitary glands of patients with Cushing's disease in vitro.
Topics: Adenoma; Adrenocorticotropic Hormone; Angiotensin I; Bromocriptine; Calcium; Corticotropin-Releasing Hormone; Cushing Syndrome; Cyclic AMP; Dexamethasone; Gonadotropin-Releasing Hormone; Humans; In Vitro Techniques; Lypressin; Pituitary Gland; Pituitary Neoplasms; Radioimmunoassay; Somatostatin; Thyrotropin-Releasing Hormone | 1984 |
Effect of pancreatic growth hormone releasing factors on GH secretion by human somatotrophic pituitary tumours in cell culture.
Topics: Adult; Bromocriptine; Cells, Cultured; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Middle Aged; Peptide Fragments; Pituitary Neoplasms; Secretory Rate; Somatostatin; Thyrotropin-Releasing Hormone | 1984 |
Decreased responsiveness of GH3 cells to the dopaminergic inhibition of prolactin.
Topics: Animals; Apomorphine; Bromocriptine; Butaclamol; Cell Line; Clone Cells; Dopamine; Dose-Response Relationship, Drug; Mice; Pituitary Neoplasms; Prolactin | 1980 |
Size reduction of a large prolactinoma by bromocriptine treatment. Report of a case.
Topics: Adenoma; Adult; Bromocriptine; Humans; Male; Pituitary Neoplasms; Prolactin | 1981 |
[Tumoral development of prolactin-secreting pituitary adenomas during pregnancy. Therapeutic approaches (author's transl)].
Topics: Adenoma; Adult; Bromocriptine; Chlormadinone Acetate; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin | 1981 |
[Operative indication of prolactinoma in the era of bromocriptine (author's transl)].
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Middle Aged; Pituitary Neoplasms; Prolactin | 1981 |
Does bromocriptine have a cytocidal effect on prolactinoma cells? Report of a case.
Topics: Adolescent; Bromocriptine; Cell Survival; Female; Humans; Pituitary Neoplasms; Prolactin | 1983 |
Discordant serum alpha-subunit and FSH concentrations in a woman with a pituitary tumour.
Topics: Adenoma, Chromophobe; Bromocriptine; Buserelin; Dexamethasone; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Glycoprotein Hormones, alpha Subunit; Humans; Middle Aged; Peptide Fragments; Pituitary Hormones, Anterior; Pituitary Neoplasms; Thyroxine | 1984 |
Evaluation and treatment of hyperprolactinaemia in women of childbearing age.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Hyperprolactinemia; Lisuride; Pituitary Neoplasms; Pregnancy; Prolactin | 1981 |
Bromocriptine in the medical management of acromegaly.
Topics: Acromegaly; Adenoma, Acidophil; Adolescent; Adult; Aged; Blood Glucose; Bromocriptine; Growth Hormone; Humans; Middle Aged; Pituitary Irradiation; Pituitary Neoplasms; Prolactin | 1980 |
The mechanism of the suppressive action of bromocriptine on adrenocorticotropin secretion in patients with Cushing's disease and Nelson's syndrome.
Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Cell Line; Cushing Syndrome; Female; Humans; Hydrocortisone; Nelson Syndrome; Pituitary Neoplasms; Prolactin | 1980 |
[New results in the field of endocrinology with relevance for medical practice. Hyperprolactemia, endocrine adenomatoses, paraneoplastic hormone secretion and hormone therapy of breast carcinoma].
Topics: Acromegaly; Adenoma; Adenoma, Acidophil; Adenoma, Chromophobe; Apudoma; Breast Neoplasms; Bromocriptine; Female; Humans; Male; Paraneoplastic Endocrine Syndromes; Pituitary Neoplasms; Prolactin; Receptors, Estrogen; Receptors, Progesterone | 1980 |
Follow-up study on treatment in 27 patients with Cushing's disease: adrenalectomy, transsphenoidal adenomectomy and medical treatment.
Topics: Adenoma; Adolescent; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Bromocriptine; Child; Cushing Syndrome; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pituitary Neoplasms; Sphenoid Bone | 1981 |
Medical and surgical management of functional pituitary tumors.
Topics: Acromegaly; Adrenocorticotropic Hormone; Bromocriptine; Cushing Syndrome; Cyproheptadine; Growth Hormone; Humans; Pituitary Neoplasms; Prolactin | 1981 |
Adrenocorticotropin-secreting pituitary adenomas originate from the anterior or the intermediate lobe in Cushing's disease: differences in the regulation of hormone secretion.
Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Bromocriptine; Cushing Syndrome; Dexamethasone; Female; Humans; Hydrocortisone; Kinetics; Male; Middle Aged; Nerve Tissue; Pituitary Gland; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin | 1982 |
Bromocriptine suppresses ACTH secretion from human pituitary tumour cells in culture by a dopaminergic mechanism.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Bromocriptine; Carcinoid Tumor; Cells, Cultured; Dopamine; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Lung Neoplasms; Male; Pituitary Neoplasms | 1981 |
Failure of bromocriptine to lower plasma catecholamines in normal men and women.
Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Epinephrine; False Negative Reactions; Female; Humans; Male; Middle Aged; Norepinephrine; Pituitary Neoplasms; Prolactin | 1982 |
[Anti-tumorous effect of bromocriptine in prolactin-secreting adenomas. A case-report (author's transl)].
Topics: Adenoma; Adult; Bromocriptine; Humans; Male; Pituitary Neoplasms; Prolactin | 1982 |
[Drug therapy of pituitary tumors].
Topics: Acromegaly; Adrenocorticotropic Hormone; Bromocriptine; Cushing Syndrome; Growth Hormone; Humans; Pituitary Neoplasms; Prolactin | 1982 |
An acth-secreting pituitary tumour arising in a patient with congenital adrenal hyperplasia.
Topics: Adenoma, Basophil; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Bromocriptine; Dexamethasone; Female; Humans; Middle Aged; Pituitary Neoplasms | 1982 |
The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
Topics: Acromegaly; Adenoma, Acidophil; Adult; Bromocriptine; Female; Growth Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1983 |
[Proton therapy of pituitary adenomas].
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Protons | 1983 |
[It has become possible to make hypophyseal adenomas regress by medical treatment].
Topics: Adenoma; Bromocriptine; Humans; Pituitary Neoplasms | 1983 |
Management of hormone-secreting pituitary microadenomas.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Bromocriptine; Combined Modality Therapy; Female; Growth Hormone; Humans; Hypophysectomy; Male; Middle Aged; Pituitary Hormones, Anterior; Pituitary Neoplasms; Prolactin | 1983 |
Effect of changes in the plasma ACTH level on the prolactin response to metoclopramide or bromocriptine in normal subjects and patients with Nelson's syndrome.
Topics: Adrenocorticotropic Hormone; Bromocriptine; Dexamethasone; Humans; Metoclopramide; Nelson Syndrome; Pituitary Neoplasms; Prolactin; Receptors, Dopamine | 1984 |
Hyperprolactinemia exerts a negative effect on the beta-endorphin content of the rat neurointermediate pituitary lobe.
Topics: Adrenocorticotropic Hormone; Animals; beta-Endorphin; beta-Lipotropin; Bromocriptine; Cell Line; Endorphins; Female; Haloperidol; Kinetics; Pituitary Gland, Anterior; Pituitary Gland, Posterior; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred BUF | 1984 |
Hyperthyroidism and acromegaly due to a thyrotropin- and growth hormone-secreting pituitary tumor. Lack of hormonal response to bromocriptine.
Topics: Acromegaly; Adenoma; Bromocriptine; Female; Growth Hormone; Humans; Hyperthyroidism; Immunoenzyme Techniques; Middle Aged; Pituitary Neoplasms; Thyrotropin | 1983 |
Prolactin and growth hormone-producing pituitary adenomas. An immunohistochemical and ultrastructural study.
Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Female; Growth Hormone; Histocytochemistry; Humans; Immunoenzyme Techniques; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1983 |
Hyperprolactinaemia.
Topics: Amenorrhea; Bromocriptine; Clinical Laboratory Techniques; Erectile Dysfunction; Female; Gonadotropin-Releasing Hormone; Humans; Male; Pituitary Diseases; Pituitary Gland; Pituitary Neoplasms; Prolactin; Radiography | 1983 |
Acromegaly and hyperprolactinemia in McCune-Albright syndrome. Evidence of hypothalamic dysfunction.
Topics: Acromegaly; Bromocriptine; Child; Female; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Follicle Stimulating Hormone; Growth Hormone; Humans; Hypopituitarism; Hypothalamus; Luteinizing Hormone; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone | 1983 |
HMG/hCG galactorrhea and hyperprolactinemia.
Topics: Bromocriptine; Female; Humans; Menotropins; Pituitary Neoplasms; Pregnancy; Prolactin | 1983 |
[Hyperprolactinemia].
Topics: Adult; Amenorrhea; Brain; Bromocriptine; Diagnosis, Differential; Female; Humans; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1983 |
A rational approach to ovulation induction.
Topics: Bromocriptine; Clomiphene; Female; Follicle Stimulating Hormone; Genital Diseases, Female; Gonadotropins; Humans; Luteinizing Hormone; Ovulation Induction; Pituitary Hormone-Releasing Hormones; Pituitary Neoplasms; Pregnancy; Prolactin; Radiography; Skull; Thyroid Gland | 1983 |
[Dopaminergic ergot combinations. A new therapeutic principle].
Topics: Bromocriptine; Dopamine Antagonists; Drug Combinations; Ergot Alkaloids; Female; Humans; Lisuride; Male; Parkinson Disease; Pituitary Neoplasms; Prolactin | 1983 |
Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas.
Topics: Adult; Bromocriptine; Child Development; Child, Preschool; Female; Hemianopsia; Humans; Infant; Infant, Newborn; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Retrospective Studies; Thyrotropin-Releasing Hormone; Visual Fields | 1983 |
Failure of bromocriptine to maintain reduction in size of a macroprolactinoma.
Topics: Bromocriptine; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1983 |
Dopaminergic regulation of prolactin secretion in the hyperprolactinemic syndrome.
Topics: Adenoma; Adult; Bromocriptine; Female; Follicle Stimulating Hormone; Humans; Levodopa; Luteinizing Hormone; Pituitary Gland; Pituitary Neoplasms; Prolactin; Radiography; Syndrome | 1983 |
A beardless young man with depressed libido.
Topics: Adenoma; Adult; Bromocriptine; Hair; Humans; Libido; Male; Pituitary Neoplasms; Prolactin; Testosterone | 1983 |
[Hyperprolactinemia in chronic renal insufficiency: an interesting model of hypothalamo-hypophyseal dysfunction].
Topics: Adult; Bromocriptine; Domperidone; Female; Humans; Hypothalamo-Hypophyseal System; Kidney Failure, Chronic; Nomifensine; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone | 1983 |
The effect of multiparity on intrasellar prolactinomas.
Topics: Adult; Bromocriptine; Female; Humans; Infertility, Female; Parity; Pituitary Function Tests; Pituitary Neoplasms; Pregnancy; Prolactin; Radiography; Thyrotropin-Releasing Hormone | 1984 |
Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
Topics: Adenoma; Amenorrhea; Bromocriptine; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Pituitary Neoplasms; Prolactin | 1984 |
Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
Topics: Adenoma; Adult; Bromocriptine; Female; Hormones; Humans; Neoplasm Invasiveness; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Sella Turcica; Thyrotropin-Releasing Hormone; Tomography, X-Ray Computed | 1984 |
Psychotic reactions during treatment of pituitary tumours with dopamine agonists.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Psychoses, Substance-Induced | 1984 |
Reduction of follicle-stimulating hormone (FSH) secretion in FSH-producing pituitary adenoma by bromocriptine.
Topics: Adenoma; Adult; Bromocriptine; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Pituitary Neoplasms; Prolactin; Testosterone; Thyrotropin-Releasing Hormone | 1984 |
Regulation of hormone release by cultured cells from a thyrotropin-growth hormone-secreting pituitary tumor. Direct inhibiting effects of 3,5,3'-triiodothyronine and dexamethasone on thyrotropin secretion.
Topics: Acromegaly; Adult; Bromocriptine; Cells, Cultured; Dexamethasone; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Hyperthyroidism; In Vitro Techniques; Pituitary Neoplasms; Thyrotropin; Thyrotropin-Releasing Hormone; Triiodothyronine | 1984 |
Restoration of LH pulsatility in patients with prolactinomas after trans-sphenoidal surgery.
Topics: Adenoma; Adult; Bromocriptine; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Pituitary Neoplasms; Prolactin | 1984 |
[Cessation of cerebrospinal fluid rhinorrhea by bromocriptine treatment of a patient with invasive prolactinoma].
Topics: Adenoma; Adult; Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Combined Modality Therapy; Humans; Male; Pituitary Neoplasms; Postoperative Complications; Prolactin; Tomography, X-Ray Computed | 1984 |
[Sellar fibrosarcoma following radiotherapy for prolactinoma].
Topics: Adult; Bromocriptine; Combined Modality Therapy; Female; Fibrosarcoma; Humans; Neoplasms, Radiation-Induced; Pituitary Irradiation; Pituitary Neoplasms; Prolactin; Sella Turcica | 1984 |
[Bromocriptine therapy from the 2d month of pregnancy induces regression of neuro-ophthalmologic complications caused by macroprolactimona].
Topics: Adult; Bromocriptine; Female; Humans; Optic Chiasm; Optic Nerve Diseases; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Prolactin | 1984 |
Bromocriptine update.
Topics: Acromegaly; Bromocriptine; Female; Humans; Hypotension, Orthostatic; Lactation; Male; Nausea; Parkinson Disease; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1984 |
[Micro- and macroprolactinomas and their treatment with bromocriptine (parlodel)].
Topics: Adenoma; Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactin | 1984 |
[Parlodel treatment of endocrine infertility in women].
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Infertility, Female; Pituitary Neoplasms; Prolactin | 1984 |
Visual field defects and reduced visual acuity during pregnancy in two patients with prolactinoma: rapid regression of symptoms under bromocriptine. Case reports.
Topics: Adult; Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Vision Disorders; Visual Acuity; Visual Fields | 1984 |
Paternity after bromocriptine therapy for hyperprolactinemia.
Topics: Adenoma, Chromophobe; Bromocriptine; Female; Fertility; Humans; Infant, Newborn; Male; Paternity; Pituitary Neoplasms; Pregnancy; Prolactin | 1984 |
Dopamine receptors in rat pituitary and estradiol-induced pituitary tumor: effect of chronic treatment with bromocriptine.
Topics: Adenoma; Animals; Bromocriptine; Estradiol; Female; Kinetics; Organ Size; Pituitary Gland, Anterior; Pituitary Neoplasms; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone | 1984 |
A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies.
Topics: Adenoma; Adult; Bromocriptine; Cells, Cultured; Female; Histocytochemistry; Humans; Hyperthyroidism; Immunochemistry; Pituitary Neoplasms; Prolactin; Radioimmunoassay; Thyrotropin; Triiodothyronine | 1984 |
Mechanism of action and tolerance of mesulergine.
Topics: Adenoma; Administration, Oral; Adult; Animals; Blood Pressure; Bromocriptine; Cells, Cultured; Dopamine Antagonists; Drug Evaluation; Ergolines; Female; Humans; Hypotension; Male; Menstruation; Middle Aged; Nausea; Pituitary Neoplasms; Prolactin; Radioimmunoassay; Random Allocation; Rats | 1984 |
Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
Topics: Adenoma; Adult; Bromocriptine; Cortodoxone; Growth Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Testosterone; Thyrotropin | 1984 |
Preventive effects of antioestrogen on mammary and pituitary tumorigenesis in rats.
Topics: Animals; Body Weight; Bromocriptine; Castration; Clomiphene; Diethylstilbestrol; Estrogen Antagonists; Male; Mammary Neoplasms, Experimental; Nitrosourea Compounds; Organ Size; Pituitary Gland; Pituitary Neoplasms; Rats; Rats, Inbred Strains | 1984 |
Prophylactic bromocriptine treatment during pregnancy in women with macroprolactinomas: report of 13 pregnancies.
Topics: Adult; Amniotic Fluid; Bromocriptine; Child, Preschool; Female; Fetal Blood; Humans; Infant, Newborn; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1984 |
[Prolactin-producing hypophyseal adenomas].
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Microsurgery; Pituitary Neoplasms; Prolactin | 1984 |
Restoration of fertility with gonadotropin and bromocriptine in a hypogonadal man after removal of macroprolactinoma.
Topics: Adult; Bromocriptine; Gonadotropins; Humans; Hypogonadism; Infertility, Male; Male; Pituitary Neoplasms; Prolactin; Sperm Count; Testosterone | 1984 |
In vivo supersensitivity of the anterior pituitary of old female rats to dopaminergic inhibition of prolactin secretion.
Topics: Adenoma; Animals; Bromocriptine; Dopamine Antagonists; Female; Isoquinolines; Kinetics; Nomifensine; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains | 1984 |
Growth and puberty arrest due to prolactinoma.
Topics: Adenoma, Chromophobe; Adolescent; Bromocriptine; Child; Child, Preschool; Combined Modality Therapy; Growth Disorders; Humans; Male; Pituitary Neoplasms; Prognosis; Prolactin; Puberty, Delayed | 1984 |
Cerebrospinal fluid rhinorrhea caused by bromocriptine therapy of prolactinoma.
Topics: Adenoma; Adult; Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Humans; Male; Pituitary Neoplasms; Prolactin | 1984 |
[Diagnosis and treatment of hyperprolactinemia].
Topics: Adenoma; Bromocriptine; Female; Galactorrhea; Humans; Male; Menstruation Disturbances; Pituitary Neoplasms; Pregnancy; Prolactin | 1984 |
Effect of a somatostatin analogue on trophic hormone levels in acromegalic patients with elevated hGH after adenomectomy and treatment with bromocriptine.
Topics: Acromegaly; Adenoma; Bromocriptine; Female; Growth Hormone; Humans; Pituitary Hormones, Anterior; Pituitary Neoplasms | 1984 |
Induction of hepatic tumors by diethylstilbestrol alone or in synergism with n-nitrosobutylurea in castrated male WF rats.
Topics: Animals; Bromocriptine; Carcinogens; Castration; Cocarcinogenesis; Diethylstilbestrol; Drug Synergism; Liver; Liver Neoplasms, Experimental; Male; Nitrosourea Compounds; Organ Size; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred WF | 1983 |
Hyperprolactinaemic amenorrhoea in Hong Kong.
Topics: Adenoma; Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hypothyroidism; Infertility, Female; Lactation Disorders; Male; Pituitary Neoplasms; Pregnancy; Prolactin | 1983 |
The dilemma of mild hyperprolactinaemia.
Topics: Bromocriptine; Female; Follow-Up Studies; Humans; Pituitary Neoplasms; Pregnancy; Prolactin; Radiography | 1984 |
Cerebrospinal fluid rhinorrhoea during treatment of pituitary tumours with bromocriptine.
Topics: Adult; Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Female; Growth Hormone; Humans; Pituitary Neoplasms; Prolactin; Skull; Tomography, X-Ray Computed | 1983 |
Hyperprolactinemic amenorrhea in a woman with a craniopharyngioma: persisting amenorrhea after prolactin suppression with bromocriptine.
Topics: Adult; Amenorrhea; Bromocriptine; Craniopharyngioma; Female; Humans; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1983 |
Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia.
Topics: Adenoma; Adult; Amenorrhea; Anovulation; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Metergoline; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin | 1983 |
Inhibitory action of bromocriptine and tamoxifen on the growth of human pituitary tumors in soft agar.
Topics: Adenoma; Agar; Bromocriptine; Cells, Cultured; Clone Cells; Female; Growth Hormone; Humans; Male; Pituitary Neoplasms; Prolactin; Tamoxifen | 1983 |
Hyperprolactinemia and pregnancy. Clinical series.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prolactin | 1983 |
Long-term follow-up of hyperprolactinemic women treated with bromocriptine.
Topics: Adenoma; Adult; Aged; Bromocriptine; Female; Follow-Up Studies; Humans; Hypogonadism; Menstruation; Middle Aged; Pituitary Gland, Anterior; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Time Factors | 1983 |
[Management of pregnancy after bromocriptine treatment of women with hyperprolactinemia and pituitary adenoma (study of 4 cases)].
Topics: Adenoma; Adult; Bromocriptine; Female; Fetal Monitoring; Follow-Up Studies; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1983 |
[Prolactinoma in men].
Topics: Adenoma; Adult; Aged; Bromocriptine; Female; Humans; Hydrocortisone; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Sella Turcica; Testosterone; Thyroxine; Tomography, X-Ray Computed | 1983 |
Hyperprolactinemia. Long-term effects of bromocriptine.
Topics: Adult; Amenorrhea; Bromocriptine; Erectile Dysfunction; Estradiol; Female; Follow-Up Studies; Galactorrhea; Humans; Infertility, Female; Luteinizing Hormone; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin; Radiography; Thyroxine; Time Factors | 1983 |
Management of patients with hyperprolactinemia and normal or abnormal tomograms.
Topics: Adolescent; Adult; Bromocriptine; Female; Humans; Infant, Newborn; Ovulation; Pituitary Neoplasms; Pregnancy; Prolactin; Prospective Studies; Time Factors; Tomography, X-Ray | 1983 |
Reversible "hypopituitarism" and disappearance of microadenoma in a prolactinoma patient treated with bromocriptine.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Hypopituitarism; Pituitary Neoplasms; Prolactin | 1983 |
[Beneficial effect of Parlodel in a case of simultaneous prolactinoma and empty sella syndrome].
Topics: Adult; Bromocriptine; Empty Sella Syndrome; Female; Humans; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1983 |
Prolactin-secreting pituitary adenomas.
Topics: Adenoma; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Radioimmunoassay; Tomography, X-Ray Computed | 1983 |
[Diagnosis and management of prolactinoma].
Topics: Adult; Bromocriptine; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1983 |
[Pneumocephalus induced by bromocriptine treatment in male prolactinoma--a case report].
Topics: Adenoma; Adult; Bromocriptine; Combined Modality Therapy; Humans; Male; Pituitary Neoplasms; Pneumocephalus; Prolactin | 1983 |
[Bromocriptine therapy of prolactinoma and hyperprolactinemia].
Topics: Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Substance Withdrawal Syndrome | 1983 |
Natural history of patients with hyperprolactinaemia.
Topics: Bromocriptine; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Infertility, Female; Menstruation; Pituitary Neoplasms; Pregnancy; Prolactin; Tomography, X-Ray Computed | 1983 |
Antiproliferative properties of bromocryptine (CB-154) on human cells: a further rationale for medical management of pituitary macroadenomas.
Topics: Adenoma; Adult; Bromocriptine; Cell Division; Female; Humans; Lymphocyte Activation; Pituitary Neoplasms; Prolactin | 1983 |
[Effect of postoperative bromocriptine treatment for prolactin-secreting pituitary adenomas].
Topics: Adenoma; Adult; Bromocriptine; Female; Galactorrhea; Humans; Male; Middle Aged; Pituitary Neoplasms; Postoperative Period; Pregnancy; Prolactin | 1983 |
[Pregnancy and hyperprolactinemia].
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Infertility, Female; Pituitary Neoplasms; Pregnancy; Prolactin | 1983 |
Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
Topics: Adenoma; Adult; Aged; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1984 |
Rapid size reduction of giant prolactinoma following medical treatment.
Topics: Adolescent; Bromocriptine; Humans; Male; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1984 |
Bromocriptine treatment reduces the cell size in human macroprolactinomas: a morphometric study.
Topics: Adenoma; Bromocriptine; Female; Humans; Male; Microscopy, Fluorescence; Pituitary Neoplasms; Prolactin; Radioimmunoassay | 1984 |
Clinical disorders in patients with hyperprolactinaemia. Experience with 59 patients.
Topics: Acromegaly; Adolescent; Adult; Amenorrhea; Bromocriptine; Bulbar Palsy, Progressive; Erectile Dysfunction; Female; Galactorrhea; Humans; Hydrocephalus; Infertility, Female; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Pregnancy; Prolactin; Radioimmunoassay; Tomography, X-Ray Computed | 1984 |
The effects of pregnancy on patients with hyperprolactinemia.
Topics: Adolescent; Adult; Amenorrhea; Breast Feeding; Bromocriptine; Estradiol; Female; Humans; Infertility, Female; Middle Aged; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin | 1984 |
Hyperprolactinemic response after bromocriptine withdrawal in women with prolactin-secreting pituitary tumors.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Middle Aged; Pituitary Neoplasms; Prolactin | 1984 |
Serum prolactin and ovarian function after discontinuation of drug treatment for hyperprolactinaemia: a study with bromocriptine and metergoline.
Topics: Adenoma; Amenorrhea; Bromocriptine; Ergolines; Female; Humans; Metergoline; Ovulation; Pituitary Neoplasms; Progesterone; Prolactin; Prospective Studies; Recurrence | 1984 |
How effective is external pituitary irradiation for growth hormone-secreting pituitary tumors?
Topics: Acromegaly; Adolescent; Adult; Aged; Bromocriptine; Combined Modality Therapy; Female; Follow-Up Studies; Growth Hormone; Humans; Male; Middle Aged; Pituitary Gland, Anterior; Pituitary Irradiation; Pituitary Neoplasms | 1984 |
Cushing's disease and marked hyperprolactinemia in a patient with a pituitary macroadenoma: effectiveness of bromocriptine treatment.
Topics: Adenoma; Adolescent; Bromocriptine; Cushing Syndrome; Humans; Male; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1984 |
[Size reduction of a nonfunctioning pituitary adenoma after bromocriptine therapy: case report].
Topics: Adenoma; Bromocriptine; Cerebral Angiography; Cytoplasmic Granules; Humans; Male; Middle Aged; Pituitary Neoplasms; Tomography, X-Ray Computed | 1984 |
Interactions between thioridazine and bromocriptine in a patient with a prolactin-secreting pituitary adenoma.
Topics: Adenoma; Adult; Bromocriptine; Drug Interactions; Humans; Male; Pituitary Neoplasms; Prolactin; Schizophrenia, Paranoid; Thioridazine; Tomography, X-Ray Computed; Visual Fields | 1984 |
Perivascular fibrosis in prolactinomas: is it increased by bromocriptine?
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Connective Tissue; Female; Humans; Microcirculation; Pituitary Neoplasms; Prolactin | 1984 |
Dopaminergic treatment of acromegaly: different effects on hormone secretion and tumor size.
Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1984 |
Bromocriptine-induced regression of a suprasellar extending prolactinoma during pregnancy.
Topics: Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Radiography; Sella Turcica; Visual Fields | 1984 |
Normal and abnormal prolactin levels during human pregnancy. Lack of influence on fetoplacental endocrine function.
Topics: Adenoma; Adolescent; Adult; Amenorrhea; Bromocriptine; Chorionic Gonadotropin; Estradiol; Female; Galactorrhea; Humans; Maternal-Fetal Exchange; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Progesterone; Prolactin | 1984 |
Necrotic changes in prolactinomas after long term administration of bromocriptine.
Topics: Adolescent; Adult; Bromocriptine; Female; Humans; Male; Necrosis; Pituitary Neoplasms; Prolactin | 1984 |
Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Histocytochemistry; Humans; Immunoenzyme Techniques; Male; Microscopy, Electron; Middle Aged; Pituitary Neoplasms; Prolactin; Radioimmunoassay | 1982 |
Tamoxifen enhances the sensitivity of dispersed prolactin-secreting pituitary tumor cells to dopamine and bromocriptine.
Topics: Animals; Bromocriptine; Dopamine; Estradiol; Female; Haloperidol; Neoplasms, Experimental; Pituitary Neoplasms; Prolactin; Rats; Tamoxifen; Thyrotropin-Releasing Hormone | 1980 |
[Value and limitations of the LHRH test in patients with amenorrhea-galactorrhea].
Topics: Adenoma; Amenorrhea; Bromocriptine; Female; Follicle Stimulating Hormone; Galactorrhea; Gonadotropin-Releasing Hormone; Humans; Lactation Disorders; Luteinizing Hormone; Pituitary Neoplasms; Pregnancy | 1980 |
Normal pituitary function and reserve after selective transsphenoidal removal of a thyrotropin-producing pituitary adenoma.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Levodopa; Metoclopramide; Microsurgery; Pituitary Gland; Pituitary Neoplasms; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 1980 |
Hyperprolactinemia in cases of infertility and amenorrhea.
Topics: Adult; Amenorrhea; Bromocriptine; Contraceptives, Oral; Estradiol; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Luteinizing Hormone; Middle Aged; Pituitary Neoplasms; Pregnancy; Progesterone; Prolactin; Radioimmunoassay | 1980 |
Prolactin: Physiology and pathology.
Topics: Adenoma; Bromocriptine; Humans; Pituitary Gland; Pituitary Neoplasms; Prolactin; Radiography; Sella Turcica; Thyrotropin-Releasing Hormone | 1980 |
Rapid regression of pituitary prolactinomas during bromocriptine treatment.
Topics: Adenoma; Adult; Bromocriptine; Humans; Kinetics; Male; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone | 1980 |
Modifications in serum growth hormone concentration induced by sulpiride in acromegalic patients pretreated with dopamine, bromocriptine, and metergoline.
Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Dopamine; Female; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Insulin; Male; Metergoline; Middle Aged; Pituitary Neoplasms; Sulpiride; Thyrotropin-Releasing Hormone | 1980 |
Diagnostic and therapeutic modalities in women with galactorrhea.
Topics: Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hypothalamo-Hypophyseal System; Lactation Disorders; Pituitary Function Tests; Pituitary Neoplasms; Pregnancy; Prolactin; Radiography; Sella Turcica; Syndrome; Thyrotropin-Releasing Hormone | 1980 |
[An endocrinological study of hyperprolactinemia and its treatment (author's transl)].
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Female; Follicle Stimulating Hormone; Humans; Infant, Newborn; Luteinizing Hormone; Pituitary Neoplasms; Pregnancy; Prolactin | 1980 |
Prolactin secretion in the empty sella syndrome, in prolactinomas and in acromegaly.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Aged; Bromocriptine; Diagnosis, Differential; Empty Sella Syndrome; Female; Humans; Levodopa; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone | 1981 |
Rapid regression of a suprasellar extending prolactinoma after bromocriptine treatment during pregnancy.
Topics: Adult; Amenorrhea; Bromocriptine; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Luteinizing Hormone; Pituitary Neoplasms; Pregnancy; Prolactin; Radioimmunoassay; Sella Turcica; Thyroxine; Time Factors | 1981 |
Spontaneous and induced pregnancies in hyperprolactinemic women.
Topics: Adenoma; Bromocriptine; Chorionic Gonadotropin; Clomiphene; Female; Humans; Infertility, Female; Menotropins; Metergoline; Ovary; Ovulation Induction; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin | 1981 |
Defective central nervous system dopaminergic function in rats with estrogen-induced pituitary tumors, as assessed by plasma prolactin concentrations.
Topics: Animals; Brain; Bromocriptine; Domperidone; Dopamine; Estradiol; Female; Hypothalamus; Median Eminence; Nomifensine; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Thyrotropin-Releasing Hormone | 1982 |
Characterization of the dopaminergic regulation of human prolactin-secreting cells cultured on extracellular matrix.
Topics: Adenoma; Adult; Apomorphine; Bromocriptine; Cells, Cultured; Dihydroergotoxine; Dopamine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin | 1982 |
[Recent advances in hormonal detection of pituitary somatotropic adenomas (author's transl)].
Topics: Acromegaly; Adenoma; Bromocriptine; Glucose; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Pituitary Neoplasms; Prolactin; Somatomedins; Thyrotropin-Releasing Hormone | 1982 |
[Post-therapeutic hormonal surveillance of somatotropic adenoma].
Topics: Acromegaly; Adenoma; Bromocriptine; Growth Hormone; Humans; Pituitary Neoplasms; Somatomedins; Thyrotropin-Releasing Hormone | 1982 |
Oral contraception in patients with hyperprolactinaemia.
Topics: Adult; Bromocriptine; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Lynestrenol; Pituitary Neoplasms; Prolactin | 1982 |
Glycoprotein hormone alpha-subunit secretion in patients with pituitary adenomas: influence of TRH, LRH and bromocriptine.
Topics: Acromegaly; Adenoma; Bromocriptine; Female; Glycoproteins; Gonadotropin-Releasing Hormone; Humans; Male; Pituitary Neoplasms; Receptors, Dopamine; Thyrotropin-Releasing Hormone | 1982 |
Hypothalamic-pituitary function following bromocriptine therapy in patients with prolactinomas.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Hypothalamo-Hypophyseal System; Infertility, Female; Metyrapone; Pituitary Hormones, Anterior; Pituitary Neoplasms; Pregnancy; Prolactin; Thyrotropin-Releasing Hormone | 1982 |
A young man with visual defect and galactorrhea.
Topics: Adenoma; Adult; Aged; Bromocriptine; Child; Female; Galactorrhea; Humans; Lactation Disorders; Male; Pituitary Neoplasms; Pregnancy; Prolactin; Vision Disorders | 1982 |
Effect of bromocriptine and metergoline in the treatment of hyperprolactinaemic states.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Metergoline; Middle Aged; Pituitary Neoplasms; Pregnancy; Progesterone; Prolactin; Testosterone | 1982 |
Bromocriptine in management of large pituitary tumours.
Topics: Bromocriptine; Humans; Pituitary Neoplasms; Visual Acuity | 1982 |
Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
Topics: Adult; Bromocriptine; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Hypopituitarism; Luteinizing Hormone; Menotropins; Ovulation Induction; Pituitary Neoplasms; Prolactin | 1982 |
Establishment of functional human pituitary tumor cell cultures.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Cell Division; Cells, Cultured; Dopamine; Female; Humans; Male; Middle Aged; Nickel; Paraneoplastic Endocrine Syndromes; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone; Triiodothyronine | 1982 |
Effective bromocriptine treatment of a pituitary macroadenoma during pregnancy.
Topics: Adenoma, Chromophobe; Adult; Bromocriptine; Female; Humans; Ovulation Induction; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, Multiple; Prolactin; Twins | 1983 |
The possible prognostic value of serum prolactin increment during pregnancy in hyperprolactinaemic patients.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Infertility, Female; Pituitary Neoplasms; Postpartum Period; Pregnancy; Pregnancy Complications; Prognosis; Prolactin | 1983 |
[Prolactin-producing pituitary adenomas as a cause of primary amenorrhea and their neurosurgical treatment].
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Female; Humans; Menstruation; Paraneoplastic Endocrine Syndromes; Pituitary Neoplasms; Pregnancy; Prolactin | 1983 |
Hyperprolactinemia and headaches.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Headache; Humans; Middle Aged; Pituitary Neoplasms; Prolactin; Time Factors | 1983 |
Pregnancy following transsphenoidal resection of prolactin-secreting pituitary tumors.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Postoperative Complications; Pregnancy; Prolactin | 1983 |
Hyperprolactinemia and delayed puberty: a report of three cases and their response to therapy.
Topics: Adolescent; Bromocriptine; Empty Sella Syndrome; Female; Humans; Male; Pituitary Neoplasms; Prolactin; Puberty, Delayed; Testosterone | 1983 |
Cavernous sinus syndrome due to prolactinoma: resolution with bromocriptine.
Topics: Bromocriptine; Cranial Nerve Diseases; Female; Humans; Middle Aged; Ophthalmoplegia; Pituitary Neoplasms; Prolactin; Syndrome; Tomography, X-Ray Computed; Trigeminal Nerve | 1983 |
Treatment of prolactinomas.
Topics: Bromocriptine; Humans; Pituitary Neoplasms; Prolactin | 1983 |
Prolactinomas as part of the multiple endocrine neoplastic syndrome type 1.
Topics: Adult; Bromocriptine; Female; Humans; Hyperparathyroidism; Hyperplasia; Male; Paraneoplastic Endocrine Syndromes; Pedigree; Pituitary Gland; Pituitary Neoplasms; Prolactin | 1983 |
Rapid decompression of anterior intracranial visual pathways with bromocriptine.
Topics: Adenoma; Bromocriptine; Female; Humans; Middle Aged; Pituitary Neoplasms; Prolactin; Time Factors; Visual Fields; Visual Pathways | 1983 |
Reenlargement of macroprolactinomas during bromocriptine treatment: report of two cases.
Topics: Adult; Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Prolactin; Time Factors; Tomography, X-Ray Computed | 1983 |
Improvement of ejaculatory incompetence with bromocriptine in a man with prolactin-secreting pituitary tumor.
Topics: Adult; Bromocriptine; Erectile Dysfunction; Humans; Male; Pituitary Neoplasms; Prolactin; Testosterone | 1983 |
[Therapy of prolactinoma with bromocriptine].
Topics: Adenoma; Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Prolactin | 1983 |
Bromocriptine reduces the size of cells in prolactin-secreting pituitary adenomas.
Topics: Adenoma; Bromocriptine; Cell Nucleus; Humans; Pituitary Neoplasms; Prolactin | 1983 |
[The influence of bromocriptine-induced pregnancy and delivery on infertile cases with pituitary microadenoma].
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Infant, Newborn; Infertility, Female; Labor, Obstetric; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1983 |
Successful pregnancies in patients with hyperprolactinemia--clinical and endocrinological studies on mothers and babies.
Topics: Adenoma; Adult; Birth Weight; Bromocriptine; Female; Growth; Humans; Infant, Newborn; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1983 |
Effect of tamoxifen on growth and prolactin secretion of rat pituitary tumours.
Topics: Animals; Bromocriptine; Castration; Cells, Cultured; DNA, Neoplasm; Female; Neoplasm Transplantation; Neoplasms, Experimental; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred WF; Tamoxifen | 1983 |
[Dramatic course of pregnancy after bromocriptine therapy of infertility of many years' duration complicated by hyperprolactinemia and suspected pituitary adenoma].
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Infertility, Female; Ovulation; Pituitary Gland, Anterior; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Time Factors | 1983 |
Clinical implication of hyperprolactinemias, especially with prolactinoma and luteal insufficiency.
Topics: Anovulation; Bromocriptine; Clomiphene; Corpus Luteum; Female; Gonadotropins, Pituitary; Humans; Pituitary Neoplasms; Prolactin | 1983 |
The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine.
Topics: Animals; Bromocriptine; Dopamine; Female; Haloperidol; Male; Phosphates; Phosphatidylinositols; Pimozide; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains; Sex Factors | 1983 |
Modern management of prolactinoma.
Topics: Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactin; Radiography; Sella Turcica | 1983 |
[Effect of treatment with bromocriptine in prolactinomas without surgical intervention].
Topics: Adolescent; Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1983 |
Bromocriptine treatment of prolactin-secreting tumors: surgical implications.
Topics: Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1983 |
[Drug therapy of hyperprolactinemia and acromegaly].
Topics: Acromegaly; Adult; Antineoplastic Agents; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1983 |
Suppression of diethylstilbestrol and N-nitrosobutylurea-induced mammary and pituitary tumorigenesis in rats by prolonged treatment with 2-bromoergocryptine.
Topics: Animals; Bromocriptine; Castration; Diethylstilbestrol; Epididymis; Male; Mammary Neoplasms, Experimental; Nitrosourea Compounds; Organ Size; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains | 1983 |
CT follow-up of microprolactinomas during bromocriptine-induced pregnancy.
Topics: Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Tomography, X-Ray Computed | 1983 |
Prolactin-producing microadenomas in pregnancy.
Topics: Adenoma; Bromocriptine; Female; Humans; Infant, Newborn; Obstetric Labor Complications; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prolactin; Vision Disorders | 1983 |
Prolactin secreting pituitary adenoma: a review and study of their implications for fertility in women.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin | 1980 |
[Prolactinoma and pregnancy].
Topics: Bromocriptine; Female; Humans; Infertility, Female; Pituitary Neoplasms; Pregnancy; Prolactin | 1982 |
[Bromocriptine and tamoxifen--a new therapeutic approach in suppression-resistant prolactin-secreting adenomas].
Topics: Adolescent; Adult; Bromocriptine; Drug Therapy, Combination; Female; Humans; Middle Aged; Pituitary Neoplasms; Prolactin; Tamoxifen | 1982 |
[Causes and treatment of prolactinemia].
Topics: Adenoma; Bromocriptine; Female; Gonads; History of Medicine; Humans; Hypogonadism; Male; Menstruation; Pituitary Neoplasms; Prolactin | 1980 |
Lack of effect of hyperprolactinemia on glucose disposal and insulin secretion in patients with prolactinomas.
Topics: Adenoma; Adult; Blood Glucose; Bromocriptine; Female; Glucose Tolerance Test; Humans; Insulin; Kinetics; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1981 |
Bromocriptine reduces pituitary tumor size and hypersection. Requiem for pituitary surgery?
Topics: Adult; Aged; Amenorrhea; Bromocriptine; Erectile Dysfunction; Female; Growth Hormone; Humans; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Visual Fields | 1982 |
CSF rhinorrhea after bromocriptine for prolactinoma.
Topics: Adenoma; Adult; Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Female; Humans; Pituitary Neoplasms; Prolactin | 1982 |
Size reduction of extrasellar pituitary tumors during bromocriptine treatment.
Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1982 |
Pregnancies in women with hyperprolactinaemia: obstetric and endocrinological management of 50 pregnancies in 37 women.
Topics: Adolescent; Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prognosis; Prolactin | 1982 |
Regression of pituitary microadenoma during and following bromocriptine therapy: persistent defect in prolactin regulation before and throughout pregnancy.
Topics: Adenoma; Adult; Bromocriptine; Chorionic Gonadotropin; Estradiol; Female; Humans; Hypothalamo-Hypophyseal System; Infant, Newborn; Lactation Disorders; Maternal-Fetal Exchange; Ovulation; Pituitary Neoplasms; Postpartum Period; Pregnancy; Pregnancy Complications; Progesterone; Prolactin | 1982 |
[Progress in the hormonal detection of pituitary prolactin adenoma].
Topics: Adenoma; Bromocriptine; Domperidone; Humans; Metoclopramide; Nomifensine; Pituitary Neoplasms; Prolactin | 1982 |
[Recent advances in post-therapeutic hormonal surveillance of prolactin adenomas (author's transl)].
Topics: Adenoma; Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Prolactin | 1982 |
[Antitumor effect of bromocriptine in 5 cases of invasive prolactinoma].
Topics: Adenoma; Adult; Bromocriptine; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1982 |
[Bromocriptine treatment of prolactinomas and primary hyperprolactinemia (author's transl)].
Topics: Adenoma; Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Prolactin | 1982 |
[Regression with purely medical treatment of pituitary prolactin adenomas].
Topics: Adenoma; Bromocriptine; Female; Humans; Middle Aged; Pituitary Neoplasms; Prolactin | 1982 |
[Prolactin-secreting pituitary adenomas: explorations and treatment (author's transl)].
Topics: Adenoma; Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Pregnancy; Prolactin | 1982 |
[Radiological control of prolactin adenomas treated with bromocriptine].
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pneumoencephalography; Prolactin; Tomography, X-Ray Computed | 1982 |
Enlargement of a prolactin-secreting pituitary microadenoma during bromocriptine treatment. Case report.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactin | 1982 |
Treatment of acromegaly by trans-sphenoidal operation, 90-yttrium implantation and bromocriptine: results in 230 patients.
Topics: Acromegaly; Adolescent; Adult; Aged; Brachytherapy; Bromocriptine; Child; Female; Growth Hormone; Humans; Male; Methods; Middle Aged; Pituitary Function Tests; Pituitary Neoplasms; Prospective Studies; Yttrium Radioisotopes | 1982 |
Structural changes in human pituitary tumor after bromocriptine therapy.
Topics: Bromocriptine; Cerebral Angiography; Growth Hormone; Humans; Male; Microscopy, Electron; Middle Aged; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1982 |
Computed tomographic demonstration of the effects of bromocriptine on pituitary microadenoma size.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Sella Turcica; Tomography, X-Ray Computed | 1982 |
Endoscopic findings in sleep apnea associated with acromegaly.
Topics: Acromegaly; Adenoma; Bromocriptine; Endoscopy; Humans; Male; Middle Aged; Pharynx; Pituitary Neoplasms; Sleep Apnea Syndromes; Tracheotomy | 1982 |
Effect of tamoxifen administration on prolactin release by invasive prolactin-secreting pituitary adenomas.
Topics: Adenoma; Adult; Bromocriptine; Drug Interactions; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tamoxifen | 1982 |
Macroprolactinomas: CT evaluation of reduction of tumor size after medical treatment.
Topics: Adolescent; Adult; Bromocriptine; Female; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1982 |
Enlargement of a prolactin-secreting pituitary microadenoma during bromocriptine treatment.
Topics: Adenoma; Bromocriptine; Humans; Pituitary Neoplasms | 1982 |
To treat or not to treat: hyperprolactinemia.
Topics: Adenoma; Bromocriptine; Female; Follow-Up Studies; Humans; Pituitary Neoplasms; Pregnancy; Prolactin | 1982 |
Effect of bromocriptine on pituitary tumors.
Topics: Adenoma; Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Prolactin | 1982 |
[Prolactinoma; current developments in diagnosis and treatment].
Topics: Adenoma; Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Prolactin | 1982 |
Bromocriptine-induced cerebrospinal fluid rhinorrhea.
Topics: Adult; Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Female; Humans; Pituitary Neoplasms; Prolactin | 1982 |
Influence of pregnancies on prolactinomas.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Infant, Newborn; Infertility, Female; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin | 1982 |
Prolactin secretion and dopamine receptors of the MtTW15 transplantable pituitary tumour.
Topics: Animals; Binding, Competitive; Bromocriptine; Dopamine; Female; Neoplasm Transplantation; Neoplasms, Experimental; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1982 |
[Pathological changes of prolactinomas treated with bromocriptine].
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1982 |
Failure of dopamine and bromocriptine to affect prolactin release and cell growth in the dopamine receptor-deficient 235-1 clone.
Topics: Animals; Bromocriptine; Cell Division; Clone Cells; Dopamine; Female; Microscopy, Electron; Neoplasm Transplantation; Neoplasms, Experimental; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Rats; Receptors, Dopamine | 1982 |
[Management of pituitary adenoma secreting prolactin].
Topics: Adenoma, Chromophobe; Bromocriptine; Female; Humans; Male; Pituitary Gland, Anterior; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin | 1982 |
[Significance of prolactinoma in management of anovulation].
Topics: Adenoma; Adult; Anovulation; Bromocriptine; Female; Humans; Hypophysectomy; Pituitary Neoplasms; Prolactin | 1982 |
Cerebrospinal fluid rhinorrhea: a complication of therapy for invasive prolactinomas.
Topics: Adult; Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Humans; Male; Middle Aged; Pituitary Neoplasms; Postoperative Complications; Prolactin | 1982 |
Rapid resolution of visual field defects and reduction in macroprolactinoma size with bromocriptine therapy. A case report.
Topics: Adenoma, Chromophobe; Adult; Bromocriptine; Female; Humans; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Vision Disorders | 1982 |
A growth-hormone--producing pituitary adenoma and an internal carotid artery aneurysm.
Topics: Acromegaly; Adenoma; Aneurysm; Bromocriptine; Carotid Artery Diseases; Carotid Artery, Internal; Cerebral Angiography; Female; Growth Hormone; Humans; Middle Aged; Pituitary Neoplasms | 1982 |
[Management of hyperprolactinemia--serum prolactin levels and ovulatory period].
Topics: Anovulation; Bromocriptine; Female; Humans; Ovulation Induction; Pituitary Neoplasms; Prolactin | 1982 |
[Results of medical and surgical treatment in 3 cases of prolactin-secreting pituitary adenoma].
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactin | 1982 |
Rapid regression of pituitary tumours during bromocriptine treatment of women with hyperprolactinaemia.
Topics: Adenoma; Adult; Aged; Bromocriptine; Female; Humans; Middle Aged; Pituitary Neoplasms; Prolactin | 1982 |
Impaired pituitary response to bromocriptine suppression: reversal after bromocriptine plus tamoxifen.
Topics: Adenoma, Chromophobe; Adolescent; Adult; Bromocriptine; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Tamoxifen | 1982 |
Use of bromocriptine as a diagnostic and therapeutic tool in hyperprolactinemic states.
Topics: Adenoma; Adolescent; Adult; Amenorrhea; Bromocriptine; Child; Female; Galactorrhea; Humans; Lactation Disorders; Male; Nomifensine; Pituitary Neoplasms; Pregnancy; Prolactin | 1982 |
Prolactin secreting pituitary adenomas, treatment and results.
Topics: Adenoma; Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1982 |
Bromocriptine-induced pregnancies in women with large prolactinomas.
Topics: Adult; Bromocriptine; Female; Humans; Infertility, Female; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1982 |
Prolactin-secreting pituitary adenoma: occurrence following prenatal exposure to diethylstilbestrol.
Topics: Adenoma; Adolescent; Bromocriptine; Chlorpromazine; Diethylstilbestrol; Female; Humans; Levodopa; Pituitary Neoplasms; Pregnancy; Prenatal Exposure Delayed Effects; Prolactin | 1982 |
[The amenorrhea-galactorrhea syndrome. Clinical and therapeutic aspects of 5 treated cases].
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Lactation Disorders; Pituitary Neoplasms; Pregnancy; Prolactin | 1980 |
Effect of bromocriptine on patients with hyperprolactinemia and amenorrhea.
Topics: Adenoma; Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Lactation Disorders; Pituitary Neoplasms; Pregnancy; Prolactin | 1980 |
[Prolactin: estimation and interest in clinical biology (author's transl)].
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Catecholamines; Child; Child, Preschool; Circadian Rhythm; Estrogens; Female; Galactorrhea; Humans; Hypothyroidism; Infant; Infant, Newborn; Male; Menopause; Pituitary Gland; Pituitary Neoplasms; Pregnancy; Prolactin; Radioimmunoassay; Sex Factors | 1980 |
Conservative management of suspected prolactin secreting pituitary adenoma during pregnancy.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Ovulation Induction; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Radiography | 1981 |
Treatment of hyperprolactinemic states with different drugs: a study with bromocriptine, metergoline, and lisuride.
Topics: Adenoma; Adolescent; Adult; Amenorrhea; Bromocriptine; Erectile Dysfunction; Ergolines; Female; Galactorrhea; Humans; Lisuride; Male; Metergoline; Middle Aged; Ovarian Function Tests; Pituitary Neoplasms; Pregnancy; Prolactin; Visual Fields | 1982 |
[Therapy of prolactin-producing pituitary adenomas].
Topics: Adenoma; Anovulation; Bromocriptine; Female; Galactorrhea; Humans; Male; Pituitary Neoplasms; Pregnancy; Prolactin | 1982 |
Bromocriptine treatment of women with suspected pituitary prolactin-secreting microadenomas.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Drug Evaluation; Female; Galactorrhea; Humans; Menstruation Disturbances; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin; Radiography; Sella Turcica | 1982 |
Prolactin and reproduction.
Topics: Adenoma; Anovulation; Bromocriptine; Clomiphene; Female; Humans; Hypothyroidism; Ovulation; Ovulation Induction; Pituitary Neoplasms; Pregnancy; Prolactin; Reproduction; Tomography, X-Ray Computed | 1981 |
The pituitary gland.
Topics: Bromocriptine; Humans; Hypopituitarism; Pituitary Diseases; Pituitary Neoplasms | 1980 |
Effect of bromocriptine on DNA synthesis, growth and hormone secretion of spontaneous pituitary tumours in the rat.
Topics: Animals; Bromocriptine; DNA, Neoplasm; Estradiol; Female; Growth Hormone; Male; Neoplasms, Experimental; Pituitary Neoplasms; Prolactin; Rats | 1981 |
Clinical and morphological findings in two cases of bromocriptine-treated prolactinomas.
Topics: Adenoma; Adult; Bromocriptine; Culture Techniques; Female; Growth Hormone; Humans; Pituitary Neoplasms; Prolactin | 1981 |
[Bromocriptine induced cystic tumour regression in advanced prolactinomas (author's transl)].
Topics: Adult; Aged; Bromocriptine; Humans; In Vitro Techniques; Male; Middle Aged; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Time Factors | 1981 |
Abnormal prolactin levels and pituitary-gonadal axis in the puerperium.
Topics: Adult; Amenorrhea; Breast Feeding; Bromocriptine; Estrogens; Female; Humans; Lactation; Luteinizing Hormone; Ovary; Pituitary Gland; Pituitary Neoplasms; Postpartum Period; Pregnancy; Prolactin | 1981 |
Surgical treatment of pituitary prolactinomas: postoperative prolactin and fertility in seventy patients.
Topics: Actuarial Analysis; Adenoma; Adolescent; Adult; Aged; Bromocriptine; Female; Fertility; Humans; Libido; Male; Middle Aged; Pituitary Neoplasms; Postoperative Care; Pregnancy; Prolactin; Testosterone | 1981 |
[Medical treatment of functioning pituitary adenomas (author's transl)].
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Cyproheptadine; Dopamine; Female; Humans; Hypotension; Male; Pituitary Neoplasms; Prolactin | 1981 |
Pituitary function in prolactinoma. Effect of surgery and postoperative bromocriptine therapy.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Ovarian Function Tests; Pituitary Function Tests; Pituitary Gland; Pituitary Neoplasms; Postoperative Period; Prolactin; Testis; Thyroid Function Tests | 1981 |
Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine.
Topics: Adult; Bromocriptine; Humans; Male; Pituitary Neoplasms; Prolactin; Radionuclide Imaging | 1981 |
[Prolactinoma and pregnancy].
Topics: Bromocriptine; Female; Humans; Infertility, Female; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin | 1981 |
[Bromocriptine-induced pregnancies in 2 women with pituitary prolactin-secreting tumor].
Topics: Adenoma; Adult; Amenorrhea; Anovulation; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin | 1981 |
Cerebellar metastasis from a prolactinoma during treatment with bromocriptine.
Topics: Adenoma; Adult; Bromocriptine; Cerebellar Neoplasms; Female; Humans; Pituitary Neoplasms; Prolactin | 1981 |
Bromocriptine treatment of pituitary adenomas.
Topics: Adenoma; Animals; Bromocriptine; Humans; Pituitary Neoplasms; Prolactin | 1981 |
Effect of bromocriptine on thyroid hormone-induced growth hormone production in cultured GH1 cells.
Topics: Animals; Bromocriptine; Cell Line; Dose-Response Relationship, Drug; Growth Hormone; Kinetics; Pituitary Neoplasms; Rats; Triiodothyronine | 1981 |
Bromocriptine as prophylactic therapy in prolactinoma during pregnancy.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin | 1981 |
Prolactinomas and optic nerve compression: disappearance of suprasellar extension and visual recovery after two weeks bromocriptine treatment.
Topics: Adenoma; Adult; Bromocriptine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Optic Nerve; Pituitary Neoplasms; Prolactin; Radionuclide Imaging; Vision Disorders | 1981 |
Size reduction of macroprolactinomas by bromocriptine or lisuride treatment.
Topics: Adolescent; Adult; Bromocriptine; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1981 |
Effects of bromocriptine-induced pregnancy on prolactin-secreting pituitary tumours.
Topics: Adult; Amenorrhea; Bromocriptine; Female; Humans; Infant, Newborn; Ovulation; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Sella Turcica; Tomography, X-Ray Computed | 1981 |
Adrenergic and dopaminergic modulation of growth hormone and prolactin secretion in normal and tumor bearing human pituitaries in monolayer culture.
Topics: Acromegaly; Adenoma; Adult; Apomorphine; Breast Neoplasms; Bromocriptine; Cells, Cultured; Dopamine; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Sympathomimetics | 1981 |
Bromocriptine inhibits colony formation by rat pituitary tumor cells in a double-layered agar clonogenic assay.
Topics: Animals; Bromocriptine; Cell Aggregation; Cell Line; Kinetics; Lymphoma; Neoplasms, Experimental; Pituitary Neoplasms; Rats | 1981 |
Bromocriptine reduction of prolactinoma size.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prospective Studies; Tomography, X-Ray Computed | 1981 |
[Hyperprolactinemia in the male: clinical aspects and therapy].
Topics: Adolescent; Adult; Aged; Bromocriptine; Erectile Dysfunction; Gynecomastia; Humans; Hypophysectomy; Male; Middle Aged; Paraneoplastic Endocrine Syndromes; Pituitary Irradiation; Pituitary Neoplasms; Postoperative Complications; Prolactin; Radioimmunoassay; Tomography, X-Ray Computed; Visual Fields | 1981 |
Suppression of prolactin macroadenoma in 8 weeks with bromocriptine.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactin | 1981 |
[Follow-up of patients with pituitary tumors before and after operation, medical treatment and radiotherapy (author's transl)].
Topics: Acromegaly; ACTH Syndrome, Ectopic; Bromocriptine; Craniopharyngioma; Cushing Syndrome; Female; Follow-Up Studies; Humans; Hypophysectomy; Male; Meningeal Neoplasms; Meningioma; Pituitary Irradiation; Pituitary Neoplasms; Prolactin; Thyrotropin | 1981 |
Bromocriptine therapy for "nonfunctioning" pituitary tumors.
Topics: Adenoma, Chromophobe; Bromocriptine; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Pituitary Hormones; Pituitary Neoplasms | 1981 |
Bromocriptine for visual field defects in prolactinomas.
Topics: Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Vision Disorders; Visual Fields | 1981 |
Bromocriptine.
Topics: Breast Diseases; Bromocriptine; Female; Humans; Lactation; Male; Parkinson Disease; Pituitary Neoplasms; Pregnancy; Prolactin | 1981 |
Treatment of prolactin producing pituitary adenomas.
Topics: Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Prolactin | 1982 |
[Pregnancy in a subject with prolactin-secreting pituitary adenoma during therapy with bromocriptine].
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1980 |
A possible role for prolactin in the control of human chorionic gonadotropin and estrogen secretion by the fetoplacental unit.
Topics: Adult; Anovulation; Bromocriptine; Chlorpromazine; Chorionic Gonadotropin; Estrogens; Female; Fetus; Humans; Infertility, Female; Pituitary Neoplasms; Placental Hormones; Pregnancy; Pregnancy Complications; Prolactin | 1980 |
The effect of pregnancy on suspected pituitary adenomas after conservative management of ovulation defects associated with galactorrhea.
Topics: Adenoma; Adult; Anovulation; Bromocriptine; Female; Follow-Up Studies; Galactorrhea; Humans; Infertility, Female; Pituitary Gland; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin | 1980 |
[Prolactinoma].
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Female; Humans; Pituitary Gland, Anterior; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin | 1980 |
Prolactin secreting adenoma in 22 men.
Topics: Adenoma; Adult; Bromocriptine; Gonadotropins; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1980 |
Reduction in pituitary tumor size by treatment with bromocriptine, case report.
Topics: Adenoma; Aged; Bromocriptine; Humans; Male; Pituitary Neoplasms | 1980 |
[A case of Forbes-Albright syndrome treated with CB-154: has the tumor really disappeared? (author's transl)].
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1980 |
Effect of antiestrogens on pituitary prolactin production in normal and pituitary tumor-bearing rats.
Topics: Animals; Bromocriptine; Female; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Neoplasms, Experimental; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Radioimmunoassay; Rats; Tamoxifen; Transplantation, Homologous | 1980 |
[Evolution of 15 pregnancies induced with bromocriptine therapy in patients with amenorrhea-galactorrhea].
Topics: Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Infertility, Female; Lactation Disorders; Pituitary Neoplasms; Pregnancy | 1980 |
Ergot drugs in the treatment of endocrine disorders: introduction.
Topics: Adenoma; Bromocriptine; Ergot Alkaloids; Female; Humans; Pituitary Neoplasms; Prolactin | 1980 |
Bromocriptine therapy of hyperprolactinemic disorders.
Topics: Adenoma; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Prolactin | 1980 |
Hyperprolactinemia: current concepts of management including medical therapy with bromocriptine.
Topics: Adenoma; Bromocriptine; Estrogens; Feedback; Female; Galactorrhea; Humans; Hypogonadism; Hypophysectomy; Luteinizing Hormone; Pituitary Irradiation; Pituitary Neoplasms; Pregnancy; Prolactin | 1980 |
Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Female; Follow-Up Studies; Galactorrhea; Humans; Lactation Disorders; Pituitary Neoplasms; Pregnancy; Prolactin | 1980 |
[Prolactin adenomas in children (author's transl)].
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Follow-Up Studies; Humans; Male; Pituitary Hormones, Anterior; Pituitary Neoplasms; Postoperative Period; Prognosis; Prolactin | 1980 |
Conservative management of pituitary prolactinomas; evidence for bromocriptine-induced regression.
Topics: Adult; Amenorrhea; Bromocriptine; Female; Humans; Menstruation; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin; Radiography; Visual Fields | 1980 |
Pregnancy in patients with prolactin-producing pituitary tumors.
Topics: Adenoma; Bromocriptine; Female; Headache; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Vision Disorders | 1980 |
Pregnancy in an acromegalic after bromocriptine therapy.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Female; Growth Hormone; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications | 1980 |
Acute changes in serum prolactin concentration have no effect on the secretion of progesterone, estradiol, or chorionic gonadotropin during early pregnancy.
Topics: Bromocriptine; Chlorpromazine; Chorionic Gonadotropin; Estradiol; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Progesterone; Prolactin | 1980 |
Update: pituitary tumor regression with bromocriptine therapy.
Topics: Adenoma; Bromocriptine; Female; Humans; Male; Pituitary Neoplasms | 1980 |
Bromocriptine as sole treatment for acromegaly.
Topics: Acromegaly; Bromocriptine; Female; Humans; Middle Aged; Pituitary Neoplasms; Radiography; Skull | 1980 |
Trends in the management of prolactinomas.
Topics: Adenoma; Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Pregnancy; Prolactin; Radiography | 1980 |
Tamoxifen suppresses both the growth of prolactin-secreting pituitary tumours and normal prolactin synthesis in the rat.
Topics: Animals; Bromocriptine; Depression, Chemical; Female; In Vitro Techniques; Neoplasms, Experimental; Pituitary Neoplasms; Prolactin; Rats; Tamoxifen | 1980 |
Effect of bromocriptine, ergotamine and other ergot alkaloids on the hormone secretion and growth of a rat pituitary tumour.
Topics: Animals; Bromocriptine; Cells, Cultured; DNA, Neoplasm; Ergot Alkaloids; Ergotamine; Female; Growth Hormone; Neoplasms, Experimental; Pituitary Neoplasms; Prolactin; Rats | 1980 |
Synthesis of DNA in oestrogen-induced pituitary tumurs in rats: effect of bromocriptine.
Topics: Adenoma; Animals; Bromocriptine; Diethylstilbestrol; DNA Polymerase I; DNA, Neoplasm; Male; Neoplasms, Experimental; Organ Size; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred F344 | 1980 |
Abnormal catecholamine mechanisms in hypothalamic-pituitary disorders.
Topics: Acromegaly; Anorexia Nervosa; Bromocriptine; Catecholamines; Cushing Syndrome; Dopamine; Epinephrine; Humans; Male; Nelson Syndrome; Norepinephrine; Pituitary Neoplasms | 1980 |
Monolayer and suspension culture of human prolactin-secreting pituitary adenoma.
Topics: Adenoma; Bromocriptine; Growth Hormone; Humans; Organ Culture Techniques; Pituitary Neoplasms; Prolactin | 1980 |
[Complete regression of prolactin-secreting pituitary tumors by bromocriptine therapy (author's transl)].
Topics: Adenoma, Chromophobe; Adult; Aged; Brain; Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1980 |
Effect of treatment with bromocriptine on the size and activity of prolactin producing pituitary tumours.
Topics: Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Radiography; Remission, Spontaneous; Sella Turcica; Sexual Behavior | 1981 |
Growth of a prolactinoma during pregnancy. Case report and review.
Topics: Adenoma, Chromophobe; Adult; Anovulation; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin | 1981 |
Regression of pituitary prolactinoma with bromocriptine administration.
Topics: Adult; Bromocriptine; Humans; Male; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin | 1981 |
Hyperprolactinemia.
Topics: Adenoma; Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Prolactin | 1981 |
Prolactin receptor expression in lymphocytes from patients with hyperprolactinemia or acromegaly.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; CD8-Positive T-Lymphocytes; Cells, Cultured; Down-Regulation; Flow Cytometry; Humans; Hyperprolactinemia; Lymphocyte Count; Lymphocytes; Middle Aged; Pituitary Neoplasms; Receptors, Prolactin | 1995 |
Induction of apoptosis in murine ACTH-secreting pituitary adenoma cells by bromocriptine.
Topics: Adenoma; Adrenocorticotropic Hormone; Animals; Antineoplastic Agents; Apoptosis; Bromocriptine; Cell Division; DNA, Neoplasm; Flow Cytometry; Mice; Pituitary Neoplasms; Protein Biosynthesis; RNA; Tumor Cells, Cultured | 1994 |
Pituitary adenomas in childhood and adolescence.
Topics: Adenoma; Adolescent; Bromocriptine; Child; Female; Fertility; Humans; Immunohistochemistry; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Staining and Labeling; Treatment Outcome | 1994 |
Effect of angiogenesis inhibitor TNP-470 on vascular formation in pituitary tumors induced by estrogen in rats.
Topics: Animals; Bromocriptine; Cyclohexanes; Estradiol; Female; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Pituitary Neoplasms; Rats; Rats, Inbred F344; Sesquiterpenes | 1994 |
Effects of gonadal steroids on the growth of human pituitary adenomas in vitro.
Topics: Adenoma; Adult; Androgens; Bromocriptine; Cell Division; Dihydrotestosterone; Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone; Hormone Antagonists; Humans; Lisuride; Male; Metribolone; Middle Aged; Pituitary Neoplasms; Progesterone; Prolactin; Receptors, Estrogen; Receptors, Progesterone; Testosterone; Thymidine; Tritium; Tumor Cells, Cultured | 1995 |
The effect of naloxone and metoclopramide on the secretion of luteinizing hormone in a hyperprolactinemic hypogonadotropic postmenopausal woman.
Topics: Aged; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Hypogonadism; Injections, Intravenous; Luteinizing Hormone; Metoclopramide; Naloxone; Narcotic Antagonists; Pituitary Neoplasms; Postmenopause; Prolactin; Prolactinoma | 1995 |
Growth of a microprolactinoma to a macroprolactinoma during estrogen therapy.
Topics: Amenorrhea; Bromocriptine; Estradiol Congeners; Female; Hormone Antagonists; Humans; Middle Aged; Pituitary Neoplasms; Prolactinoma; Tomography, X-Ray Computed | 1995 |
Effects of bromocriptine on staining indices of Ki-67 and proliferating cell nuclear antigen, and nucleolar organizer region number in pituitary adenomas.
Topics: Adult; Bromocriptine; Female; Humans; Immunohistochemistry; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactinoma; Proliferating Cell Nuclear Antigen; Treatment Outcome | 1995 |
Mammosomatotroph adenoma causing gigantism in an 8-year old boy: a possible pathogenetic mechanism.
Topics: Adenoma; Base Sequence; Bromocriptine; Child; DNA Primers; Dose-Response Relationship, Drug; Gigantism; Growth Hormone; GTP-Binding Proteins; Humans; Male; Molecular Sequence Data; Pituitary Neoplasms; Prolactin; Tumor Cells, Cultured | 1995 |
In vivo effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors.
Topics: Animals; Antineoplastic Agents; Bromocriptine; Cabergoline; Cytoplasmic Granules; Dopamine Agonists; Endoplasmic Reticulum; Ergolines; Estradiol; Female; Microscopy, Electron; Organ Size; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred F344 | 1995 |
Desensitization to somatostatin analogue (Octreotide) observed in a patient with acromegaly.
Topics: Acromegaly; Adenoma; Adult; Amenorrhea; Bromocriptine; Drug Resistance; Female; Growth Hormone; Humans; Insulin-Like Growth Factor I; Octreotide; Pituitary Neoplasms | 1995 |
In vivo visualization of pituitary dopaminergic receptors by iodine-123 methoxybenzamide (IBZM) correlates with sensitivity to dopamine agonists in two patients with macroprolactinomas.
Topics: Adult; Benzamides; Brain; Bromocriptine; Female; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Pyrrolidines; Receptors, Dopamine; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 1995 |
DNA synthesis by pituitary tumours, with reference to plasma hormone levels and to effects of bromocriptine.
Topics: Acromegaly; Adolescent; Adult; Aged; Bromocriptine; Child; DNA, Neoplasm; Female; Growth Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 1995 |
Dopamine responsiveness of human prolactinoma cells as determined by the reverse hemolytic plaque assay.
Topics: Adolescent; Adult; Bromocriptine; Dopamine; Female; Hemolytic Plaque Technique; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 1995 |
Effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors: in vitro culture studies.
Topics: Animals; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Estradiol; Female; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred F344; Tumor Cells, Cultured | 1995 |
Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology.
Topics: Adenoma; Adenoma, Chromophobe; Adult; Biomarkers, Tumor; Bromocriptine; Cytoplasmic Granules; Diabetes Mellitus; Female; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Hypertension; Keratins; Middle Aged; Neoplasm Proteins; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone; Treatment Outcome | 1993 |
Nonfunctioning pituitary adenoma.
Topics: Adenoma; Bromocriptine; Dopamine Agonists; Humans; Pituitary Neoplasms | 1994 |
Prolactinoma.
Topics: Bromocriptine; Female; Humans; Male; Menstruation; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma | 1994 |
Inappropriate secretion of thyroid stimulating hormone.
Topics: Bromocriptine; Dopamine Agonists; Glucocorticoids; Humans; Octreotide; Pituitary Neoplasms; Somatostatin; Thyroid Hormones; Thyroidectomy; Thyrotropin | 1994 |
Gonadotroph adenomas.
Topics: Adenoma; Bromocriptine; Dopamine; Dopamine Agonists; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hormones; Humans; Hypopituitarism; Luteinizing Hormone; Male; Osteoporosis; Pituitary Neoplasms | 1994 |
Prolactin-producing pituitary tumor: resistance to dopamine agonist therapy. Case report.
Topics: Adenoma; Adolescent; Aminoquinolines; Bromocriptine; Dopamine Agonists; Drug Resistance; Female; Humans; Microscopy, Electron; Pituitary Neoplasms; Prolactin; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Estrogen; RNA, Messenger | 1995 |
Prolactinomas resistant to dopamine agonists: insights into pathogenesis and therapy.
Topics: Adult; Bromocriptine; Drug Resistance; Female; Humans; Pituitary Neoplasms; Prolactinoma | 1994 |
Two macroprolactinomas presenting with neurological signs.
Topics: Adult; Bromocriptine; Female; Hemiplegia; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Tomography, X-Ray Computed; Vision Disorders; Visual Fields | 1995 |
[Do articular manifestations appear in prolactinomas?].
Topics: Adult; Arthritis; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies | 1995 |
[Diagnostic and therapeutic approach to hyperprolactinemia].
Topics: Amenorrhea; Anovulation; Bromocriptine; Diagnostic Imaging; Female; Galactorrhea; Humans; Hyperprolactinemia; Menstruation Disturbances; Pituitary Neoplasms; Prolactinoma | 1995 |
Bromocriptine for prolactinoma-related dissociative disorder and depression.
Topics: Bromocriptine; Depressive Disorder; Dissociative Disorders; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Middle Aged; Neurocognitive Disorders; Pituitary Neoplasms; Prolactin; Prolactinoma | 1995 |
Prolactinomas: present day management.
Topics: Bromocriptine; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma | 1995 |
Treatment of macroprolactinomas at Auckland Hospital 1975-91.
Topics: Adolescent; Adult; Aged; Bromocriptine; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; New Zealand; Pituitary Neoplasms; Postoperative Complications; Prolactinoma; Retrospective Studies; Treatment Outcome | 1995 |
[Hyperprolactinemia: importance of early therapy].
Topics: Adenoma; Adult; beta-Endorphin; Bromocriptine; Cushing Syndrome; Female; Humans; Hyperprolactinemia; Neoplasm Recurrence, Local; Pituitary Neoplasms; Time Factors | 1994 |
Large somatostatin-insensitive thyrotrophin-secreting pituitary tumour responsive to D-thyroxine and dopamine agonists.
Topics: Bromocriptine; Dextrothyroxine; Dopamine Agents; Drug Resistance; Female; Humans; Middle Aged; Octreotide; Pituitary Neoplasms; Radionuclide Imaging; Thyrotoxicosis; Thyrotropin; Tomography, X-Ray Computed | 1993 |
Inhibitory effects of the dopamine agonists quinagolide (CV 205-502) and bromocriptine on prolactin secretion and growth of SMtTW pituitary tumors in the rat.
Topics: Aminoquinolines; Animals; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Female; Neoplasm Transplantation; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred WF; Ultrasonography | 1994 |
Terguride as a new anti-hyperprolactinemic agent: characterization in rats and dogs in comparison with bromocriptine.
Topics: Animals; Bromocriptine; Dogs; Dopamine Agents; Estradiol; Female; Glutathione; Hyperprolactinemia; Lactation; Lisuride; Luteinizing Hormone; Male; Motor Activity; Pituitary Neoplasms; Prolactinoma; Rats; Rats, Wistar; Receptors, Dopamine D2; Reserpine; Stereotyped Behavior; Vomiting | 1993 |
Lichen sclerosus associated with prolactinoma.
Topics: Adult; Bromocriptine; Female; Humans; Lichenoid Eruptions; Pituitary Neoplasms; Prolactinoma; Vulvar Diseases | 1994 |
McCune-Albright syndrome and acromegaly: clinical studies and responses to treatment in five cases.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Bromocriptine; Female; Fibrous Dysplasia, Polyostotic; Growth Hormone; Humans; Magnetic Resonance Imaging; Male; Octreotide; Pituitary Neoplasms; Thyrotropin-Releasing Hormone | 1994 |
3D-FT thin sections MRI of prolactin-secreting pituitary microadenomas.
Topics: Adolescent; Adult; Bromocriptine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma | 1994 |
Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas.
Topics: Adenoma; Adenylyl Cyclases; Adolescent; Adult; Alternative Splicing; Base Sequence; Bromocriptine; Drug Resistance; Female; Gene Expression; Growth Hormone; Humans; Male; Molecular Sequence Data; Pituitary Neoplasms; Polymerase Chain Reaction; Prolactinoma; Receptors, Dopamine D2 | 1994 |
Hyperprolactinemia in women--a series of 71 cases.
Topics: Adult; Bromocriptine; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Hypophysectomy; Infertility, Female; Pituitary Neoplasms; Pregnancy; Prolactinoma | 1993 |
Macroprolactinoma expansion during pregnancy.
Topics: Adult; Bromocriptine; Female; Humans; Infant, Newborn; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Tomography, X-Ray Computed | 1993 |
Usefulness of thyrotropin-releasing hormone test, SMS 201-995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas.
Topics: Adenoma; Administration, Oral; Aged; Bromocriptine; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Injections, Intravenous; Luteinizing Hormone; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Thyrotropin-Releasing Hormone; Tomography, X-Ray Computed | 1994 |
Prolactinomas in men masquerading as invasive skull base tumours.
Topics: Adolescent; Adult; Bromocriptine; Combined Modality Therapy; Diagnosis, Differential; Humans; Hypophysectomy; Immunoenzyme Techniques; Male; Middle Aged; Pituitary Gland; Pituitary Irradiation; Pituitary Neoplasms; Postoperative Complications; Prolactin; Prolactinoma; Tomography, X-Ray Computed | 1994 |
Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
Topics: Adolescent; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Lisuride; Molecular Weight; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiography | 1994 |
Induction of apoptosis in rat somatotrophin-secreting pituitary adenoma cells by bromocriptine.
Topics: Adenoma; Animals; Apoptosis; Bromocriptine; Cell Cycle; DNA, Neoplasm; Flow Cytometry; Growth Hormone; Pituitary Neoplasms; Rats | 1993 |
[Long-acting and repeatable dose bromocriptine in the prolonged treatment of prolactinoma].
Topics: Adult; Bromocriptine; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors; Vision Disorders | 1994 |
Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease.
Topics: Adult; Autoimmune Diseases; Bromocriptine; Female; Humans; Hyperprolactinemia; Lupus Erythematosus, Systemic; Pituitary Neoplasms; Prolactinoma; Radiography; Time Factors | 1994 |
Visual loss in pregnant women with pituitary adenomas.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Cohort Studies; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Risk Factors; Tomography, X-Ray Computed; Vision Disorders; Visual Fields | 1994 |
Shrinkage of pituitary PRL-secernent adenoma after short-term treatment with bromocriptine long-acting repeatable injections.
Topics: Adolescent; Adult; Bromocriptine; Delayed-Action Preparations; Female; Humans; Injections; Pituitary Neoplasms; Prolactin; Prolactinoma | 1994 |
[Rhinorrhea and otorrhea: rare complications of the medical treatment in invasive prolactinomas].
Topics: Adult; Bromocriptine; Cerebrospinal Fluid Otorrhea; Cerebrospinal Fluid Rhinorrhea; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma | 1994 |
Bromocriptine treatment of postoperative prolactinoma patients.
Topics: Adolescent; Adult; Bromocriptine; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma | 1994 |
Immunohistochemical expression of protein kinase C type III in human pituitary adenomas.
Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Cushing Syndrome; Dopamine Agents; Female; Humans; Immunohistochemistry; Isoenzymes; Male; Middle Aged; Pituitary Neoplasms; Preoperative Care; Prolactinoma; Protein Kinase C | 1993 |
Edema--an infrequently recognized complication of bromocriptine and other ergot dopaminergic drugs.
Topics: Aminoquinolines; Bromocriptine; Dopamine Agents; Edema; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactinoma | 1993 |
Intracranial dissemination of a macroprolactinoma.
Topics: Aminoquinolines; Brain Neoplasms; Bromocriptine; Combined Modality Therapy; Drug Therapy, Combination; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Radiotherapy Dosage; Somatostatin | 1993 |
Bromocriptine-induced schizophrenia.
Topics: Bromocriptine; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Schizophrenia | 1993 |
Effect of bromocriptine and SMS 201-995 on growth of human somatotrophic and non-functioning pituitary adenoma cells in vitro.
Topics: Adenoma; Adult; Aged; Bromocriptine; Cell Count; Cell Division; Culture Media; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Tumor Cells, Cultured | 1994 |
Pulsatile thyrotropin and prolactin secretion in a patient with a mixed thyrotropin- and prolactin-secreting pituitary adenoma.
Topics: Adenoma; Adult; Bromocriptine; Circadian Rhythm; Cluster Analysis; Follow-Up Studies; Humans; Hyperthyroidism; Male; Octreotide; Pituitary Neoplasms; Prolactin; Prolactinoma; Pulsatile Flow; Thyrotropin; Visual Acuity | 1994 |
Escape phenomenon after successful bromocriptine and octreotide treatment in thyroid stimulating hormone secreting pituitary adenoma residual tissue.
Topics: Adenoma; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Humans; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Thyrotropin | 1994 |
Prolactin-secreting macroadenomas in adolescents. Response to bromocriptine therapy.
Topics: Adolescent; Bromocriptine; Child; Female; Humans; Magnetic Resonance Imaging; Male; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Prolactinoma | 1993 |
Restoration by bromocriptine of glucocorticoid receptors and glucocorticoid negative feedback on prolactin secretion in estrogen-induced pituitary tumors.
Topics: Animals; Antibodies, Monoclonal; Bromocriptine; Dexamethasone; Diethylstilbestrol; Feedback; Glucocorticoids; Immunoenzyme Techniques; Male; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Rats; Receptors, Glucocorticoid | 1993 |
[Nursing care of pituitary prolactinoma with bromocriptine].
Topics: Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactinoma | 1993 |
Rapid resolution of visual abnormalities with medical therapy alone in patients with large prolactinomas.
Topics: Adult; Bromocriptine; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Vision Disorders; Visual Acuity; Visual Fields | 1993 |
Malignant growth of a recurrent macroprolactinoma after radiation therapy.
Topics: Bromocriptine; Cell Transformation, Neoplastic; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lisuride; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Pituitary Irradiation; Pituitary Neoplasms; Prolactin; Prolactinoma; Tomography, X-Ray Computed | 1993 |
Evaluation of three-dimensional MRI exploration of prolactin-secreting microadenomas.
Topics: Adolescent; Adult; Arachnoid; Bromocriptine; Contrast Media; Diagnosis, Differential; Evaluation Studies as Topic; Female; Follow-Up Studies; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 1993 |
Reversible dementia due to macroprolactinoma. Case report.
Topics: Behavior; Bromocriptine; Dementia; Humans; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Pituitary Neoplasms; Prolactinoma | 1993 |
Plasma calcitonin, IGF-I levels and vertebral bone mineral density in hyperprolactinemic women during bromocriptine treatment.
Topics: Adult; Bone Density; Bromocriptine; Calcitonin; Calcium; Estradiol; Female; Growth Hormone; Humans; Hyperprolactinemia; Insulin-Like Growth Factor I; Lumbar Vertebrae; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Radioimmunoassay; Time Factors | 1993 |
Effects of recombinant human activin A on growth hormone secretion by human somatotrophinomas in vitro.
Topics: Activins; Aged; Bromocriptine; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Growth Substances; Humans; Inhibins; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Recombinant Proteins; Stimulation, Chemical; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured | 1993 |
Imaging of dopamine D2 and somatostatin receptors in vivo using single-photon emission tomography in a patient with a TSH/PRL-producing pituitary macroadenoma.
Topics: Administration, Oral; Bromocriptine; Humans; Injections, Subcutaneous; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Prolactinoma; Receptors, Dopamine D2; Receptors, Somatostatin; Thyrotropin; Tomography, Emission-Computed, Single-Photon | 1993 |
Nerve growth factor suppresses the transforming phenotype of human prolactinomas.
Topics: Animals; Binding, Competitive; Bromocriptine; Cell Division; Cell Membrane; Humans; Kinetics; Mice; Mice, Nude; Neoplasm Transplantation; Nerve Growth Factors; Phenotype; Pituitary Neoplasms; Prolactin; Prolactinoma; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Receptor, trkA; Receptors, Dopamine D2; Receptors, Nerve Growth Factor; Sulpiride; Thymidine; Transplantation, Heterologous; Tumor Cells, Cultured | 1993 |
Long-term treatment of acromegalic patients with repeatable parenteral depot-bromocriptine.
Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Delayed-Action Preparations; Female; Growth Hormone; Humans; Injections, Intramuscular; Male; Middle Aged; Pituitary Neoplasms; Pregnancy | 1993 |
[Prolactin-secreting macroadenoma in an adolescent girl: response to the medical treatment and follow-up method].
Topics: Adolescent; Bromocriptine; Female; Follicle Stimulating Hormone; Follow-Up Studies; Growth Hormone; Humans; Luteinizing Hormone; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactin; Prolactinoma | 1993 |
Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation.
Topics: Adenoma; Bromocriptine; Cell Transformation, Neoplastic; Child; Gigantism; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hyperplasia; Magnetic Resonance Imaging; Male; Octreotide; Pituitary Gland; Pituitary Neoplasms; Prolactin | 1993 |
Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary.
Topics: Adenoma; Bromocriptine; Female; Glucose Tolerance Test; Gonadotropin-Releasing Hormone; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Immunohistochemistry; In Situ Hybridization; Insulin-Like Growth Factor I; Middle Aged; Pituitary Neoplasms; Prolactin; RNA, Messenger; Thyrotropin-Releasing Hormone | 1993 |
Long term therapy of patients with macroprolactinoma using repeatable injectable bromocriptine.
Topics: Adolescent; Adult; Aged; Bromocriptine; Estradiol; Female; Humans; Injections, Intramuscular; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 1993 |
Spontaneous shrinking of a macroprolactinoma.
Topics: Adult; Bromocriptine; Follow-Up Studies; Garlic; Humans; Male; Neoplasm Regression, Spontaneous; Pituitary Neoplasms; Plants, Medicinal; Prolactin; Prolactinoma; Tomography, X-Ray Computed | 1993 |
[Statistical survey of prolactin producing tumor in Japan].
Topics: Adult; Age Factors; Bromocriptine; Female; Humans; Japan; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Function Tests; Pituitary Neoplasms; Prognosis; Prolactin; Prolactinoma; Reference Standards; Sex Factors | 1993 |
Topical effect of bromocriptine on rat-transplanted human prolactinomas.
Topics: Animals; Bromocriptine; Cell Division; Humans; Immunoenzyme Techniques; Injections, Intralesional; Neoplasm Transplantation; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Tumor Cells, Cultured | 1993 |
Effect of chronic bromocriptine treatment on psychological profile of patients with PRL-secreting pituitary adenomas.
Topics: Adult; Aggression; Anxiety; Bromocriptine; Female; Hormones; Hostility; Humans; Middle Aged; MMPI; Pituitary Neoplasms; Prolactinoma; Psychological Tests | 1993 |
Long-acting injectable bromocriptine (Parlodel LAR) in the chronic treatment of prolactin-secreting macroadenomas.
Topics: Adenoma; Adolescent; Adult; Analysis of Variance; Bromocriptine; Delayed-Action Preparations; Female; Humans; Injections; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Prospective Studies; Visual Fields | 1993 |
Aspects of medical therapy of neuroendocrine disorders.
Topics: Bromocriptine; Cushing Syndrome; Endocrine System Diseases; Humans; Nervous System Diseases; Neurosecretory Systems; Octreotide; Pituitary Neoplasms; Prolactinoma | 1993 |
[Prolactin adenoma developed during puberty. Diagnosis and long-term course. 9 cases].
Topics: Adolescent; Bromocriptine; Child; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Pituitary Neoplasms; Prolactinoma; Puberty; Time Factors | 1993 |
Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Cell Division; Dopamine; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Nerve Growth Factors; Pituitary Neoplasms; Prolactin; Prolactinoma; Sensitivity and Specificity | 1995 |
Normal growth and pubertal development during bromocriptine therapy in two patients with prolactinoma.
Topics: Adolescent; Bromocriptine; Dopamine Agonists; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Puberty | 1995 |
Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: long term follow-up.
Topics: Adolescent; Adult; Aged; Amenorrhea; Bromocriptine; Female; Follow-Up Studies; Growth Hormone; Humans; Middle Aged; Neoplasm Recurrence, Local; Pituitary Gland; Pituitary Neoplasms; Pregnancy; Pregnancy Outcome; Prolactinoma; Reoperation | 1996 |
[A case of oligozoospermia with marginal hyperprolactinemia due to pituitary microadenoma].
Topics: Adenoma; Adult; Bromocriptine; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Male; Oligospermia; Pituitary Neoplasms; Pregnancy | 1996 |
Relative resistance of a macroprolactinoma to bromocriptine therapy during pregnancy.
Topics: Adult; Bromocriptine; Drug Resistance, Neoplasm; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Vision Disorders | 1996 |
Early loss of the retinoblastoma gene is associated with impaired growth inhibitory innervation during melanotroph carcinogenesis in Rb+/- mice.
Topics: Animals; Animals, Newborn; Base Sequence; Bromocriptine; Cell Division; Cell Transformation, Neoplastic; Dopamine; Dopamine Agonists; Gene Deletion; Gene Expression Regulation, Neoplastic; Genes, Retinoblastoma; Heterozygote; Mice; Mice, Mutant Strains; Molecular Sequence Data; Pituitary Gland; Pituitary Neoplasms; Receptors, Dopamine; Tumor Cells, Cultured | 1996 |
Hyperprolactinemia and reproductive disorders--a profile from north east.
Topics: Bromocriptine; Female; Humans; Hyperprolactinemia; Hypothyroidism; Incidence; India; Infertility, Female; Menstruation Disturbances; Pituitary Neoplasms; Pregnancy; Prolactinoma | 1995 |
Long-term follow-up of women with amenorrhea-galactorrhea treated with bromocriptine.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Female; Follow-Up Studies; Galactorrhea; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone; Tomography, X-Ray Computed | 1995 |
[Macroprolactinoma].
Topics: Bromocriptine; Dopamine Agonists; Humans; Male; Middle Aged; Pituitary Neoplasms; Prognosis; Prolactin; Prolactinoma | 1996 |
Cyclic Cushing's disease in long-term remission with a daily low dose of bromocriptine.
Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Cushing Syndrome; Dopamine Antagonists; Humans; Hydrocortisone; Hypophysectomy; Male; Middle Aged; Periodicity; Pituitary Neoplasms; Recurrence; Remission Induction | 1996 |
Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism.
Topics: Animals; Antineoplastic Agents; Bromocriptine; Cell Division; Dopamine Agents; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Nerve Growth Factors; Oligonucleotides, Antisense; Pituitary Neoplasms; Prolactinoma; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Receptor, Nerve Growth Factor; Receptor, trkA; Receptors, Dopamine D2; Receptors, Nerve Growth Factor; Tumor Cells, Cultured | 1996 |
15-year-old boy with ocular palsy and headache. Invasive macroprolactinoma.
Topics: Adolescent; Bromocriptine; Cortisone; Dopamine Agonists; Eye Diseases; Headache; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Radionuclide Imaging; Thyroxine; Treatment Outcome | 1996 |
[Prolactin-secreting adenoma].
Topics: Bromocriptine; Diagnosis, Differential; Dopamine Agents; Female; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma | 1996 |
[Medical treatment of pituitary adenoma].
Topics: Adenoma; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Bromocriptine; Dopamine Agonists; Humans; Octreotide; Peptides, Cyclic; Pituitary Neoplasms; Somatostatin; Treatment Outcome | 1996 |
Bromocriptine as adjunctive therapy to clozapine in treatment-resistant schizophrenia.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Clozapine; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Pituitary Neoplasms; Prolactinoma; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1996 |
Outcome of pregnancies in women with treated or untreated hyperprolactinemia.
Topics: Abortion, Induced; Abortion, Spontaneous; Adenoma; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Ovulation Induction; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy, Tubal | 1995 |
Alteration of G alpha subunits mRNA levels in bromocriptine resistant prolactinomas.
Topics: Adenoma; Adult; Bromocriptine; Dopamine Agonists; Drug Resistance, Neoplasm; Female; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Macromolecular Substances; Male; Pituitary Neoplasms; Polymerase Chain Reaction; Prolactinoma; Receptors, Dopamine D2; Reproducibility of Results; RNA, Messenger; Transcription, Genetic | 1996 |
[Seizures as a late complication of bromocriptine therapy in patients with prolactin-producing macroadenomas: correlation between lateral extension of the adenoma and seizure onset].
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Drug Administration Schedule; Female; Hormone Antagonists; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Seizures | 1996 |
Prolactinomas resistant to bromocriptine: long-term efficacy of quinagolide and outcome of pregnancy.
Topics: Aminoquinolines; Bromocriptine; Dopamine Agonists; Drug Resistance; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma | 1996 |
Symptoms of pituitary apoplexy rapidly reversed with bromocriptine. Case report.
Topics: Adult; Bromocriptine; Humans; Magnetic Resonance Imaging; Male; Oculomotor Nerve Diseases; Pituitary Apoplexy; Pituitary Neoplasms; Prolactinoma | 1996 |
Effect of bromocriptine on the sensitivity of pituitary tumor cells to radiation.
Topics: Animals; Bromocriptine; Cell Count; Dose-Response Relationship, Radiation; Pituitary Neoplasms; Rats; Tumor Cells, Cultured | 1996 |
Development of acromegaly during treatment of hyperprolactinemia with bromocriptine: an unusual acidophil stem cell adenoma.
Topics: Acromegaly; Adenoma, Acidophil; Adult; Bromocriptine; Female; Growth Hormone; Hormone Antagonists; Humans; Hyperprolactinemia; Pituitary Neoplasms | 1996 |
Chiasmal herniation as a complication of bromocriptine therapy.
Topics: Bromocriptine; Cranial Nerve Diseases; Dopamine Agonists; Encephalocele; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Optic Chiasm; Pituitary Neoplasms; Prolactinoma; Vision Disorders; Visual Fields | 1996 |
Macroprolactinomas as cause of delayed puberty. A report of two cases and effects of medical therapy.
Topics: Adolescent; Bromocriptine; Dopamine Agonists; Dwarfism, Pituitary; Hemianopsia; Humans; Male; Ophthalmoplegia; Pituitary Neoplasms; Prolactinoma; Puberty, Delayed | 1996 |
Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Aged; Benzamides; Bromocriptine; Cerebellum; Corpus Striatum; Cushing Syndrome; Dopamine Agonists; Female; Humans; Lisuride; Male; Middle Aged; Nelson Syndrome; Pituitary Neoplasms; Prolactinoma; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon | 1996 |
Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
Topics: Adult; Aldosterone; Bromocriptine; Case-Control Studies; Dopamine Agonists; Dopamine Antagonists; Drug Interactions; Female; Humans; Metoclopramide; Pituitary Neoplasms; Prolactin; Prolactinoma; Radioimmunoassay; Reference Values | 1996 |
Large macroprolactinoma treated with bromocriptine alone.
Topics: Administration, Oral; Adult; Bromocriptine; Dopamine Agonists; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Tomography, X-Ray Computed | 1996 |
Prolactin receptor messenger ribonucleic acid in normal and neoplastic human pituitary tissues.
Topics: Adenoma; Adult; Aged; Bromocriptine; Female; Hormone Antagonists; Humans; In Situ Hybridization; Male; Middle Aged; Pituitary Neoplasms; Polymerase Chain Reaction; Receptors, Prolactin; Reference Values; RNA, Messenger; Tissue Distribution; Transcription, Genetic | 1997 |
[Hyperthyroidism in TSH-producing hypophyseal adenoma].
Topics: Adenoma; Bromocriptine; Follow-Up Studies; Humans; Hyperthyroidism; Hypophysectomy; Magnetic Resonance Imaging; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Radionuclide Imaging; Thyrotropin; Time Factors | 1997 |
[Pregnancy in hyperprolactinemic patients].
Topics: Adult; Breast Feeding; Bromocriptine; Combined Modality Therapy; Female; Humans; Hyperprolactinemia; Hypophysectomy; Infant, Newborn; Magnetic Resonance Imaging; Pituitary Gland; Pituitary Neoplasms; Postoperative Complications; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactin; Prolactinoma; Retrospective Studies; Tomography, X-Ray Computed | 1996 |
Hyperprolactinemia in postmenopausal women.
Topics: Adenoma; Aged; Bromocriptine; Dopamine Agonists; Female; Follow-Up Studies; Gonadotropins, Pituitary; Humans; Hyperprolactinemia; Middle Aged; Pituitary Neoplasms; Postmenopause; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 1997 |
Management of prolactinomas.
Topics: Bromocriptine; Dopamine Agonists; Female; Humans; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactinoma | 1997 |
[Hippocampal hemosiderin deposit due to large pituitary adenoma presenting temporal lobe epilepsy--a case report].
Topics: Adenoma; Adult; Bromocriptine; Electroencephalography; Epilepsy, Temporal Lobe; Hemosiderin; Hippocampus; Hormone Antagonists; Humans; Male; Pituitary Neoplasms | 1997 |
Transformation of a human mixed GH-PRL adenoma cell population in response to long-term bromocriptine treatment.
Topics: Adenoma; Bromocriptine; Child; Child, Preschool; Culture Techniques; Female; Hormone Antagonists; Human Growth Hormone; Humans; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin | 1997 |
Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study.
Topics: Adolescent; Adult; Age Factors; Aged; Biomarkers; Bromocriptine; Cell Division; Female; Humans; Ki-67 Antigen; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Proliferating Cell Nuclear Antigen; Retrospective Studies; Sex Factors | 1997 |
[Management of pituitary adenoma in pregnancy].
Topics: Adenoma; Breast Feeding; Bromocriptine; Cesarean Section; Dopamine Agonists; Female; Hormone Antagonists; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Retrospective Studies | 1996 |
Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors.
Topics: Adenoma; Adenoma, Islet Cell; Aminoquinolines; Bromocriptine; Dopamine Agonists; Endocrine Gland Neoplasms; Hormone Antagonists; Hormones; Humans; Insulinoma; Pancreatic Neoplasms; Pituitary Neoplasms; Prolactinoma; Receptors, Somatostatin; Somatostatin; Tumor Cells, Cultured | 1997 |
Management of incidental pituitary microadenomas: a cost-effectiveness analysis.
Topics: Adenoma; Bromocriptine; Cost-Benefit Analysis; Dexamethasone; Humans; Insulin-Like Growth Factor I; Magnetic Resonance Imaging; Markov Chains; Models, Statistical; Pituitary Neoplasms; Prolactin; Prolactinoma | 1997 |
[Bromocriptine monotherapy of a prolactinoma causing erectile dysfunction].
Topics: Adult; Bromocriptine; Dopamine Agonists; Erectile Dysfunction; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Prolactinoma; Radiography | 1997 |
Evidence for dopamine agonists in the treatment of acromegaly.
Topics: Acromegaly; Adenoma; Aminoquinolines; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Humans; Octreotide; Pituitary Neoplasms; Somatostatin | 1997 |
Hyperprolactinaemia in males: a heterogeneous disorder.
Topics: Adult; Aged; Bromocriptine; Follow-Up Studies; Hormone Antagonists; Humans; Hyperprolactinemia; Hypogonadism; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Tomography, X-Ray Computed | 1997 |
Effects of bromocriptine and terguride on cell proliferation and apoptosis in the estrogen-stimulated anterior pituitary gland of the rat.
Topics: Animals; Apoptosis; Bromocriptine; Cell Division; Cell Migration Inhibition; Dopamine Agonists; Estradiol; Female; Hormone Antagonists; Lisuride; Neoplastic Cells, Circulating; Pituitary Gland; Pituitary Neoplasms; Prolactinoma; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar | 1997 |
Sarcomatous transformation of pituitary adenoma after bromocriptine therapy.
Topics: Adenoma; Adult; Antibodies, Neoplasm; Antigens, Neoplasm; Biomarkers, Tumor; Bromocriptine; Cell Transformation, Neoplastic; Combined Modality Therapy; Female; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Pituitary Neoplasms; Sarcoma | 1998 |
Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy.
Topics: Adult; Aged; Bromocriptine; Drug Synergism; Female; Growth Hormone; Hormone Antagonists; Humans; Male; Middle Aged; Oligopeptides; Pituitary Neoplasms; Prolactin; Prolactinoma; Sermorelin; Statistics, Nonparametric | 1998 |
Heterogeneous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically nonfunctioning pituitary adenomas.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Bromocriptine; Case-Control Studies; Dopamine Agonists; Female; Humans; In Situ Hybridization; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Receptors, Dopamine D2; RNA, Messenger; Tumor Cells, Cultured | 1998 |
Late development of resistance to bromocriptine in a patient with macroprolactinoma.
Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 1998 |
Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy.
Topics: Acromegaly; Adenoma; Adult; Aged; Antineoplastic Agents, Hormonal; Bromocriptine; Dose Fractionation, Radiation; Female; Follow-Up Studies; Hormone Antagonists; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Linear Models; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Radiation Injuries; Radiosurgery; Radiotherapy Dosage; Recurrence; Reoperation; Retreatment; Treatment Outcome | 1998 |
[Disappearance of the radiographic image of a macroprolactinoma after treatment with bromocriptine].
Topics: Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Pituitary Neoplasms; Prolactinoma; Remission, Spontaneous; Tomography, X-Ray Computed | 1998 |
Tamoxifen inhibits GH3 cell growth in culture via enhancement of apoptosis.
Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Bromocriptine; Cell Count; Cell Division; Dopamine Agonists; Estradiol; Humans; Microscopy, Electron; Neoplasms, Radiation-Induced; Pituitary Neoplasms; Prolactin; Rats; Receptors, Dopamine; Tamoxifen; Tumor Cells, Cultured | 1998 |
Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels.
Topics: Adult; Bromocriptine; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Regression Analysis; Retrospective Studies; Weight Gain | 1998 |
Analyzing amenorrhea.
Topics: Adult; Amenorrhea; Bromocriptine; Contraceptives, Oral; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Hypothalamus; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy Tests; Prolactinoma; Uterus | 1998 |
Pituitary apoplexy in an adolescent with prolactin-secreting adenoma.
Topics: Adolescent; Bromocriptine; Female; Humans; Hydrocortisone; Magnetic Resonance Imaging; Pituitary Apoplexy; Pituitary Neoplasms; Prolactinoma | 1998 |
Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up.
Topics: Adolescent; Amenorrhea; Aminoquinolines; Bromocriptine; Child; Dopamine Agonists; Drug Resistance; Female; Follow-Up Studies; Galactorrhea; Growth Disorders; Humans; Male; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Puberty | 1998 |
Surgery combined with dopamine agonists versus dopamine agonists alone in long-term treatment of macroprolactinoma: a retrospective study.
Topics: Adolescent; Adult; Aged; Bromocriptine; Combined Modality Therapy; Dopamine Agonists; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Hypotension, Orthostatic; Male; Middle Aged; Nausea; Pituitary Gland; Pituitary Hormones; Pituitary Neoplasms; Prolactin; Prolactinoma; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Surgical Procedures, Operative; Treatment Outcome; Vision Disorders; Visual Fields | 1998 |
Prolactin-secreting macroadenoma in a prepubertal girl.
Topics: Bromocriptine; Child; Combined Modality Therapy; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Postoperative Care; Prolactin; Prolactinoma; Puberty; Tomography, X-Ray Computed | 1998 |
Shock syndrome induced by bromocriptine test in a patient with prolactinoma--case report.
Topics: Aged; Bromocriptine; Humans; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactinoma; Shock; Syndrome; Vasodilator Agents | 1998 |
Serum prolactin concentration in patients taking neuroleptic drugs.
Topics: Adolescent; Adult; Antipsychotic Agents; Bromocriptine; Diagnosis, Differential; Female; Fluoroimmunoassay; Humans; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiography | 1998 |
Surgical indication after bromocriptine therapy on giant prolactinomas: effects and limitations of the medical treatment.
Topics: Adult; Aged; Brain; Bromocriptine; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 1998 |
Differential actions of the dopamine agonist bromocriptine on growth of SMtTW tumors exhibiting a prolactin and/or a somatotroph cell phenotype: relation to dopamine D2 receptor expression.
Topics: Animals; Bromocriptine; Cell Differentiation; Cell Division; Dopamine Agonists; Female; Growth Hormone; Humans; Immunohistochemistry; In Situ Hybridization; Neoplasm Transplantation; Phenotype; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred WF; Receptors, Dopamine D2; Tumor Cells, Cultured | 1999 |
Hormonal replacement therapy in menopausal women with a history of hyperprolactinemia.
Topics: Adenoma; Adult; Bromocriptine; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hyperprolactinemia; Menopause; Middle Aged; Pituitary Neoplasms; Progestins; Prolactin; Thyrotropin-Releasing Hormone; Tomography, X-Ray Computed | 1998 |
Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Bromocriptine; Drug Resistance; Female; Glycoprotein Hormones, alpha Subunit; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Radiotherapy; Thyroid Hormones; Thyrotropin; Thyrotropin-Releasing Hormone; Tomography, X-Ray Computed; Treatment Outcome | 1999 |
The long-term effects of pregnancy and bromocriptine treatment on prolactinomas--the value of radiologic studies.
Topics: Adult; Bromocriptine; Chorionic Gonadotropin; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Retrospective Studies; Tomography, X-Ray Computed | 1997 |
Reduction of plasma gonadotropin levels and pituitary tumor size by treatment with bromocriptine in a patient with gonadotropinoma.
Topics: Adenoma; Aged; Bromocriptine; Dopamine Agonists; Follow-Up Studies; Gonadotropins, Pituitary; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms | 1999 |
Induction of apoptosis in cells of GH3 line by bromocryptine.
Topics: Adenoma; Animals; Apoptosis; Bromocriptine; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Hormone Antagonists; Microscopy, Electron; Mitochondria; Necrosis; Pituitary Neoplasms; Rats; Tumor Cells, Cultured; Vacuoles | 1999 |
Secondary infertility as early symptom in a man with multiple endocrine neoplasia-type 1.
Topics: Adenoma; Adult; Bromocriptine; Erectile Dysfunction; Exons; Hormone Antagonists; Humans; Hyperprolactinemia; Male; Multiple Endocrine Neoplasia Type 1; Mutation; Neoplasm Proteins; Oligospermia; Pituitary Neoplasms; Postoperative Period; Proto-Oncogene Proteins; Sperm Count | 1999 |
Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.
Topics: Adenoma; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Drug Tolerance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Retrospective Studies; Sex Characteristics | 1999 |
Long-term treatment with bromocriptine of a plurihormonal pituitary adenoma secreting thyrotropin, growth hormone and prolactin.
Topics: Acromegaly; Adenoma; Amenorrhea; Bromocriptine; Female; Growth Hormone-Releasing Hormone; Hormone Antagonists; Human Growth Hormone; Humans; Hyperthyroidism; Middle Aged; Pituitary Neoplasms; Prolactin; Reference Values; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine | 1999 |
Rapid enlargement and recurrence of a preexisting intrasellar craniopharyngioma during the course of two pregnancies. Case report.
Topics: Adult; Bromocriptine; Craniopharyngioma; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Hormone Antagonists; Humans; Neoplasm Recurrence, Local; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Sphenoid Bone | 1999 |
[Prolactinoma as a cause of primary amenorrhea in a 16-year-old girl].
Topics: Adolescent; Amenorrhea; Bromocriptine; Female; Gonadal Steroid Hormones; Hormone Antagonists; Humans; Menarche; Pituitary Neoplasms; Prolactinoma | 1999 |
Gangliocytoma masquerading as a prolactinoma. Case report.
Topics: Adult; Bromocriptine; Diagnosis, Differential; Follow-Up Studies; Ganglioneuroma; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Neoplasm, Residual; Neurofilament Proteins; Pituitary Neoplasms; Prolactin; Prolactinoma; Synaptophysin; Temporal Lobe | 1999 |
Receptor imaging with 111In-pentreotide and 123I-methoxybenzamide, and inhibition tests with octreotide and bromocriptine of mixed growth hormone/prolactin-secreting pituitary tumors.
Topics: Adult; Benzamides; Bromocriptine; Contrast Media; Growth Hormone; Humans; Indium Radioisotopes; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Prolactin; Pyrrolidines; Radionuclide Imaging; Tomography | 1999 |
Interferon-alpha-2a is a potent inhibitor of hormone secretion by cultured human pituitary adenomas.
Topics: Adenoma; Bromocriptine; Dopamine Agonists; Gastrinoma; Gastrins; Human Growth Hormone; Humans; Insulin; Insulin Secretion; Insulinoma; Interferon alpha-2; Interferon-alpha; Octreotide; Pancreatic Neoplasms; Pituitary Neoplasms; Prolactin; Prolactinoma; Recombinant Proteins; Somatostatin; Tumor Cells, Cultured | 1999 |
High prolactin level.
Topics: Adenoma; Bromocriptine; Diagnosis, Differential; Dopamine; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Predictive Value of Tests; Prolactin; Prolactinoma | 2000 |
Peripubertal prolactinomas: clinical presentation and long-term outcome with different therapeutic approaches.
Topics: Adolescent; Bromocriptine; Child; Female; Humans; Male; Pituitary Neoplasms; Prolactinoma | 2000 |
Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.
Topics: Adolescent; Adult; Aminoquinolines; Analysis of Variance; Biomarkers; Bone Density; Bone Remodeling; Bromocriptine; Cabergoline; Case-Control Studies; Collagen; Collagen Type I; Dopamine Agonists; Ergolines; Female; Femur Neck; Humans; Longitudinal Studies; Lumbar Vertebrae; Male; Middle Aged; Osteocalcin; Osteoporosis; Peptides; Pituitary Neoplasms; Prolactinoma; Regression Analysis | 2000 |
Prolactin-secreting pituitary adenoma in neuroleptic treated patients with psychotic disorder.
Topics: Adult; Aminoquinolines; Antipsychotic Agents; Bipolar Disorder; Bromocriptine; Clozapine; Comorbidity; Dopamine Agonists; Dopamine Antagonists; Drug Interactions; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Psychoses, Substance-Induced; Psychotic Disorders | 2000 |
Acute shrinkage of a macroprolactinoma masquerading as pituitary apoplexy.
Topics: Adult; Bromocriptine; Diagnostic Errors; Humans; Magnetic Resonance Imaging; Male; Pituitary Apoplexy; Pituitary Neoplasms; Prolactinoma | 2000 |
Microprolactinoma: medical or surgical treatment as first line approach? The case for medical therapy.
Topics: Bromocriptine; Dopamine Agonists; Humans; Pituitary Neoplasms; Prolactin; Prolactinoma | 2000 |
Hormone secretion by cell culture of human GH-PRL secreting pituitary adenomas: effects of bromocriptine.
Topics: Adenoma; Bromocriptine; Dopamine Agonists; Female; Growth Hormone; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Tumor Cells, Cultured | 1998 |
Involvement of p38 mitogen-activated protein kinase activation in bromocriptine-induced apoptosis in rat pituitary GH3 cells.
Topics: Animals; Apoptosis; Bromocriptine; Dopamine D2 Receptor Antagonists; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pituitary Neoplasms; Prolactinoma; Rats; Receptors, Thyrotropin-Releasing Hormone; Signal Transduction; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured | 2000 |
Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
Topics: Adult; Amenorrhea; Bromocriptine; Case-Control Studies; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Luteinizing Hormone; Pituitary Neoplasms; Prolactin; Prolactinoma; Secretory Rate; Statistics, Nonparametric | 2000 |
[Prolactinomas in Yaounde: analytical study of 36 consecutive cases followed in the internal medicine department of the Yaounde Hospital from 1990 to 1996].
Topics: Bromocriptine; Cameroon; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Surgical Procedures, Operative; Testosterone; Tomography, X-Ray Computed | 2000 |
[Prolactinoma in a child showing high MIB-1 labeling index: a case report].
Topics: Bromocriptine; Child; Hormone Antagonists; Humans; Hypophysectomy; Ki-67 Antigen; Male; Mitotic Index; Pituitary Neoplasms; Postoperative Care; Prolactin; Prolactinoma; Radiotherapy, Adjuvant | 2000 |
Cerebrospinal fluid (CSF) rhinorrhoea occurring six days after commencement of bromocriptine for invasive macroprolactinoma.
Topics: Adult; Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Dopamine Agonists; Humans; Male; Pituitary Neoplasms; Prolactinoma | 2000 |
[Prolactinoma in man: clinical and histological characteristics].
Topics: Adolescent; Adult; Bromocriptine; Cell Division; Drug Resistance; Female; Hormone Antagonists; Humans; Ki-67 Antigen; Male; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Prolactinoma; Proliferating Cell Nuclear Antigen; Retrospective Studies; Sex Characteristics | 2000 |
Plasma levels of vascular endothelial growth factor in patients with acromegaly.
Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Endothelial Growth Factors; Female; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Lymphokines; Male; Middle Aged; Pituitary Neoplasms; Retrospective Studies; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Naval aviator with pituitary prolactin secreting microadenoma: case report and aeromedical concerns.
Topics: Adenoma; Adult; Aerospace Medicine; Bromocriptine; Hormone Antagonists; Humans; Hyperprolactinemia; Male; Military Personnel; Pituitary Neoplasms; Prolactin | 2000 |
Optic chiasmal herniation--an under recognized complication of dopamine agonist therapy for macroprolactinoma.
Topics: Adult; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Hernia; Humans; Male; Middle Aged; Optic Chiasm; Pituitary Neoplasms; Prolactin; Prolactinoma; Vision Disorders; Visual Acuity | 2000 |
Delayed puberty associated with hyperprolactinemia caused by pituitary microadenoma.
Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Bone Density; Bromocriptine; Female; Follicle Stimulating Hormone; Hormone Antagonists; Human Growth Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Magnetic Resonance Imaging; Menarche; Ovulation; Pituitary Neoplasms; Puberty, Delayed; Thyrotropin | 2000 |
[Role of hypothalamo-hypophyseal-adrenal axis in the pathogenesis of arterial hypertension in patients with prolactinoma of the anterior lobe of the hypophysis].
Topics: Adult; Aldosterone; Bromocriptine; Data Interpretation, Statistical; Dopamine; Dopamine Agonists; Female; Humans; Hyperaldosteronism; Hyperprolactinemia; Hypertension; Hypothalamo-Hypophyseal System; Pituitary Neoplasms; Pituitary-Adrenal System; Prolactin; Prolactinoma; Radioimmunoassay; Renin | 2000 |
Transsphenoidal surgery for pituitary gigantism and galactorrhea in a 3.5 year old child.
Topics: Bromocriptine; Child, Preschool; Dopamine Agonists; Female; Galactorrhea; Gigantism; Human Growth Hormone; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Postoperative Complications; Prolactin; Prolactinoma; Sphenoid Bone | 2000 |
Development of pituitary adenoma treatment--a critical essay.
Topics: Acromegaly; Adenoma; Bromocriptine; History, 19th Century; History, 20th Century; Humans; Nasal Bone; Pituitary Neoplasms; Sphenoid Bone | 1999 |
Efficacy of quinagolide in resistance to dopamine agonists: results of a multicenter study. Club de l'Hypophyse.
Topics: Aminoquinolines; Bromocriptine; Dopamine Agonists; Drug Resistance, Neoplasm; Female; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies | 2000 |
Long-term follow-up of 246 hyperprolactinemic patients.
Topics: Adenoma; Adult; Bromocriptine; Estradiol; Female; Follow-Up Studies; Hormone Antagonists; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Retrospective Studies | 2001 |
[Decreased tumor size in hypophyseal macroadenoma--empty sella syndrome].
Topics: Bromocriptine; Empty Sella Syndrome; Female; Follow-Up Studies; Humans; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 2001 |
Pituitary adenomas in childhood and adolescence. Clinical analysis of 10 cases.
Topics: Acromegaly; Adenoma; Adolescent; Amenorrhea; Bromocriptine; Cabergoline; Child; Ergolines; Female; Headache; Human Growth Hormone; Humans; Male; Neoplasm Recurrence, Local; Octreotide; Pituitary Neoplasms; Prolactinoma; Puberty, Delayed; Radiotherapy; Treatment Outcome; Vision Disorders; Visual Fields | 2001 |
Pregnancy in a patient with prolactinoma off treatment.
Topics: Adult; Bromocriptine; Diabetes, Gestational; Female; Hormone Antagonists; Humans; Infertility, Female; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactinoma | 2000 |
The effect of prolactin and bromocriptine on human peripheral immune status.
Topics: Adenoma; Adult; Bromocriptine; CD3 Complex; CD4-CD8 Ratio; CD56 Antigen; Female; Flow Cytometry; HLA-DR Antigens; Humans; Hyperprolactinemia; Killer Cells, Natural; Lymphocyte Subsets; Lymphocytes; Male; Pituitary Neoplasms; Prolactin; Receptors, IgG; Receptors, Interleukin-2 | 2001 |
[Increased T1 signal of the residual normal anterior pituitary gland following medical treatment of pituitary prolactinoma].
Topics: Adult; Bromocriptine; Drug Monitoring; Female; Humans; Magnetic Resonance Imaging; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome | 2001 |
Rapid re-expansion of a macroprolactinoma after early discontinuation of bromocriptine.
Topics: Adult; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Time Factors | 2000 |
Pituitary tumours in adolescence: clinical behaviour and neuroimaging features of seven cases.
Topics: Adolescent; Amenorrhea; Bromocriptine; Child; Craniotomy; Female; Galactorrhea; Growth Disorders; Growth Hormone; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Retrospective Studies | 2001 |
Pregnancy in hyperprolactinemic infertile women treated with vaginal bromocriptine: report of two cases and review of the literature.
Topics: Adenoma; Administration, Intravaginal; Adult; Bromocriptine; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Infertility, Female; Pituitary Neoplasms; Pregnancy | 2001 |
[Reversible blindness caused by an invasive prolactinoma].
Topics: Acute Disease; Adult; Blindness; Bromocriptine; Diagnosis, Differential; Dopamine Agonists; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma | 2001 |
Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year-old male.
Topics: Biopsy; Breast Neoplasms, Male; Bromocriptine; Carcinoma, Ductal, Breast; Estradiol; Hormone Antagonists; Humans; Hypogonadism; Male; Mammography; Mastectomy; Middle Aged; Neoplasms, Multiple Primary; Obesity; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone; Tomography, X-Ray Computed | 2001 |
Dopamine D2 receptor gene expression in human adenohypophysial adenomas.
Topics: Adenoma; Bromocriptine; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Humans; Immunohistochemistry; In Situ Hybridization; Pituitary Gland, Anterior; Pituitary Neoplasms; Receptors, Dopamine D2; Signal Transduction | 2001 |
Microvessel density in pituitary adenomas and carcinomas.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD34; Antigens, Nuclear; Bromocriptine; Carcinoma; Child; Dopamine Agonists; Female; Hormones; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Male; Microcirculation; Middle Aged; Neoplasm Invasiveness; Neovascularization, Pathologic; Nuclear Proteins; Octreotide; Pituitary Neoplasms | 2001 |
Clinical features and medical treatment of male prolactinomas.
Topics: Adult; Bromocriptine; Decompression, Surgical; Dopamine Agonists; Hormone Antagonists; Humans; Libido; Lisuride; Male; Middle Aged; Optic Chiasm; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Treatment Outcome; Visual Fields | 2001 |
Anti-tumoral action of octreotide and bromocriptine on the experimental rat prolactinoma: anti-proliferative and pro-apoptotic effects.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bromocriptine; Cell Division; Diethylstilbestrol; DNA Fragmentation; Drug Implants; In Situ Nick-End Labeling; Male; Octreotide; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Rats, Inbred F344 | 2001 |
Increased exocytosis of secretory granules in contrast to reduced serum hormone levels in pituitary adenomas of humans and rats treated with dopamine agonist.
Topics: Adenoma; Animals; Bromocriptine; Dopamine Agonists; Exocytosis; Humans; Immunohistochemistry; Microscopy, Immunoelectron; Pituitary Neoplasms; Prolactin; Rats; Secretory Vesicles; Subcellular Fractions | 2001 |
Gamma Knife radiosurgery as a primary surgical treatment for hypersecreting pituitary adenomas.
Topics: Adenoma; Adenoma, Acidophil; Adenoma, Basophil; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Bromocriptine; Female; Follow-Up Studies; Human Growth Hormone; Humans; Hyperglycemia; Hyperprolactinemia; Hypertension; Infertility, Female; Male; Middle Aged; Pituitary Hormones; Pituitary Neoplasms; Pregnancy; Pregnancy Outcome; Prolactin; Prolactinoma; Radiosurgery; Safety; Treatment Outcome | 2000 |
Retention of dopamine 2 receptor mRNA and absence of the protein in craniospinal and extracranial metastasis of a malignant prolactinoma: a case report.
Topics: Brain Neoplasms; Bromocriptine; Dopamine Agonists; Humans; Immunohistochemistry; In Situ Hybridization; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Proteins; Pituitary Neoplasms; Prolactin; Prolactinoma; Receptors, Dopamine D2; RNA, Messenger; Spinal Neoplasms; Vision Disorders | 2002 |
Three-dimensional imaging of hormone-secreting cells and their microvessel environment in estrogen-induced prolactinoma of the rat pituitary gland by confocal laser scanning microscopy.
Topics: Adrenocorticotropic Hormone; Animals; Bromocriptine; Estradiol; Estrogens; Female; Growth Hormone; Hormone Antagonists; Imaging, Three-Dimensional; Immunohistochemistry; Microcirculation; Microscopy, Confocal; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Rats, Wistar | 2001 |
Resolution of migraine with aura after successful treatment of a pituitary microadenoma.
Topics: Adenoma; Adult; Bromocriptine; Dopamine Agonists; Female; Humans; Migraine with Aura; Pituitary Neoplasms | 2002 |
Gender-related differences in prolactin secretion in pituitary prolactinomas.
Topics: Adolescent; Adult; Age Factors; Bromocriptine; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Sex Factors | 2002 |
[Progress in studies of endocrinology and metabolism in the field of internal medicine in the last 100 years: Therapy for patients with pituitary neoplasm].
Topics: Bromocriptine; History, 19th Century; History, 20th Century; Humans; Neurosurgical Procedures; Octreotide; Pituitary Neoplasms; Radiosurgery; Radiotherapy | 2002 |
SUNCT syndrome in two patients with prolactinomas and bromocriptine-induced attacks.
Topics: Adult; Bromocriptine; Female; Headache; Hormone Antagonists; Humans; Pituitary Neoplasms; Prolactinoma | 2002 |
The pathophysiology of hyperprolactinemic states and the role of newer ergot compounds in their treatment.
Topics: Acetonitriles; Amenorrhea; Bromocriptine; Dopamine; Ergolines; Ergot Alkaloids; Female; Galactorrhea; Humans; Levodopa; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactin Release-Inhibiting Factors | 1978 |
Impact of new diagnostic methods on the differential diagnosis and treatment of secondary amenorrhoea.
Topics: Amenorrhea; Bromocriptine; Contraceptives, Oral; Diagnosis, Differential; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Pituitary Function Tests; Pituitary Neoplasms; Pneumoencephalography; Pregnancy; Prolactin; Tomography; Tomography, X-Ray Computed | 1977 |
Bromocriptine inhibits prolactin and growth-hormone release by human pituitary tumours in culture.
Topics: Adenoma; Bromocriptine; Culture Techniques; Ergolines; Growth Hormone; Humans; Pituitary Neoplasms; Prolactin | 1977 |
Treatment of pituitary microadenomas.
Topics: Adenoma; Bromocriptine; Humans; Hypophysectomy; Pituitary Neoplasms; Postoperative Care | 1977 |
Radiological evidence for regression of prolactinoma after treatment with bromocriptine.
Topics: Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactin; Radiography; Remission, Spontaneous | 1978 |
Bromocriptine in pituitary tumours.
Topics: Adenoma; Antineoplastic Agents; Bromocriptine; Humans; Paraneoplastic Endocrine Syndromes; Pituitary Neoplasms; Prolactin | 1978 |
A defect in catecholamine neurons in patients with prolactin-secreting pituitary adenoma.
Topics: Adenoma; Administration, Oral; Brain; Bromocriptine; Dopamine; Epinephrine; Female; Humans; Male; Norepinephrine; Paraneoplastic Endocrine Syndromes; Pituitary Neoplasms; Prolactin; Receptors, Adrenergic | 1978 |
Serum-prolactin in female infertility.
Topics: Adenoma; Adult; Bromocriptine; Diagnosis, Differential; Female; Humans; Infertility, Female; Pituitary Neoplasms; Prolactin | 1978 |
Bromocriptine, pituitary tumours, and pregnancy.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications | 1978 |
Regression of pituitary prolactinoma after treatment with bromocriptine.
Topics: Adenoma, Chromophobe; Bromocriptine; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paraneoplastic Endocrine Syndromes; Pituitary Neoplasms; Prolactin; Remission, Spontaneous | 1979 |
Tests of prolactin secretion in diagnosis of prolactinomas.
Topics: Adolescent; Adult; Bromocriptine; Circadian Rhythm; Female; Humans; Levodopa; Metoclopramide; Paraneoplastic Endocrine Syndromes; Pituitary Function Tests; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Stimulation, Chemical; Thyrotropin-Releasing Hormone | 1979 |
Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.
Topics: Acromegaly; Adult; Aged; Bromocriptine; Female; Follow-Up Studies; Growth Hormone; Humans; Male; Middle Aged; Pituitary Irradiation; Pituitary Neoplasms; Prolactin; Radiotherapy, High-Energy; Time Factors; Tomography, X-Ray Computed | 1979 |
Bromocriptine and pituitary tumours.
Topics: Bromocriptine; Humans; Pituitary Neoplasms; Prolactin | 1979 |
[Clinical evaluation of large prolactinoma (author's transl)].
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1979 |
Delivery after bromocriptine therapy.
Topics: Adenoma; Adult; Bromocriptine; Delivery, Obstetric; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic | 1977 |
[Diagnosis of hyperprolactinaemias: respective value of response to THR and to bromocriptine (author's transl)].
Topics: Adenoma; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Infertility, Female; Pituitary Diseases; Pituitary Neoplasms; Pregnancy; Prolactin; Thyrotropin-Releasing Hormone | 1978 |
Serum growth hormone and ultrastructural studies of adenohypophysial tissue in bromocriptine treated acromegalic patients.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Bromocriptine; Drug Interactions; Female; Glucose Tolerance Test; Growth Hormone; Humans; Male; Microscopy, Electron; Middle Aged; Pituitary Gland, Anterior; Pituitary Neoplasms; Thyrotropin; Thyrotropin-Releasing Hormone | 1978 |
The dynamics of growth hormone and prolactin secretion in acromegalic patients with "mixed" pituitary tumours.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Female; Glucose Tolerance Test; Growth Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone | 1979 |
Treatment of prolactin-secreting pituitary tumours in young women by needle implantation of radioactive yttrium.
Topics: Adult; Amenorrhea; Bromocriptine; Circadian Rhythm; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Infertility, Female; Luteinizing Hormone; Methods; Pituitary Neoplasms; Pregnancy; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Yttrium Radioisotopes | 1978 |
The incidence of complications during pregnancy after treatment of hyperprolactinemia with bromocriptine in patients with radiologically evident pituitary tumors.
Topics: Adult; Bromocriptine; Female; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Tomography, X-Ray Computed | 1979 |
Hormone secretion by dispersed cell cultures of human pituitary adenomas: effects of theophylline, thyrotropin-releasing hormone, somatostatin, and 2-bromo-alpha-ergocryptine.
Topics: Adenoma; Bromocriptine; Cells, Cultured; Dose-Response Relationship, Drug; Growth Hormone; Humans; Pituitary Hormone-Releasing Hormones; Pituitary Hormones, Anterior; Pituitary Neoplasms; Prolactin; Somatostatin; Theophylline; Thyrotropin-Releasing Hormone | 1979 |
Prolactin-secreting pituitary adenomas: prolactin dynamics before and after transsphenoidal surgery.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Hypothalamus; Metergoline; Metoclopramide; Pituitary Gland; Pituitary Neoplasms; Postpartum Period; Pregnancy; Prolactin; Radioimmunoassay; Thyrotropin-Releasing Hormone | 1979 |
Pituitary microadenoma: diagnostic studies.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Metoclopramide; Pituitary Function Tests; Pituitary Neoplasms; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone | 1979 |
Human pituitary adenomas with hypersecretion of TSH and prolactin. Evidence that receptor sites for dopamin may be absent on TSH producing while present on prolactin producing cells.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Hyperthyroidism; Levodopa; Male; Pituitary Neoplasms; Prolactin; Receptors, Dopamine; Thyrotropin; Thyrotropin-Releasing Hormone | 1979 |
The diagnostic value of pharmacodynamic tests in the hyperprolactinaemic syndrome.
Topics: Adult; Bromocriptine; Chlorpromazine; Female; Follicular Phase; Galactorrhea; Humans; Levodopa; Pituitary Neoplasms; Postpartum Period; Pregnancy; Prolactin; Thyrotropin-Releasing Hormone | 1979 |
Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Female; Growth Hormone; Humans; In Vitro Techniques; Male; Middle Aged; Perfusion; Pituitary Hormones, Anterior; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone | 1978 |
Prolactin and adrenal androgen secretion.
Topics: Adolescent; Adrenal Glands; Adult; Bromocriptine; Dehydroepiandrosterone; Female; Humans; Hydrocortisone; Male; Metabolic Clearance Rate; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin; Secretory Rate; Sulpiride; Thyrotropin-Releasing Hormone | 1978 |
Hormonally induced renal neoplasia in the male Syrian hamster and the inhibitory effect of 2-bromo-alpha-ergocryptine methanesulfonate.
Topics: Animals; Body Weight; Bromocriptine; Cell Count; Cricetinae; Diethylstilbestrol; Ergolines; Growth Hormone; Hyperplasia; Kidney Neoplasms; Kidney Tubules, Proximal; Male; Mesylates; Organ Size; Pituitary Gland; Pituitary Neoplasms; Prolactin; Testis | 1975 |
Endocrine and metabolic diseases. Pituitary diseases.
Topics: Adrenocorticotropic Hormone; Bromocriptine; Clomiphene; Diabetes Insipidus; Female; Growth Hormone; Humans; Hyperpituitarism; Hypogonadism; Hypopituitarism; Infertility, Female; Male; Pituitary Diseases; Pituitary Gland; Pituitary Neoplasms; Prolactin; Thyrotropin; Vasopressins | 1976 |
Hydatidiform mole arising twice during bromocriptine therapy. Case report.
Topics: Adenoma, Acidophil; Adult; Bromocriptine; Female; Humans; Hydatidiform Mole; Pituitary Neoplasms; Pregnancy; Prolactin; Uterine Neoplasms | 1977 |
Hyperprolactinemia. Morphologic and clinical considerations.
Topics: Adenoma; Adenoma, Acidophil; Bromocriptine; Cytoplasmic Granules; Humans; Mitochondria; Paraneoplastic Endocrine Syndromes; Pituitary Gland; Pituitary Neoplasms; Prolactin | 1978 |
[From the determination of prolactin to use of its inhibitor: bromocriptine].
Topics: Adenoma; Adult; Bromocriptine; Female; Genital Diseases, Female; Humans; Hypogonadism; Infertility, Female; Lactation Disorders; Pituitary Neoplasms; Pregnancy; Prolactin | 1978 |
Prolactin-secreting tumors and hypogonadism in 22 men.
Topics: Adenoma, Acidophil; Adenoma, Chromophobe; Adult; Aged; Bromocriptine; Erectile Dysfunction; Female; Galactorrhea; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin; Testosterone; Vision Disorders | 1978 |
[Tumour regression in pituitary adenoma by bromocriptin (author's transl)].
Topics: Adenoma; Adult; Bromocriptine; Cyclic AMP; DNA, Neoplasm; Female; Humans; Pituitary Neoplasms | 1978 |
Space occupying growth of a pituitary adenoma producing hGH and hPrl during bromocriptin therapy.
Topics: Acromegaly; Adenoma, Acidophil; Bromocriptine; Female; Growth Hormone; Humans; Middle Aged; Pituitary Irradiation; Pituitary Neoplasms; Prolactin; Yttrium Radioisotopes | 1977 |
Bromocriptine fails to stop growth of eosinophilic adenomas in acromegaly.
Topics: Acromegaly; Adenoma, Acidophil; Bromocriptine; Humans; Pituitary Neoplasms | 1979 |
[Twin pregnancy following bromocriptine in an acromegalic patient staying sterile after removal of a pituitary adenoma. Immunocytochemical study of the tumor (author's transl)].
Topics: Acromegaly; Adenoma, Acidophil; Adult; Amenorrhea; Bromocriptine; Female; Growth Hormone; Histocytochemistry; Humans; Immunologic Techniques; Infertility, Female; Pituitary Neoplasms; Pregnancy; Pregnancy, Multiple; Prolactin | 1979 |
Investigation and management of symptomatic hyperprolactinaemia.
Topics: Adenoma; Amenorrhea; Bromocriptine; Estrogens; Female; Galactorrhea; Humans; Infertility, Female; Luteinizing Hormone; Oligomenorrhea; Pituitary Neoplasms; Pregnancy; Prolactin; Radioimmunoassay; Radioligand Assay | 1979 |
Hyperprolactinaemia in amenorrhoea - incidence and clinical significance.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Follicle Stimulating Hormone; Galactorrhea; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Pituitary Gland; Pituitary Neoplasms; Pregnancy; Prolactin; Radiography | 1977 |
Value of luteinizing hormone-releasing hormone testing in bromocriptine treatment of amenorrhea and hyperprolactinemia in patients with pituitary tumors.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Ovulation Induction; Pituitary Neoplasms; Prolactin | 1978 |
Effect of hyperprolactinemia and 2-BR-alpha-ergocryptine on neuroendocrine mechanism(s) for gonadotropin control.
Topics: Animals; Bromocriptine; Castration; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Hypothalamus, Middle; Luteinizing Hormone; Male; Neoplasm Transplantation; Neoplasms, Experimental; Neurosecretory Systems; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Rats; Sex Factors | 1978 |
Normal pregnancies after treatment of hyperprolactinemia with bromoergocryptine, despite suspected pituitary tumors.
Topics: Adult; Amenorrhea; Bromocriptine; Female; Follow-Up Studies; Galactorrhea; Gonadotropin-Releasing Hormone; Humans; Lactation Disorders; Luteinizing Hormone; Ovulation; Pituitary Neoplasms; Pregnancy; Prolactin; Sella Turcica | 1978 |
Functional delineation of hyperprolactinemic-amenorrhea.
Topics: Adenoma; Adult; Amenorrhea; Androgens; Bromocriptine; Dopamine; Estrogens; Female; Galactorrhea; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Hydrocortisone; Levodopa; Pituitary Neoplasms; Pregnancy; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone | 1977 |
Radioimmunoassay of thyrotrophin-releasing hormone (TRH) in normal subjects, in abnormal thyroid states and under catecholaminergic influences.
Topics: Adenoma; Adult; Bromocriptine; Child; Chlorpromazine; Female; Humans; Hyperthyroidism; Hypothyroidism; Infant, Newborn; Levodopa; Male; Pituitary Neoplasms; Pregnancy; Radioimmunoassay; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 1978 |
Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas.
Topics: Adenoma; Adenylyl Cyclase Inhibitors; Bromocriptine; Dopamine; Fluphenazine; Humans; Norepinephrine; Pituitary Neoplasms; Prolactin; Receptors, Dopamine | 1979 |
Regression of pituitary tumors, a possible effect of bromergocryptine.
Topics: Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactin | 1979 |
Bromocriptine treatment of prolactinomas.
Topics: Adenoma; Adult; Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Female; Humans; Pituitary Neoplasms; Prolactin | 1979 |
Bromocriptine treatment of prolactinomas.
Topics: Adenoma; Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactin | 1979 |
Bromocriptine treatment of prolactinomas.
Topics: Adenoma; Bromocriptine; Humans; Pituitary Neoplasms; Prolactin | 1979 |
Bromocriptine treatment of prolactinomas.
Topics: Adenoma; Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Prolactin | 1979 |
Bromocriptine and pituitary disorders.
Topics: Acromegaly; Adenoma; Bromocriptine; Female; Humans; Infertility, Female; Paraneoplastic Endocrine Syndromes; Pituitary Diseases; Pituitary Neoplasms; Prolactin | 1979 |
Pituitary tumours during pregnancy in mothers treated with bromocriptine.
Topics: Adult; Bromocriptine; Female; Humans; Infertility, Female; Pituitary Neoplasms; Pregnancy; Pregnancy Complications | 1979 |
The inability of bromocriptine to inhibit prolactin secretion by transplantable rat pituitary tumors: observations on the mechanism and dynamics of the autofeedback regulation of prolactin secretion.
Topics: Animals; Bromocriptine; Ergot Alkaloids; Feedback; Female; Kinetics; Neoplasms, Experimental; Pituitary Neoplasms; Prolactin; Rats | 1979 |
Hyperprolactinemia: still perplexing but eminently treatable.
Topics: Adenoma; Bromocriptine; Female; Humans; Infertility, Female; Lactation; Male; Pituitary Neoplasms; Pregnancy; Prolactin | 1979 |
[Hyperprolactinemia. A formerly rare syndrome is moving into hospital and private practice].
Topics: Acromegaly; Adenoma; Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Pituitary Neoplasms; Pregnancy; Prolactin | 1979 |
In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
Topics: Adenoma; Bromocriptine; Cells, Cultured; Dopamine; Growth Hormone; Humans; Levodopa; Pituitary Neoplasms; Prolactin | 1979 |
[Bromoergocryptine (CB 154) and pregnancy. Notes on 2 cases].
Topics: Adenoma, Chromophobe; Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Lactation Disorders; Pituitary Neoplasms; Pregnancy | 1979 |
[Acute exacerbation of prolactin-secreting adenomas during pregnancy following the treatment of sterility. 2 cases (author's transl)].
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Clomiphene; Female; Galactorrhea; Humans; Infertility, Female; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Radiography; Sella Turcica | 1979 |
Pregnancies in women with hyperprolactinaemia: clinical course and obstetric complications of 41 pregnancies in 27 women.
Topics: Adult; Brachytherapy; Bromocriptine; Cesarean Section; Female; Humans; Labor, Induced; Pituitary Irradiation; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Yttrium Radioisotopes | 1979 |
Restoration of the prolactin response to sulpiride by metergoline administration in hyperprolactinemic patients.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Dopamine; Ergolines; Female; Humans; Metergoline; Pituitary Gland; Pituitary Neoplasms; Prolactin; Sulpiride | 1979 |
Effects of bromocriptine on pituitary tumour size.
Topics: Adult; Bromocriptine; Female; Hormones; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prospective Studies; Radiography | 1979 |
The effect of pregnancy and lactation on pituitary prolactin-secreting tumours.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Female; Follow-Up Studies; Galactorrhea; Humans; Infant, Newborn; Lactation; Lactation Disorders; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin | 1979 |
Pregnancy in patients presenting with hyperprolactinaemia.
Topics: Bromocriptine; Female; Humans; Infertility, Female; Pituitary Irradiation; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Radiography; Sella Turcica | 1979 |
[Pregnancy after treatment with bromoergocryptin in patient with pituitary tumor. Report of a case].
Topics: Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Lactation Disorders; Ovulation; Pituitary Neoplasms; Pregnancy | 1979 |
[Amenorrhoea and hyperprolactinaemia (author's transl)].
Topics: Adenoma; Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Prolactin | 1979 |
[Amenorrhoea and hyperprolactinaemia (author's transl)].
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Menstruation Disturbances; Pituitary Neoplasms; Prolactin | 1979 |
Divorce and remarriage in a 65-year-old male following transphenoidal surgery and bromocriptine of hyperprolactinemic impotence: a dilemma.
Topics: Bromocriptine; Divorce; Erectile Dysfunction; Humans; Male; Marriage; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin | 1979 |
Pituitary tumor made symptomatic during hormone therapy and induced pregnancy.
Topics: Adenoma, Chromophobe; Adolescent; Adult; Bromocriptine; Child; Contraceptives, Oral; Female; Humans; Infant, Newborn; Infertility, Female; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Vision Disorders | 1979 |
[Prolactin. New answers to old questions].
Topics: Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Male; Pituitary Neoplasms; Pregnancy; Prolactin | 1977 |
Serum levels of prolactin in basal conditions and after administration of 2-bromo-5alpha-ergocryptine in normal and galactorrheic subjects.
Topics: Adenoma; Adult; Amenorrhea; Anovulation; Bromocriptine; Female; Galactorrhea; Humans; Lactation Disorders; Male; Pituitary Neoplasms; Pregnancy; Prolactin | 1978 |
Bromocriptine treatment of seven women with primary amenorrhoea and prolactin-secreting pituitary tumours.
Topics: Adenoma, Chromophobe; Adolescent; Adult; Amenorrhea; Bromocriptine; Child; Female; Galactorrhea; Humans; Pituitary Neoplasms; Pregnancy; Prolactin; Puberty | 1979 |
[Bromocryptin therapy of hyperprolactinemic changes in the cycle].
Topics: Adult; Bromocriptine; Female; Galactorrhea; Gonadotropins; Humans; Infertility, Female; Menstruation Disturbances; Pituitary Neoplasms; Pregnancy; Prolactin | 1978 |
Persisting suppression of prolactin secretion after long-term treatment with bromocriptine in patients with prolactinomas.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Female; Follow-Up Studies; Galactorrhea; Humans; Male; Pituitary Neoplasms; Pregnancy; Prolactin; Time Factors | 1979 |
Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Galactorrhea; Hemianopsia; Humans; Lactation Disorders; Luteinizing Hormone; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Syndrome; Visual Fields | 1977 |
Bromocryptine therapy in cases of amenorrhea-galactorrhea.
Topics: Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Hypothyroidism; Lactation Disorders; Luteinizing Hormone; Pituitary Neoplasms; Pregnancy; Prolactin; Thyrotropin | 1977 |
Bromocriptine treatment of acromegaly.
Topics: Acromegaly; Adult; Bromocriptine; Dose-Response Relationship, Drug; Drug Evaluation; Ergolines; Female; Glucose Tolerance Test; Growth Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms | 1977 |
Visual abnormalities in a pregnancy following bromocriptin medication.
Topics: Adult; Amenorrhea; Bromocriptine; Cesarean Section; Ergolines; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Luteinizing Hormone; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Sella Turcica; Thyrotropin; Tomography, X-Ray; Vision Disorders; Visual Acuity; Visual Fields | 1977 |
[Amenorrhea and bromocryptine].
Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Humans; Pituitary Neoplasms; Prolactin | 1977 |
Rapid deterioration of visual fields during bromocriptine-induced pregnancy in a patient with a pituitary adenoma.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Syndrome; Vision Disorders; Visual Fields | 1977 |
[Clinical experience with CB-154 in cases of pituitary adenoma].
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Growth Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms | 1977 |
[Acute pituitary failure as the presentation of a prolactin cell adenoma during a pregnancy made possible by bromocriptine (author's transl)].
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Eye Manifestations; Female; Galactorrhea; Humans; Hypophysectomy; Infertility, Female; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin | 1977 |
[Influence of primary hyperprolactinemia on male sex behavior].
Topics: Adenoma; Adult; Bromocriptine; Erectile Dysfunction; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Sella Turcica | 1977 |
Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumors.
Topics: Abortion, Spontaneous; Adenoma; Adult; Amenorrhea; Bromocriptine; Chorionic Gonadotropin; Female; Humans; Infertility, Female; Ovulation Induction; Pituitary Gland; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Radiography | 1978 |
Sellar enlargement with hyperprolactinemia and a Rathke's pouch cyst.
Topics: Adult; Bromocriptine; Craniopharyngioma; Empty Sella Syndrome; Female; Humans; Infant, Newborn; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Sella Turcica | 1978 |
[Longitudinal study of 18 cases of prolactin adenoma. Therapeutic results (author's transl)].
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Hypophysectomy; Longitudinal Studies; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1978 |
Bromocriptine treatment of males with pituitary tumours, hyperprolactinaemia, and hypogonadism.
Topics: Bromocriptine; Humans; Hypogonadism; Male; Pituitary Neoplasms; Prolactin; Sexual Behavior; Testosterone | 1978 |
Acute visual loss during pregnancy after bromocriptine-induced ovulation. The elusive tumor.
Topics: Acute Disease; Adenoma, Chromophobe; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Ovulation Induction; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Vision Disorders; Visual Acuity | 1978 |
[Hyperprolactinemia, male impotence, oligozoospermia and the treatment with Bromocriptin (author's transl)].
Topics: Bromocriptine; Erectile Dysfunction; Humans; Male; Middle Aged; Oligospermia; Pituitary Neoplasms; Prolactin | 1978 |
[The pathological secretion of prolactin (author's transl)].
Topics: Adenoma; Amenorrhea; Bromocriptine; Chorionic Gonadotropin; Corpus Luteum; Female; Humans; Pituitary Neoplasms; Progesterone; Prolactin | 1978 |
Prolactin and female reproduction.
Topics: Amenorrhea; Anovulation; Bromocriptine; Female; Galactorrhea; Humans; Infertility, Female; Menstruation; Pituitary Neoplasms; Pregnancy; Prolactin | 1978 |
[Effect of L dopa, dopamine and CB 154 on prolactin secretion from human pituitary adenomas in vitro (proceedings) (author's transl)].
Topics: Adenoma; Bromocriptine; Depression, Chemical; Dopamine; Humans; In Vitro Techniques; Levodopa; Pituitary Neoplasms; Prolactin | 1978 |
Regression of a prolactin-secreting pituitary tumor during long-term treatment with bromocriptine.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Pituitary Neoplasms; Pregnancy; Prolactin | 1978 |
Bromocriptine in obstetrics and gynaecology.
Topics: Amenorrhea; Bromocriptine; Female; Humans; Infertility, Female; Lactation; Pituitary Neoplasms; Polycystic Ovary Syndrome; Pregnancy; Prolactin | 1978 |
Hyperprolactinaemia-hypogonadism syndromes.
Topics: Adenoma; Amenorrhea; Bromocriptine; Female; Galactorrhea; Gonadotropins, Pituitary; Humans; Hypogonadism; Lactation; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Syndrome; Visual Fields | 1978 |
Prolactin suppression in the treatment of female infertility.
Topics: Bromocriptine; Female; Humans; Infertility, Female; Menstruation Disturbances; Pituitary Neoplasms; Prolactin | 1978 |
The amenorrhea galactorrhea syndrome.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Lactation Disorders; Pituitary Neoplasms; Pregnancy; Prolactin; Syndrome | 1978 |
Treatment of patients with prolactinomas.
Topics: Adenoma; Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hypopituitarism; Male; Middle Aged; Pituitary Function Tests; Pituitary Neoplasms; Pregnancy; Prolactin | 1978 |
[Prolactin and human reproduction].
Topics: Adenoma; Amenorrhea; Bromocriptine; Female; Humans; Lactation; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin | 1978 |
Reduction in size of a pituitary tumor by bromocriptine therapy.
Topics: Adenoma; Adult; Bromocriptine; Humans; Male; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1979 |
The prolactinoma problem.
Topics: Adenoma; Adolescent; Adult; Amenorrhea; Animals; Bromocriptine; Contraceptives, Oral; Estrogens; Female; Galactorrhea; Humans; Pituitary Neoplasms; Pregnancy; Prolactin; Rats | 1979 |
Prolactin-secreting tumors and hypogonadism in men.
Topics: Animals; Bromocriptine; Chorionic Gonadotropin; Erectile Dysfunction; Female; Humans; Hypogonadism; Libido; Luteinizing Hormone; Male; Naloxone; Pituitary Neoplasms; Prolactin; Rats; Testosterone | 1979 |
Hypothalamic pituitary disorders expressed by galactorrhea. A dynamic evaluation.
Topics: Amino Acids; Bromocriptine; Clomiphene; Female; Galactorrhea; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Hypothalamo-Hypophyseal System; Insulin; Lactation Disorders; Levodopa; Male; Pituitary Diseases; Pituitary Neoplasms; Pregnancy; Prolactin; Psychotropic Drugs; Stimulation, Chemical; Thyrotropin-Releasing Hormone; Water | 1975 |
Clinical and endocrine features of hyperprolactinaemic amenorrhoea.
Topics: Adult; Amenorrhea; Bromocriptine; Clomiphene; Estradiol; Female; Follicle Stimulating Hormone; Galactorrhea; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Menstruation; Ovulation; Pituitary Neoplasms; Pregnancy; Progesterone; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine | 1976 |
Prolactin: a diabetogenic hormone.
Topics: Adenoma; Adult; Animals; Blood Glucose; Bromocriptine; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Rats | 1977 |
Management of hyperprolactinaemic amenorrhoea.
Topics: Adult; Amenorrhea; Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactin | 1977 |
[Bromocriptine treatment of infertile women with amenorrhoea--galactorrhoea].
Topics: Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Infertility, Female; Lactation Disorders; Ovulation; Pituitary Neoplasms; Pregnancy | 1977 |
Galactorrhea-amenorrhea syndromes: etiology and treatment.
Topics: Adenoma; Amenorrhea; Bromocriptine; Chiari-Frommel Syndrome; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Pituitary Function Tests; Pituitary Neoplasms; Pregnancy; Recurrence; Syndrome | 1976 |
Bromocriptine in the treatment of the hyperprolactinaemia-hypogonadism syndromes.
Topics: Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Hypogonadism; Male; Pituitary Neoplasms; Pregnancy; Prolactin | 1976 |
[Hyperprolactinemic amenorrhea. Clinical relevance, endocrine features, therapy (author's transl)].
Topics: Adult; Amenorrhea; Bromocriptine; Female; Follicle Stimulating Hormone; Galactorrhea; Gonadotropins; Humans; Luteinizing Hormone; Ovulation; Pituitary Neoplasms; Pregnancy; Prolactin | 1976 |
Hyperprolactinaemia: its physiology and investigation.
Topics: Adenoma, Chromophobe; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Male; Metabolic Diseases; Metoclopramide; Pituitary Neoplasms; Pregnancy; Prolactin | 1976 |
[Surgical and medicamentous treatment of pituitary tumors producing prolactin].
Topics: Bromocriptine; Female; Hormones, Ectopic; Humans; Male; Pituitary Neoplasms; Prolactin | 1976 |
Bromocriptine:dopamine-receptor agonist.
Topics: Acromegaly; Aged; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Parkinson Disease; Pituitary Neoplasms; Receptors, Dopamine | 1976 |
Pregnancy following bromocryptine therapy for the amenorrhoea-galactorrhoea syndrome due to a pituitary tumour.
Topics: Adenoma, Chromophobe; Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Pituitary Neoplasms; Pregnancy; Syndrome | 1976 |
Disorders of prolactin secretion.
Topics: Adenoma; Breast Feeding; Bromocriptine; Female; Humans; Hypogonadism; Male; Pituitary Neoplasms; Pregnancy; Prolactin | 1976 |
Raised serum prolactin levels in amenorrhoea.
Topics: Adult; Amenorrhea; Bromocriptine; Female; Follicle Stimulating Hormone; Galactorrhea; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menstruation; Ovulation; Pituitary Neoplasms; Pregnancy; Prolactin; Radioimmunoassay; Thyrotropin | 1975 |
Letter: Prolactin studies, pituitary tumour, and reproductive function.
Topics: Acromegaly; Amenorrhea; Bromocriptine; Female; Fertility Agents, Female; Humans; Ovulation; Pituitary Neoplasms; Prolactin | 1975 |
Pregnancy, prolactin, and pituitary tumours.
Topics: Adult; Amenorrhea; Bromocriptine; Clomiphene; Diabetes Insipidus; Female; Humans; Labor, Obstetric; Menotropins; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy in Diabetics; Prolactin; Vision Disorders; Visual Fields; Yttrium Radioisotopes | 1975 |
Bromocriptine treatment of female infertility: report of 13 pregnancies.
Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Pituitary Irradiation; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Vision Disorders; Visual Fields | 1975 |
Letter: CB-154.
Topics: Adenoma; Adult; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Pituitary Neoplasms | 1976 |
[Value of alpha subunit assay in pituitary pathology].
Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Female; Glycoprotein Hormones, alpha Subunit; Gonadotropins, Pituitary; Humans; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Prolactinoma | 1992 |
Prolactinomas and resistance to dopamine agonists.
Topics: Adolescent; Adult; Aminoquinolines; Bromocriptine; Child; Drug Resistance; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 1992 |
Usefulness of CV 205-502 in a case of allergy to ergot-derived drugs.
Topics: Adult; Aminoquinolines; Bromocriptine; Drug Hypersensitivity; Female; Humans; Lisuride; Pituitary Neoplasms; Prolactin; Prolactinoma | 1992 |
[Bromocriptine for macroprolactinomas. Discussion of 3 cases treated successfully].
Topics: Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma | 1992 |
Clinical management of prolactinomas: a ten-year experience.
Topics: Adolescent; Adult; Aged; Bromocriptine; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma | 1992 |
Increased plasma VIP concentration in patients with prolactinoma.
Topics: Adult; Analysis of Variance; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Vasoactive Intestinal Peptide | 1992 |
Effects of the dopamine agonist CV 205-502 in human prolactinomas resistant to bromocriptine.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Resistance; Female; Growth Hormone; Humans; Luteinizing Hormone; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Tomography, X-Ray Computed; Triiodothyronine; Tumor Cells, Cultured | 1992 |
Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line.
Topics: Adenoma, Acidophil; Adolescent; Adult; Aged; Bromocriptine; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Somatostatin; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured | 1992 |
Visual loss associated with bromocriptine.
Topics: Aged; Bromocriptine; Female; Humans; Hypotension; Pituitary Neoplasms; Posture; Prolactin; Vision Disorders; Visual Fields | 1992 |
Effectiveness of computer-assisted perimetry in the follow-up of patients with pituitary microadenoma responsive to medical treatment.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Bromocriptine; Diagnosis, Computer-Assisted; Evaluation Studies as Topic; Female; Humans; Male; Octreotide; Pituitary Neoplasms; Prolactinoma; Scotoma; Visual Field Tests | 1992 |
The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex.
Topics: Acromegaly; Adult; Age Factors; Aged; Aged, 80 and over; Bromocriptine; Female; Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Prolactin; Sex Factors; Thyrotropin-Releasing Hormone | 1992 |
A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Bromocriptine; Dopamine; Female; Humans; Metoclopramide; Neoplasms, Multiple Primary; Nifedipine; Pituitary Neoplasms; Prolactin; Prolactinoma | 1992 |
Atypical McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma: natural history, long-term follow-up, and SMS 201-995--bromocriptine combined treatment results.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Drug Therapy, Combination; Female; Fibrous Dysplasia, Polyostotic; Growth Hormone; Humans; Hyperprolactinemia; Octreotide; Pituitary Neoplasms | 1992 |
[A case of prolactinoma presenting with CSF rhinorrhea and CSF otorrhea during bromocriptine therapy].
Topics: Bromocriptine; Cerebrospinal Fluid Otorrhea; Cerebrospinal Fluid Rhinorrhea; Drainage; Female; Humans; Hypophysectomy; Middle Aged; Pituitary Neoplasms; Prolactinoma | 1992 |
Surgery, dopamine agonist therapy of combined treatment--results in prolactinoma patients after a 12 month follow-up.
Topics: Adolescent; Adult; Aged; Bromocriptine; Combined Modality Therapy; Dopamine; Female; Humans; Hyperprolactinemia; Hypophysectomy; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Hormones, Anterior; Pituitary Neoplasms; Postoperative Complications; Prolactin; Prolactinoma; Tomography, X-Ray Computed | 1992 |
Results of continuous long-term intravenous application of octreotide via an implantable pump system in acromegaly resistant to operative and X-ray therapy.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Growth Hormone; Humans; Infusion Pumps, Implantable; Insulin-Like Growth Factor I; Magnetic Resonance Imaging; Male; Middle Aged; Octreotide; Pituitary Gland; Pituitary Irradiation; Pituitary Neoplasms | 1992 |
Long-term in-vitro treatment of human growth hormone (GH)-secreting pituitary adenoma cells with octreotide causes accumulation of intracellular GH and GH mRNA levels.
Topics: Adenoma; Bromocriptine; Dose-Response Relationship, Drug; Female; Growth Hormone; Humans; In Vitro Techniques; Male; Octreotide; Pituitary Neoplasms; RNA, Messenger; Time Factors; Tumor Cells, Cultured | 1992 |
Cerebrospinal fluid rhinorrhea occurring in long-term bromocriptine treatment for macroprolactinomas.
Topics: Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Female; Humans; Middle Aged; Pituitary Neoplasms; Prolactinoma | 1992 |
[Prolactinoma as atypical tumor of the nasopharynx].
Topics: Administration, Oral; Adult; Bromocriptine; Humans; Male; Nasopharyngeal Neoplasms; Pituitary Neoplasms; Prolactinoma; Tomography, X-Ray Computed | 1992 |
[Evaluation of nuclear magnetic resonance imaging in tridimensional acquisition in the investigation of prolactin microadenoma].
Topics: Adolescent; Adult; Bromocriptine; Female; Gadolinium; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Pituitary Neoplasms; Prolactinoma | 1992 |
Resolution of possible paradoxical responses of gonadotropins to thyrotropin-releasing hormone with bromocriptine therapy in a patient with follicle-stimulating hormone-secreting pituitary adenoma.
Topics: Adenoma; Aged; Bromocriptine; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Luteinizing Hormone; Male; Pituitary Neoplasms; Remission Induction; Thyrotropin-Releasing Hormone | 1992 |
Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
Topics: Adenoma; Adult; Aged; Bromocriptine; Female; Growth Hormone; Humans; Kallikreins; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Tissue Kallikreins | 1992 |
Malignant prolactinoma.
Topics: Bromocriptine; Combined Modality Therapy; Female; Humans; Middle Aged; Orbital Neoplasms; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma | 1992 |
Hyperprolactinemia and lens opacities.
Topics: Adult; Bromocriptine; Cataract; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Sex Factors | 1992 |
Prolactin secreting pituitary carcinoma.
Topics: Adult; Brain; Bromocriptine; Combined Modality Therapy; Humans; Hypophysectomy; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pituitary Irradiation; Pituitary Neoplasms; Prolactin; Prolactinoma | 1992 |
[Regression of visual disorders under bromocriptine in patients with prolactin-secreting macroadenoma].
Topics: Adult; Bromocriptine; Eye Diseases; Female; Humans; Male; Pituitary Neoplasms; Prolactinoma | 1992 |
Tissue kallikrein is associated with prolactin-secreting cells within human growth hormone-secreting adenomas.
Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Female; Growth Hormone; Humans; Immunohistochemistry; Kallikreins; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 1992 |
[Immediate efficacy of bromocriptine (BrC)-LAR in the treatment of macroprolactinomas: apropos of a case].
Topics: Bromocriptine; Delayed-Action Preparations; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors | 1992 |
[Experiences with bromocriptine treatment of female infertility due to hyperprolactinemia].
Topics: Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Pituitary Neoplasms; Prolactinoma; Retrospective Studies | 1992 |
Macroprolactinomas with suprasellar extension: effect of bromocriptine withdrawal during one or more pregnancies.
Topics: Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Retrospective Studies; Tomography, X-Ray Computed | 1992 |
Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal.
Topics: Adenoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Growth Hormone; Humans; Magnetic Resonance Imaging; Male; Octreotide; Pituitary Neoplasms; Prolactin | 1992 |
Treatment of extensively invasive (giant) prolactinomas with bromocriptine.
Topics: Adult; Bromocriptine; Humans; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactinoma | 1992 |
Cytocidal effects of bromocriptine, somatostatin analog, and heat on growth hormone-secreting pituitary adenoma in vitro.
Topics: Adenoma; Bromocriptine; Combined Modality Therapy; Culture Media; Growth Hormone; Humans; Hyperthermia, Induced; Microscopy, Electron; Pituitary Neoplasms; Prolactin; Tumor Cells, Cultured | 1992 |
[Apparent contradictory findings in the immunohistochemical detection of hormone production in hypophyseal adenoma].
Topics: Adenoma; Bromocriptine; Humans; Immunohistochemistry; Microscopy, Immunoelectron; Pituitary Gland; Pituitary Hormones; Pituitary Neoplasms | 1992 |
TSH producing pituitary tumor: biochemical diagnosis and long-term medical management with octreotide.
Topics: Adenoma; Bromocriptine; Humans; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 1992 |
Treatment of macroprolactinomas with the long-acting and repeatable form of bromocriptine: a report on 29 cases.
Topics: Adult; Aged; Bromocriptine; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Nausea; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma | 1992 |
Combined bromocriptine and growth hormone (GH) treatment in GH-deficient children with macroprolactinoma in situ.
Topics: Adolescent; Bromocriptine; Drug Therapy, Combination; Female; Growth Hormone; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Sella Turcica | 1992 |
Effectiveness and long-term tolerability of the slow release oral form of bromocriptine on tumoral and non-tumoral hyperprolactinemia.
Topics: Administration, Oral; Adolescent; Adult; Bromocriptine; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Time Factors | 1992 |
Cabergoline in the long-term therapy of hyperprolactinemic disorders.
Topics: Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Menstruation Disturbances; Middle Aged; Ovulation; Pituitary Neoplasms; Prolactinoma | 1992 |
Effect of the new dopaminergic agonist CV 205-502 on plasma prolactin levels and tumour size in bromocriptine-resistant prolactinomas.
Topics: Adult; Aged; Aminoquinolines; Bromocriptine; Dopamine Agents; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Prospective Studies; Retrospective Studies | 1991 |
[The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Female; Growth Hormone; Humans; Hypothalamus; Levodopa; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Somatostatin; Thyrotropin; Thyrotropin-Releasing Hormone | 1991 |
CV 205-502 treatment of macroprolactinomas.
Topics: Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Drug Resistance; Endocrine System Diseases; Female; Galactorrhea; Gonads; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 1991 |
Thyrotropin-secreting pituitary adenomas: report of seven cases.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Bromocriptine; Circadian Rhythm; Female; Glycoprotein Hormones, alpha Subunit; Growth Hormone; Humans; Hyperthyroidism; Male; Methimazole; Middle Aged; Octreotide; Pituitary Neoplasms; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone | 1991 |
Pituitary prolactinoma associated with polycystic ovary--case report.
Topics: Adult; Amenorrhea; Bromocriptine; Female; Gonadotropin-Releasing Hormone; Humans; Hyperprolactinemia; Pituitary Neoplasms; Polycystic Ovary Syndrome; Prolactinoma; Vision Disorders | 1991 |
Decreased prolactin level in secretory granules and their increased exocytosis in estrogen-induced pituitary hyperplasia in rats treated with a dopamine agonist.
Topics: Animals; Bromocriptine; Cytoplasmic Granules; Estrogens; Exocytosis; Female; Microscopy, Electron; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Proteins; Rats; Rats, Inbred Strains | 1991 |
[Retroperitoneal fibrosis in a patient treated with bromocriptine for a prolactinoma].
Topics: Bromocriptine; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retroperitoneal Fibrosis; Tomography, X-Ray Computed; Urinary Catheterization | 1991 |
[Use of bromocriptine during pregnancy and appearance of partial empty sella turcica in women with prolactinoma].
Topics: Adult; Bromocriptine; Empty Sella Syndrome; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma | 1991 |
Zinc and bromocriptine long-term administration in patients with prolactinomas: effects on prolactin and thymulin circulating levels.
Topics: Adult; Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Radioimmunoassay; Thymic Factor, Circulating; Zinc | 1991 |
Oral and injectable long-lasting bromocriptine preparations in hyperprolactinemia: comparison of their prolactin lowering activity, tolerability and safety.
Topics: Adult; Amenorrhea; Bromocriptine; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Oligomenorrhea; Pituitary Neoplasms; Prolactin; Prolactinoma; Sexual Dysfunction, Physiological; Tomography, X-Ray Computed | 1991 |
Patterns of gastrin secretion in patients with nonfunctioning pituitary adenomas.
Topics: Adenoma; Adult; Aged; Analysis of Variance; Biomarkers, Tumor; Bromocriptine; Corticotropin-Releasing Hormone; Female; Gastrins; Gonadotropin-Releasing Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Middle Aged; Octreotide; Pentagastrin; Pituitary Gland; Pituitary Neoplasms; Secretin; Thyrotropin-Releasing Hormone | 1991 |
A giant prolactinoma and the effect of chronic bromocriptine therapy on basal and TRH-stimulated serum prolactin levels.
Topics: Bromocriptine; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Thyrotropin-Releasing Hormone | 1991 |
Meningitis as a late complication of surgically and medically treated pituitary adenoma.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Hypophysectomy; Meningitis; Pituitary Gland; Pituitary Neoplasms; Sphenoid Sinus; Time Factors; Tomography, X-Ray Computed | 1991 |
[The course of prolactinomas in adolescents].
Topics: Adolescent; Adult; Bromocriptine; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Luteinizing Hormone; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Thyrotropin | 1991 |
[Gonadotropic pituitary adenoma and pregnancy. Value of bromocriptine].
Topics: Adenoma; Adult; Bromocriptine; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Pituitary Neoplasms; Pregnancy; Prolactin; Radioimmunoassay; Tomography, X-Ray Computed | 1991 |
Long-term effects of radiotherapy and bromocriptine treatment in patients with previous surgery for macroprolactinomas.
Topics: Adult; Aged; Bromocriptine; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pituitary Neoplasms; Postoperative Care; Prognosis; Prolactin; Prolactinoma; Radiotherapy; Radiotherapy Dosage; Retrospective Studies | 1991 |
Acute effects of Parlodel-LAR and response to long-term treatment with bromocriptine in a patient with a follicle stimulating hormone-secreting pituitary adenoma.
Topics: Adenoma; Aged; Bromocriptine; Follicle Stimulating Hormone; Humans; Male; Pituitary Neoplasms; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Tomography, X-Ray Computed | 1991 |
Experience with bromocriptine for the treatment of female infertility due to hyperprolactinemia.
Topics: Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Pituitary Neoplasms; Prolactinoma; Retrospective Studies | 1991 |
PET studies with L-[1-11C]tyrosine, L-[methyl-11C]methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromocryptine treatment.
Topics: Adult; Bromocriptine; Carbon Radioisotopes; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Pituitary Neoplasms; Prolactinoma; Tomography, Emission-Computed; Tyrosine | 1991 |
Effects of bromocriptine on experimental GH3 cell tumors.
Topics: Animals; Bromocriptine; Growth Hormone; Osmolar Concentration; Pituitary Neoplasms; Prolactin; Tumor Cells, Cultured | 1991 |
Reduction of pituitary tumor size with clinical and biochemical improvement with bromocriptine in a normoprolactinemic Cushing's disease.
Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Cushing Syndrome; Dexamethasone; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactin; Reserpine | 1990 |
[Effect of dopamine and bromocriptine on secretion of growth hormone by pituitary growth hormone secreting tumor in cell culture].
Topics: Adenoma, Acidophil; Adenoma, Chromophobe; Bromocriptine; Dopamine; Growth Hormone; Humans; Octreotide; Pituitary Neoplasms; Tumor Cells, Cultured | 1990 |
A comparison among the effectiveness of growth hormone suppression in active acromegaly of bromocriptine and long acting somatostatin analogue (SMS 201-995).
Topics: Acromegaly; Adult; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Growth Hormone; Humans; Hypoglycemia; Octreotide; Pituitary Neoplasms; Somatostatin | 1990 |
[Prolactinoma is more frequent among men than among women. A dopamine agonist is effective in the treatment].
Topics: Adult; Aged; Bromocriptine; Dopamine Agents; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Sex Factors; Sweden | 1990 |
Prolactin reduction after combined therapy for prolactin macroadenomas.
Topics: Adenoma; Adult; Bromocriptine; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Libido; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Retrospective Studies | 1991 |
Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Immunohistochemistry; Male; Microscopy, Electron; Middle Aged; Nucleic Acid Hybridization; Pituitary Neoplasms; Prolactin | 1991 |
Withdrawal of bromocriptine after long-term therapy for macroprolactinomas; effect on plasma prolactin and tumour size.
Topics: Adult; Aged; Bromocriptine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 1991 |
Positron emission tomography of pituitary macroadenomas: hormone production and effects of therapies.
Topics: Adenoma; Adult; Aged; Antineoplastic Agents; Bromocriptine; Combined Modality Therapy; Energy Metabolism; Female; Glucose; Hormones; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Octreotide; Pituitary Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1991 |
[Comparison of the therapeutic results of bromocriptine treatment of prolactin microadenoma and macroadenoma].
Topics: Adult; Bromocriptine; Female; Humans; Infertility, Female; Pituitary Neoplasms; Prolactin; Prolactinoma | 1990 |
Treatment of hyperprolactinemia in major depression.
Topics: Adult; Bromocriptine; Depressive Disorder; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Prolactinoma | 1990 |
Differential response to aminergic stimuli and biological behavior of growth hormone secreting pituitary adenomas.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Bromocriptine; Cyproheptadine; Diazepam; Female; Growth Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms; Thyrotropin-Releasing Hormone | 1990 |
[Clinical study of hypogonadotropic hypogonadism].
Topics: Adult; Bromocriptine; Chorionic Gonadotropin; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypogonadism; Luteinizing Hormone; Male; Pituitary Neoplasms; Prognosis; Prolactin; Puberty; Testosterone | 1990 |
[Prolactin adenomas in Dakar].
Topics: Adult; Amenorrhea; Bromocriptine; Combined Modality Therapy; Female; Galactorrhea; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prevalence; Prolactinoma; Radiography; Retrospective Studies; Sella Turcica; Senegal; Vision Disorders | 1990 |
Thyrotropin-and prolactin--secreting pituitary tumor dissociated hormonal response to bromocriptine.
Topics: Adult; Bromocriptine; Humans; Male; Pituitary Neoplasms; Prolactin; Thyrotropin | 1990 |
Promoting action of prolactin released from a grafted transplantable pituitary tumor (MtT/F84) on rat prostate carcinogenesis.
Topics: Aminobiphenyl Compounds; Animals; Bromocriptine; Carcinogens; Carcinoma; Cocarcinogenesis; Male; Neoplasm Metastasis; Neoplasm Transplantation; Organ Size; Pituitary Neoplasms; Precancerous Conditions; Prolactin; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred F344; Seminal Vesicles | 1990 |
[Alteration of prolactin secretion after transsphenoidal adenomectomy for prolactinomas].
Topics: Adolescent; Adult; Bromocriptine; Female; Follow-Up Studies; Humans; Hypophysectomy; Male; Pituitary Neoplasms; Postoperative Period; Prolactin; Prolactinoma | 1990 |
Long-term radiographic follow-up of the sella turcica in hyperprolactinaemic women.
Topics: Adult; Bromocriptine; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Middle Aged; Pituitary Neoplasms; Prolactinoma; Radiography; Sella Turcica; Time Factors | 1990 |
Management of prolactin-secreting pituitary adenomas.
Topics: Bromocriptine; Combined Modality Therapy; Female; Humans; Neoplasm Staging; Pituitary Neoplasms; Prolactinoma | 1990 |
Acromegaly, multinodular goiter and silent polyostotic fibrous dysplasia. A variant of the McCune-Albright syndrome.
Topics: Acromegaly; Adenoma; Adult; Brain; Bromocriptine; Female; Fibrous Dysplasia, Polyostotic; Goiter; Growth Hormone; Humans; Magnetic Resonance Imaging; Menstruation Disturbances; Octreotide; Pituitary Neoplasms; Prolactin | 1990 |
Lymphocyte abnormalities in patients with macro- and micro-prolactinoma: different effects of bromocriptine treatment in the two groups.
Topics: Antibodies, Monoclonal; Antigens, CD; Bromocriptine; HLA-DR Antigens; Humans; Lymphocyte Activation; Lymphocytes; Pituitary Neoplasms; Prolactin; Prolactinoma; Reference Values | 1990 |
NK activity in patients with pathological hyperprolactinemia: effect of bromocriptine.
Topics: Adult; Bromocriptine; Female; Humans; Killer Cells, Natural; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Reference Values | 1990 |
[2 cases of macroprolactinoma in adolescence].
Topics: Adolescent; Age Factors; Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Prolactinoma | 1990 |
[What is new in hyperprolactinemia?].
Topics: Abortion, Spontaneous; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Pituitary Neoplasms; Pregnancy; Prolactinoma | 1990 |
Results of primary treatment with bromocriptine of prolactinomas with extrasellar extension.
Topics: Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma | 1990 |
Parlodel LAR in the treatment of macroprolactinomas.
Topics: Adult; Bromocriptine; Delayed-Action Preparations; Drug Tolerance; Female; Humans; Male; Middle Aged; Pharmaceutical Vehicles; Pituitary Neoplasms; Prolactin; Prolactinoma; Visual Fields | 1990 |
[Treatment of macroprolactinomas with delayed bromocriptine. Effectiveness of a single intramuscular injection].
Topics: Adolescent; Adult; Aged; Bromocriptine; Delayed-Action Preparations; Drug Evaluation; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Vision Disorders | 1990 |
Acromegaly and primary amenorrhea: ovulation and pregnancy induced by SMS 201-995 and bromocriptine.
Topics: Acromegaly; Adenoma; Adult; Amenorrhea; Bromocriptine; Female; Humans; Octreotide; Ovulation Induction; Pituitary Neoplasms; Pregnancy | 1990 |
Visual function improvement in patients with macroprolactinomas treated with bromocriptine.
Topics: Adult; Aged; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Tomography, X-Ray Computed; Vision, Ocular; Visual Acuity; Visual Fields | 1990 |
[Treatment of prolactin-secreting pituitary tumors with bromocriptine].
Topics: Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 1990 |
The occurrence of macroscopical pituitary calcifications in prolactinomas.
Topics: Bromocriptine; Calculi; Female; Humans; Pituitary Diseases; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiography; Sella Turcica | 1990 |
Spontaneous prolactin transplantable tumor in the Wistar/Furth rat (SMtTW): a new animal model of human prolactinoma.
Topics: Animals; Bromocriptine; Disease Models, Animal; Female; Microscopy, Electron; Neoplasm Transplantation; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats | 1990 |
Octreotide treatment of acromegaly.
Topics: Acromegaly; Blood Glucose; Bromocriptine; Dose-Response Relationship, Drug; Drug Combinations; Growth Hormone; Half-Life; Humans; Injections, Intravenous; Injections, Subcutaneous; Octreotide; Pituitary Gland; Pituitary Neoplasms; Prolactin | 1990 |
New perspectives in medical management of hyperprolactinemia.
Topics: Adenoma; Bromocriptine; Cabergoline; Delayed-Action Preparations; Empty Sella Syndrome; Ergolines; Female; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms | 1990 |
CSF rhinorrhea after dopamine agonist treatment for invasive macroprolactinoma.
Topics: Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Humans; Pituitary Neoplasms; Prolactinoma | 1990 |
Giant invasive prolactinoma: a case report and review of nine further cases.
Topics: Adult; Aged; Bromocriptine; Dopamine; Female; Humans; Jugular Veins; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Prolactinoma; RNA, Messenger; Tumor Cells, Cultured | 1990 |
Bromocriptine increasingly suppresses the in vitro gonadotropin and alpha-subunit release from pituitary adenomas during long term culture.
Topics: Adenoma; Adult; Aged; Bromocriptine; Female; Gonadotropins, Pituitary; Humans; Male; Middle Aged; Pituitary Neoplasms; Time Factors; Tumor Cells, Cultured | 1990 |
[Acromegaly and pregnancy].
Topics: Abortion, Induced; Acromegaly; Adenoma; Adult; Bromocriptine; Cesarean Section; Combined Modality Therapy; Female; Growth Hormone; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications | 1990 |
Follicle-stimulating hormone- and alpha-subunit-secreting pituitary tumor treated with bromocriptine.
Topics: Adenoma; Bromocriptine; Chromatography, Gel; Follicle Stimulating Hormone; Glycoprotein Hormones, alpha Subunit; Humans; Male; Middle Aged; Peptide Fragments; Pituitary Hormones, Anterior; Pituitary Neoplasms; Prolactin; Radioimmunoassay; Thyrotropin; Visual Fields | 1985 |
Pure alpha-subunit-secreting mouse pituitary tumor: inhibition of growth and secretion by combined treatment with thyroxine and bromocriptine.
Topics: Animals; Bromocriptine; DNA; Drug Therapy, Combination; Glycoprotein Hormones, alpha Subunit; Male; Mice; Neoplasms, Experimental; Peptide Fragments; Pituitary Hormones, Anterior; Pituitary Neoplasms; Prolactin; Thyroxine | 1985 |
[Cytocidal effect of bromocriptine on human pituitary adenoma cells. Light and electron microscopical studies in vitro].
Topics: Adenoma; Bromocriptine; Cell Survival; Cells, Cultured; Drug Evaluation, Preclinical; Humans; Microscopy, Electron; Pituitary Neoplasms | 1985 |
Effective bromocriptine therapy for large, calcified prolactinoma--pathogenesis of calcifications.
Topics: Adenoma, Chromophobe; Adult; Bromocriptine; Calcinosis; Humans; Male; Pituitary Neoplasms; Prolactin | 1986 |
Secretion of glycoprotein hormone alpha-subunit by pituitary tumors.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Bromocriptine; Chromatography, Gel; Female; Glycoprotein Hormones, alpha Subunit; Growth Hormone; Humans; Male; Menopause; Middle Aged; Osmolar Concentration; Peptide Fragments; Pituitary Hormones, Anterior; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone | 1987 |
[Evaluation of the elution pattern of the serum and CSF prolactin fractionated by gel filtration chromatography in cases of bromocriptine-resistant prolactinoma].
Topics: Bromocriptine; Chromatography, Gel; Drug Resistance; Female; Male; Pituitary Neoplasms; Prolactin | 1987 |
Dopaminergic regulation of alpha-subunit secretion and messenger ribonucleic acid levels in alpha-secreting pituitary tumors.
Topics: Adenoma; Adult; Aged; Bromocriptine; Dopamine; Female; Glycoprotein Hormones, alpha Subunit; Gonadotropin-Releasing Hormone; Histocytochemistry; Humans; Immunoenzyme Techniques; Male; Middle Aged; Pituitary Hormones, Anterior; Pituitary Neoplasms; RNA, Messenger; RNA, Neoplasm; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured | 1988 |
[Effect of bromocriptine on estrogen-induced rat prolactinoma].
Topics: Animals; Bromocriptine; Cytoplasm; Estradiol; Female; Male; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains | 1987 |
Bromocriptine-induced morphological changes in cultured growth hormone-producing pituitary adenoma cells.
Topics: Adenoma; Bromocriptine; Growth Hormone; Humans; Pituitary Neoplasms; Tumor Cells, Cultured; Vacuoles | 1989 |
Bromocriptine treatment of acromegaly: possible dose dependency of the tumor size-reducing effect.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Dose-Response Relationship, Drug; Female; Growth Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms; Thyrotropin-Releasing Hormone; Time Factors | 1989 |
Retroperitoneal fibrosis in a patient with macroprolactinoma treated with bromocriptine.
Topics: Bromocriptine; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retroperitoneal Fibrosis | 1989 |
The combination therapy with bromocriptine and cyproheptadine in patients with acromegaly.
Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Cyproheptadine; Drug Therapy, Combination; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone; Time Factors; Tomography, X-Ray Computed | 1989 |
Glycoprotein hormone alpha-subunit and prolactin release by cultured pituitary adenoma cells from acromegalic patients: correlation with GH release.
Topics: Acromegaly; Adenoma; Bromocriptine; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Octreotide; Pituitary Neoplasms; Prolactin; Thyrotropin; Tumor Cells, Cultured | 1989 |
Perifusion studies of bromocriptine-treated and untreated macroprolactinomas: effects of dopamine, bromocriptine and TRH.
Topics: Bromocriptine; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Humans; Perfusion; Pituitary Neoplasms; Prolactin; Prolactinoma; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured | 1989 |
In vitro short-term effects of SMS 201-995, bromocriptine and TRH on growth hormone cell morphology from human pituitary adenomas.
Topics: Adenoma; Adult; Bromocriptine; Female; Growth Hormone; Humans; Immunohistochemistry; Male; Microscopy, Electron; Middle Aged; Models, Biological; Octreotide; Pituitary Neoplasms; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured | 1989 |
Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine.
Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; In Vitro Techniques; Luteinizing Hormone; Male; Pituitary Hormone-Releasing Hormones; Pituitary Neoplasms; Secretory Rate; Sex Factors; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured | 1989 |
Effectiveness and tolerability of long term treatment with cabergoline, a new long-lasting ergoline derivative, in hyperprolactinemic patients.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Cabergoline; Dopamine Agents; Ergolines; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin | 1989 |
[Prolactin and pregnancy].
Topics: Adult; Amniotic Fluid; Anencephaly; Bromocriptine; Female; Fetal Blood; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma | 1989 |
Long-term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR, in patients with tumorous hyperprolactinemia.
Topics: Adenoma; Amenorrhea; Bromocriptine; Delayed-Action Preparations; Drug Administration Schedule; Female; Galactorrhea; Humans; Hyperprolactinemia; Male; Pharmaceutical Vehicles; Pituitary Neoplasms | 1989 |
Severe hyperthyroidism due to neoplastic TSH hypersecretion in an old man.
Topics: Bromocriptine; Cardiovascular Diseases; Humans; Hyperthyroidism; Male; Methimazole; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Thyrotropin; Thyroxine; Triiodothyronine | 1989 |
[Treatment of hypophyseal prolactin-secreting macroadenomas].
Topics: Adult; Bromocriptine; Combined Modality Therapy; Female; Humans; Male; Pituitary Neoplasms; Prolactinoma; Retrospective Studies | 1989 |
Studies of two thyrotrophin-secreting pituitary adenomas: evidence for dopamine receptor deficiency.
Topics: Adenoma; Adult; Biological Assay; Bromocriptine; Chromatography, Gel; Domperidone; Female; Humans; Immunohistochemistry; Microscopy, Electron; Middle Aged; Pituitary Neoplasms; Receptors, Dopamine; Thyrotropin | 1989 |
Bromocriptine therapy for non-functioning pituitary adenoma.
Topics: Adenoma; Adult; Aged; Bromocriptine; Combined Modality Therapy; Female; Hormones; Humans; Male; Middle Aged; Pituitary Neoplasms; Retrospective Studies; Tomography, X-Ray Computed | 1989 |
Prolactinomas presenting as primary amenorrhoea and delayed or arrested puberty: response to medical therapy.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Combined Modality Therapy; Female; Humans; Male; Pituitary Neoplasms; Prolactinoma; Puberty, Delayed | 1989 |
Anatomical and functional effects of estrogen-induced prolactinomas on the rat hypothalamus.
Topics: Animals; Bromocriptine; Estrogens; Female; Hypothalamus; Pituitary Neoplasms; Prolactinoma; Rats; Rats, Inbred F344 | 1989 |
[Clinico-diagnostic indicators and late results of the treatment of infertility in hyperprolactinemia].
Topics: Adenoma; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Pituitary Neoplasms; Prolactin; Time Factors | 1989 |
[Clinical course and the effectiveness of conservative treatment of prolactin-secreting pituitary adenoma].
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Hypophysectomy; Pituitary Neoplasms; Prolactin | 1989 |
Development of an invasive macroprolactinoma: a possible consequence of prolonged oestrogen replacement. Case report.
Topics: Adult; Bromocriptine; Estrogen Replacement Therapy; Female; Humans; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactinoma | 1989 |
[Long-term bromocriptine treatment of giant prolactinoma: report of a case].
Topics: Adult; Bromocriptine; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma | 1989 |
Rapid improvement of visual defects with parenteral depot-bromocriptine in a patient with a non-functioning pituitary adenoma.
Topics: Adenoma; Bromocriptine; Delayed-Action Preparations; Female; Humans; Immunohistochemistry; Middle Aged; Pituitary Neoplasms; Radiography; Visual Acuity; Visual Fields | 1989 |
Rhinorrhea following dopamine agonist therapy of invasive macroprolactinoma.
Topics: Adult; Aged; Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma | 1989 |
A simple rapid method for prolactin assay by reversed passive hemagglutination: evaluation of its clinical application.
Topics: Amenorrhea; Antibodies, Monoclonal; Bromocriptine; Female; Hemagglutination Tests; Humans; Metoclopramide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Radioimmunoassay | 1989 |
Prolactinoma in an adolescent girl: unusual response to bromocriptine therapy.
Topics: Adolescent; Bromocriptine; Female; Humans; Menstruation; Obesity; Pituitary Neoplasms; Prolactin; Prolactinoma | 1989 |
Abnormal dopamine sensitivity in some human prolactinomas.
Topics: Bromocriptine; Cells, Cultured; Dopamine; Female; Humans; Pituitary Neoplasms; Prolactinoma; Receptors, Dopamine | 1989 |
Effects of pregnancy, delivery and lactation in hyperprolactinemia with prolactin producing pituitary adenoma.
Topics: Adenoma; Bromocriptine; Combined Modality Therapy; Female; Humans; Hyperprolactinemia; Hypophysectomy; Labor, Obstetric; Lactation; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1989 |
Resistance to bromocriptine in prolactinomas.
Topics: 17-Hydroxycorticosteroids; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adolescent; Adult; Bromocriptine; Cell Membrane; Dopamine; Drug Resistance; Female; Growth Hormone; Humans; Kinetics; Luteinizing Hormone; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Receptors, Dopamine; Spiperone; Thyrotropin; Thyroxine; Tumor Cells, Cultured | 1989 |
Outcome of treatment with bromocriptine in patients with hyperprolactinaemia.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Middle Aged; Ovulation; Pituitary Neoplasms; Pregnancy | 1989 |
Hypersecretion of gonadotropins by a pituitary adenoma: pituitary dynamic studies and treatment with bromocriptine in one patient.
Topics: Adenoma; Bromocriptine; Combined Modality Therapy; Female; Gonadotropins; Humans; Middle Aged; Pituitary Neoplasms | 1989 |
Cerebrospinal fluid rhinorrhea occurring in long-term bromocriptine treatment for macroprolactinomas.
Topics: Adult; Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Tomography, X-Ray Computed | 1989 |
A bromocriptine-responsive corticotroph adenoma secreting alpha-MSH in a patient with Cushing's disease.
Topics: Adenoma, Chromophobe; Adrenocorticotropic Hormone; Adult; alpha-MSH; Bromocriptine; Cushing Syndrome; Female; Humans; Pituitary Neoplasms | 1988 |
The use of bromocriptine in hyperprolactinemia and galactorrhea in Singapore.
Topics: Adenoma; Adult; Bromocriptine; Female; Galactorrhea; Humans; Infertility, Female; Infertility, Male; Lactation Disorders; Male; Pituitary Neoplasms; Pregnancy; Prolactin | 1985 |
Present status of neurosurgery in the treatment of prolactinomas.
Topics: Adrenergic alpha-Agonists; Bromocriptine; Diagnosis, Differential; Female; Humans; Male; Pituitary Neoplasms; Postoperative Care; Pregnancy; Pregnancy Complications; Premedication; Prolactin; Time Factors | 1985 |
[100 years of acromegaly: general lessons about a rare disease].
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Drug Therapy, Combination; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Octreotide; Pituitary Neoplasms; Somatostatin | 1986 |
On the functional relationship between 45Ca2+ release and prolactin secretion in cultured rat pituitary tumour (GH3) cells.
Topics: Adenoma; Animals; Bromocriptine; Calcium; Cell Line; Kinetics; Pituitary Neoplasms; Prolactin; Rats; Somatostatin; Thyrotropin-Releasing Hormone | 1986 |
Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Somatomedins; Somatostatin; Thyrotropin-Releasing Hormone | 1986 |
Rapid regression through bromocriptine therapy of a suprasellar extending prolactinoma during pregnancy.
Topics: Adult; Bromocriptine; Female; Humans; Infant, Newborn; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Sella Turcica; Time Factors | 1986 |
Phorbol ester and phospholipase C-induced growth hormone secretion from pituitary somatotroph adenoma cells in culture: effects of somatostatin, bromocriptine, and pertussis toxin.
Topics: Adenoma; Bromocriptine; Cells, Cultured; Drug Interactions; Growth Hormone; GTP-Binding Proteins; Humans; Pertussis Toxin; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositols; Pituitary Neoplasms; Protein Kinase C; Secretory Rate; Somatostatin; Tetradecanoylphorbol Acetate; Type C Phospholipases; Virulence Factors, Bordetella | 1987 |
Immunohistochemical, electron microscopic and morphometric studies of estrogen-induced rat prolactinomas after bromocriptine treatment.
Topics: Animals; Bromocriptine; Female; Histocytochemistry; Immunoenzyme Techniques; Microscopy, Electron; Organ Size; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains | 1987 |
A comparison between the effects of SMS 201-995, bromocriptine and a combination of both drugs on hormone release by the cultured pituitary tumour cells of acromegalic patients.
Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Drug Interactions; Female; Growth Hormone; Humans; Immunoenzyme Techniques; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Prolactin; Radioimmunoassay; Somatostatin; Tumor Cells, Cultured | 1987 |
Control of hyperprolactinemia with pergolide.
Topics: Bromocriptine; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Prolactin | 1986 |
Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995.
Topics: Acromegaly; Adult; Antineoplastic Agents; Bromocriptine; Female; Glucose Tolerance Test; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Receptors, Opioid; Somatostatin; Thyrotropin-Releasing Hormone | 1988 |
Sipple's syndrome associated with a large prolactinoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Bromocriptine; Carcinoma; Humans; Male; Multiple Endocrine Neoplasia; Parathyroid Neoplasms; Pheochromocytoma; Pituitary Neoplasms; Prolactin; Thyroid Neoplasms | 1987 |
[Drug therapy of pituitary neoplasms].
Topics: Adrenocorticotropic Hormone; Bromocriptine; Cyproheptadine; Delayed-Action Preparations; Female; Growth Hormone; Humans; Male; Pituitary Neoplasms; Prolactin; Somatostatin | 1987 |
Response of luteinizing hormone secreting pituitary adenoma to a long-acting somatostatin analogue.
Topics: Adenoma; Adult; Antineoplastic Agents; Bromocriptine; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Octreotide; Pituitary Neoplasms; Somatostatin | 1988 |
Somatostatin analog treatment of acromegaly: new aspects.
Topics: Acromegaly; Bromocriptine; Follow-Up Studies; Growth Hormone; Humans; Insulin-Like Growth Factor I; Octreotide; Pituitary Neoplasms; Prolactin; Somatostatin | 1988 |
[Treatment of acromegaly].
Topics: Acromegaly; Adenoma; Bromocriptine; Humans; Pituitary Neoplasms; Radiotherapy Dosage; Somatostatin | 1988 |
Pituitary adenomas: possible role of bromocriptine in intratumoral hemorrhage.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Bromocriptine; Child; Female; Hemorrhage; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies | 1989 |
Successful treatment of a prolactin-producing pituitary macroadenoma with intravaginal bromocriptine mesylate: a novel approach to intolerance of oral therapy.
Topics: Administration, Intravaginal; Adult; Bromocriptine; Female; Humans; Nausea; Pituitary Neoplasms; Prolactinoma; Vomiting | 1989 |
Experience relating to pregnancy, lactation, and the after-weaning condition of hyperprolactinemic patients treated with bromocriptine.
Topics: Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Lactation; Menstruation; Pituitary Neoplasms; Postpartum Period; Pregnancy; Prolactin; Prolactinoma; Weaning | 1989 |
Growth of prolactinoma despite lowering of serum prolactin by bromocriptine.
Topics: Adult; Bromocriptine; Female; Humans; Magnetic Resonance Imaging; Male; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Tomography, X-Ray Computed; Visual Acuity; Visual Fields | 1989 |
Third nerve palsy: the presenting sign of a pituitary adenoma in five patients and the only neurological sign in four patients.
Topics: Adenoma, Chromophobe; Adult; Aged; Bromocriptine; Humans; Male; Middle Aged; Ophthalmoplegia; Pituitary Neoplasms; Tomography, X-Ray Computed | 1985 |
[Effect of parlodel treatment on prolactin-secreting tumors of the pituitary].
Topics: Adenoma; Adult; Bromocriptine; Combined Modality Therapy; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1985 |
[Combination of domperidone and bromocriptine in the treatment of prolactinoma].
Topics: Bromocriptine; Domperidone; Drug Therapy, Combination; Humans; Pituitary Neoplasms; Prolactin | 1986 |
[Parlodel treatment in the diagnosis of hyperprolactinemia].
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Menstruation Disturbances; Pituitary Neoplasms | 1986 |
Magnetic resonance imaging of tumours of the sellar region. Evaluation of treatment with bromocriptine retard.
Topics: Adenoma; Adult; Aged; Bromocriptine; Female; Growth Hormone; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Sella Turcica | 1986 |
The hormonal effects of pituitary surgery and irradiation: a review of 59 cases.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Aged; Bromocriptine; Combined Modality Therapy; Female; Follicle Stimulating Hormone; Growth Hormone; Hormones; Humans; Hypophysectomy; Luteinizing Hormone; Male; Pituitary Irradiation; Pituitary Neoplasms; Prolactin; Retrospective Studies; Testosterone; Thyroid Gland; Thyrotropin; Thyroxine | 1985 |
Effect of ovine corticotrophin releasing factor, bromocriptine, and dopamine on release of ACTH and beta-endorphin in a patient with Cushing's disease.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Animals; beta-Endorphin; Bromocriptine; Corticotropin-Releasing Hormone; Cushing Syndrome; Dexamethasone; Dopamine; Endorphins; Humans; Male; Metyrapone; Pituitary Neoplasms; Receptors, Dopamine; Sheep | 1985 |
Metastasis of an occult gastric carcinoma suggesting growth of a prolactinoma during bromocriptine therapy: a case report with a review of the literature.
Topics: Adenocarcinoma, Mucinous; Adenoma; Aged; Bromocriptine; Female; Humans; Hypophysectomy; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Pituitary Gland; Pituitary Neoplasms; Postoperative Complications; Prolactin; Stomach Neoplasms | 1985 |
Probable ACTH-secreting pituitary tumour in association with Addison's disease.
Topics: Addison Disease; Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Circadian Rhythm; Corticotropin-Releasing Hormone; D-Ala(2),MePhe(4),Met(0)-ol-enkephalin; Dexamethasone; Humans; Hydrocortisone; Lypressin; Male; Middle Aged; Pituitary Function Tests; Pituitary Neoplasms | 1985 |
Direct action of opiates on bromocriptine-inhibited prolactin release by human prolactinoma cells in primary culture.
Topics: Adenoma; Bromocriptine; Cells, Cultured; Cyclazocine; Dopamine; Drug Interactions; Ethylketocyclazocine; Female; Humans; Male; Narcotics; Pituitary Neoplasms; Prolactin; Receptors, Opioid | 1985 |
The medical treatment of the hypersecreting pituitary gland.
Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Bromocriptine; Cyproheptadine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Gland; Pituitary Neoplasms; Prolactin; Valproic Acid | 1985 |
Transsphenoidal surgery following unsuccessful prior therapy. An assessment of benefits and risks in 158 patients.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Chordoma; Combined Modality Therapy; Craniopharyngioma; Craniotomy; Female; Humans; Male; Neoplasm Recurrence, Local; Pituitary Diseases; Pituitary Neoplasms; Postoperative Complications; Prolactin; Reoperation; Retrospective Studies; Risk; Sphenoid Bone | 1985 |
Acromegaly and insulin resistance: a case study.
Topics: Acromegaly; Adenoma, Acidophil; Bromocriptine; C-Peptide; Female; Glucagon; Glucose; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Insulin Resistance; Middle Aged; Pituitary Neoplasms; Tomography, X-Ray Computed | 1986 |
The effect of ovine corticotrophin releasing factor (oCRF), bromocriptine and TRH on the secretion of ACTH and alpha-MSH in Nelson's syndrome and Cushing's disease.
Topics: Adrenocorticotropic Hormone; Adult; Animals; Arginine Vasopressin; Bromocriptine; Corticotropin-Releasing Hormone; Cushing Syndrome; Humans; Melanocyte-Stimulating Hormones; Middle Aged; Nelson Syndrome; Pituitary Neoplasms; Sheep; Thyrotropin-Releasing Hormone | 1986 |
MR imaging of pituitary adenoma: CT, clinical, and surgical correlation.
Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Humans; Magnetic Resonance Spectroscopy; Pituitary Neoplasms; Prolactin; Prospective Studies; Sphenoid Sinus; Tomography, X-Ray Computed | 1987 |
Increased creatine kinase activity in pituitary tumours of rat and man.
Topics: Adenoma; Adrenocorticotropic Hormone; Animals; Bromocriptine; Cell Line; Creatine Kinase; Diethylstilbestrol; Estradiol; Female; Growth Hormone; Organ Size; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred WF | 1987 |
Treatment of pituitary macroadenomas secreting PRL, HGH or ACTH with long-acting bromocriptine.
Topics: Acromegaly; Adenoma; Adrenocorticotropic Hormone; Adult; Bromocriptine; Delayed-Action Preparations; Female; Growth Hormone; Humans; Male; Middle Aged; Nelson Syndrome; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1987 |
Effects of bromocriptine on prolactin release, electrical membrane properties and transmembrane Ca2+ fluxes in cultured rat pituitary adenoma cells.
Topics: Action Potentials; Adenoma; Animals; Bromocriptine; Calcium; Cell Membrane Permeability; Cells, Cultured; Pituitary Neoplasms; Potassium Chloride; Prolactin; Rats; Thyrotropin-Releasing Hormone | 1986 |
Pregnancy after combined treatment with bromocriptine and tamoxifen in two patients with pituitary prolactinomas.
Topics: Adult; Animals; Bromocriptine; Callitrichinae; Drug Therapy, Combination; Female; Follicle Stimulating Hormone; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Rabbits; Rats; Tamoxifen | 1986 |
Regulation of prolactin secretion in canine pituitary-dependent hyperadrenocorticism.
Topics: Adrenal Cortex Diseases; Adrenal Cortex Neoplasms; Animals; Bromocriptine; Dogs; Female; Male; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone | 1986 |
The long-term effects of megavoltage radiotherapy as sole or combined therapy for large prolactinomas: studies with high definition computerized tomography.
Topics: Adolescent; Adult; Bromocriptine; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Radiotherapy, High-Energy; Time Factors; Tomography, X-Ray Computed | 1986 |
Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
Topics: Adenoma; Adult; Bromocriptine; Domperidone; Female; Humans; Hypophysectomy; Nomifensine; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone | 1987 |
The effects of bromocriptine, thyrotropin-releasing hormone, and gonadotropin-releasing hormone on hormone secretion by gonadotropin-secreting pituitary adenomas in vivo and in vitro.
Topics: Adenoma; Aged; Bromocriptine; Cells, Cultured; Gonadotropins, Pituitary; Humans; Male; Middle Aged; Pituitary Hormone-Releasing Hormones; Pituitary Neoplasms; Secretory Rate; Thyrotropin-Releasing Hormone | 1987 |
Luteinizing hormone-secreting pituitary tumor: biosynthetic characterization and clinical studies.
Topics: Adenoma; Bromocriptine; Combined Modality Therapy; Dopamine; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Pituitary Neoplasms; Prolactin; RNA, Messenger; RNA, Neoplasm; Testosterone; Triptorelin Pamoate | 1987 |
Rapid progression of a growth hormone producing tumour during dopamine agonist treatment.
Topics: Acromegaly; Adult; Bromocriptine; Growth Hormone; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms | 1987 |
In vivo and in vitro modulation of growth hormone and prolactin of a mixed somatotropic-lactotropic pituitary microadenoma.
Topics: Adenoma, Chromophobe; Adult; Bromocriptine; Chlorpromazine; Depression, Chemical; Female; Growth Hormone; Humans; In Vitro Techniques; Levodopa; Pituitary Neoplasms; Prolactin; Stimulation, Chemical; Thyrotropin-Releasing Hormone | 1987 |
Dihydroergocriptine in management of microprolactinomas.
Topics: Adult; Bromocriptine; Dihydroergotoxine; Drug Administration Schedule; Female; Humans; Pituitary Neoplasms; Prolactin; Time Factors | 1987 |
Macroprolactinomas and functionless pituitary tumours. Immunostaining and effect of dopamine agonist therapy.
Topics: Adenoma; Adult; Aged; Bromocriptine; Female; Follicle Stimulating Hormone; Humans; Immunoenzyme Techniques; Luteinizing Hormone; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Receptors, Dopamine | 1987 |
Successful treatment of infertility in a man with a bromocriptine-resistant prolactinoma.
Topics: Adenoma; Adult; Bromocriptine; Chorionic Gonadotropin; Drug Resistance; Humans; Infertility, Male; Male; Menotropins; Pituitary Neoplasms; Prolactin | 1987 |
Evidence for the release of a novel pituitary polypeptide (7B2) from the growth hormone-producing pituitary adenoma of patients with acromegaly.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Corticotropin-Releasing Hormone; Female; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Male; Middle Aged; Nerve Tissue Proteins; Neuroendocrine Secretory Protein 7B2; Pituitary Hormones; Pituitary Neoplasms; Potassium; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured | 1988 |
Transient dopaminergic inhibition of prolactin release from hybrid cells derived by fusion of normal rat pituitary and GH4C1 tumor cells.
Topics: Animals; Bromocriptine; Cell Fusion; Cell Line; Cells, Cultured; Dopamine; Female; Growth Hormone; Hybrid Cells; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred WF; Spiperone; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide | 1988 |
Clinical response of thyrotropin-secreting macroadenoma to bromocriptine and radiotherapy.
Topics: Adenoma; Bromocriptine; Dexamethasone; Humans; Iodine Radioisotopes; Male; Metoclopramide; Middle Aged; Pituitary Neoplasms; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Visual Fields | 1988 |
[Clinical treatment of prolactinoma in women: analysis of 40 cases].
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Menstruation Disturbances; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma | 1988 |
[Macroprolactinoma reduction and pregnancy induction with bromocriptine].
Topics: Adult; Amenorrhea; Bromocriptine; Drug Evaluation; Female; Galactorrhea; Humans; Pituitary Neoplasms; Pregnancy; Prolactinoma; Remission Induction | 1988 |
[Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
Topics: Adenoma; Adult; Bromocriptine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Pituitary Neoplasms; Prolactin; Radiography; Sella Turcica | 1985 |
A case of large prolactinoma supposed to be cured by bromocriptine therapy.
Topics: Adult; Bromocriptine; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma | 1988 |
Effects of bromocriptine on prolactin cellular hypertrophy, proliferation and secretory activity in diethylstilbestrol-induced pituitary tumors.
Topics: Animals; Bromocriptine; Cell Cycle; Cell Division; Cell Separation; Diethylstilbestrol; Female; Flow Cytometry; Hypertrophy; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred F344 | 1988 |
Kallikrein gene expression in estrogen-induced pituitary tumors.
Topics: Animals; Bromocriptine; Diethylstilbestrol; Female; Gene Expression Regulation; Kallikreins; Nucleic Acid Hybridization; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred F344; RNA Probes; RNA, Messenger | 1988 |
[Success of a parlodel test in the differential diagnosis of syndromes of disturbed prolactin secretion].
Topics: Adenoma; Bromocriptine; Diagnosis, Differential; Female; Humans; Pituitary Neoplasms; Predictive Value of Tests; Prolactin; Thyrotropin | 1988 |
Effect of bromocriptine on secretion and morphology of human prolactin cell adenomas in vitro.
Topics: Adult; Aged; Bromocriptine; Cells, Cultured; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma | 1988 |
Pituitary apoplexy manifested during a bromocriptine test in a patient with a growth hormone- and prolactin-producing pituitary adenoma.
Topics: Adenoma; Bromocriptine; Female; Humans; Middle Aged; Pituitary Apoplexy; Pituitary Neoplasms; Vision Disorders | 1988 |
Diagnostic problems and operative treatment of pituitary microadenomas.
Topics: Acromegaly; Adenoma; Adrenocortical Hyperfunction; Adult; Bromocriptine; Combined Modality Therapy; Cushing Syndrome; Humans; Pituitary Neoplasms; Retrospective Studies | 1988 |
Treatment of prolactinomas and growth hormone-producing adenomas with an injectable bromocriptine retard preparation and a somatostatin analogue delivered by an implantable pump.
Topics: Acromegaly; Adenoma; Antineoplastic Agents; Bromocriptine; Delayed-Action Preparations; Female; Growth Hormone; Hormones; Humans; Magnetic Resonance Imaging; Male; Octreotide; Pituitary Neoplasms; Prolactin; Prolactinoma | 1988 |
Changes in prolactinomas and somatotropinomas in humans treated with bromocriptine.
Topics: Bromocriptine; Cytoplasmic Granules; Exocytosis; Growth Hormone; Humans; Microscopy, Electron; Necrosis; Pituitary Neoplasms; Prolactinoma | 1988 |
Ultrastructural study of prolactinoma after bromocriptine therapy.
Topics: Adolescent; Adult; Bromocriptine; Cytoplasmic Granules; Female; Humans; Male; Microscopy, Electron; Middle Aged; Pituitary Neoplasms; Prolactinoma | 1988 |
[Prolactin adenomas in women under 20 years of age: apropos of 11 cases].
Topics: Adolescent; Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactinoma; Retrospective Studies | 1988 |
Changes of blood flow in oestrogen-induced hyperplastic anterior pituitary lobe following bromocriptine administration.
Topics: Adenoma; Animals; Blood Flow Velocity; Bromocriptine; Diethylstilbestrol; Female; Hyperplasia; Pituitary Gland, Anterior; Pituitary Neoplasms; Rats; Rats, Inbred F344 | 1987 |
[Macroprolactinoma in a 16-year-old patient].
Topics: Adenoma; Adolescent; Bromocriptine; Combined Modality Therapy; Female; Humans; Magnetic Resonance Imaging; Optic Chiasm; Pituitary Gland; Pituitary Neoplasms; Prolactin | 1988 |
Estrogen-induced prolactinoma in a man.
Topics: Adult; Bromocriptine; Estradiol; Estrogens; Humans; Male; Pituitary Gland; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed; Transsexualism | 1988 |
Pathological hyperprolactinemia suppresses hot flashes in menopausal women.
Topics: Adenoma; Bromocriptine; Climacteric; Female; Humans; Hyperprolactinemia; Middle Aged; Pituitary Neoplasms; Prolactin | 1988 |
Hypothalamic syndrome due to macroprolactinoma; regression with bromocriptine treatment.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Hypothalamic Diseases; Pituitary Neoplasms; Prolactin | 1988 |
Management of prolactinomas associated with very high serum prolactin levels.
Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Retrospective Studies; Tomography, X-Ray Computed | 1988 |
[Bromocriptine therapy in macroprolactinomas with extrasellar extension].
Topics: Adolescent; Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Sella Turcica; Time Factors; Visual Acuity; Visual Fields | 1988 |
Effectiveness of a single injectable dose of bromocriptine long acting in the treatment of macroprolactinomas.
Topics: Adenoma; Adult; Bromocriptine; Delayed-Action Preparations; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1988 |
Validation of the role of bromocriptine in the primary treatment of prolactinomas.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms | 1988 |
Long-acting injectable bromocriptine treatment for macroprolactinomas.
Topics: Adenoma; Adult; Aged; Bromocriptine; Delayed-Action Preparations; Female; Humans; Hyperprolactinemia; Middle Aged; Pituitary Neoplasms; Prolactin; Visual Acuity | 1988 |
[Reduction of tumor size and clinical normalization of a macroprolactinoma during chronic treatment with bromocriptine].
Topics: Administration, Oral; Bromocriptine; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1988 |
Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients.
Topics: Acromegaly; Adenoma; Bromocriptine; Combined Modality Therapy; Endocrine System Diseases; Follow-Up Studies; Growth Hormone; Humans; Microsurgery; Pituitary Neoplasms; Postoperative Complications; Recurrence; Sphenoid Bone | 1988 |
Ultrastructural morphology of nontumorous prolactin cells in human pituitaries harboring prolactin-producing adenoma.
Topics: Adenoma; Bromocriptine; Cell Nucleus; Cytoplasm; Cytoplasmic Granules; Humans; Organoids; Pituitary Gland; Pituitary Neoplasms; Prolactin | 1988 |
Bromocriptine-induced trigeminal neuralgia attacks in a patient with a pituitary tumor.
Topics: Adenoma; Bromocriptine; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Trigeminal Neuralgia | 1988 |
Primary treatment of macroprolactinomas with Parlodel LAR.
Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed; Visual Acuity | 1988 |
Inhibitory effect of cabergoline on the development of estrogen-induced prolactin-secreting adenomas of the pituitary.
Topics: Adenoma; Animals; Antineoplastic Agents; Body Weight; Bromocriptine; Cabergoline; DNA, Neoplasm; Ergolines; Estrogens; Female; Mitosis; Pituitary Neoplasms; Prolactin; Rats | 1988 |
Bromocriptine-unresponsive prolactin macroadenoma in a prepubertal female.
Topics: Adenoma; Bromocriptine; Child; Combined Modality Therapy; Female; Growth Disorders; Humans; Pituitary Neoplasms; Prolactin; Puberty, Delayed | 1988 |
Long-term treatment of hyperprolactinaemia with bromocriptine: effect of drug withdrawal.
Topics: Adenoma; Adult; Bromocriptine; Combined Modality Therapy; Female; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Prolactin; Time Factors | 1987 |
Use of bromocriptine for treatment of Cushing's disease caused by an adenoma originating from the intermediate lobe of the pituitary.
Topics: Adenoma; Bromocriptine; Child; Cushing Syndrome; Female; Humans; Male; Pituitary Gland, Anterior; Pituitary Neoplasms | 1987 |
[Bromocriptine for prolactin-secreting macroadenomas of the pituitary].
Topics: Adenoma; Adult; Bromocriptine; Humans; Middle Aged; Pituitary Neoplasms; Prolactin | 1987 |
Results of combined surgical and medical therapy in patients with prolactin-secreting pituitary macroadenomas.
Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1987 |
Pregnancy following sequential bromocriptine therapy in a hyperprolactinemic subject.
Topics: Adult; Bromocriptine; Drug Administration Schedule; Female; Humans; Infant, Newborn; Menstrual Cycle; Pituitary Neoplasms; Pregnancy; Prolactin | 1987 |
Effective management of a suprasellar extending prolactinoma during pregnancy.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Tomography, X-Ray Computed; Visual Fields | 1987 |
Hyperprolactinaemia in Zimbabwean women.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Middle Aged; Pituitary Neoplasms; Pregnancy; Zimbabwe | 1987 |
Oestrogen treatment of adolescent tall girls; short term side effects.
Topics: Adenoma; Adolescent; Bromocriptine; Child; Diethylstilbestrol; Estrogens; Ethinyl Estradiol; Female; Galactorrhea; Growth Disorders; Humans; Pituitary Neoplasms | 1986 |
A 16 year old boy with poor vision and nasal obstruction.
Topics: Adenoma; Adolescent; Bromocriptine; Combined Modality Therapy; Humans; Male; Neoplasm Invasiveness; Nose Diseases; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed; Vision Disorders; Visual Fields | 1987 |
Hypothalamic corticotropin-releasing factor immunoreactivity is reduced during induction of pituitary tumors by chronic estrogen treatment.
Topics: Animals; Bromocriptine; Corticotropin-Releasing Hormone; Estradiol; Female; Hypothalamus; Organ Size; Ovariectomy; Pituitary Gland, Anterior; Pituitary Neoplasms; Rats; Rats, Inbred Strains | 1987 |
Absence of growth hormone response to L-dopa and bromocriptine in hyperprolactinemic women with pituitary microadenoma.
Topics: Adenoma; Adult; Bromocriptine; Female; Growth Hormone; Humans; Hyperprolactinemia; Insulin; Levodopa; Pituitary Neoplasms | 1986 |
[Pregnancy and hyperprolactinemia. Review of therapeutic measures apropos of a series of 35 patients].
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Combined Modality Therapy; Female; Humans; Hyperprolactinemia; Hypophysectomy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic | 1986 |
Relationship between the methods of treatment for prolactinomas and the puerperal lactation.
Topics: Adult; Bottle Feeding; Breast Feeding; Bromocriptine; Female; Humans; Lactation; Pituitary Neoplasms; Pregnancy; Prolactin | 1987 |
Demonstration of specific dopamine receptors on human pituitary adenomas.
Topics: Adenoma; Adult; Bromocriptine; Female; Growth Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Receptors, Dopamine; Spiperone | 1987 |
Hyperprolactinaemia--current dilemma.
Topics: Bromocriptine; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin | 1986 |
Effects of a new long-acting form of bromocriptine on tumorous hyperprolactinemia.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Bromocriptine; Delayed-Action Preparations; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1987 |
Abducent palsy after rapid shrinkage of a prolactinoma.
Topics: Abducens Nerve; Adult; Bromocriptine; Cranial Nerve Diseases; Humans; Male; Paralysis; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1987 |
Short-term management of macroprolactinomas with a new injectable form of bromocriptine.
Topics: Adult; Bromocriptine; Delayed-Action Preparations; Female; Headache; Humans; Injections, Intramuscular; Male; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed; Vision Disorders | 1987 |
[Antitumor effect of bromocriptine on estrogen-induced rat prolactinomas: special reference to changes in secretory granules by stereological analysis].
Topics: Animals; Bromocriptine; Cytoplasmic Granules; Estradiol; Female; Histocytochemistry; Microscopy, Electron; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats | 1987 |
[Therapeutic results in hyperprolactinemic sterility patients].
Topics: Adenoma; Adult; Bromocriptine; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Infertility, Female; Pituitary Neoplasms; Pregnancy; Prolactin | 1987 |
Non-functioning pituitary adenomas do not regress during bromocriptine therapy but possess membrane-bound dopamine receptors which bind bromocriptine.
Topics: Adenoma; Adult; Aged; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Gland, Anterior; Pituitary Neoplasms; Receptors, Dopamine | 1986 |
Long-acting bromocriptine for the acute treatment of large macroprolactinomas.
Topics: Bromocriptine; Delayed-Action Preparations; Female; Headache; Humans; Male; Pituitary Neoplasms; Prolactin; Visual Acuity; Visual Fields | 1987 |
Influence of bromocriptine and oestrogen on prolactin synthesis, secretion and tumour growth in vivo in rats.
Topics: Animals; Bromocriptine; Diethylstilbestrol; Female; Microscopy, Electron; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred F344; RNA, Messenger | 1987 |
Storage and release of secretory granules in human prolactinomas: modification by bromocriptine.
Topics: Adult; Bromocriptine; Cytoplasmic Granules; Female; Humans; Male; Microscopy, Electron; Middle Aged; Pituitary Neoplasms; Prolactin; Time Factors | 1987 |
Rapid improvement in visual field defects following bromocriptine treatment of patients with non-functioning pituitary adenomas.
Topics: Adenoma, Chromophobe; Aged; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Time Factors; Visual Fields | 1986 |
Prolactin secretion and menstrual function after long-term bromocriptine treatment.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Humans; Hyperprolactinemia; Menstruation; Pituitary Neoplasms; Prolactin; Time Factors | 1987 |
Immunohistochemical, electron microscopic, and morphometric studies of human prolactinomas after short-term bromocriptine treatment.
Topics: Bromocriptine; Cytoplasm; Cytoplasmic Granules; Humans; Immunohistochemistry; Microscopy, Electron; Microtubules; Pituitary Neoplasms; Prolactin; Time Factors | 1987 |
Normal growth and pubertal development during bromocriptine treatment for a prolactin-secreting pituitary macroadenoma.
Topics: Adenoma; Bromocriptine; Child; Growth; Humans; Male; Pituitary Neoplasms; Prolactin; Puberty | 1987 |
Visual field improvement induced by bromocriptine treatment.
Topics: Adenoma; Bromocriptine; Humans; Pituitary Neoplasms; Visual Fields | 1987 |
Giant invasive prolactinomas.
Topics: Adult; Bromocriptine; Cobalt Radioisotopes; Combined Modality Therapy; Ear, Inner; Humans; Male; Middle Aged; Neoplasm Invasiveness; Paranasal Sinuses; Pituitary Gland; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1987 |
Growth rate of human pituitary adenomas.
Topics: Adenoma; Adolescent; Adult; Aged; Antibodies, Monoclonal; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms | 1987 |
Short-term preoperative treatment of macroprolactinomas by dopamine agonists.
Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Premedication; Prolactin; Tomography, X-Ray Computed | 1987 |
Prolactin-secreting adenomas: the preoperative response to bromocriptine treatment and surgical outcome.
Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Child; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Premedication; Prolactin | 1987 |
Continued growth of a large pituitary prolactinoma despite high dose bromocriptine.
Topics: Adolescent; Bromocriptine; Dose-Response Relationship, Drug; Humans; Male; Pituitary Neoplasms; Prolactin | 1987 |
Bromocriptine inhibits incorporation of [3H]thymidine into rat pituitary tumor cells.
Topics: Animals; Bromocriptine; Clone Cells; DNA, Neoplasm; Pituitary Neoplasms; Prolactin; Rats; Receptors, Dopamine; Thymidine; Thymidine Kinase | 1986 |
Report of the National Symposium on the Clinical Management of Prolactin-Related Reproductive Disorders.
Topics: Adenoma; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Infertility, Female; Luteal Phase; Ovarian Diseases; Pituitary Neoplasms; Pregnancy; Prolactin; Visual Fields | 1986 |
Long-term medical therapy and follow-up of pediatric-adolescent patients with prolactin-secreting macroadenomas.
Topics: Adenoma; Adolescent; Adult; Amenorrhea; Bromocriptine; Child; Female; Follow-Up Studies; Galactorrhea; Humans; Hypophysectomy; Pituitary Neoplasms; Pregnancy; Prolactin; Sella Turcica; Tomography, X-Ray Computed; Visual Fields | 1986 |
Mechanisms of action of inhibitors of prolactin secretion in GH3 pituitary cells. I. Ca2+-dependent inhibition of amino acid incorporation.
Topics: Acetylcholine; Amino Acids; Animals; Bromocriptine; Calcium; Carbachol; Cell Line; Chlorpromazine; Imidazoles; Magnesium; Nifedipine; Pituitary Neoplasms; Prolactin; Protein Processing, Post-Translational; Rats; Trifluoperazine; Verapamil | 1986 |
[Follow-up of a pediatric prolactin-producing hypophyseal tumor].
Topics: Adenoma; Adolescent; Bromocriptine; Child; Combined Modality Therapy; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1986 |
Osteoporosis in men with hyperprolactinemic hypogonadism.
Topics: Adenoma; Adult; Aged; Bone and Bones; Bromocriptine; Follow-Up Studies; Forearm; Humans; Hyperprolactinemia; Hypogonadism; Lumbar Vertebrae; Male; Middle Aged; Minerals; Osteoporosis; Pituitary Neoplasms; Radionuclide Imaging; Testosterone | 1986 |
Depot-bromocriptine treatment for prolactinomas and acromegaly.
Topics: Acromegaly; Adolescent; Adult; Aged; Bromocriptine; Delayed-Action Preparations; Female; Growth Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1986 |
Long-lasting suppression of prolactin secretion and rapid shrinkage of prolactinomas after a long-acting, injectable form of bromocriptine.
Topics: Adolescent; Adult; Bromocriptine; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Male; Microspheres; Middle Aged; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed; Visual Fields | 1986 |
Pituitary tumour causing gigantism. Morphology and in vitro hormone secretion.
Topics: Adolescent; Bromocriptine; Gigantism; Growth Hormone; Humans; Kinetics; Male; Organ Culture Techniques; Pituitary Neoplasms; Prolactin; Testosterone | 1986 |
Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1986 |
Discordant responses of prolactinoma to two different dopamine agonists.
Topics: Adult; Bromocriptine; Drug Resistance; Ergolines; Female; Humans; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1986 |
Ultrastructural morphometry of prolactin secreting adenomas treated with dopamine agonists.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Cell Nucleolus; Cell Nucleus; Dopamine; Endoplasmic Reticulum; Ergolines; Ergot Alkaloids; Exocytosis; Female; Humans; Lisuride; Male; Mitochondria; Organoids; Pituitary Neoplasms; Prolactin | 1986 |
Treatment of prolactinoma based on the results of transsphenoidal operations.
Topics: Adolescent; Adult; Aged; Amenorrhea; Bromocriptine; Child; Female; Humans; Hypopituitarism; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Postoperative Complications; Prolactin; Sphenoid Bone | 1986 |
Bromocriptine treatment of prolactin secreting macroadenomas: a radiological, ophthalmological and endocrinological study.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Hypogonadism; Hypothyroidism; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed; Visual Acuity | 1986 |
Transient intrasellar collection of air during bromocriptine treatment of a prolactinoma.
Topics: Adult; Air; Bone Diseases; Bromocriptine; Humans; Male; Pituitary Neoplasms; Prolactin; Sella Turcica; Tomography, X-Ray Computed | 1986 |
The management of hyperprolactinaemia.
Topics: Bromocriptine; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Tomography, X-Ray Computed | 1986 |
Dopamine agonists for reducing depression associated with hyperprolactinemia.
Topics: Analysis of Variance; Bromocriptine; Depression; Depressive Disorder; Drug Evaluation; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Prolactin | 1986 |
Ultrastructural localization of prolactin in the human pituitary prolactinomas and its changes by bromocriptine treatment.
Topics: Bromocriptine; Histocytochemistry; Humans; Immunochemistry; Microscopy, Electron; Pituitary Neoplasms; Prolactin | 1986 |
Ultrastructural localization of prolactin in estrogen-induced prolactinoma of the rat pituitary. Experimental models for the human prolactinomas and the effects of bromocriptine.
Topics: Animals; Bromocriptine; Estrogens; Female; Histocytochemistry; Immunochemistry; Microscopy, Electron; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains | 1986 |
Long-term bromocriptine treatment for prolactin-secreting macroadenoma.
Topics: Adolescent; Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactin; Time Factors | 1986 |
Differences in the interaction between dopamine and estradiol on prolactin release by cultured normal and tumorous human pituitary cells.
Topics: Aged; Aged, 80 and over; Bromocriptine; Cells, Cultured; Dopamine; Estradiol; Female; Humans; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Tamoxifen | 1986 |
Pregnancy after treatment in patients with prolactinoma: operation versus bromocriptine.
Topics: Adult; Bromocriptine; Female; Follow-Up Studies; Humans; Microsurgery; Pituitary Neoplasms; Pregnancy; Prolactin; Retrospective Studies | 1986 |
Management of prolactinomas--1986.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1986 |
Parenteral bromocriptine in the treatment of hormonally active pituitary tumours.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Aged; Bromocriptine; Female; Growth Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1986 |
Failure of prophylactic surgery to avert massive pituitary expansion in pregnancy.
Topics: Bromocriptine; Female; Humans; Pituitary Gland; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1986 |
Treatment options in the management of prolactin-secreting pituitary tumors.
Topics: Bromocriptine; Combined Modality Therapy; Humans; Neoplasm Staging; Pituitary Neoplasms; Prognosis; Prolactin | 1986 |
Sensitive and specific bromocriptine radioimmunoassay with iodine label: measurement of bromocriptine in human plasma.
Topics: Adenoma; Bromocriptine; Humans; Iodine Radioisotopes; Pituitary Neoplasms; Prolactin; Radioimmunoassay | 1986 |
[Therapeutic effect of small doses of bromocriptine on prolactinoma].
Topics: Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactin | 1986 |
Advances in diagnosis and treatment of pituitary tumors.
Topics: Bromocriptine; Combined Modality Therapy; Costs and Cost Analysis; Female; Humans; Magnetic Resonance Spectroscopy; Neurosecretory Systems; Pituitary Neoplasms; Pregnancy; Tomography, X-Ray Computed; Vision, Ocular; Visual Fields | 1986 |
[Growth hormone-producing pituitary adenoma in an 8-year-old girl: case report].
Topics: Adenoma; Bromocriptine; Child; Female; Growth Hormone; Humans; Pituitary Neoplasms | 1986 |
Pituitary tumours: surgery or medical shrinkage.
Topics: Bromocriptine; Combined Modality Therapy; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1986 |
[Histological changes and operative findings of pituitary adenomas after bromocriptine treatment].
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin | 1986 |
[Effect of tamoxifen on the treatment of pituitary adenomas with bromocriptine].
Topics: Adenoma; Adenoma, Chromophobe; Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tamoxifen | 1987 |
In-vitro effects of bromocriptine on isolated pituitary adenoma cells. Ultrastructural and morphometrical studies.
Topics: Adenoma; Adult; Aged; Bromocriptine; Female; Growth Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Subcellular Fractions | 1985 |
Management of extra-sellar pituitary tumours with bromocriptine: comparison of prolactin secreting and non-functioning tumours using half-field visual evoked potentials and computerised tomography.
Topics: Adult; Bromocriptine; Evoked Potentials, Visual; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prospective Studies; Sella Turcica; Tomography, X-Ray Computed | 1985 |
Bromocriptine-related psychosis and treatment.
Topics: Adult; Bromocriptine; Female; Haloperidol; Humans; Pituitary Neoplasms; Prolactin; Psychoses, Substance-Induced; Substance Withdrawal Syndrome; Valproic Acid | 1985 |
Immunofluorescence demonstration of tubulin and actin in estrogen-induced rat prolactinoma cells in vitro. Alteration of their distribution after bromocriptine, colchicine and cytochalasin B treatments.
Topics: Actins; Adenoma; Animals; Bromocriptine; Cells, Cultured; Colchicine; Cytochalasin B; Estradiol; Female; Fluorescent Antibody Technique; Microtubule Proteins; Neoplasm Proteins; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains; Tubulin | 1985 |
[Evolution of prolactinomas during and after medical treatment].
Topics: Adenoma; Bromocriptine; Humans; Pituitary Neoplasms; Prolactin | 1985 |
Time course of induction of prolactin-secreting pituitary tumors with diethylstilbestrol in male rats: response of tuberoinfundibular dopaminergic neurons.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Bromocriptine; Diethylstilbestrol; Dihydroxyphenylalanine; Dopamine; Hypothalamus; Kinetics; Male; Median Eminence; Neurons; Organ Size; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred F344; Seminal Vesicles; Testis; Testosterone; Tuber Cinereum | 1985 |
Long term suppression of prolactin concentrations after bromocriptine induced regression of pituitary prolactinomas.
Topics: Adult; Bromocriptine; Female; Follow-Up Studies; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1985 |
Differential effects of extracellular matrix on secretion of prolactin and growth hormone by rat pituitary tumour cells in vitro.
Topics: Animals; Bromocriptine; Cell Division; Cell Line; Cornea; DNA, Neoplasm; Endothelium; Extracellular Matrix; Growth Hormone; Neoplasm Proteins; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains; Thyrotropin-Releasing Hormone | 1985 |
Bromocriptine treatment of microprolactinomas: evidence of stable prolactin decrease after drug withdrawal.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Domperidone; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone; Time Factors; Tomography, X-Ray Computed | 1985 |
Prolactinomas in men: clinical characteristics and the effect of bromocriptine treatment.
Topics: Adult; Aged; Bromocriptine; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Radiography; Sella Turcica; Testosterone; Visual Field Tests | 1985 |
Presence of high affinity dopamine receptors in estrone-induced, prolactin-secreting rat pituitary adenomas: a model for human prolactinomas.
Topics: Adenoma; Animals; Bromocriptine; Disease Models, Animal; Dopamine; Estrone; Female; Guanosine Triphosphate; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred F344; Receptors, Dopamine; Thyrotropin-Releasing Hormone | 1985 |
Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Growth Hormone; Guanfacine; Guanidines; Humans; Immunochemistry; Middle Aged; Phenylacetates; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone | 1985 |
Serum gonadotrophin pulsatile secretion in men with Prl-secreting and non-secreting pituitary tumours.
Topics: Adenoma; Adult; Bromocriptine; Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Testosterone | 1985 |
[Drug therapy of hypophyseal tumors].
Topics: Acromegaly; Bromocriptine; Combined Modality Therapy; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Long-Term Care; Luteinizing Hormone; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Receptors, Dopamine | 1985 |
Long-term bromocriptine therapy may restore the inhibitory control of prolactin release in some patients with pathological hyperprolactinemia.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Male; Metoclopramide; Middle Aged; Pituitary Function Tests; Pituitary Neoplasms; Pregnancy; Prolactin; Thyrotropin-Releasing Hormone; Time Factors | 1985 |
Drugs that induce ovulation.
Topics: Adenoma; Anovulation; Bromocriptine; Clomiphene; Female; Gonadotropin-Releasing Hormone; Humans; Menotropins; Ovulation Induction; Pituitary Neoplasms; Prolactin | 1985 |
[Primary hyperprolactinemic amenorrhea. Report of 4 patients].
Topics: Adenoma; Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Luteinizing Hormone; Menstrual Cycle; Pituitary Hormone-Releasing Hormones; Pituitary Neoplasms; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone | 1985 |
[Results of endocrinologic diagnosis in sterility patients. A clinical report of experiences].
Topics: Adenoma; Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Hyperprolactinemia; Infertility, Female; Menstruation Disturbances; Oligomenorrhea; Pituitary Neoplasms; Pregnancy; Prolactin; Testosterone | 1985 |
Hormonal regulation of prolactin release by human prolactinoma cells cultured in serum-free conditions.
Topics: Adenoma; Bromocriptine; Cell Line; Cell Survival; Cells, Cultured; Cholera Toxin; Culture Media; Estradiol; Female; Humans; Kinetics; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone; Triiodothyronine | 1985 |
Increased thyroid-stimulating hormone response to thyrotropin-releasing hormone in hyperprolactinemic women.
Topics: Adenoma; Adult; Bromocriptine; Female; Follicular Phase; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine | 1985 |
Management of prolactinomas. A reappraisal.
Topics: Adenoma; Bromocriptine; Ergolines; Female; Humans; Lisuride; Metergoline; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Radiotherapy Dosage; Radiotherapy, High-Energy; Time Factors | 1985 |
Hyperprolactinemia. Its relation to galactorrhea, amenorrhea, pituitary tumor and its management.
Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Lactation Disorders; Middle Aged; Pituitary Neoplasms; Prolactin | 1985 |
Syndrome of inappropriate antidiuresis in the absence of arginine vasopressin.
Topics: Adult; Arginine Vasopressin; Bromocriptine; Craniopharyngioma; Growth Hormone; Humans; Hydrocortisone; Inappropriate ADH Syndrome; Luteinizing Hormone; Male; Pituitary Neoplasms; Prolactin; Thyroxine | 1986 |
Cytosuppressive effect of bromocriptine on human prolactinomas: stereological analysis of ultrastructural alterations with special reference to secretory granules.
Topics: Adenoma; Adult; Bromocriptine; Cytoplasmic Granules; Endoplasmic Reticulum; Exocytosis; Female; Golgi Apparatus; Humans; Male; Microscopy, Electron; Middle Aged; Pituitary Neoplasms; Prolactin | 1986 |
Inhibition of human chorionic gonadotropin production by prolactin from term human trophoblast.
Topics: Adult; Animals; Bromocriptine; Chorionic Gonadotropin; Culture Techniques; Female; Humans; Pituitary Neoplasms; Placenta; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Sheep | 1986 |
Current concepts in acromegaly: etiology, diagnosis, and treatment.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Female; Glucose Tolerance Test; Growth Hormone; Humans; Male; Pituitary Neoplasms | 1986 |
Extrasellar prolactinomas: successful management of 24 patients using bromocriptine.
Topics: Adult; Bromocriptine; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Pituitary Function Tests; Pituitary Neoplasms; Pregnancy; Prolactin; Tomography, X-Ray Computed; Visual Fields | 1986 |
[Hyperprolactinemia].
Topics: Adenoma; Adult; Bromocriptine; Combined Modality Therapy; Female; Hormones; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1986 |
[Large prolactinomas treated with bromocriptine].
Topics: Adult; Aged; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed; Visual Fields | 1986 |
Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases.
Topics: Biological Assay; Brain Neoplasms; Bromocriptine; Combined Modality Therapy; Ergolines; Female; Histocytochemistry; Hormones; Humans; Microscopy, Electron; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Pergolide; Pituitary Neoplasms; Prolactin | 1985 |
Recurrent prolactinoma and meningioma following irradiation and bromocriptine treatment.
Topics: Adult; Bromocriptine; Humans; Male; Meningioma; Neoplasms, Radiation-Induced; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1985 |
Immunomodulation in rats by transplantable anterior pituitary tumors.
Topics: Adenoma; Animals; Antibody Formation; Bromocriptine; Dinitrochlorobenzene; Female; Growth Hormone; Hypophysectomy; Neoplasm Transplantation; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains; Rats, Inbred WF | 1985 |
Prolactin levels in pregnancy: comparison of normal subjects with patients having micro- or macroadenomas after early bromocriptine withdrawal.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Infertility, Female; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1985 |
Bioactive forms of serum lactogens: effects of treatment of prolactinoma patients with bromocriptine.
Topics: Adenoma; Adult; Biological Assay; Bromocriptine; Chromatography, DEAE-Cellulose; Chromatography, Gel; Female; Growth Hormone; Humans; Pituitary Neoplasms; Prolactin; Radioimmunoassay | 1985 |
Rapid enlargement of non-functioning pituitary tumour following withdrawal of bromocriptine.
Topics: Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactin; Substance Withdrawal Syndrome | 1985 |
Drugs in pregnancy: assessment of Parlodel.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Amenorrhea; Bromocriptine; Female; Follow-Up Studies; Galactorrhea; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy, Multiple; Prolactin; Risk | 1985 |
[Impotentia coeundi in prolactinoma].
Topics: Bromocriptine; Combined Modality Therapy; Erectile Dysfunction; Humans; Hypophysectomy; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Testosterone | 1985 |
Bromocriptine therapy as pre-operative adjunct of non-functional pituitary macroadenomas.
Topics: Adenoma; Adult; Bromocriptine; Cytoplasmic Granules; Endoplasmic Reticulum; Female; Golgi Apparatus; Humans; Male; Middle Aged; Mitochondria; Organoids; Pituitary Neoplasms; Preoperative Care | 1985 |
Bromocriptine-induced removal of endoplasmic membranes from prolactinoma cells.
Topics: Adenoma; Bromocriptine; Endoplasmic Reticulum; Golgi Apparatus; Humans; Intracellular Membranes; Pituitary Neoplasms; Prolactin | 1985 |
Effects of chronic bromocriptine treatment of an estrone-induced, prolactin-secreting rat pituitary adenoma.
Topics: Adenoma; Animals; Bromocriptine; Dopamine; Estrone; Female; Microscopy, Electron; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred F344; Receptors, Dopamine | 1985 |
Relationship between maternal prolactin levels during pregnancy and lactation in women with pituitary adenoma.
Topics: Adenoma; Adult; Bromocriptine; Combined Modality Therapy; Female; Fetal Blood; Humans; Hypophysectomy; Lactation; Pituitary Neoplasms; Postpartum Period; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1985 |
Effects of bromocriptine on prolactin-secreting pituitary adenomas. Mechanism of reduction in tumor size evaluated by light and electron microscopic, immunohistochemical, and morphometric analysis.
Topics: Adenoma; Adult; Bromocriptine; Cell Nucleus; Cytoplasm; Drug Administration Schedule; Female; Histocytochemistry; Humans; Immunochemistry; Male; Microscopy, Electron; Middle Aged; Necrosis; Pituitary Neoplasms; Prolactin | 1985 |
Return of menstruation and normalization of prolactin in hyperprolactinemic women with bromocriptine-induced pregnancy.
Topics: Adult; Bromocriptine; Female; Follow-Up Studies; Humans; Infertility, Female; Menstruation; Ovulation Induction; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1985 |
[Hyperprolactinemia and ovulatory dysfunction].
Topics: Adult; Anovulation; Bromocriptine; Female; Humans; Levodopa; Pituitary Neoplasms; Prolactin | 1985 |
Pituitary apoplexy in an acromegalic patient during bromocriptine therapy. Case report.
Topics: Adenoma; Bromocriptine; Cerebrovascular Disorders; Endocrine Glands; Female; Growth Hormone; Humans; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Tomography, X-Ray Computed | 1985 |
Low doses of dopamine agonists in the long-term treatment of macroprolactinomas.
Topics: Adenoma; Adult; Aged; Bromocriptine; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Radiography; Receptors, Dopamine | 1985 |
Cerebrospinal fluid rhinorrhea during treatment with bromocriptine for prolactinoma.
Topics: Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Humans; Hypophysectomy; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Sella Turcica; Tomography, X-Ray Computed | 1985 |
[Prolactin producing hypophyseal adenoma: diagnosis and therapeutic possibilities].
Topics: Adenoma; Adult; Bromocriptine; Combined Modality Therapy; Female; Humans; Male; Pituitary Neoplasms; Prolactin | 1985 |
Dramatic and rapid shrinkage of a massive invasive prolactinoma with bromocriptine: a case report.
Topics: Bromocriptine; Female; Humans; Middle Aged; Pituitary Neoplasms; Prolactin; Time Factors | 1985 |
The effect of dopamine agonist therapy on large functionless pituitary tumours.
Topics: Adenoma, Chromophobe; Adult; Bromocriptine; Dopamine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prospective Studies | 1985 |
The electrical properties of isolated human prolactin-secreting adenoma cells and their modification by dopamine.
Topics: Adenoma; Bromocriptine; Domperidone; Dopamine; Dose-Response Relationship, Drug; Electrophysiology; Flupenthixol; Haloperidol; Humans; In Vitro Techniques; Membrane Potentials; Phenethylamines; Pituitary Neoplasms; Prolactin; Receptors, Dopamine; Spiperone; Time Factors | 1985 |
Delayed puberty and hypoplastic uterus associated with hyperprolactinemia: successful treatment with bromocriptine.
Topics: Adenoma; Adolescent; Amenorrhea; Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactin; Puberty, Delayed; Ultrasonics; Uterus | 1985 |
Bromocriptine effects on cultured human prolactin-producing pituitary adenomas: in vitro ultrastructural, morphometric, and immunoelectron microscopic studies.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Cells, Cultured; Female; Histocytochemistry; Humans; Immunochemistry; Male; Microscopy, Electron; Pituitary Neoplasms | 1985 |
Effect of chronic bromocriptine administration on tumor size in patients with "nonsecreting" pituitary adenomas.
Topics: Adenoma; Adult; Aged; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Time Factors; Tomography, X-Ray Computed; Vision, Ocular; Visual Fields | 1985 |
Microprolactinoma and large prolactinoma: are they two different diseases.
Topics: Bromocriptine; Diagnosis, Differential; Humans; Pituitary Neoplasms; Prolactin | 1985 |
[Functional hyperprolactinemia].
Topics: Adenoma; Bromocriptine; Female; Humans; Pituitary Diseases; Pituitary Neoplasms; Prolactin | 1985 |
[Bromocriptine treatment of hyperprolactinemia].
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pituitary Neoplasms; Pregnancy; Prolactin; Tomography, X-Ray Computed | 1985 |
[Bromocriptine therapy of prolactinoma in pregnancy].
Topics: Adenoma; Adult; Bromocriptine; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1985 |
[Hyperprolactinemia and its treatment (analysis of 107 cases)].
Topics: Adenoma, Chromophobe; Adolescent; Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin | 1985 |
[Bromocriptine in the treatment of galactorrhea with anovulation; report of 53 cases].
Topics: Adult; Anovulation; Bromocriptine; Female; Galactorrhea; Humans; Lactation Disorders; Pituitary Neoplasms; Pregnancy; Prolactin | 1985 |
[A case of male prolactinoma presenting extremely high serum prolactin levels and biphasic response to CB-154 suppression test].
Topics: Adenoma; Adult; Bromocriptine; Humans; Male; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1985 |
Co-existing prolactinoma with primary empty sella.
Topics: Adult; Bromocriptine; Empty Sella Syndrome; Female; Humans; Pituitary Neoplasms; Pregnancy; Prolactin | 1985 |
Concurrent use of bromocriptine and fluphenazine.
Topics: Adenoma, Chromophobe; Bromocriptine; Drug Interactions; Drug Therapy, Combination; Fluphenazine; Humans; Male; Middle Aged; Pituitary Neoplasms; Psychotic Disorders | 1985 |
Spontaneous sparsely-granulated prolactin-producing pituitary adenomas in aging rats. A prospective study of the effect of bromocriptine.
Topics: Adenoma; Age Factors; Animals; Bromocriptine; Cytoplasmic Granules; Female; Microscopy, Electron; Organ Size; Pituitary Neoplasms; Prolactin; Prospective Studies; Rats; Rats, Inbred Strains | 1985 |
Management of pituitary gigantism. The role of bromocriptine and radiotherapy.
Topics: Body Height; Bromocriptine; Child; Gigantism; Growth Hormone; Humans; Male; Pituitary Neoplasms; Prolactin | 1985 |
Hormonal and morphologic effects of bromocriptine on normal rat pituitary and GH3 tumor cells.
Topics: Animals; Bromocriptine; Cell Count; Cell Line; Depression, Chemical; Female; Growth Hormone; Microscopy, Electron; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains | 1985 |
Establishment and characterization of a new human cultured cell line from a prolactin-secreting pituitary adenoma.
Topics: Adenoma; Bromocriptine; Cell Division; Cell Line; Cimetidine; Estradiol; Humans; Pituitary Neoplasms; Prolactin | 1985 |
Mosaic Turner's syndrome and pituitary microadenoma.
Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Mosaicism; Pituitary Hormones, Anterior; Pituitary Neoplasms; Prolactin; Turner Syndrome | 1985 |
Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas treated with bromocriptine.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Diagnosis, Differential; Female; Galactorrhea; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin | 1985 |
Interactions of steroids with prolactin secretion in vitro.
Topics: Bromocriptine; Cells, Cultured; Dopamine; Estradiol; Humans; Kinetics; Pituitary Gland; Pituitary Neoplasms; Prolactin; Steroids; Tamoxifen | 1985 |
Hyperprolactinemia and sexual function in men.
Topics: Adenoma; Adult; Bromocriptine; Erectile Dysfunction; Follow-Up Studies; Humans; Hyperprolactinemia; Male; Middle Aged; Penile Erection; Pituitary Neoplasms; Prolactin; Psychotherapy; Sex | 1985 |
Which treatment for hyperprolactinemic females?
Topics: Adenoma; Bromocriptine; Female; Humans; Hyperprolactinemia; Ovary; Pituitary Neoplasms; Risk | 1985 |
Medical treatment of hyperprolactinemia.
Topics: Adenoma; Bromocriptine; Drug Resistance; Female; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Prognosis; Prolactin; Reference Values | 1985 |
Follow-up of children born of bromocriptine-treated mothers.
Topics: Adenoma; Birth Weight; Bromocriptine; Child Development; Female; Follow-Up Studies; Humans; Infant, Newborn; Male; Maternal-Fetal Exchange; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, First; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Time Factors | 1985 |
Prolactinoma during pregnancy causing compression symptoms responding to bromocriptine therapy.
Topics: Adult; Bromocriptine; Constriction, Pathologic; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1985 |
Effects of bromocriptine on hormone production and cell growth in cultured rat pituitary cells.
Topics: Adenoma; Animals; Bromocriptine; Cell Division; Cell Line; Cell Survival; Growth Hormone; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Rats | 1985 |
Inhibition by 2-bromo-alpha-ergocriptine and tamoxifen of the growth of an estrogen-dependent transplantable pituitary tumor (MtT/F84) in F344 rats.
Topics: Animals; Bromocriptine; Dose-Response Relationship, Drug; Estradiol; Female; Neoplasm Transplantation; Pituitary Neoplasms; Rats; Rats, Inbred F344; Receptors, Dopamine; Receptors, Estrogen; Tamoxifen | 1985 |
Assessment by computed tomography of the response of pituitary macroadenomas to bromocriptine.
Topics: Adenoma; Adult; Aged; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Tomography, X-Ray Computed | 1985 |
Visual function in prolactinoma patients treated with bromocriptine.
Topics: Adult; Aged; Bromocriptine; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Vision, Ocular; Visual Acuity; Visual Fields | 1985 |
[Hyperprolactinemia and pregnancy].
Topics: Adenoma; Bromocriptine; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Pregnancy; Pregnancy Complications | 1985 |
[Permanent remission of a macroprolactinoma after treatment with bromocriptine].
Topics: Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactin | 1985 |
Changes in computed tomographic findings in microprolactinomas before and after bromocriptine.
Topics: Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1985 |
Effects of bromocriptine on cell cycle distribution and cell morphology in cultured rat pituitary adenoma cells.
Topics: Adenoma; Animals; Autoradiography; Bromocriptine; Cell Cycle; Cell Line; Cells, Cultured; DNA; Flow Cytometry; Mitosis; Pituitary Neoplasms; Rats | 1985 |
Treatment of galactorrhea-amenorrhea.
Topics: Adenoma; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Lactation Disorders; Pituitary Neoplasms | 1985 |
[Current status of gynecologic hormone therapy. Prolactin-induced disorders].
Topics: Adenoma; Bromocriptine; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Infertility, Female; Luteinizing Hormone; Pituitary Neoplasms; Pregnancy; Prolactin | 1985 |
[Results of treatment in the hyperprolactinemic anovulatory syndrome].
Topics: Adenoma; Adolescent; Adult; Anovulation; Bromocriptine; Combined Modality Therapy; Female; Humans; Infertility, Female; Pituitary Neoplasms; Pregnancy; Prognosis; Prolactin | 1985 |
[Results of bromocriptine treatment of giant or invasive prolactin adenomas. Apropos of 20 cases].
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Time Factors | 1985 |
[Results of different types of treatment in prolactin adenoma].
Topics: Adenoma; Bromocriptine; Ergolines; Female; Humans; Male; Metergoline; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1985 |
A case of hypophyseal prolactinoma with treatable delusions of dermatozoiasis.
Topics: Aged; Bromocriptine; Delusions; Female; Haloperidol; Humans; Hypochondriasis; Insecta; Pituitary Neoplasms; Prolactin | 1985 |
Original articles.
Topics: Adenoma, Chromophobe; Adolescent; Adult; Aged; Bromocriptine; Female; Humans; Hypoglycemia; Levodopa; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin; Radioimmunoassay | 1974 |